<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>drug discovery</title>
		<link>https://biospectrumasia.com/rssfeed/pharma/drug%20discovery</link>
		<atom:link href="https://biospectrumasia.com/rssfeed/pharma/drug%20discovery" rel="self" type="application/rss+xml" />
		<description>drug discovery</description>
					<item>
			<title>Korea&#039;s LOTTE Biologics secures major commercial manufacturing agreement ahead of Songdo Plant 1 launch</title>
			<atom:link href="https://biospectrumasia.com/news/34/28698/koreas-lotte-biologics-secures-major-commercial-manufacturing-agreement-ahead-of-songdo-plant-1-launch.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28698/koreas-lotte-biologics-secures-major-commercial-manufacturing-agreement-ahead-of-songdo-plant-1-launch.html</link>
			<pubDate>Wed, 18 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-28698.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28698/koreas-lotte-biologics-secures-major-commercial-manufacturing-agreement-ahead-of-songdo-plant-1-launch.html</guid>
		</item>	
				<item>
			<title>Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/28699/sino-biological-launches-4rise-high-throughput-wet-lab-services-to-accelerate-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28699/sino-biological-launches-4rise-high-throughput-wet-lab-services-to-accelerate-ai-driven-drug-discovery.html</link>
			<pubDate>Tue, 17 Nov 2026 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28699/sino-biological-launches-4rise-high-throughput-wet-lab-services-to-accelerate-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Exploring the links between metabolic health, ageing and cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html</link>
			<pubDate>Tue, 17 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_edition__oncology_leaders_300kb-28686.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28686/exploring-the-links-between-metabolic-health-ageing-and-cancer.html</guid>
		</item>	
				<item>
			<title>At AI4Sci, Nobel laureates Fred Ramsdell and Sir Konstantin Novoselov explore healthcare’s next frontier</title>
			<atom:link href="https://biospectrumasia.com/news/34/28670/at-ai4sci-nobel-laureates-fred-ramsdell-and-sir-konstantin-novoselov-explore-healthcares-next-frontier.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28670/at-ai4sci-nobel-laureates-fred-ramsdell-and-sir-konstantin-novoselov-explore-healthcares-next-frontier.html</link>
			<pubDate>Thu, 12 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia__visionary_science_leaders_300kb-28670.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28670/at-ai4sci-nobel-laureates-fred-ramsdell-and-sir-konstantin-novoselov-explore-healthcares-next-frontier.html</guid>
		</item>	
				<item>
			<title>Laboratoires Pierre Fabre and XtalPi announce AI-driven collaboration focused on drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/28657/laboratoires-pierre-fabre-and-xtalpi-announce-ai-driven-collaboration-focused-on-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28657/laboratoires-pierre-fabre-and-xtalpi-announce-ai-driven-collaboration-focused-on-drug-discovery.html</link>
			<pubDate>Mon, 09 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_9_11_2026_231859_img_magnific_com-28657.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28657/laboratoires-pierre-fabre-and-xtalpi-announce-ai-driven-collaboration-focused-on-drug-discovery.html</guid>
		</item>	
				<item>
			<title>L’Oréal-UNESCO For Women in Science awards emerging Singapore researchers shaping the future of science</title>
			<atom:link href="https://biospectrumasia.com/news/34/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html</link>
			<pubDate>Fri, 06 Nov 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/img_300kb-28653.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28653/loral-unesco-for-women-in-science-awards-emerging-singapore-researchers-shaping-the-future-of-science.html</guid>
		</item>	
				<item>
			<title>SG Austria/Austrianova announces peer-reviewed publication on implanted Cell-in-a-Box encapsulated cells for sustained delivery of anti-ageing protein Klotho</title>
			<atom:link href="https://biospectrumasia.com/news/34/28615/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28615/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html</link>
			<pubDate>Fri, 30 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/austrianova_transparent_1-28615.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28615/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html</guid>
		</item>	
				<item>
			<title>SG Austria/Austrianova announces peer-reviewed publication on implanted Cell-in-a-Box encapsulated cells for sustained delivery of anti-ageing protein Klotho</title>
			<atom:link href="https://biospectrumasia.com/news/34/28616/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28616/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html</link>
			<pubDate>Fri, 30 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/austrianova_transparent_1-28616.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28616/sg-austria-austrianova-announces-peer-reviewed-publication-on-implanted-cell-in-a-box-encapsulated-cells-for-sustained-delivery-of-anti-ageing-protein-klotho.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma inks $400 M deal with AI Proteins to develop novel miniprotein-based therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html</link>
			<pubDate>Mon, 26 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28576.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28576/japans-astellas-pharma-inks-400-m-deal-with-ai-proteins-to-develop-novel-miniprotein-based-therapeutics.html</guid>
		</item>	
				<item>
			<title>HighTide presents preclinical HTD1801 findings in polycystic kidney disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/28582/hightide-presents-preclinical-htd1801-findings-in-polycystic-kidney-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28582/hightide-presents-preclinical-htd1801-findings-in-polycystic-kidney-disease.html</link>
			<pubDate>Mon, 26 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1792746889_img_hightide_therapeutics_logo_300kb-28582.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28582/hightide-presents-preclinical-htd1801-findings-in-polycystic-kidney-disease.html</guid>
		</item>	
				<item>
			<title>NUS researchers identify how ovarian tissue stiffness can impair egg development</title>
			<atom:link href="https://biospectrumasia.com/news/34/28572/nus-researchers-identify-how-ovarian-tissue-stiffness-can-impair-egg-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28572/nus-researchers-identify-how-ovarian-tissue-stiffness-can-impair-egg-development.html</link>
			<pubDate>Thu, 22 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nus_logo_full_horizontal-28572.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28572/nus-researchers-identify-how-ovarian-tissue-stiffness-can-impair-egg-development.html</guid>
		</item>	
				<item>
			<title>ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html</link>
			<pubDate>Wed, 14 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-28514.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28514/itochu-corp-signs-capital-alliance-agreement-with-molcure-inc-for-ai-based-drug-discovery-in-japan.html</guid>
		</item>	
				<item>
			<title>Beyond Patent Expiry: Rethinking the Future of Mature Medicines in Asia-Pacific</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/28524/beyond-patent-expiry-rethinking-the-future-of-mature-medicines-in-asia-pacific.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/28524/beyond-patent-expiry-rethinking-the-future-of-mature-medicines-in-asia-pacific.html</link>
			<pubDate>Wed, 14 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_dr_varun_sethi_under_400kb-28524.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/28524/beyond-patent-expiry-rethinking-the-future-of-mature-medicines-in-asia-pacific.html</guid>
		</item>	
				<item>
			<title>Open for Trials, Open for Deals: Japan Rewrites Its Biotech Playbook</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html</link>
			<pubDate>Wed, 14 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cb670735_302d_408c_82e4_41f6af342377-28530.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/28530/open-for-trials-open-for-deals-japan-rewrites-its-biotech-playbook.html</guid>
		</item>	
				<item>
			<title>AI drug discovery must deliver repeatable value beyond hype: Insilico Medicine’s Feng Ren</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html</link>
			<pubDate>Tue, 13 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_feng_ren_2_300kb-28519.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/28519/ai-drug-discovery-must-deliver-repeatable-value-beyond-hype-insilico-medicines-feng-ren.html</guid>
		</item>	
				<item>
			<title>Everest Medicines announces NMPA acceptance of LEROCHOL BLA for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</link>
			<pubDate>Mon, 12 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/everest_medicines_500-28506.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28506/everest-medicines-announces-nmpa-acceptance-of-lerochol-bla-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>Sartorius, MAbSilico join forces to accelerate AI-driven cell line development</title>
			<atom:link href="https://biospectrumasia.com/news/34/28468/sartorius-mabsilico-join-forces-to-accelerate-ai-driven-cell-line-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28468/sartorius-mabsilico-join-forces-to-accelerate-ai-driven-cell-line-development.html</link>
			<pubDate>Fri, 02 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28468.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28468/sartorius-mabsilico-join-forces-to-accelerate-ai-driven-cell-line-development.html</guid>
		</item>	
				<item>
			<title>High-salt diet may drive fatty liver disease differently in lean people: Duke-NUS pre-clinical study</title>
			<atom:link href="https://biospectrumasia.com/news/34/28466/high-salt-diet-may-drive-fatty-liver-disease-differently-in-lean-people-duke-nus-pre-clinical-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28466/high-salt-diet-may-drive-fatty-liver-disease-differently-in-lean-people-duke-nus-pre-clinical-study.html</link>
			<pubDate>Thu, 01 Oct 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nus_cover_image_schools_duke_nus-28466.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28466/high-salt-diet-may-drive-fatty-liver-disease-differently-in-lean-people-duke-nus-pre-clinical-study.html</guid>
		</item>	
				<item>
			<title>Bhutan to develop Molecular Foundation Model for global diagnostics and drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/28452/bhutan-to-develop-molecular-foundation-model-for-global-diagnostics-and-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28452/bhutan-to-develop-molecular-foundation-model-for-global-diagnostics-and-drug-development.html</link>
			<pubDate>Tue, 29 Sep 2026 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_9_2026_12827_www_prnewswire_com-28452.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28452/bhutan-to-develop-molecular-foundation-model-for-global-diagnostics-and-drug-development.html</guid>
		</item>	
				<item>
			<title>Deep Origin deploys AI-powered ADMET models across drug discovery programmes</title>
			<atom:link href="https://biospectrumasia.com/news/34/28446/deep-origin-deploys-ai-powered-admet-models-across-drug-discovery-programmes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28446/deep-origin-deploys-ai-powered-admet-models-across-drug-discovery-programmes.html</link>
			<pubDate>Mon, 28 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28446.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28446/deep-origin-deploys-ai-powered-admet-models-across-drug-discovery-programmes.html</guid>
		</item>	
				<item>
			<title>Lundbeck wins Japan approval for Vyepti in migraine prevention</title>
			<atom:link href="https://biospectrumasia.com/news/34/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html</link>
			<pubDate>Mon, 21 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_9_2026_124344_www_bing_com-28398.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28398/lundbeck-wins-japan-approval-for-vyepti-in-migraine-prevention.html</guid>
		</item>	
				<item>
			<title>Japan approves LEQEMBI Pen for at-home treatment of early Alzheimer’s disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/28399/japan-approves-leqembi-pen-for-at-home-treatment-of-early-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28399/japan-approves-leqembi-pen-for-at-home-treatment-of-early-alzheimers-disease.html</link>
			<pubDate>Fri, 18 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_4_-28399.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28399/japan-approves-leqembi-pen-for-at-home-treatment-of-early-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech reports Phase III benefit for trastuzumab botidotin in HER2-positive breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html</link>
			<pubDate>Tue, 15 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_kelun_biotech_logo-28373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28373/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positive-breast-cancer.html</guid>
		</item>	
				<item>
			<title>NUS researchers use magnetic pulses to reprogram immune cells against breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/28374/nus-researchers-use-magnetic-pulses-to-reprogram-immune-cells-against-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28374/nus-researchers-use-magnetic-pulses-to-reprogram-immune-cells-against-breast-cancer.html</link>
			<pubDate>Tue, 15 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nus_logo_full_vertical_7b7-28374.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28374/nus-researchers-use-magnetic-pulses-to-reprogram-immune-cells-against-breast-cancer.html</guid>
		</item>	
				<item>
			<title>CMS begins clinical rollout of Silevimig, first bispecific antibody for rabies passive immunisation</title>
			<atom:link href="https://biospectrumasia.com/news/34/28358/cms-begins-clinical-rollout-of-silevimig-first-bispecific-antibody-for-rabies-passive-immunisation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28358/cms-begins-clinical-rollout-of-silevimig-first-bispecific-antibody-for-rabies-passive-immunisation.html</link>
			<pubDate>Thu, 10 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28358.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28358/cms-begins-clinical-rollout-of-silevimig-first-bispecific-antibody-for-rabies-passive-immunisation.html</guid>
		</item>	
				<item>
			<title>Ascletis starts US Phase I trial of oral amylin agonist ASC36 for obesity</title>
			<atom:link href="https://biospectrumasia.com/news/34/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html</link>
			<pubDate>Wed, 09 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5fd2c260_21c0_11ef_ad1f_e33a28dd5e74_ascletis_company_logo-28343.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28343/ascletis-starts-us-phase-i-trial-of-oral-amylin-agonist-asc36-for-obesity.html</guid>
		</item>	
				<item>
			<title>Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/28322/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28322/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cholestorol_16x9-28322.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28322/everest-medicines-lerochol-bla-accepted-in-china-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>Everest Medicines wins China approval for CARDAMYST in acute PSVT</title>
			<atom:link href="https://biospectrumasia.com/news/34/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html</link>
			<pubDate>Mon, 07 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28335.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28335/everest-medicines-wins-china-approval-for-cardamyst-in-acute-psvt.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma enters into drug discovery partnership with Aitia for neurological diseases treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html</link>
			<pubDate>Fri, 04 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_9_2026_164442_www_bing_com-28319.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28319/japans-ono-pharma-enters-into-drug-discovery-partnership-with-aitia-for-neurological-diseases-treatment.html</guid>
		</item>	
				<item>
			<title>Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28304.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28304/singapore-becomes-first-asean-market-to-subsidise-vutrisiran-for-transthyretin-amyloidosis.html</guid>
		</item>	
				<item>
			<title>Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30</title>
			<atom:link href="https://biospectrumasia.com/news/34/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html</link>
			<pubDate>Wed, 02 Sep 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28306.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28306/ascletis-doses-first-participant-in-global-phase-iii-trial-of-oral-glp-1-candidate-asc30.html</guid>
		</item>	
				<item>
			<title>Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand</title>
			<atom:link href="https://biospectrumasia.com/news/34/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2-28285.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28285/fosun-pharma-strengthens-innovation-pipeline-as-henlius-and-global-drug-portfolio-expand.html</guid>
		</item>	
				<item>
			<title>DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion</title>
			<atom:link href="https://biospectrumasia.com/news/34/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1967211931_header_1024x360-28287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28287/dualitybio-and-genentech-partner-on-next-generation-adcs-in-deal-worth-over-1-billion.html</guid>
		</item>	
				<item>
			<title>Formosa Pharma files European trial application for Kadcyla biosimilar TSY-110</title>
			<atom:link href="https://biospectrumasia.com/news/34/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</link>
			<pubDate>Mon, 31 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28288.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28288/formosa-pharma-files-european-trial-application-for-kadcyla-biosimilar-tsy-110.html</guid>
		</item>	
				<item>
			<title>Antengene receives Australian clearance for Phase I ATG-201 autoimmune disease trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28282.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28282/antengene-receives-australian-clearance-for-phase-i-atg-201-autoimmune-disease-trial.html</guid>
		</item>	
				<item>
			<title>Alebund advances renal pipeline as AP301 enters China regulatory review</title>
			<atom:link href="https://biospectrumasia.com/news/34/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html</link>
			<pubDate>Fri, 28 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1736499971658-28283.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28283/alebund-advances-renal-pipeline-as-ap301-enters-china-regulatory-review.html</guid>
		</item>	
				<item>
			<title>Shimadzu invests in OptQC to advance next-generation R&amp;D infrastructure for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html</link>
			<pubDate>Wed, 26 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_26_8_2026_13322_www_optqc_com-28263.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28263/shimadzu-invests-in-optqc-to-advance-next-generation-rd-infrastructure-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>ABio on developing LANFA as a next-generation alternative to PEG in drug delivery</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html</link>
			<pubDate>Tue, 25 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/koichi_yoshimi_abio_interview-28255.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/28255/abio-on-developing-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery.html</guid>
		</item>	
				<item>
			<title>Deep Origin explores combining AI and physics to improve virtual screening in drug discovery</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/28256/deep-origin-explores-combining-ai-and-physics-to-improve-virtual-screening-in-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/28256/deep-origin-explores-combining-ai-and-physics-to-improve-virtual-screening-in-drug-discovery.html</link>
			<pubDate>Tue, 25 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/garegin_papoian_deep_origin_interview-28256.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/28256/deep-origin-explores-combining-ai-and-physics-to-improve-virtual-screening-in-drug-discovery.html</guid>
		</item>	
				<item>
			<title>CureGene doses first participant in Phase I trial of liver-targeting CG-0416</title>
			<atom:link href="https://biospectrumasia.com/news/34/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28248.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28248/curegene-doses-first-participant-in-phase-i-trial-of-liver-targeting-cg-0416.html</guid>
		</item>	
				<item>
			<title>Akeso receives China clinical trial clearance for B7-H3 ADC AK157D1</title>
			<atom:link href="https://biospectrumasia.com/news/34/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html</link>
			<pubDate>Mon, 24 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/updated_akeso_logo_2_3-28250.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28250/akeso-receives-china-clinical-trial-clearance-for-b7-h3-adc-ak157d1.html</guid>
		</item>	
				<item>
			<title>Indian societies issue first joint consensus on personalised obesity management</title>
			<atom:link href="https://biospectrumasia.com/news/34/28237/indian-societies-issue-first-joint-consensus-on-personalised-obesity-management.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28237/indian-societies-issue-first-joint-consensus-on-personalised-obesity-management.html</link>
			<pubDate>Fri, 21 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ossi_esi_1_1_-28237.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28237/indian-societies-issue-first-joint-consensus-on-personalised-obesity-management.html</guid>
		</item>	
				<item>
			<title>Brown University Health and Arcamyra to launch Phase I trial of ACM-CpG in peritoneal carcinomatosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html</link>
			<pubDate>Thu, 20 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/26765_brown_university_health_logo-28229.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28229/brown-university-health-and-arcamyra-to-launch-phase-i-trial-of-acm-cpg-in-peritoneal-carcinomatosis.html</guid>
		</item>	
				<item>
			<title>Apodex launches TRACES benchmark to evaluate AI for scientific discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/28215/apodex-launches-traces-benchmark-to-evaluate-ai-for-scientific-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28215/apodex-launches-traces-benchmark-to-evaluate-ai-for-scientific-discovery.html</link>
			<pubDate>Tue, 18 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oyhc6r7oviaspknzvb8ac-28215.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28215/apodex-launches-traces-benchmark-to-evaluate-ai-for-scientific-discovery.html</guid>
		</item>	
				<item>
			<title>Ascletis begins two US Phase I studies of once-monthly obesity candidates</title>
			<atom:link href="https://biospectrumasia.com/news/34/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html</link>
			<pubDate>Thu, 13 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_6_-28191.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28191/ascletis-begins-two-us-phase-i-studies-of-once-monthly-obesity-candidates.html</guid>
		</item>	
				<item>
			<title>Dx&amp;Vx expands KRNA nucleic acid stabilisation programme into Latin America</title>
			<atom:link href="https://biospectrumasia.com/news/34/28192/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28192/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html</link>
			<pubDate>Thu, 13 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_7_-28192.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28192/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html</guid>
		</item>	
				<item>
			<title>Dx&amp;Vx expands KRNA nucleic acid stabilisation programme into Latin America</title>
			<atom:link href="https://biospectrumasia.com/news/34/28193/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28193/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html</link>
			<pubDate>Thu, 13 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_7_-28193.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28193/dxvx-expands-krna-nucleic-acid-stabilisation-programme-into-latin-america.html</guid>
		</item>	
				<item>
			<title>Tumour-like tissue environments offer new target for HIV cure research</title>
			<atom:link href="https://biospectrumasia.com/news/34/28159/tumour-like-tissue-environments-offer-new-target-for-hiv-cure-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28159/tumour-like-tissue-environments-offer-new-target-for-hiv-cure-research.html</link>
			<pubDate>Thu, 06 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28159.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28159/tumour-like-tissue-environments-offer-new-target-for-hiv-cure-research.html</guid>
		</item>	
				<item>
			<title>Experimental RNA therapy reduces lung cancer tumours in preclinical model</title>
			<atom:link href="https://biospectrumasia.com/news/34/28154/experimental-rna-therapy-reduces-lung-cancer-tumours-in-preclinical-model.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28154/experimental-rna-therapy-reduces-lung-cancer-tumours-in-preclinical-model.html</link>
			<pubDate>Wed, 05 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28154.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28154/experimental-rna-therapy-reduces-lung-cancer-tumours-in-preclinical-model.html</guid>
		</item>	
				<item>
			<title>CPHI South East Asia 2026 draws more than 11,000 pharma professionals</title>
			<atom:link href="https://biospectrumasia.com/news/34/28146/cphi-south-east-asia-2026-draws-more-than-11000-pharma-professionals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28146/cphi-south-east-asia-2026-draws-more-than-11000-pharma-professionals.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-28146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28146/cphi-south-east-asia-2026-draws-more-than-11000-pharma-professionals.html</guid>
		</item>	
				<item>
			<title>ArkBio completes cohort dosing in Australian Phase I trial of influenza candidate AK0406</title>
			<atom:link href="https://biospectrumasia.com/news/34/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oc4jrpdtydsauabcnsdapsscuba1770104576934_200x200-28147.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28147/arkbio-completes-cohort-dosing-in-australian-phase-i-trial-of-influenza-candidate-ak0406.html</guid>
		</item>	
				<item>
			<title>Ribo reports positive Phase IIa data for FXI-targeting siRNA vortosiran</title>
			<atom:link href="https://biospectrumasia.com/news/34/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html</link>
			<pubDate>Tue, 04 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/suzhou_ribo_life_science_co_ltd_logo-28148.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28148/ribo-reports-positive-phase-iia-data-for-fxi-targeting-sirna-vortosiran.html</guid>
		</item>	
				<item>
			<title>Kelun-Biotech receives China clearance to begin clinical development of dual-payload ADC</title>
			<atom:link href="https://biospectrumasia.com/news/34/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html</link>
			<pubDate>Mon, 03 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_kelun_biotech_logo-28139.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28139/kelun-biotech-receives-china-clearance-to-begin-clinical-development-of-dual-payload-adc.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine launches industry&#039;s first drug discovery and development Benchmark as a Service</title>
			<atom:link href="https://biospectrumasia.com/news/34/28128/insilico-medicine-launches-industrys-first-drug-discovery-and-development-benchmark-as-a-service.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28128/insilico-medicine-launches-industrys-first-drug-discovery-and-development-benchmark-as-a-service.html</link>
			<pubDate>Sat, 01 Aug 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_8_2026_205041_www_bing_com-28128.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28128/insilico-medicine-launches-industrys-first-drug-discovery-and-development-benchmark-as-a-service.html</guid>
		</item>	
				<item>
			<title>Ribo reports Phase 2a data for Factor XI siRNA in coronary artery disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/28088/ribo-reports-phase-2a-data-for-factor-xi-sirna-in-coronary-artery-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28088/ribo-reports-phase-2a-data-for-factor-xi-sirna-in-coronary-artery-disease.html</link>
			<pubDate>Thu, 23 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-28088.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28088/ribo-reports-phase-2a-data-for-factor-xi-sirna-in-coronary-artery-disease.html</guid>
		</item>	
				<item>
			<title>HUYABIO reports Phase 3 success for HBI-8000 in advanced melanoma</title>
			<atom:link href="https://biospectrumasia.com/news/34/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_9_-28060.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28060/huyabio-reports-phase-3-success-for-hbi-8000-in-advanced-melanoma.html</guid>
		</item>	
				<item>
			<title>Innovent licenses Phase 2-ready anti-CD40L antibody to Spero</title>
			<atom:link href="https://biospectrumasia.com/news/34/28061/innovent-licenses-phase-2-ready-anti-cd40l-antibody-to-spero.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28061/innovent-licenses-phase-2-ready-anti-cd40l-antibody-to-spero.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logopng-28061.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28061/innovent-licenses-phase-2-ready-anti-cd40l-antibody-to-spero.html</guid>
		</item>	
				<item>
			<title>Dizal licenses EGFR lung cancer therapy Zegfrovy to AstraZeneca</title>
			<atom:link href="https://biospectrumasia.com/news/34/28063/dizal-licenses-egfr-lung-cancer-therapy-zegfrovy-to-astrazeneca.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28063/dizal-licenses-egfr-lung-cancer-therapy-zegfrovy-to-astrazeneca.html</link>
			<pubDate>Mon, 20 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo-28063.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28063/dizal-licenses-egfr-lung-cancer-therapy-zegfrovy-to-astrazeneca.html</guid>
		</item>	
				<item>
			<title>Human Cells Are Rewriting the Rules of Drug Development</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/28047/human-cells-are-rewriting-the-rules-of-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/28047/human-cells-are-rewriting-the-rules-of-drug-development.html</link>
			<pubDate>Fri, 17 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nina_bauer_biospectrum_interview_under_400kb-28047.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/28047/human-cells-are-rewriting-the-rules-of-drug-development.html</guid>
		</item>	
				<item>
			<title>Insmed reports 12-month TPIP data in pulmonary arterial hypertension</title>
			<atom:link href="https://biospectrumasia.com/news/34/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html</link>
			<pubDate>Fri, 17 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-28051.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28051/insmed-reports-12-month-tpip-data-in-pulmonary-arterial-hypertension.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine partners with Taiwan&#039;s Bora Pharma for AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/28031/insilico-medicine-partners-with-taiwans-bora-pharma-for-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28031/insilico-medicine-partners-with-taiwans-bora-pharma-for-ai-driven-drug-discovery.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-28031.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28031/insilico-medicine-partners-with-taiwans-bora-pharma-for-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Drug Approval Opens the Door, but Commercial Execution Determines Who Wins</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/28035/drug-approval-opens-the-door-but-commercial-execution-determines-who-wins.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/28035/drug-approval-opens-the-door-but-commercial-execution-determines-who-wins.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/toshiyo_chen_bio_asia_taiwan_under_400kb-28035.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/28035/drug-approval-opens-the-door-but-commercial-execution-determines-who-wins.html</guid>
		</item>	
				<item>
			<title>Maxona receives FDA IND clearance for non-opioid acute pain therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html</link>
			<pubDate>Thu, 16 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_1_-28039.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28039/maxona-receives-fda-ind-clearance-for-non-opioid-acute-pain-therapy.html</guid>
		</item>	
				<item>
			<title>Lynk completes Phase III enrolment for oral JAK1 inhibitor in ankylosing spondylitis</title>
			<atom:link href="https://biospectrumasia.com/news/34/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html</link>
			<pubDate>Wed, 15 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai_genetics_autoimmune_neurosicence-28029.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28029/lynk-completes-phase-iii-enrolment-for-oral-jak1-inhibitor-in-ankylosing-spondylitis.html</guid>
		</item>	
				<item>
			<title>Lynk doses first patient in Phase II vitiligo trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html</link>
			<pubDate>Tue, 14 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2026_07_11_13-28019.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28019/lynk-doses-first-patient-in-phase-ii-vitiligo-trial.html</guid>
		</item>	
				<item>
			<title>OTR Therapeutics, LG Chem partner to develop novel oncology assets from China</title>
			<atom:link href="https://biospectrumasia.com/news/34/28010/otr-therapeutics-lg-chem-partner-to-develop-novel-oncology-assets-from-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28010/otr-therapeutics-lg-chem-partner-to-develop-novel-oncology-assets-from-china.html</link>
			<pubDate>Mon, 13 Jul 2026 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_7_2026_15223_www_otr_tx_com-28010.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28010/otr-therapeutics-lg-chem-partner-to-develop-novel-oncology-assets-from-china.html</guid>
		</item>	
				<item>
			<title>West Synchrony Prefillable Syringe System Available at CPHI Southeast Asia</title>
			<atom:link href="https://biospectrumasia.com/news/34/28008/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/28008/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html</link>
			<pubDate>Mon, 13 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/westpharmaceuticalservicesbooth_2-28008.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/28008/west-synchrony-prefillable-syringe-system-available-at-cphi-southeast-asia.html</guid>
		</item>	
				<item>
			<title>BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/27999/biomed-x-and-boehringer-ingelheim-expand-xseed-labs-to-advance-next-generation-eye-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27999/biomed-x-and-boehringer-ingelheim-expand-xseed-labs-to-advance-next-generation-eye-therapies.html</link>
			<pubDate>Fri, 10 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nib_launch_edited___vertical_1_-27999.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27999/biomed-x-and-boehringer-ingelheim-expand-xseed-labs-to-advance-next-generation-eye-therapies.html</guid>
		</item>	
				<item>
			<title>Evogene and Tel Aviv University to accelerate AI-driven small-molecule drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27978/evogene-and-tel-aviv-university-to-accelerate-ai-driven-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27978/evogene-and-tel-aviv-university-to-accelerate-ai-driven-small-molecule-drug-discovery.html</link>
			<pubDate>Wed, 08 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_8_7_2026_191740_www_prnewswire_com-27978.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27978/evogene-and-tel-aviv-university-to-accelerate-ai-driven-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Insilico starts Phase III trial of AI-discovered IPF therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html</link>
			<pubDate>Wed, 08 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-27981.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27981/insilico-starts-phase-iii-trial-of-ai-discovered-ipf-therapy.html</guid>
		</item>	
				<item>
			<title>Ascletis submits US IND applications for once-monthly obesity candidates</title>
			<atom:link href="https://biospectrumasia.com/news/34/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cta_2_24_06_2026_-27970.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27970/ascletis-submits-us-ind-applications-for-once-monthly-obesity-candidates.html</guid>
		</item>	
				<item>
			<title>Brii Bio reports Phase 2b chronic hepatitis B combination data</title>
			<atom:link href="https://biospectrumasia.com/news/34/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brii-27971.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27971/brii-bio-reports-phase-2b-chronic-hepatitis-b-combination-data.html</guid>
		</item>	
				<item>
			<title>REPROCELL seeks Japan approval for stem cell therapy in spinocerebellar ataxia</title>
			<atom:link href="https://biospectrumasia.com/news/34/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html</link>
			<pubDate>Mon, 06 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/reprocell_logo_800_640_tile-27972.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27972/reprocell-seeks-japan-approval-for-stem-cell-therapy-in-spinocerebellar-ataxia.html</guid>
		</item>	
				<item>
			<title>AustinPx CEO Elizabeth Hickman on Scaling Complex Oral Drugs Through the Thermo Fisher KinetiSol Collaboration</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/27899/austinpx-ceo-elizabeth-hickman-on-scaling-complex-oral-drugs-through-the-thermo-fisher-kinetisol-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/27899/austinpx-ceo-elizabeth-hickman-on-scaling-complex-oral-drugs-through-the-thermo-fisher-kinetisol-collaboration.html</link>
			<pubDate>Sun, 05 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elizabeth_hickman_bio2026_400kb-27899.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/27899/austinpx-ceo-elizabeth-hickman-on-scaling-complex-oral-drugs-through-the-thermo-fisher-kinetisol-collaboration.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine inks deal worth $600 M with Takeda to advance strategic AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html</link>
			<pubDate>Fri, 03 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-27957.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27957/insilico-medicine-inks-deal-worth-600-m-with-takeda-to-advance-strategic-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Viking starts Phase 1 trial of amylin-based weight-loss candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html</link>
			<pubDate>Fri, 03 Jul 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eb4bbad80120571d875800a6c4b0bcba-27961.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27961/viking-starts-phase-1-trial-of-amylin-based-weight-loss-candidate.html</guid>
		</item>	
				<item>
			<title>METiS TechBio and Boulevard Bio Enter $1.6 billion Global License Agreement for Trispecific T-cell Engager</title>
			<atom:link href="https://biospectrumasia.com/news/34/27953/metis-techbio-and-boulevard-bio-enter-1-6-billion-global-license-agreement-for-trispecific-t-cell-engager.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27953/metis-techbio-and-boulevard-bio-enter-1-6-billion-global-license-agreement-for-trispecific-t-cell-engager.html</link>
			<pubDate>Wed, 01 Jul 2026 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27953/metis-techbio-and-boulevard-bio-enter-1-6-billion-global-license-agreement-for-trispecific-t-cell-engager.html</guid>
		</item>	
				<item>
			<title>Servier enrols first US patient in rare paediatric epilepsy study</title>
			<atom:link href="https://biospectrumasia.com/news/34/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/servier-27919.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27919/servier-enrols-first-us-patient-in-rare-paediatric-epilepsy-study.html</guid>
		</item>	
				<item>
			<title>Innovative Molecules doses first patient in Phase 2a herpes trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innovative_molecules_logo-27921.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27921/innovative-molecules-doses-first-patient-in-phase-2a-herpes-trial.html</guid>
		</item>	
				<item>
			<title>NeuroSense reports Phase 2 biomarker findings for PrimeC in Alzheimer’s disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</link>
			<pubDate>Fri, 26 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo_positive_horizontal_e1633873048940-27922.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27922/neurosense-reports-phase-2-biomarker-findings-for-primec-in-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>Puerto Rico Is Reclaiming Its Place as a Global Biopharma Innovation and Manufacturing Hub</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/27903/puerto-rico-is-reclaiming-its-place-as-a-global-biopharma-innovation-and-manufacturing-hub.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/27903/puerto-rico-is-reclaiming-its-place-as-a-global-biopharma-innovation-and-manufacturing-hub.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_bio2026_lan_nguyen_under400kb-27903.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/27903/puerto-rico-is-reclaiming-its-place-as-a-global-biopharma-innovation-and-manufacturing-hub.html</guid>
		</item>	
				<item>
			<title>Policy, Talent and Innovation Are Fueling Pennsylvania&#039;s Life Sciences Growth</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/27905/policy-talent-and-innovation-are-fueling-pennsylvanias-life-sciences-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/27905/policy-talent-and-innovation-are-fueling-pennsylvanias-life-sciences-growth.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biospectrum_asia_bio2026_kurt_imhof_under400kb-27905.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/27905/policy-talent-and-innovation-are-fueling-pennsylvanias-life-sciences-growth.html</guid>
		</item>	
				<item>
			<title>CeleCor submits FDA application for investigational heart attack drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html</link>
			<pubDate>Thu, 25 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celecor_logo-27911.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27911/celecor-submits-fda-application-for-investigational-heart-attack-drug.html</guid>
		</item>	
				<item>
			<title>China&#039;s Abbisko deepens R&amp;D collaboration with Eli Lilly for novel drug programmes</title>
			<atom:link href="https://biospectrumasia.com/news/34/27892/chinas-abbisko-deepens-rd-collaboration-with-eli-lilly-for-novel-drug-programmes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27892/chinas-abbisko-deepens-rd-collaboration-with-eli-lilly-for-novel-drug-programmes.html</link>
			<pubDate>Wed, 24 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27892.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27892/chinas-abbisko-deepens-rd-collaboration-with-eli-lilly-for-novel-drug-programmes.html</guid>
		</item>	
				<item>
			<title>Haisco licenses oncology and complement candidates to Nuvectis</title>
			<atom:link href="https://biospectrumasia.com/news/34/27895/haisco-licenses-oncology-and-complement-candidates-to-nuvectis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27895/haisco-licenses-oncology-and-complement-candidates-to-nuvectis.html</link>
			<pubDate>Wed, 24 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/haisco_pharmaceutical_77327-27895.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27895/haisco-licenses-oncology-and-complement-candidates-to-nuvectis.html</guid>
		</item>	
				<item>
			<title>NVIDIA Announces BioNeMo Agent Toolkit</title>
			<atom:link href="https://biospectrumasia.com/news/34/27897/nvidia-announces-bionemo-agent-toolkit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27897/nvidia-announces-bionemo-agent-toolkit.html</link>
			<pubDate>Wed, 24 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nvidia_bionemo_agent_toolkit_1_-27897.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27897/nvidia-announces-bionemo-agent-toolkit.html</guid>
		</item>	
				<item>
			<title>The Smallest Arteries May Hold the Key to Some of Medicine’s Biggest Unmet Needs</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/27901/the-smallest-arteries-may-hold-the-key-to-some-of-medicines-biggest-unmet-needs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/27901/the-smallest-arteries-may-hold-the-key-to-some-of-medicines-biggest-unmet-needs.html</link>
			<pubDate>Wed, 24 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/steffen_bolz_microvascular_bio2026_under_400kb-27901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/27901/the-smallest-arteries-may-hold-the-key-to-some-of-medicines-biggest-unmet-needs.html</guid>
		</item>	
				<item>
			<title>AnHorn secures US and Taiwan regulatory milestones for CIPN candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/27878/anhorn-secures-us-and-taiwan-regulatory-milestones-for-cipn-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27878/anhorn-secures-us-and-taiwan-regulatory-milestones-for-cipn-candidate.html</link>
			<pubDate>Tue, 23 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anhorn_medicines_logo-27878.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27878/anhorn-secures-us-and-taiwan-regulatory-milestones-for-cipn-candidate.html</guid>
		</item>	
				<item>
			<title>SystImmune, Biokin secure first China approval for bispecific ADC iza-bren</title>
			<atom:link href="https://biospectrumasia.com/news/34/27879/systimmune-biokin-secure-first-china-approval-for-bispecific-adc-iza-bren.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27879/systimmune-biokin-secure-first-china-approval-for-bispecific-adc-iza-bren.html</link>
			<pubDate>Tue, 23 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/systimmune_logo-27879.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27879/systimmune-biokin-secure-first-china-approval-for-bispecific-adc-iza-bren.html</guid>
		</item>	
				<item>
			<title>Lys Therapeutics raises over €25M to advance neurovascular antibody</title>
			<atom:link href="https://biospectrumasia.com/news/34/27881/lys-therapeutics-raises-over-25m-to-advance-neurovascular-antibody.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27881/lys-therapeutics-raises-over-25m-to-advance-neurovascular-antibody.html</link>
			<pubDate>Tue, 23 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lys_therapeutics_logo-27881.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27881/lys-therapeutics-raises-over-25m-to-advance-neurovascular-antibody.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s SK Biopharma collaborates with Insilico Medicine for $2.5 B AI-drug discovery deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/27849/koreas-sk-biopharma-collaborates-with-insilico-medicine-for-2-5-b-ai-drug-discovery-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27849/koreas-sk-biopharma-collaborates-with-insilico-medicine-for-2-5-b-ai-drug-discovery-deal.html</link>
			<pubDate>Mon, 22 Jun 2026 01:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-27849.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27849/koreas-sk-biopharma-collaborates-with-insilico-medicine-for-2-5-b-ai-drug-discovery-deal.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s LG AI Research, D&amp;D Pharmatech partner to accelerate oral peptide drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27834/koreas-lg-ai-research-dd-pharmatech-partner-to-accelerate-oral-peptide-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27834/koreas-lg-ai-research-dd-pharmatech-partner-to-accelerate-oral-peptide-drug-discovery.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_6_2026_121756_www_upi_com-27834.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27834/koreas-lg-ai-research-dd-pharmatech-partner-to-accelerate-oral-peptide-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Insilico Begins Phase I Study of AI-Driven NLRP3 Inhibitor</title>
			<atom:link href="https://biospectrumasia.com/news/34/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_7_-27835.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27835/insilico-begins-phase-i-study-of-ai-driven-nlrp3-inhibitor.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Axcelead DDP joins Eli Lilly TuneLab to advance AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html</link>
			<pubDate>Thu, 18 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_6_2026_115740_axcelead_us_com-27837.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27837/japans-axcelead-ddp-joins-eli-lilly-tunelab-to-advance-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>MindWalk Positions Biological Context Layer as AI Drug Discovery Bottleneck</title>
			<atom:link href="https://biospectrumasia.com/news/34/27829/mindwalk-positions-biological-context-layer-as-ai-drug-discovery-bottleneck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27829/mindwalk-positions-biological-context-layer-as-ai-drug-discovery-bottleneck.html</link>
			<pubDate>Wed, 17 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/a05a69459440a472962a428976194d17-27829.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27829/mindwalk-positions-biological-context-layer-as-ai-drug-discovery-bottleneck.html</guid>
		</item>	
				<item>
			<title>Hillhurst Bio Doses First Subject in Phase 2a Parkinson’s Trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html</link>
			<pubDate>Tue, 16 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hillhurst_bio_logo2-27820.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27820/hillhurst-bio-doses-first-subject-in-phase-2a-parkinsons-trial.html</guid>
		</item>	
				<item>
			<title>Genentech Gains FDA Priority Review for Oral SERD in Early Breast Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html</link>
			<pubDate>Fri, 12 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/w_gen_02-27799.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27799/genentech-gains-fda-priority-review-for-oral-serd-in-early-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Nuvalent Gains FDA Priority Review for ALK-Positive NSCLC Candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html</link>
			<pubDate>Thu, 11 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nuvalent_og_image-27792.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27792/nuvalent-gains-fda-priority-review-for-alk-positive-nsclc-candidate.html</guid>
		</item>	
				<item>
			<title>Pfizer Secures FDA Approval for Expanded Hympavzi Use in Hemophilia</title>
			<atom:link href="https://biospectrumasia.com/news/34/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html</link>
			<pubDate>Wed, 10 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vertanical_min-27784.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27784/pfizer-secures-fda-approval-for-expanded-hympavzi-use-in-hemophilia.html</guid>
		</item>	
				<item>
			<title>VERTANICAL Secures First European Marketing Authorisation for Exilby in Chronic Low Back Pain</title>
			<atom:link href="https://biospectrumasia.com/news/34/27776/vertanical-secures-first-european-marketing-authorisation-for-exilby-in-chronic-low-back-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27776/vertanical-secures-first-european-marketing-authorisation-for-exilby-in-chronic-low-back-pain.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_4_-27776.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27776/vertanical-secures-first-european-marketing-authorisation-for-exilby-in-chronic-low-back-pain.html</guid>
		</item>	
				<item>
			<title>Argo Biopharma to Present Updated Phase II Data for siRNA HAE Therapy at EAACI 2026</title>
			<atom:link href="https://biospectrumasia.com/news/34/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1757041743797-27777.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27777/argo-biopharma-to-present-updated-phase-ii-data-for-sirna-hae-therapy-at-eaaci-2026.html</guid>
		</item>	
				<item>
			<title>Shionogi Receives US FDA Approval for Oral COVID-19 Post-Exposure Prophylaxis</title>
			<atom:link href="https://biospectrumasia.com/news/34/27779/shionogi-receives-us-fda-approval-for-oral-covid-19-post-exposure-prophylaxis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27779/shionogi-receives-us-fda-approval-for-oral-covid-19-post-exposure-prophylaxis.html</link>
			<pubDate>Tue, 09 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_5_-27779.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27779/shionogi-receives-us-fda-approval-for-oral-covid-19-post-exposure-prophylaxis.html</guid>
		</item>	
				<item>
			<title>EMA Accepts Teva and Medincell’s MAA for Monthly Olanzapine Long-Acting Injectable</title>
			<atom:link href="https://biospectrumasia.com/news/34/27764/ema-accepts-teva-and-medincells-maa-for-monthly-olanzapine-long-acting-injectable.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27764/ema-accepts-teva-and-medincells-maa-for-monthly-olanzapine-long-acting-injectable.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_2_-27764.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27764/ema-accepts-teva-and-medincells-maa-for-monthly-olanzapine-long-acting-injectable.html</guid>
		</item>	
				<item>
			<title>FDA Approves Genentech’s Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer Treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/27766/fda-approves-genentechs-tecentriq-for-ctdna-guided-adjuvant-bladder-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27766/fda-approves-genentechs-tecentriq-for-ctdna-guided-adjuvant-bladder-cancer-treatment.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/genentech-27766.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27766/fda-approves-genentechs-tecentriq-for-ctdna-guided-adjuvant-bladder-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Chime Biologics Partners with Daewoong Pharmaceutical to Advance Global Dupilumab Biosimilar Development</title>
			<atom:link href="https://biospectrumasia.com/news/34/27767/chime-biologics-partners-with-daewoong-pharmaceutical-to-advance-global-dupilumab-biosimilar-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27767/chime-biologics-partners-with-daewoong-pharmaceutical-to-advance-global-dupilumab-biosimilar-development.html</link>
			<pubDate>Mon, 08 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_6_2026_124416_chimebiologics_com_27752-27767.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27767/chime-biologics-partners-with-daewoong-pharmaceutical-to-advance-global-dupilumab-biosimilar-development.html</guid>
		</item>	
				<item>
			<title>AbbVie Secures EC Approval for AQUIPTA as Acute Migraine Treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/27754/abbvie-secures-ec-approval-for-aquipta-as-acute-migraine-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27754/abbvie-secures-ec-approval-for-aquipta-as-acute-migraine-treatment.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/22541_23102_4032-27754.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27754/abbvie-secures-ec-approval-for-aquipta-as-acute-migraine-treatment.html</guid>
		</item>	
				<item>
			<title>Amgen Receives EC Approval for IMDYLLTRA in Extensive-Stage Small Cell Lung Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/27755/amgen-receives-ec-approval-for-imdylltra-in-extensive-stage-small-cell-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27755/amgen-receives-ec-approval-for-imdylltra-in-extensive-stage-small-cell-lung-cancer.html</link>
			<pubDate>Fri, 05 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/featured_image_imdelltra_tarlatamab_for_the_treatment_of_extensive_stage_small_cell_lung_cancer_e1740504455336-27755.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27755/amgen-receives-ec-approval-for-imdylltra-in-extensive-stage-small-cell-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6</title>
			<atom:link href="https://biospectrumasia.com/news/34/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html</link>
			<pubDate>Thu, 04 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1780494921_omnix_medical-27744.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27744/omnix-medical-announces-first-patients-dosed-in-phase-ii-trial-of-antimicrobial-lead-compound-omn6.html</guid>
		</item>	
				<item>
			<title>Vertex’s Povetacicept BLA Accepted by US FDA for IgA Nephropathy</title>
			<atom:link href="https://biospectrumasia.com/news/34/27747/vertexs-povetacicept-bla-accepted-by-us-fda-for-iga-nephropathy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27747/vertexs-povetacicept-bla-accepted-by-us-fda-for-iga-nephropathy.html</link>
			<pubDate>Thu, 04 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hjyczambgaavyor-27747.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27747/vertexs-povetacicept-bla-accepted-by-us-fda-for-iga-nephropathy.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27736/thermo-fisher-scientific-unveils-next-generation-innovations-at-asms-2026-to-accelerate-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27736/thermo-fisher-scientific-unveils-next-generation-innovations-at-asms-2026-to-accelerate-drug-discovery.html</link>
			<pubDate>Wed, 03 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1780404126_tmo_asms_2026_5_final_5_29-27736.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27736/thermo-fisher-scientific-unveils-next-generation-innovations-at-asms-2026-to-accelerate-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Singapore becomes first APAC market to approve MSD&#039;s Enflonsia for infant RSV prevention</title>
			<atom:link href="https://biospectrumasia.com/news/34/27726/singapore-becomes-first-apac-market-to-approve-msds-enflonsia-for-infant-rsv-prevention.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27726/singapore-becomes-first-apac-market-to-approve-msds-enflonsia-for-infant-rsv-prevention.html</link>
			<pubDate>Tue, 02 Jun 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2_6_2026_12253_www_bing_com-27726.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27726/singapore-becomes-first-apac-market-to-approve-msds-enflonsia-for-infant-rsv-prevention.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine and Human Longevity to co-develop industry-first AI foundation model for longevity science</title>
			<atom:link href="https://biospectrumasia.com/news/34/27689/insilico-medicine-and-human-longevity-to-co-develop-industry-first-ai-foundation-model-for-longevity-science.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27689/insilico-medicine-and-human-longevity-to-co-develop-industry-first-ai-foundation-model-for-longevity-science.html</link>
			<pubDate>Thu, 28 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_5_2026_121513_-27689.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27689/insilico-medicine-and-human-longevity-to-co-develop-industry-first-ai-foundation-model-for-longevity-science.html</guid>
		</item>	
				<item>
			<title>China Formalises Regulatory Data Protection Measures for Drug Applications</title>
			<atom:link href="https://biospectrumasia.com/news/34/27676/china-formalises-regulatory-data-protection-measures-for-drug-applications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27676/china-formalises-regulatory-data-protection-measures-for-drug-applications.html</link>
			<pubDate>Thu, 21 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/logo-27676.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27676/china-formalises-regulatory-data-protection-measures-for-drug-applications.html</guid>
		</item>	
				<item>
			<title>South Korea’s Biopharma Expansion Signals Next Decade Of Global Innovation Growth At API China 2026</title>
			<atom:link href="https://biospectrumasia.com/news/34/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html</link>
			<pubDate>Thu, 14 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d4b0f482_f208_48c5_8c87_cbf56e30d9a1-27644.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27644/south-koreas-biopharma-expansion-signals-next-decade-of-global-innovation-growth-at-api-china-2026.html</guid>
		</item>	
				<item>
			<title>AMR innovation faces growing investment gap despite rising global health threat</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/27646/amr-innovation-faces-growing-investment-gap-despite-rising-global-health-threat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/27646/amr-innovation-faces-growing-investment-gap-despite-rising-global-health-threat.html</link>
			<pubDate>Thu, 14 May 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/michael_lamprecht_1_-27646.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/27646/amr-innovation-faces-growing-investment-gap-despite-rising-global-health-threat.html</guid>
		</item>	
				<item>
			<title>Qubit Pharmaceuticals announces strategic collaboration with Singapore’s Centre for Quantum Technologies to advance quantum algorithms for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27581/qubit-pharmaceuticals-announces-strategic-collaboration-with-singapores-centre-for-quantum-technologies-to-advance-quantum-algorithms-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27581/qubit-pharmaceuticals-announces-strategic-collaboration-with-singapores-centre-for-quantum-technologies-to-advance-quantum-algorithms-for-drug-discovery.html</link>
			<pubDate>Thu, 30 Apr 2026 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27581/qubit-pharmaceuticals-announces-strategic-collaboration-with-singapores-centre-for-quantum-technologies-to-advance-quantum-algorithms-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>4D Path partners with Daiichi Sankyo to advance AI-driven ADC programme</title>
			<atom:link href="https://biospectrumasia.com/news/34/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html</link>
			<pubDate>Wed, 15 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_15_4_2026_121016_-27499.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27499/4d-path-partners-with-daiichi-sankyo-to-advance-ai-driven-adc-programme.html</guid>
		</item>	
				<item>
			<title>Expecto Health Science Partners with Neuratrial to Pioneer AI-Driven CRO Operating Model</title>
			<atom:link href="https://biospectrumasia.com/news/34/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</link>
			<pubDate>Wed, 08 Apr 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuratrial_and_expecto_health_sciences_strategic_partnership_-27470.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27470/expecto-health-science-partners-with-neuratrial-to-pioneer-ai-driven-cro-operating-model.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine inks $2.75 B global R&amp;D collaboration with Eli Lilly</title>
			<atom:link href="https://biospectrumasia.com/news/34/27428/insilico-medicine-inks-2-75-b-global-rd-collaboration-with-eli-lilly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27428/insilico-medicine-inks-2-75-b-global-rd-collaboration-with-eli-lilly.html</link>
			<pubDate>Mon, 30 Mar 2026 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_3_2026_135617_www_bing_com-27428.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27428/insilico-medicine-inks-2-75-b-global-rd-collaboration-with-eli-lilly.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine and Tenacia Biotech expand AI-driven CNS collaboration worth $94.75 M</title>
			<atom:link href="https://biospectrumasia.com/news/34/27426/insilico-medicine-and-tenacia-biotech-expand-ai-driven-cns-collaboration-worth-94-75-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27426/insilico-medicine-and-tenacia-biotech-expand-ai-driven-cns-collaboration-worth-94-75-m.html</link>
			<pubDate>Mon, 30 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_3_2026_14343_-27426.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27426/insilico-medicine-and-tenacia-biotech-expand-ai-driven-cns-collaboration-worth-94-75-m.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health</title>
			<atom:link href="https://biospectrumasia.com/news/34/27403/insilico-medicine-and-aska-pharma-expand-partnership-to-discover-novel-targets-for-womens-health.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27403/insilico-medicine-and-aska-pharma-expand-partnership-to-discover-novel-targets-for-womens-health.html</link>
			<pubDate>Wed, 25 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_25_3_2026_12546_www_bing_com-27403.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27403/insilico-medicine-and-aska-pharma-expand-partnership-to-discover-novel-targets-for-womens-health.html</guid>
		</item>	
				<item>
			<title>SK pharmteco and Prozomix collaborates to enhance Biocatalysis capabilities for global drug manufacturing</title>
			<atom:link href="https://biospectrumasia.com/news/34/27405/sk-pharmteco-and-prozomix-collaborates-to-enhance-biocatalysis-capabilities-for-global-drug-manufacturing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27405/sk-pharmteco-and-prozomix-collaborates-to-enhance-biocatalysis-capabilities-for-global-drug-manufacturing.html</link>
			<pubDate>Wed, 25 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna_closely-27405.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27405/sk-pharmteco-and-prozomix-collaborates-to-enhance-biocatalysis-capabilities-for-global-drug-manufacturing.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s EDDC launches R&amp;D collaboration with Daiichi Sankyo to advance Next‑Gen NK Cell engagers</title>
			<atom:link href="https://biospectrumasia.com/news/34/27399/singapores-eddc-launches-rd-collaboration-with-daiichi-sankyo-to-advance-nextgen-nk-cell-engagers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27399/singapores-eddc-launches-rd-collaboration-with-daiichi-sankyo-to-advance-nextgen-nk-cell-engagers.html</link>
			<pubDate>Tue, 24 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wmremove_transformed_33_-27399.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27399/singapores-eddc-launches-rd-collaboration-with-daiichi-sankyo-to-advance-nextgen-nk-cell-engagers.html</guid>
		</item>	
				<item>
			<title>Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up</title>
			<atom:link href="https://biospectrumasia.com/news/34/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html</link>
			<pubDate>Thu, 12 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alexander__27242-27340.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27340/digital-manufacturing-must-lead-the-next-phase-of-cell-and-gene-therapy-scale-up.html</guid>
		</item>	
				<item>
			<title>Heath Coats Highlights Evolving FDA Inspection Expectations At Charles River APAC Biomanufacturing Leadership Summit</title>
			<atom:link href="https://biospectrumasia.com/news/34/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html</link>
			<pubDate>Tue, 10 Mar 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heathcoat_1_-27315.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27315/heath-coats-highlights-evolving-fda-inspection-expectations-at-charles-river-apac-biomanufacturing-leadership-summit.html</guid>
		</item>	
				<item>
			<title>Collaboration between Israel and Australia to advance AI-driven cancer therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/27222/collaboration-between-israel-and-australia-to-advance-ai-driven-cancer-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27222/collaboration-between-israel-and-australia-to-advance-ai-driven-cancer-therapeutics.html</link>
			<pubDate>Fri, 20 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_20_2_2026_185639_-27222.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27222/collaboration-between-israel-and-australia-to-advance-ai-driven-cancer-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html</link>
			<pubDate>Wed, 18 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_18_2_2026_165439_www_bing_com-27210.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27210/japans-daiichi-sankyo-collaborates-with-bostongene-to-accelerate-ai-based-drug-development.html</guid>
		</item>	
				<item>
			<title>Korean startup Galux raises $29 M to advance AI-driven protein design for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27208/korean-startup-galux-raises-29-m-to-advance-ai-driven-protein-design-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27208/korean-startup-galux-raises-29-m-to-advance-ai-driven-protein-design-for-drug-discovery.html</link>
			<pubDate>Tue, 17 Feb 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-27208.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27208/korean-startup-galux-raises-29-m-to-advance-ai-driven-protein-design-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Veritas In Silico partners with SpiroChem for discovery of next generation RNA drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html</link>
			<pubDate>Wed, 28 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_1_2026_151330_spirochem_com-27126.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27126/japans-veritas-in-silico-partners-with-spirochem-for-discovery-of-next-generation-rna-drugs.html</guid>
		</item>	
				<item>
			<title>Pierre Fabre Laboratories Bets On Generative AI With Iktos To Reimagine The Future Of Oncology Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27078/pierre-fabre-laboratories-bets-on-generative-ai-with-iktos-to-reimagine-the-future-of-oncology-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27078/pierre-fabre-laboratories-bets-on-generative-ai-with-iktos-to-reimagine-the-future-of-oncology-drug-discovery.html</link>
			<pubDate>Fri, 09 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6ee07ce0_874d_40c6_85db_64f1458634d5_md-27078.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27078/pierre-fabre-laboratories-bets-on-generative-ai-with-iktos-to-reimagine-the-future-of-oncology-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Iktos And Servier Enter Strategic AI Led Drug Discovery Collaboration Valued At Over â‚¬1 Billion</title>
			<atom:link href="https://biospectrumasia.com/news/34/27076/iktos-and-servier-enter-strategic-ai-led-drug-discovery-collaboration-valued-at-over-1-billion.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27076/iktos-and-servier-enter-strategic-ai-led-drug-discovery-collaboration-valued-at-over-1-billion.html</link>
			<pubDate>Thu, 08 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/614e74a4_0e9c_4482_bb63_fbb09bc7e6cc_md-27076.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27076/iktos-and-servier-enter-strategic-ai-led-drug-discovery-collaboration-valued-at-over-1-billion.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine announces $888 M multi-year collaboration with Servier for drug discovery in oncology</title>
			<atom:link href="https://biospectrumasia.com/news/34/27056/insilico-medicine-announces-888-m-multi-year-collaboration-with-servier-for-drug-discovery-in-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27056/insilico-medicine-announces-888-m-multi-year-collaboration-with-servier-for-drug-discovery-in-oncology.html</link>
			<pubDate>Mon, 05 Jan 2026 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd1-27056.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27056/insilico-medicine-announces-888-m-multi-year-collaboration-with-servier-for-drug-discovery-in-oncology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Meiji Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html</link>
			<pubDate>Fri, 19 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd-27024.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/27024/japans-meiji-seika-pharma-collaborates-with-mbc-biolabs-for-global-innovation-in-drug-discovery.html</guid>
		</item>	
				<item>
			<title>ESMO Asia 2025 highlights urgent medical need in platinum-resistant advanced ovarian cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/26980/esmo-asia-2025-highlights-urgent-medical-need-in-platinum-resistant-advanced-ovarian-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26980/esmo-asia-2025-highlights-urgent-medical-need-in-platinum-resistant-advanced-ovarian-cancer.html</link>
			<pubDate>Fri, 05 Dec 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_2025_10_06_145412-26980.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26980/esmo-asia-2025-highlights-urgent-medical-need-in-platinum-resistant-advanced-ovarian-cancer.html</guid>
		</item>	
				<item>
			<title>BostonGene and Kyoto University accelerate precision drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html</link>
			<pubDate>Thu, 13 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_13_11_2025_133627_-26875.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26875/bostongene-and-kyoto-university-accelerate-precision-drug-development.html</guid>
		</item>	
				<item>
			<title>Insilico and Lilly enter $100 M research and licensing collaboration to advance AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/26857/insilico-and-lilly-enter-100-m-research-and-licensing-collaboration-to-advance-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26857/insilico-and-lilly-enter-100-m-research-and-licensing-collaboration-to-advance-ai-driven-drug-discovery.html</link>
			<pubDate>Tue, 11 Nov 2025 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_12_11_2025_0414_www_bing_com-26857.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26857/insilico-and-lilly-enter-100-m-research-and-licensing-collaboration-to-advance-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Harbour BioMed and Evinova China announce strategic collaboration to accelerate AI-enabled drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/26843/harbour-biomed-and-evinova-china-announce-strategic-collaboration-to-accelerate-ai-enabled-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26843/harbour-biomed-and-evinova-china-announce-strategic-collaboration-to-accelerate-ai-enabled-drug-development.html</link>
			<pubDate>Mon, 10 Nov 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_10_11_2025_133944_-26843.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26843/harbour-biomed-and-evinova-china-announce-strategic-collaboration-to-accelerate-ai-enabled-drug-development.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai inks $1.08 B deal with Rani Therapeutics for multiple high-value therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html</link>
			<pubDate>Tue, 21 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_21_10_2025_124044_ir_ranitherapeutics_com-26770.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26770/japans-chugai-inks-1-08-b-deal-with-rani-therapeutics-for-multiple-high-value-therapeutics.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s Nanyang Biologics plans NASDAQ listing through $1.5 B biz combination</title>
			<atom:link href="https://biospectrumasia.com/news/34/26746/singapores-nanyang-biologics-plans-nasdaq-listing-through-1-5-b-biz-combination.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26746/singapores-nanyang-biologics-plans-nasdaq-listing-through-1-5-b-biz-combination.html</link>
			<pubDate>Tue, 14 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_14_10_2025_195841_www_nanyangbiologics_com-26746.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26746/singapores-nanyang-biologics-plans-nasdaq-listing-through-1-5-b-biz-combination.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo establishes third research institute in US</title>
			<atom:link href="https://biospectrumasia.com/news/34/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html</link>
			<pubDate>Fri, 03 Oct 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-26711.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26711/japans-daiichi-sankyo-establishes-third-research-institute-in-us.html</guid>
		</item>	
				<item>
			<title>Merck and Siemens accelerate AI and data-driven drug discovery and development</title>
			<atom:link href="https://biospectrumasia.com/news/34/26667/merck-and-siemens-accelerate-ai-and-data-driven-drug-discovery-and-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26667/merck-and-siemens-accelerate-ai-and-data-driven-drug-discovery-and-development.html</link>
			<pubDate>Wed, 24 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_24_9_2025_124633_press_siemens_com-26667.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26667/merck-and-siemens-accelerate-ai-and-data-driven-drug-discovery-and-development.html</guid>
		</item>	
				<item>
			<title>xFOREST Therapeutics, Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html</link>
			<pubDate>Fri, 19 Sep 2025 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26654/xforest-therapeutics-axcelead-ddp-launch-joint-research-initiative-on-rna-structure-targeted-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Nanyang Biologics partners with NVIDIA, HPE &amp; Equinix to build AI-powered drug discovery platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/26587/nanyang-biologics-partners-with-nvidia-hpe-equinix-to-build-ai-powered-drug-discovery-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26587/nanyang-biologics-partners-with-nvidia-hpe-equinix-to-build-ai-powered-drug-discovery-platform.html</link>
			<pubDate>Wed, 03 Sep 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/picture1-26587.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26587/nanyang-biologics-partners-with-nvidia-hpe-equinix-to-build-ai-powered-drug-discovery-platform.html</guid>
		</item>	
				<item>
			<title>Probio launches cGMP AAV manufacturing services at new Hopewell facility</title>
			<atom:link href="https://biospectrumasia.com/news/34/26484/probio-launches-cgmp-aav-manufacturing-services-at-new-hopewell-facility.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26484/probio-launches-cgmp-aav-manufacturing-services-at-new-hopewell-facility.html</link>
			<pubDate>Tue, 12 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/probio_action_images_170-26484.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26484/probio-launches-cgmp-aav-manufacturing-services-at-new-hopewell-facility.html</guid>
		</item>	
				<item>
			<title>XtalPi and DoveTree announce landmark AI drug discovery collaboration worth $6 B</title>
			<atom:link href="https://biospectrumasia.com/news/34/26467/xtalpi-and-dovetree-announce-landmark-ai-drug-discovery-collaboration-worth-6-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26467/xtalpi-and-dovetree-announce-landmark-ai-drug-discovery-collaboration-worth-6-b.html</link>
			<pubDate>Thu, 07 Aug 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai-26467.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26467/xtalpi-and-dovetree-announce-landmark-ai-drug-discovery-collaboration-worth-6-b.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas announces partnership with Korea Institute of Startup and Entrepreneurship Development</title>
			<atom:link href="https://biospectrumasia.com/news/34/26356/japans-astellas-announces-partnership-with-korea-institute-of-startup-and-entrepreneurship-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26356/japans-astellas-announces-partnership-with-korea-institute-of-startup-and-entrepreneurship-development.html</link>
			<pubDate>Thu, 17 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_17_7_2025_123145_-26356.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26356/japans-astellas-announces-partnership-with-korea-institute-of-startup-and-entrepreneurship-development.html</guid>
		</item>	
				<item>
			<title>Gero&#039;s ProtoBindâ€‘Diff redefines drug discovery by designing molecules from sequence alone</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/26290/geros-protobinddiff-redefines-drug-discovery-by-designing-molecules-from-sequence-alone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/26290/geros-protobinddiff-redefines-drug-discovery-by-designing-molecules-from-sequence-alone.html</link>
			<pubDate>Wed, 02 Jul 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gero_ceo-26290.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/26290/geros-protobinddiff-redefines-drug-discovery-by-designing-molecules-from-sequence-alone.html</guid>
		</item>	
				<item>
			<title>SK Biosciences partners with PhnyX Lab to streamline drug discovery research using AI</title>
			<atom:link href="https://biospectrumasia.com/news/34/26267/sk-biosciences-partners-with-phnyx-lab-to-streamline-drug-discovery-research-using-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26267/sk-biosciences-partners-with-phnyx-lab-to-streamline-drug-discovery-research-using-ai.html</link>
			<pubDate>Fri, 27 Jun 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_6_2025_154849_biz_chosun_com-26267.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26267/sk-biosciences-partners-with-phnyx-lab-to-streamline-drug-discovery-research-using-ai.html</guid>
		</item>	
				<item>
			<title>Nuclera and Cytiva team up to accelerate characterisation of proteins for drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/26119/nuclera-and-cytiva-team-up-to-accelerate-characterisation-of-proteins-for-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26119/nuclera-and-cytiva-team-up-to-accelerate-characterisation-of-proteins-for-drug-development.html</link>
			<pubDate>Fri, 30 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_30_5_2025_174350_www_nuclera_com-26119.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26119/nuclera-and-cytiva-team-up-to-accelerate-characterisation-of-proteins-for-drug-development.html</guid>
		</item>	
				<item>
			<title>China&#039;s Viva Biotech launches new AI-driven drug discovery platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/26044/chinas-viva-biotech-launches-new-ai-driven-drug-discovery-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/26044/chinas-viva-biotech-launches-new-ai-driven-drug-discovery-platform.html</link>
			<pubDate>Fri, 16 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_16_5_2025_102611_aidd_vivabiotech_com-26044.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/26044/chinas-viva-biotech-launches-new-ai-driven-drug-discovery-platform.html</guid>
		</item>	
				<item>
			<title>HistoIndex secures S$9 Million investment to drive next phase of expansion in digital pathology in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/25978/histoindex-secures-s9-million-investment-to-drive-next-phase-of-expansion-in-digital-pathology-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25978/histoindex-secures-s9-million-investment-to-drive-next-phase-of-expansion-in-digital-pathology-in-singapore.html</link>
			<pubDate>Fri, 02 May 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/genesisscreen_1536x1371_1_-25978.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25978/histoindex-secures-s9-million-investment-to-drive-next-phase-of-expansion-in-digital-pathology-in-singapore.html</guid>
		</item>	
				<item>
			<title>Singapore deepens research collaboration in applied AI for drug discovery and life sciences</title>
			<atom:link href="https://biospectrumasia.com/news/34/25948/singapore-deepens-research-collaboration-in-applied-ai-for-drug-discovery-and-life-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25948/singapore-deepens-research-collaboration-in-applied-ai-for-drug-discovery-and-life-sciences.html</link>
			<pubDate>Mon, 28 Apr 2025 08:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1745820809972-25948.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25948/singapore-deepens-research-collaboration-in-applied-ai-for-drug-discovery-and-life-sciences.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono collaborates with Jorna Therapeutics to generate novel RNA editing therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html</link>
			<pubDate>Tue, 22 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical_banner_with_doctor_holding_tablet_23_2149611236-25918.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25918/japans-ono-collaborates-with-jorna-therapeutics-to-generate-novel-rna-editing-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PRISM BioLab and Elix join forces to accelerate AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html</link>
			<pubDate>Mon, 14 Apr 2025 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ppi-25879.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25879/japans-prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Engine Biosciences and Experimental Drug Development Centre partner to advance cancer therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/25842/engine-biosciences-and-experimental-drug-development-centre-partner-to-advance-cancer-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25842/engine-biosciences-and-experimental-drug-development-centre-partner-to-advance-cancer-therapies.html</link>
			<pubDate>Tue, 08 Apr 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/institute_1pmgg1h2a-25842.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25842/engine-biosciences-and-experimental-drug-development-centre-partner-to-advance-cancer-therapies.html</guid>
		</item>	
				<item>
			<title>HiRO and Hallym University Sacred Heart Hospital to advance drug development in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/34/25756/hiro-and-hallym-university-sacred-heart-hospital-to-advance-drug-development-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25756/hiro-and-hallym-university-sacred-heart-hospital-to-advance-drug-development-in-korea.html</link>
			<pubDate>Fri, 21 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiro-25756.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25756/hiro-and-hallym-university-sacred-heart-hospital-to-advance-drug-development-in-korea.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine secures $110 M Series E financing to advance AI-driven drug discovery innovation</title>
			<atom:link href="https://biospectrumasia.com/news/34/25719/insilico-medicine-secures-110-m-series-e-financing-to-advance-ai-driven-drug-discovery-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25719/insilico-medicine-secures-110-m-series-e-financing-to-advance-ai-driven-drug-discovery-innovation.html</link>
			<pubDate>Thu, 13 Mar 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai-25719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25719/insilico-medicine-secures-110-m-series-e-financing-to-advance-ai-driven-drug-discovery-innovation.html</guid>
		</item>	
				<item>
			<title>Korean firm LG to develop AI model for protein multistate structure prediction</title>
			<atom:link href="https://biospectrumasia.com/news/34/25548/korean-firm-lg-to-develop-ai-model-for-protein-multistate-structure-prediction.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25548/korean-firm-lg-to-develop-ai-model-for-protein-multistate-structure-prediction.html</link>
			<pubDate>Sun, 09 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lg-25548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25548/korean-firm-lg-to-develop-ai-model-for-protein-multistate-structure-prediction.html</guid>
		</item>	
				<item>
			<title>GHIT announces $12.7 M worth investment for developing diagnostics and drugs for malaria, NTDs</title>
			<atom:link href="https://biospectrumasia.com/news/34/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_103927_-25514.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25514/ghit-announces-12-7-m-worth-investment-for-developing-diagnostics-and-drugs-for-malaria-ntds.html</guid>
		</item>	
				<item>
			<title>APAC takes centre-stage in AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/25516/apac-takes-centre-stage-in-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/25516/apac-takes-centre-stage-in-ai-driven-drug-discovery.html</link>
			<pubDate>Sat, 01 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ai-25516.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/25516/apac-takes-centre-stage-in-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>â€œThere remains a high unmet need for new &amp; alternative treatment options for prurigo nodularis &amp; atopic dermatitisâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/25521/there-remains-a-high-unmet-need-for-new-alternative-treatment-options-for-prurigo-nodularis-atopic-dermatitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/25521/there-remains-a-high-unmet-need-for-new-alternative-treatment-options-for-prurigo-nodularis-atopic-dermatitis.html</link>
			<pubDate>Sat, 01 Feb 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gerry_muhle_headshot_1_-25521.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/25521/there-remains-a-high-unmet-need-for-new-alternative-treatment-options-for-prurigo-nodularis-atopic-dermatitis.html</guid>
		</item>	
				<item>
			<title>Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351</title>
			<atom:link href="https://biospectrumasia.com/news/34/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html</link>
			<pubDate>Fri, 31 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_31_1_2025_232244_chugai_pharmabody_com-25525.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25525/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody-aid351.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research</title>
			<atom:link href="https://biospectrumasia.com/news/34/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html</link>
			<pubDate>Wed, 29 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_29_1_2025_121956_en_prnasia_com-25507.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25507/japans-thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery-and-disease-research.html</guid>
		</item>	
				<item>
			<title>AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html</link>
			<pubDate>Tue, 28 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lab-25500.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25500/ab2-bio-signs-licensing-agreement-worth-500-m-with-nippon-shinyaku-for-ultra-rare-autoimmune-disease-treatment.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Inventia announces groundbreaking advancement in 3D cell culture technology</title>
			<atom:link href="https://biospectrumasia.com/news/34/25501/australias-inventia-announces-groundbreaking-advancement-in-3d-cell-culture-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25501/australias-inventia-announces-groundbreaking-advancement-in-3d-cell-culture-technology.html</link>
			<pubDate>Tue, 28 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_28_1_2025_111546_inventia_life-25501.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25501/australias-inventia-announces-groundbreaking-advancement-in-3d-cell-culture-technology.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Daiichi Sankyo establishes Smart research lab in US to expedite drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html</link>
			<pubDate>Thu, 23 Jan 2025 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jap-25476.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25476/japans-daiichi-sankyo-establishes-smart-research-lab-in-us-to-expedite-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html</link>
			<pubDate>Wed, 18 Dec 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-25340.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25340/takeda-tohoku-university-form-alliance-to-strengthen-drug-discovery-capabilities-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai and Biogen Japan collaborate to lead dementia genomics R&amp;D with NCNP in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html</link>
			<pubDate>Tue, 26 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dementia_detected_through_brain_imaging_872147_67724-25258.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25258/eisai-and-biogen-japan-collaborate-to-lead-dementia-genomics-rd-with-ncnp-in-japan.html</guid>
		</item>	
				<item>
			<title>Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC</title>
			<atom:link href="https://biospectrumasia.com/news/34/25155/hong-kong-based-insilico-medicine-enters-into-revolving-loan-facility-of-up-to-100-m-with-hsbc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25155/hong-kong-based-insilico-medicine-enters-into-revolving-loan-facility-of-up-to-100-m-with-hsbc.html</link>
			<pubDate>Tue, 05 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_5_11_2024_134923_www_eurekalert_org-25155.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25155/hong-kong-based-insilico-medicine-enters-into-revolving-loan-facility-of-up-to-100-m-with-hsbc.html</guid>
		</item>	
				<item>
			<title>Biomedical engineers in Australia design high-speed 3D bioprinter as gamechanger for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/25149/biomedical-engineers-in-australia-design-high-speed-3d-bioprinter-as-gamechanger-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25149/biomedical-engineers-in-australia-design-high-speed-3d-bioprinter-as-gamechanger-for-drug-discovery.html</link>
			<pubDate>Mon, 04 Nov 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_11_2024_11409_www_unimelb_edu_au-25149.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25149/biomedical-engineers-in-australia-design-high-speed-3d-bioprinter-as-gamechanger-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/25113/hong-kong-innovation-center-opens-to-provide-one-stop-support-for-early-stage-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25113/hong-kong-innovation-center-opens-to-provide-one-stop-support-for-early-stage-drug-discovery.html</link>
			<pubDate>Wed, 30 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hk-25113.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25113/hong-kong-innovation-center-opens-to-provide-one-stop-support-for-early-stage-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Joint venture company established in Japan to incubate early drug discovery programs</title>
			<atom:link href="https://biospectrumasia.com/news/34/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html</link>
			<pubDate>Tue, 22 Oct 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25056/joint-venture-company-established-in-japan-to-incubate-early-drug-discovery-programs.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences</title>
			<atom:link href="https://biospectrumasia.com/news/34/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html</link>
			<pubDate>Mon, 14 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/adc-25047.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25047/japans-ono-pharma-inks-700-m-adc-deal-with-korean-firm-ligachem-biosciences.html</guid>
		</item>	
				<item>
			<title>Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding</title>
			<atom:link href="https://biospectrumasia.com/news/34/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html</link>
			<pubDate>Sun, 13 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ddd-25042.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25042/japanese-startup-alpha-fusion-accelerates-astatine-based-drug-discovery-with-series-b-funding.html</guid>
		</item>	
				<item>
			<title>World Companion Diagnostics and Liquid Biopsy Summit APAC to Unite 100+ Precision Medicine Experts</title>
			<atom:link href="https://biospectrumasia.com/news/34/25027/world-companion-diagnostics-and-liquid-biopsy-summit-apac-to-unite-100-precision-medicine-experts.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25027/world-companion-diagnostics-and-liquid-biopsy-summit-apac-to-unite-100-precision-medicine-experts.html</link>
			<pubDate>Thu, 10 Oct 2024 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cdx_apac_x_biospectrum_asia_press_release_image-25027.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25027/world-companion-diagnostics-and-liquid-biopsy-summit-apac-to-unite-100-precision-medicine-experts.html</guid>
		</item>	
				<item>
			<title>Eli Lilly invests $4.5 B to create Lilly Medicine Foundry for drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/25001/eli-lilly-invests-4-5-b-to-create-lilly-medicine-foundry-for-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/25001/eli-lilly-invests-4-5-b-to-create-lilly-medicine-foundry-for-drug-development.html</link>
			<pubDate>Fri, 04 Oct 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_4_10_2024_124244_www_lilly_com-25001.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/25001/eli-lilly-invests-4-5-b-to-create-lilly-medicine-foundry-for-drug-development.html</guid>
		</item>	
				<item>
			<title>BIOCHINA 2025: China&#039;s Largest Bio Convention to Host Over 3,000 Biotech Companies</title>
			<atom:link href="https://biospectrumasia.com/news/34/24874/biochina-2025-chinas-largest-bio-convention-to-host-over-3000-biotech-companies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24874/biochina-2025-chinas-largest-bio-convention-to-host-over-3000-biotech-companies.html</link>
			<pubDate>Thu, 12 Sep 2024 12:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/picture_1-24874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24874/biochina-2025-chinas-largest-bio-convention-to-host-over-3000-biotech-companies.html</guid>
		</item>	
				<item>
			<title>Bridge Biotherapeutics &amp; HitGen initiate research collaboration to advance novel cancer therapeutics programme</title>
			<atom:link href="https://biospectrumasia.com/news/34/24756/bridge-biotherapeutics-hitgen-initiate-research-collaboration-to-advance-novel-cancer-therapeutics-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24756/bridge-biotherapeutics-hitgen-initiate-research-collaboration-to-advance-novel-cancer-therapeutics-programme.html</link>
			<pubDate>Sat, 24 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-24756.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24756/bridge-biotherapeutics-hitgen-initiate-research-collaboration-to-advance-novel-cancer-therapeutics-programme.html</guid>
		</item>	
				<item>
			<title>Partnership in China to boost development of antibody drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/24702/partnership-in-china-to-boost-development-of-antibody-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24702/partnership-in-china-to-boost-development-of-antibody-drugs.html</link>
			<pubDate>Wed, 07 Aug 2024 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24702/partnership-in-china-to-boost-development-of-antibody-drugs.html</guid>
		</item>	
				<item>
			<title>Australia invests $2 M to establish Queensland Drug Discovery Alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/24670/australia-invests-2-m-to-establish-queensland-drug-discovery-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24670/australia-invests-2-m-to-establish-queensland-drug-discovery-alliance.html</link>
			<pubDate>Thu, 01 Aug 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_1_8_2024_152918_uniquest_com_au-24670.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24670/australia-invests-2-m-to-establish-queensland-drug-discovery-alliance.html</guid>
		</item>	
				<item>
			<title>AstraZeneca partners with Japanese startup United Immunity for drug delivery tech research</title>
			<atom:link href="https://biospectrumasia.com/news/34/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html</link>
			<pubDate>Tue, 30 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dd-24651.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24651/astrazeneca-partners-with-japanese-startup-united-immunity-for-drug-delivery-tech-research.html</guid>
		</item>	
				<item>
			<title>Innovent and WeComput announce strategic partnership to advance AI-driven drug discovery and development </title>
			<atom:link href="https://biospectrumasia.com/news/34/24629/innovent-and-wecomput-announce-strategic-partnership-to-advance-ai-driven-drug-discovery-and-development-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24629/innovent-and-wecomput-announce-strategic-partnership-to-advance-ai-driven-drug-discovery-and-development-.html</link>
			<pubDate>Fri, 26 Jul 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24629/innovent-and-wecomput-announce-strategic-partnership-to-advance-ai-driven-drug-discovery-and-development-.html</guid>
		</item>	
				<item>
			<title>Innovations in Pharmaceutical Drug Delivery Systems</title>
			<atom:link href="https://biospectrumasia.com/news/34/24715/innovations-in-pharmaceutical-drug-delivery-systems.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24715/innovations-in-pharmaceutical-drug-delivery-systems.html</link>
			<pubDate>Sat, 13 Jul 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/8miepnanomedicine_777-24715.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24715/innovations-in-pharmaceutical-drug-delivery-systems.html</guid>
		</item>	
				<item>
			<title>Scientists in Australia invent new AI tool for rapid and cost-effective drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/24453/scientists-in-australia-invent-new-ai-tool-for-rapid-and-cost-effective-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24453/scientists-in-australia-invent-new-ai-tool-for-rapid-and-cost-effective-drug-discovery.html</link>
			<pubDate>Wed, 19 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_19_6_2024_15927_www_monash_edu-24453.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24453/scientists-in-australia-invent-new-ai-tool-for-rapid-and-cost-effective-drug-discovery.html</guid>
		</item>	
				<item>
			<title>AbbVie inks deal worth $1.56 B with China&#039;s FutureGen to develop IBD therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/24435/abbvie-inks-deal-worth-1-56-b-with-chinas-futuregen-to-develop-ibd-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24435/abbvie-inks-deal-worth-1-56-b-with-chinas-futuregen-to-develop-ibd-therapy.html</link>
			<pubDate>Mon, 17 Jun 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmaa-24435.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24435/abbvie-inks-deal-worth-1-56-b-with-chinas-futuregen-to-develop-ibd-therapy.html</guid>
		</item>	
				<item>
			<title>Kissei grants Korean rights for GnRH antagonist Linzagolix to JW Pharmaceutical </title>
			<atom:link href="https://biospectrumasia.com/news/34/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html</link>
			<pubDate>Thu, 13 Jun 2024 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24429/kissei-grants-korean-rights-for-gnrh-antagonist-linzagolix-to-jw-pharmaceutical-.html</guid>
		</item>	
				<item>
			<title>Eisai expands venture investment to 4 billion yen to accelerate drug discovery innovation</title>
			<atom:link href="https://biospectrumasia.com/news/34/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html</link>
			<pubDate>Tue, 04 Jun 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24372/eisai-expands-venture-investment-to-4-billion-yen-to-accelerate-drug-discovery-innovation.html</guid>
		</item>	
				<item>
			<title>Oncocross expands collaboration with JW Pharma for AI-based oncology drug discovery in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/34/24309/oncocross-expands-collaboration-with-jw-pharma-for-ai-based-oncology-drug-discovery-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24309/oncocross-expands-collaboration-with-jw-pharma-for-ai-based-oncology-drug-discovery-in-korea.html</link>
			<pubDate>Mon, 27 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screenshot_27_5_2024_223021_www_oncocross_com-24309.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24309/oncocross-expands-collaboration-with-jw-pharma-for-ai-based-oncology-drug-discovery-in-korea.html</guid>
		</item>	
				<item>
			<title>$8 million funding for a new centre for pancreatic cancer in Australia </title>
			<atom:link href="https://biospectrumasia.com/news/34/24291/8-million-funding-for-a-new-centre-for-pancreatic-cancer-in-australia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24291/8-million-funding-for-a-new-centre-for-pancreatic-cancer-in-australia-.html</link>
			<pubDate>Thu, 23 May 2024 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24291/8-million-funding-for-a-new-centre-for-pancreatic-cancer-in-australia-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Shionogi announces $150 M deal to develop first oral therapy for Pompe Disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html</link>
			<pubDate>Mon, 13 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pill-24225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24225/japans-shionogi-announces-150-m-deal-to-develop-first-oral-therapy-for-pompe-disease.html</guid>
		</item>	
				<item>
			<title>UQ develops new drug for sepsis</title>
			<atom:link href="https://biospectrumasia.com/news/34/24222/uq-develops-new-drug-for-sepsis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24222/uq-develops-new-drug-for-sepsis.html</link>
			<pubDate>Fri, 10 May 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24222/uq-develops-new-drug-for-sepsis.html</guid>
		</item>	
				<item>
			<title>Singapore scientists develop high-precision tissue analysis AI tool to support drug discovery, diagnosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/24204/singapore-scientists-develop-high-precision-tissue-analysis-ai-tool-to-support-drug-discovery-diagnosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24204/singapore-scientists-develop-high-precision-tissue-analysis-ai-tool-to-support-drug-discovery-diagnosis.html</link>
			<pubDate>Wed, 08 May 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/senior_woaman_biochemist_checking_manifestations_virus_working_modern_equipped_laboratory_team_doctors_examining_vaccine_evolution_using_high_tech_researching_diagnosis_against_covid19_482257_3744-24204.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24204/singapore-scientists-develop-high-precision-tissue-analysis-ai-tool-to-support-drug-discovery-diagnosis.html</guid>
		</item>	
				<item>
			<title>Japanese Foundation for Cancer Research collaborates with Takeda Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html</link>
			<pubDate>Wed, 24 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-24119.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24119/japanese-foundation-for-cancer-research-collaborates-with-takeda-pharma.html</guid>
		</item>	
				<item>
			<title>invoX Pharma and Insilico Medicine partner to enhance R&amp;D using AI</title>
			<atom:link href="https://biospectrumasia.com/news/34/24120/invox-pharma-and-insilico-medicine-partner-to-enhance-rd-using-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24120/invox-pharma-and-insilico-medicine-partner-to-enhance-rd-using-ai.html</link>
			<pubDate>Wed, 24 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-24120.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24120/invox-pharma-and-insilico-medicine-partner-to-enhance-rd-using-ai.html</guid>
		</item>	
				<item>
			<title>Takeda, Astellas and Sumitomo to establish JV for drug discovery programmes in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html</link>
			<pubDate>Tue, 23 Apr 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pill-24112.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/24112/takeda-astellas-and-sumitomo-to-establish-jv-for-drug-discovery-programmes-in-japan.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sosei Heptares inks â‚¬750 M deal with Boehringer Ingelheim for schizophrenia treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html</link>
			<pubDate>Tue, 12 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sz-23913.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23913/japans-sosei-heptares-inks-750-m-deal-with-boehringer-ingelheim-for-schizophrenia-treatment.html</guid>
		</item>	
				<item>
			<title>China Life Science Conference and China Life Science Expo (CILSE) Set to Drive Innovation and Collaboration in Guangzhou</title>
			<atom:link href="https://biospectrumasia.com/news/34/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html</link>
			<pubDate>Thu, 07 Mar 2024 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23888/china-life-science-conference-and-china-life-science-expo-cilse-set-to-drive-innovation-and-collaboration-in-guangzhou.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s BioGate Precision Medicine Corp develops pancreatic cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/23885/taiwans-biogate-precision-medicine-corp-develops-pancreatic-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23885/taiwans-biogate-precision-medicine-corp-develops-pancreatic-cancer-therapy.html</link>
			<pubDate>Thu, 07 Mar 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1af4c351_a0bd_4510_800f_ca12a895d6aa-23885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23885/taiwans-biogate-precision-medicine-corp-develops-pancreatic-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>European firm Iktos opens a subsidiary in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html</link>
			<pubDate>Thu, 15 Feb 2024 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23755/european-firm-iktos-opens-a-subsidiary-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda, Dundee and Cambridge reunite in fight against dementia</title>
			<atom:link href="https://biospectrumasia.com/news/34/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html</link>
			<pubDate>Wed, 14 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dementia-23742.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23742/takeda-dundee-and-cambridge-reunite-in-fight-against-dementia.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Chugai to position Singapore subsidiary as permanent global drug discovery research centre</title>
			<atom:link href="https://biospectrumasia.com/news/34/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html</link>
			<pubDate>Mon, 05 Feb 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibody-23677.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23677/japans-chugai-to-position-singapore-subsidiary-as-permanent-global-drug-discovery-research-centre.html</guid>
		</item>	
				<item>
			<title>Nikon builds new research hubs in US &amp; Japan to support for drug discovery and innovation</title>
			<atom:link href="https://biospectrumasia.com/news/34/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html</link>
			<pubDate>Fri, 26 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nikon-23632.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23632/nikon-builds-new-research-hubs-in-us-japan-to-support-for-drug-discovery-and-innovation.html</guid>
		</item>	
				<item>
			<title>Sanyou Biopharma launches Super Trillion Peptide Molecule Discovery Platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/23605/sanyou-biopharma-launches-super-trillion-peptide-molecule-discovery-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23605/sanyou-biopharma-launches-super-trillion-peptide-molecule-discovery-platform.html</link>
			<pubDate>Mon, 22 Jan 2024 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-23605.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23605/sanyou-biopharma-launches-super-trillion-peptide-molecule-discovery-platform.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Ono Pharma enters into research collaboration with UK Dementia Research Institute</title>
			<atom:link href="https://biospectrumasia.com/news/34/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html</link>
			<pubDate>Thu, 21 Dec 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23504.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23504/japans-ono-pharma-enters-into-research-collaboration-with-uk-dementia-research-institute.html</guid>
		</item>	
				<item>
			<title>Japanese firm PRISM BioLab inks $660 M drug discovery pact with Eli Lilly</title>
			<atom:link href="https://biospectrumasia.com/news/34/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html</link>
			<pubDate>Thu, 30 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-23404.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23404/japanese-firm-prism-biolab-inks-660-m-drug-discovery-pact-with-eli-lilly.html</guid>
		</item>	
				<item>
			<title>Laxxon Medical joins German Accelerator&#039;s Southeast Asia Market Access Class of 2023</title>
			<atom:link href="https://biospectrumasia.com/news/34/23364/laxxon-medical-joins-german-accelerators-southeast-asia-market-access-class-of-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23364/laxxon-medical-joins-german-accelerators-southeast-asia-market-access-class-of-2023.html</link>
			<pubDate>Wed, 22 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_197722757-23364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23364/laxxon-medical-joins-german-accelerators-southeast-asia-market-access-class-of-2023.html</guid>
		</item>	
				<item>
			<title>Partnership in Japan for for mRNA drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html</link>
			<pubDate>Mon, 20 Nov 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23349/partnership-in-japan-for-for-mrna-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Astellas Pharma &amp; University of Tsukuba partner to create new drug discovery startups</title>
			<atom:link href="https://biospectrumasia.com/news/34/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html</link>
			<pubDate>Fri, 17 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-23333.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23333/japans-astellas-pharma-university-of-tsukuba-partner-to-create-new-drug-discovery-startups.html</guid>
		</item>	
				<item>
			<title>Japan-Singapore partnership to accelerate innovation in drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html</link>
			<pubDate>Tue, 07 Nov 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-23279.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23279/japan-singapore-partnership-to-accelerate-innovation-in-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japanese firms Fujitsu and TOPPAN Holdings collaborate to expand medical big data business</title>
			<atom:link href="https://biospectrumasia.com/news/34/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html</link>
			<pubDate>Thu, 19 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/data-23176.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23176/japanese-firms-fujitsu-and-toppan-holdings-collaborate-to-expand-medical-big-data-business.html</guid>
		</item>	
				<item>
			<title>Monash University joins forces with spin-out Orio Therapeutics to transform regenerative medicine</title>
			<atom:link href="https://biospectrumasia.com/news/34/23136/monash-university-joins-forces-with-spin-out-orio-therapeutics-to-transform-regenerative-medicine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23136/monash-university-joins-forces-with-spin-out-orio-therapeutics-to-transform-regenerative-medicine.html</link>
			<pubDate>Tue, 10 Oct 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23136/monash-university-joins-forces-with-spin-out-orio-therapeutics-to-transform-regenerative-medicine.html</guid>
		</item>	
				<item>
			<title>Japan-based Fujitsu and RIKEN develop AI drug discovery technology utilising generative AI </title>
			<atom:link href="https://biospectrumasia.com/news/34/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html</link>
			<pubDate>Tue, 10 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23137.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23137/japan-based-fujitsu-and-riken-develop-ai-drug-discovery-technology-utilising-generative-ai-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Kyushu University signs strategic partnership agreement with GSK</title>
			<atom:link href="https://biospectrumasia.com/news/34/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html</link>
			<pubDate>Mon, 09 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-23118.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23118/japans-kyushu-university-signs-strategic-partnership-agreement-with-gsk.html</guid>
		</item>	
				<item>
			<title>First-of-its-kind partnership in Singapore to advance drug discovery </title>
			<atom:link href="https://biospectrumasia.com/news/34/23114/first-of-its-kind-partnership-in-singapore-to-advance-drug-discovery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23114/first-of-its-kind-partnership-in-singapore-to-advance-drug-discovery-.html</link>
			<pubDate>Fri, 06 Oct 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-23114.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23114/first-of-its-kind-partnership-in-singapore-to-advance-drug-discovery-.html</guid>
		</item>	
				<item>
			<title>Leveraging data intelligence for precision drug development</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/23090/leveraging-data-intelligence-for-precision-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/23090/leveraging-data-intelligence-for-precision-drug-development.html</link>
			<pubDate>Fri, 29 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sebastian_bather_gm_asia_veeva_systems-23090.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/23090/leveraging-data-intelligence-for-precision-drug-development.html</guid>
		</item>	
				<item>
			<title>BioCurate and Takeda renew alliance to accelerate discoveries of new drugs and therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html</link>
			<pubDate>Sun, 24 Sep 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23054/biocurate-and-takeda-renew-alliance-to-accelerate-discoveries-of-new-drugs-and-therapeutics.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/34/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html</link>
			<pubDate>Wed, 20 Sep 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6-23042.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/23042/japans-peptidream-inks-40-m-deal-with-genentech-for-novel-peptide-radioisotope-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Chinese firms lay focus on AI for drug discovery </title>
			<atom:link href="https://biospectrumasia.com/news/34/22913/chinese-firms-lay-focus-on-ai-for-drug-discovery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22913/chinese-firms-lay-focus-on-ai-for-drug-discovery-.html</link>
			<pubDate>Thu, 24 Aug 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22913/chinese-firms-lay-focus-on-ai-for-drug-discovery-.html</guid>
		</item>	
				<item>
			<title>Korea-US partnership to revolutionise AI-based early drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/22868/korea-us-partnership-to-revolutionise-ai-based-early-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22868/korea-us-partnership-to-revolutionise-ai-based-early-drug-discovery.html</link>
			<pubDate>Wed, 16 Aug 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22868.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22868/korea-us-partnership-to-revolutionise-ai-based-early-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Otsuka Unit Astex, expands $35 million drug discovery collaboration with Merck</title>
			<atom:link href="https://biospectrumasia.com/news/34/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html</link>
			<pubDate>Fri, 11 Aug 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22870/otsuka-unit-astex-expands-35-million-drug-discovery-collaboration-with-merck.html</guid>
		</item>	
				<item>
			<title>Japan-based Chugai Pharma and Omron focus on automation for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html</link>
			<pubDate>Mon, 17 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-22736.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22736/japan-based-chugai-pharma-and-omron-focus-on-automation-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>AI &amp; Biotech- Transforming each other!</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/22691/ai-biotech-transforming-each-other.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/22691/ai-biotech-transforming-each-other.html</link>
			<pubDate>Wed, 05 Jul 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/32-22691.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/22691/ai-biotech-transforming-each-other.html</guid>
		</item>	
				<item>
			<title>XtalPi partners with Lilly, using AI + Robotics to uncover first-in-class therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/22548/xtalpi-partners-with-lilly-using-ai-robotics-to-uncover-first-in-class-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22548/xtalpi-partners-with-lilly-using-ai-robotics-to-uncover-first-in-class-therapeutics.html</link>
			<pubDate>Mon, 05 Jun 2023 19:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22548/xtalpi-partners-with-lilly-using-ai-robotics-to-uncover-first-in-class-therapeutics.html</guid>
		</item>	
				<item>
			<title>University of Sydney inks MoU with Pharos Therapeutics for AI-based drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/22528/university-of-sydney-inks-mou-with-pharos-therapeutics-for-ai-based-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22528/university-of-sydney-inks-mou-with-pharos-therapeutics-for-ai-based-drug-discovery.html</link>
			<pubDate>Wed, 31 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aus-22528.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22528/university-of-sydney-inks-mou-with-pharos-therapeutics-for-ai-based-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Japan govt injects $200M to support third phase operations of GHIT Fund</title>
			<atom:link href="https://biospectrumasia.com/news/34/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html</link>
			<pubDate>Fri, 26 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22495.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22495/japan-govt-injects-200m-to-support-third-phase-operations-of-ghit-fund.html</guid>
		</item>	
				<item>
			<title>Korea-US partnership to co-develop therapy for Parkinson&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/22501/korea-us-partnership-to-co-develop-therapy-for-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22501/korea-us-partnership-to-co-develop-therapy-for-parkinsons-disease.html</link>
			<pubDate>Fri, 26 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22501.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22501/korea-us-partnership-to-co-develop-therapy-for-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Korean firm Avixgen to expedite drug pipeline development and pursue IPO in 2025 </title>
			<atom:link href="https://biospectrumasia.com/news/34/22490/korean-firm-avixgen-to-expedite-drug-pipeline-development-and-pursue-ipo-in-2025-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22490/korean-firm-avixgen-to-expedite-drug-pipeline-development-and-pursue-ipo-in-2025-.html</link>
			<pubDate>Thu, 25 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22490.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22490/korean-firm-avixgen-to-expedite-drug-pipeline-development-and-pursue-ipo-in-2025-.html</guid>
		</item>	
				<item>
			<title>Biodrug Design Accelerator platform launches in Japan to accelerate peptide drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html</link>
			<pubDate>Thu, 18 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22453.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22453/biodrug-design-accelerator-platform-launches-in-japan-to-accelerate-peptide-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/34/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html</link>
			<pubDate>Fri, 12 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-22431.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22431/japans-otsuka-pharma-gets-us-fda-nod-for-drug-to-treat-agitation-during-alzheimers.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html</link>
			<pubDate>Mon, 08 May 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-22413.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22413/japans-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Daewoong Pharma inks $477 M deal with US partner for autoimmune disease treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/22358/koreas-daewoong-pharma-inks-477-m-deal-with-us-partner-for-autoimmune-disease-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22358/koreas-daewoong-pharma-inks-477-m-deal-with-us-partner-for-autoimmune-disease-treatment.html</link>
			<pubDate>Fri, 28 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/korea-22358.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22358/koreas-daewoong-pharma-inks-477-m-deal-with-us-partner-for-autoimmune-disease-treatment.html</guid>
		</item>	
				<item>
			<title>New drug discovery research collaboration between Korea &amp; UK</title>
			<atom:link href="https://biospectrumasia.com/news/34/22307/new-drug-discovery-research-collaboration-between-korea-uk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22307/new-drug-discovery-research-collaboration-between-korea-uk.html</link>
			<pubDate>Wed, 19 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22307.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22307/new-drug-discovery-research-collaboration-between-korea-uk.html</guid>
		</item>	
				<item>
			<title>Eisai invests Â¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html</link>
			<pubDate>Sat, 08 Apr 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22244.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22244/eisai-invests-8-5-b-to-revamp-tsukuba-research-laboratories-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese firm Takeda Pharma inks $415 M deal for celiac disease research</title>
			<atom:link href="https://biospectrumasia.com/news/34/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html</link>
			<pubDate>Mon, 03 Apr 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celiac-22214.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22214/japanese-firm-takeda-pharma-inks-415-m-deal-for-celiac-disease-research.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s NEC establishes European subsidiaries for strengthening global AI drug development biz</title>
			<atom:link href="https://biospectrumasia.com/news/34/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html</link>
			<pubDate>Fri, 31 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-22201.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22201/japans-nec-establishes-european-subsidiaries-for-strengthening-global-ai-drug-development-biz.html</guid>
		</item>	
				<item>
			<title>GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases </title>
			<atom:link href="https://biospectrumasia.com/news/34/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html</link>
			<pubDate>Thu, 30 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ntd-22189.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22189/ghit-fund-in-japan-invests-2-9-m-for-treatment-of-neglected-tropical-diseases-.html</guid>
		</item>	
				<item>
			<title>Collaboration in Korea to develop innovative therapeutic antibodies</title>
			<atom:link href="https://biospectrumasia.com/news/34/22115/collaboration-in-korea-to-develop-innovative-therapeutic-antibodies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22115/collaboration-in-korea-to-develop-innovative-therapeutic-antibodies.html</link>
			<pubDate>Fri, 17 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-22115.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22115/collaboration-in-korea-to-develop-innovative-therapeutic-antibodies.html</guid>
		</item>	
				<item>
			<title>Australia achieves clinical trial success for psoriasis drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/22107/australia-achieves-clinical-trial-success-for-psoriasis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22107/australia-achieves-clinical-trial-success-for-psoriasis-drug.html</link>
			<pubDate>Wed, 15 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-22107.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22107/australia-achieves-clinical-trial-success-for-psoriasis-drug.html</guid>
		</item>	
				<item>
			<title>Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/34/22096/breakthrough-neurological-drug-comes-from-new-zealand-to-treat-rett-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22096/breakthrough-neurological-drug-comes-from-new-zealand-to-treat-rett-syndrome.html</link>
			<pubDate>Mon, 13 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-22096.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22096/breakthrough-neurological-drug-comes-from-new-zealand-to-treat-rett-syndrome.html</guid>
		</item>	
				<item>
			<title>Australia to launch revolutionary new cholesterol drug in next two years</title>
			<atom:link href="https://biospectrumasia.com/news/34/22065/australia-to-launch-revolutionary-new-cholesterol-drug-in-next-two-years.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/22065/australia-to-launch-revolutionary-new-cholesterol-drug-in-next-two-years.html</link>
			<pubDate>Tue, 07 Mar 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aus-22065.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/22065/australia-to-launch-revolutionary-new-cholesterol-drug-in-next-two-years.html</guid>
		</item>	
				<item>
			<title>Japanese firms Teijin and Axcelead establish joint venture for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html</link>
			<pubDate>Thu, 23 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-21980.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21980/japanese-firms-teijin-and-axcelead-establish-joint-venture-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Inventia partners with Merck to develop 3D models for neuro disease drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/21952/australias-inventia-partners-with-merck-to-develop-3d-models-for-neuro-disease-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21952/australias-inventia-partners-with-merck-to-develop-3d-models-for-neuro-disease-drug-discovery.html</link>
			<pubDate>Fri, 17 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d-21952.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21952/australias-inventia-partners-with-merck-to-develop-3d-models-for-neuro-disease-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Advances in Oncology Drug Development</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/21900/advances-in-oncology-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/21900/advances-in-oncology-drug-development.html</link>
			<pubDate>Tue, 07 Feb 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clarivate-21900.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/21900/advances-in-oncology-drug-development.html</guid>
		</item>	
				<item>
			<title>New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer  </title>
			<atom:link href="https://biospectrumasia.com/news/34/21809/new-study-uses-alphafold-and-ai-to-accelerate-design-of-novel-drug-for-liver-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21809/new-study-uses-alphafold-and-ai-to-accelerate-design-of-novel-drug-for-liver-cancer-.html</link>
			<pubDate>Fri, 20 Jan 2023 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21809/new-study-uses-alphafold-and-ai-to-accelerate-design-of-novel-drug-for-liver-cancer-.html</guid>
		</item>	
				<item>
			<title>&quot;We&#039;re dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial&quot;</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/21775/were-dedicated-to-multiple-sclerosis-with-two-approved-therapies-and-evobrutinib-currently-in-phase-3-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/21775/were-dedicated-to-multiple-sclerosis-with-two-approved-therapies-and-evobrutinib-currently-in-phase-3-trial.html</link>
			<pubDate>Mon, 16 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-21775.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/21775/were-dedicated-to-multiple-sclerosis-with-two-approved-therapies-and-evobrutinib-currently-in-phase-3-trial.html</guid>
		</item>	
				<item>
			<title>Otsuka and SchrÃ¶dinger announce single-target, drug discovery partnership in neurology</title>
			<atom:link href="https://biospectrumasia.com/news/34/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html</link>
			<pubDate>Fri, 13 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/5-21762.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21762/otsuka-and-schrdinger-announce-single-target-drug-discovery-partnership-in-neurology.html</guid>
		</item>	
				<item>
			<title>BioNTech expands by leveraging AI-powered Drug discovery, design and development </title>
			<atom:link href="https://biospectrumasia.com/news/34/21746/biontech-expands-by-leveraging-ai-powered-drug-discovery-design-and-development-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21746/biontech-expands-by-leveraging-ai-powered-drug-discovery-design-and-development-.html</link>
			<pubDate>Wed, 11 Jan 2023 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-21746.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21746/biontech-expands-by-leveraging-ai-powered-drug-discovery-design-and-development-.html</guid>
		</item>	
				<item>
			<title>Japanese startup Veritas In Silico inks new partnership for mRNA-targeted small molecule drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html</link>
			<pubDate>Fri, 30 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21690.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21690/japanese-startup-veritas-in-silico-inks-new-partnership-for-mrna-targeted-small-molecule-drug-discovery.html</guid>
		</item>	
				<item>
			<title>China-based startup XtalPi joins hands with Singapore&#039;s national platform for cancer drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/21648/china-based-startup-xtalpi-joins-hands-with-singapores-national-platform-for-cancer-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21648/china-based-startup-xtalpi-joins-hands-with-singapores-national-platform-for-cancer-drug-discovery.html</link>
			<pubDate>Wed, 21 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-21648.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21648/china-based-startup-xtalpi-joins-hands-with-singapores-national-platform-for-cancer-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares &amp; Eli Lilly ink $730 M deal for treatment of diabetes and metabolic diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html</link>
			<pubDate>Tue, 20 Dec 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-21636.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21636/sosei-heptares-eli-lilly-ink-730-m-deal-for-treatment-of-diabetes-and-metabolic-diseases.html</guid>
		</item>	
				<item>
			<title>GARDP and Mitsubishi Tanabe Pharma Corporation announce partnership in search for new antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/34/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html</link>
			<pubDate>Mon, 28 Nov 2022 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21502/gardp-and-mitsubishi-tanabe-pharma-corporation-announce-partnership-in-search-for-new-antibiotics.html</guid>
		</item>	
				<item>
			<title>GARDP and Sumitomo Pharma announce partnership in search for new antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/34/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html</link>
			<pubDate>Thu, 24 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anti-21488.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21488/gardp-and-sumitomo-pharma-announce-partnership-in-search-for-new-antibiotics.html</guid>
		</item>	
				<item>
			<title>NextCure and LegoChem Biosciences partner to develop antibody drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/34/21447/nextcure-and-legochem-biosciences-partner-to-develop-antibody-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21447/nextcure-and-legochem-biosciences-partner-to-develop-antibody-drug-conjugates.html</link>
			<pubDate>Wed, 16 Nov 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21447/nextcure-and-legochem-biosciences-partner-to-develop-antibody-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Chugai extends R&amp;D collaboration in Singapore earmarking S$282M over next 5 years</title>
			<atom:link href="https://biospectrumasia.com/company-results/34/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/34/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html</link>
			<pubDate>Wed, 16 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_6_-21452.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/34/21452/chugai-extends-rd-collaboration-in-singapore-earmarking-s282m-over-next-5-years.html</guid>
		</item>	
				<item>
			<title>Korea Drug Development Fund invests in novel oncology candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/21429/korea-drug-development-fund-invests-in-novel-oncology-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21429/korea-drug-development-fund-invests-in-novel-oncology-candidate.html</link>
			<pubDate>Tue, 15 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/korea-21429.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21429/korea-drug-development-fund-invests-in-novel-oncology-candidate.html</guid>
		</item>	
				<item>
			<title>Ono Pharma inks neuro drug discovery collaboration with Captor Therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/34/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html</link>
			<pubDate>Tue, 15 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-21441.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21441/ono-pharma-inks-neuro-drug-discovery-collaboration-with-captor-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Ono Pharmaceutical inks immuno-oncology partnership with Memo Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html</link>
			<pubDate>Fri, 04 Nov 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-21375.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21375/ono-pharmaceutical-inks-immuno-oncology-partnership-with-memo-therapeutics.html</guid>
		</item>	
				<item>
			<title>Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan</title>
			<atom:link href="https://biospectrumasia.com/news/34/21104/bora-pharma-partners-with-tairx-to-manufacture-breakthrough-anticancer-drug-in-taiwan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21104/bora-pharma-partners-with-tairx-to-manufacture-breakthrough-anticancer-drug-in-taiwan.html</link>
			<pubDate>Mon, 26 Sep 2022 02:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-21104.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21104/bora-pharma-partners-with-tairx-to-manufacture-breakthrough-anticancer-drug-in-taiwan.html</guid>
		</item>	
				<item>
			<title>Huawei Cloud&#039;s Pangu drug molecule model accelerates new drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/21062/huawei-clouds-pangu-drug-molecule-model-accelerates-new-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/21062/huawei-clouds-pangu-drug-molecule-model-accelerates-new-drug-discovery.html</link>
			<pubDate>Mon, 19 Sep 2022 00:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-21062.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/21062/huawei-clouds-pangu-drug-molecule-model-accelerates-new-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Vietnam researchers develop probiotics of the next generation for respiratory infections</title>
			<atom:link href="https://biospectrumasia.com/news/34/20887/vietnam-researchers-develop-probiotics-of-the-next-generation-for-respiratory-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20887/vietnam-researchers-develop-probiotics-of-the-next-generation-for-respiratory-infections.html</link>
			<pubDate>Wed, 17 Aug 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20887/vietnam-researchers-develop-probiotics-of-the-next-generation-for-respiratory-infections.html</guid>
		</item>	
				<item>
			<title>Innovent Biologics, Sanofi to develop cancer medicines for China</title>
			<atom:link href="https://biospectrumasia.com/news/34/20826/innovent-biologics-sanofi-to-develop-cancer-medicines-for-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20826/innovent-biologics-sanofi-to-develop-cancer-medicines-for-china.html</link>
			<pubDate>Fri, 05 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20826.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20826/innovent-biologics-sanofi-to-develop-cancer-medicines-for-china.html</guid>
		</item>	
				<item>
			<title>Singapore develops new compounds to kill multi drug-resistant TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/20815/singapore-develops-new-compounds-to-kill-multi-drug-resistant-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20815/singapore-develops-new-compounds-to-kill-multi-drug-resistant-tb.html</link>
			<pubDate>Thu, 04 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3-20815.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20815/singapore-develops-new-compounds-to-kill-multi-drug-resistant-tb.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and AbbVie enter new multi-target collaboration worth $1.2 B</title>
			<atom:link href="https://biospectrumasia.com/news/34/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html</link>
			<pubDate>Wed, 03 Aug 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20816.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20816/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration-worth-1-2-b.html</guid>
		</item>	
				<item>
			<title>LoQus23 and HitGen announce research collaboration focused on DNA-encoded library based drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/20780/loqus23-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20780/loqus23-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery.html</link>
			<pubDate>Thu, 28 Jul 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20780/loqus23-and-hitgen-announce-research-collaboration-focused-on-dna-encoded-library-based-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Singapore develops drug molecule for treating atrial fibrillation</title>
			<atom:link href="https://biospectrumasia.com/news/34/20707/singapore-develops-drug-molecule-for-treating-atrial-fibrillation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20707/singapore-develops-drug-molecule-for-treating-atrial-fibrillation.html</link>
			<pubDate>Mon, 18 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20707.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20707/singapore-develops-drug-molecule-for-treating-atrial-fibrillation.html</guid>
		</item>	
				<item>
			<title>Japanese startup Elix introduces &#039;all-in-one&#039; platform for AI drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html</link>
			<pubDate>Fri, 15 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-20698.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20698/japanese-startup-elix-introduces-all-in-one-platform-for-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Eurofins DiscoverX expands APAC operations with new biotech office in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/20597/eurofins-discoverx-expands-apac-operations-with-new-biotech-office-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20597/eurofins-discoverx-expands-apac-operations-with-new-biotech-office-in-china.html</link>
			<pubDate>Mon, 04 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_11_-20597.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20597/eurofins-discoverx-expands-apac-operations-with-new-biotech-office-in-china.html</guid>
		</item>	
				<item>
			<title>Singapore approves GSK&#039;s new cancer therapy for ovarian cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/20600/singapore-approves-gsks-new-cancer-therapy-for-ovarian-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20600/singapore-approves-gsks-new-cancer-therapy-for-ovarian-cancer.html</link>
			<pubDate>Mon, 04 Jul 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20600.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20600/singapore-approves-gsks-new-cancer-therapy-for-ovarian-cancer.html</guid>
		</item>	
				<item>
			<title>Starpharma signs expanded DEP research agreement with Roche</title>
			<atom:link href="https://biospectrumasia.com/news/34/20578/starpharma-signs-expanded-dep-research-agreement-with-roche.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20578/starpharma-signs-expanded-dep-research-agreement-with-roche.html</link>
			<pubDate>Tue, 28 Jun 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20578/starpharma-signs-expanded-dep-research-agreement-with-roche.html</guid>
		</item>	
				<item>
			<title>META Pharmaceuticals, raises $15M to accelerate its pipeline development</title>
			<atom:link href="https://biospectrumasia.com/news/34/20505/meta-pharmaceuticals-raises-15m-to-accelerate-its-pipeline-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20505/meta-pharmaceuticals-raises-15m-to-accelerate-its-pipeline-development.html</link>
			<pubDate>Wed, 15 Jun 2022 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20505/meta-pharmaceuticals-raises-15m-to-accelerate-its-pipeline-development.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Hanall Biopharma&#039;s US partner to expand batoclimab&#039;s indications</title>
			<atom:link href="https://biospectrumasia.com/news/34/20478/koreas-hanall-biopharmas-us-partner-to-expand-batoclimabs-indications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20478/koreas-hanall-biopharmas-us-partner-to-expand-batoclimabs-indications.html</link>
			<pubDate>Fri, 10 Jun 2022 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20478/koreas-hanall-biopharmas-us-partner-to-expand-batoclimabs-indications.html</guid>
		</item>	
				<item>
			<title>ILIAS Biologics signed an MOU with HK inno.N for joint research</title>
			<atom:link href="https://biospectrumasia.com/news/34/20437/ilias-biologics-signed-an-mou-with-hk-inno-n-for-joint-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20437/ilias-biologics-signed-an-mou-with-hk-inno-n-for-joint-research.html</link>
			<pubDate>Mon, 06 Jun 2022 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20437/ilias-biologics-signed-an-mou-with-hk-inno-n-for-joint-research.html</guid>
		</item>	
				<item>
			<title>Korean startups ILIAS Biologics and HK inno.N join hands for new biomedicines</title>
			<atom:link href="https://biospectrumasia.com/news/34/20438/korean-startups-ilias-biologics-and-hk-inno-n-join-hands-for-new-biomedicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20438/korean-startups-ilias-biologics-and-hk-inno-n-join-hands-for-new-biomedicines.html</link>
			<pubDate>Mon, 06 Jun 2022 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_130099715-20438.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20438/korean-startups-ilias-biologics-and-hk-inno-n-join-hands-for-new-biomedicines.html</guid>
		</item>	
				<item>
			<title>Japanese startup LUCA Science raises $30.3 M in Series B funding </title>
			<atom:link href="https://biospectrumasia.com/news/34/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html</link>
			<pubDate>Mon, 06 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20436.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20436/japanese-startup-luca-science-raises-30-3-m-in-series-b-funding-.html</guid>
		</item>	
				<item>
			<title>Sanyou launches Super-Trillion Innovative Antibody Drug Discovery Platform (STAL)</title>
			<atom:link href="https://biospectrumasia.com/news/34/20427/sanyou-launches-super-trillion-innovative-antibody-drug-discovery-platform-stal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20427/sanyou-launches-super-trillion-innovative-antibody-drug-discovery-platform-stal.html</link>
			<pubDate>Fri, 03 Jun 2022 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20427/sanyou-launches-super-trillion-innovative-antibody-drug-discovery-platform-stal.html</guid>
		</item>	
				<item>
			<title>Standigm signs MOU with Merck Korea for AI drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/20417/standigm-signs-mou-with-merck-korea-for-ai-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20417/standigm-signs-mou-with-merck-korea-for-ai-drug-discovery-research.html</link>
			<pubDate>Thu, 02 Jun 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-20417.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20417/standigm-signs-mou-with-merck-korea-for-ai-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>MGI and King Abdullah International Medical Research Center partner for Genomic Research</title>
			<atom:link href="https://biospectrumasia.com/news/34/20409/mgi-and-king-abdullah-international-medical-research-center-partner-for-genomic-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20409/mgi-and-king-abdullah-international-medical-research-center-partner-for-genomic-research.html</link>
			<pubDate>Wed, 01 Jun 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20409/mgi-and-king-abdullah-international-medical-research-center-partner-for-genomic-research.html</guid>
		</item>	
				<item>
			<title>Sirnaomics launches Phase I clinical trial of RNAi Therapeutic STP705 </title>
			<atom:link href="https://biospectrumasia.com/news/34/20400/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20400/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html</link>
			<pubDate>Tue, 31 May 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20400/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html</guid>
		</item>	
				<item>
			<title>Sirnaomics launches Phase I clinical trial of RNAi Therapeutic STP705 </title>
			<atom:link href="https://biospectrumasia.com/news/34/20401/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20401/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html</link>
			<pubDate>Tue, 31 May 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20401/sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-.html</guid>
		</item>	
				<item>
			<title>China&#039;s Zelixir Biotech predicts monkeypox protein structures for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/20404/chinas-zelixir-biotech-predicts-monkeypox-protein-structures-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20404/chinas-zelixir-biotech-predicts-monkeypox-protein-structures-for-drug-discovery.html</link>
			<pubDate>Tue, 31 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/111-20404.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20404/chinas-zelixir-biotech-predicts-monkeypox-protein-structures-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/20364/insilico-medicine-explores-use-of-3cl-protease-inhibitor-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20364/insilico-medicine-explores-use-of-3cl-protease-inhibitor-for-covid-19-treatment.html</link>
			<pubDate>Wed, 25 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2-20364.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20364/insilico-medicine-explores-use-of-3cl-protease-inhibitor-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>LUCA Science and Kyowa Kirin announce joint research agreement on mitochondrial disease treatment with novel mitochondria modality</title>
			<atom:link href="https://biospectrumasia.com/news/34/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html</link>
			<pubDate>Wed, 18 May 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20313/luca-science-and-kyowa-kirin-announce-joint-research-agreement-on-mitochondrial-disease-treatment-with-novel-mitochondria-modality.html</guid>
		</item>	
				<item>
			<title>Japanese firms initiate joint research on next-gen IT drug discovery technology</title>
			<atom:link href="https://biospectrumasia.com/news/34/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html</link>
			<pubDate>Tue, 17 May 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-20302.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20302/japanese-firms-initiate-joint-research-on-next-gen-it-drug-discovery-technology.html</guid>
		</item>	
				<item>
			<title>Inmagene gets FDA&#039;s IND clearance for OX40 antagonist</title>
			<atom:link href="https://biospectrumasia.com/news/34/20205/inmagene-gets-fdas-ind-clearance-for-ox40-antagonist.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20205/inmagene-gets-fdas-ind-clearance-for-ox40-antagonist.html</link>
			<pubDate>Mon, 02 May 2022 21:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20205/inmagene-gets-fdas-ind-clearance-for-ox40-antagonist.html</guid>
		</item>	
				<item>
			<title>University of Tokyo, Astellas further advance development of innovative medicines</title>
			<atom:link href="https://biospectrumasia.com/news/34/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html</link>
			<pubDate>Wed, 27 Apr 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-20173.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20173/university-of-tokyo-astellas-further-advance-development-of-innovative-medicines.html</guid>
		</item>	
				<item>
			<title>FDA grants Fast Track designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program</title>
			<atom:link href="https://biospectrumasia.com/news/34/20087/fda-grants-fast-track-designation-for-paradigm-biopharmaceuticals-phase-iii-osteoarthritis-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20087/fda-grants-fast-track-designation-for-paradigm-biopharmaceuticals-phase-iii-osteoarthritis-program.html</link>
			<pubDate>Thu, 14 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_157198133-20087.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20087/fda-grants-fast-track-designation-for-paradigm-biopharmaceuticals-phase-iii-osteoarthritis-program.html</guid>
		</item>	
				<item>
			<title>TauRx&#039;s late-stage clinical trial reaches new milestone</title>
			<atom:link href="https://biospectrumasia.com/news/34/20082/taurxs-late-stage-clinical-trial-reaches-new-milestone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/20082/taurxs-late-stage-clinical-trial-reaches-new-milestone.html</link>
			<pubDate>Thu, 14 Apr 2022 22:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-20082.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/20082/taurxs-late-stage-clinical-trial-reaches-new-milestone.html</guid>
		</item>	
				<item>
			<title>Otsuka and Akebia seek USFDA approval for renal anemia drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html</link>
			<pubDate>Fri, 01 Apr 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19988.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19988/otsuka-and-akebia-seek-usfda-approval-for-renal-anemia-drug-.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine partners with EQRx for AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/19937/insilico-medicine-partners-with-eqrx-for-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19937/insilico-medicine-partners-with-eqrx-for-ai-driven-drug-discovery.html</link>
			<pubDate>Fri, 25 Mar 2022 23:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-19937.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19937/insilico-medicine-partners-with-eqrx-for-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Biogen and Eisai amend collaboration agreements on Alzheimer&#039;s disease treatments</title>
			<atom:link href="https://biospectrumasia.com/news/34/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html</link>
			<pubDate>Mon, 21 Mar 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-19898.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19898/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments.html</guid>
		</item>	
				<item>
			<title>Astellas&#039; menopause drug fails in Asia trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/19868/astellas-menopause-drug-fails-in-asia-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19868/astellas-menopause-drug-fails-in-asia-trial.html</link>
			<pubDate>Wed, 16 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/21-19868.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19868/astellas-menopause-drug-fails-in-asia-trial.html</guid>
		</item>	
				<item>
			<title>RedHill inks deal worth $6M with Kukbo for COVID-19 drug in South Korea </title>
			<atom:link href="https://biospectrumasia.com/news/34/19874/redhill-inks-deal-worth-6m-with-kukbo-for-covid-19-drug-in-south-korea-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19874/redhill-inks-deal-worth-6m-with-kukbo-for-covid-19-drug-in-south-korea-.html</link>
			<pubDate>Wed, 16 Mar 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-19874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19874/redhill-inks-deal-worth-6m-with-kukbo-for-covid-19-drug-in-south-korea-.html</guid>
		</item>	
				<item>
			<title>China approves SCG&#039;s T Cell Therapy IND to treat Hepatitis B virus</title>
			<atom:link href="https://biospectrumasia.com/news/34/19842/china-approves-scgs-t-cell-therapy-ind-to-treat-hepatitis-b-virus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19842/china-approves-scgs-t-cell-therapy-ind-to-treat-hepatitis-b-virus.html</link>
			<pubDate>Mon, 14 Mar 2022 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hepatitis_b_origin-19842.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19842/china-approves-scgs-t-cell-therapy-ind-to-treat-hepatitis-b-virus.html</guid>
		</item>	
				<item>
			<title>China&#039;s Gan &amp; Lee Pharma begins first-in-human trial for diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/19831/chinas-gan-lee-pharma-begins-first-in-human-trial-for-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19831/chinas-gan-lee-pharma-begins-first-in-human-trial-for-diabetes-drug.html</link>
			<pubDate>Fri, 11 Mar 2022 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-19831.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19831/chinas-gan-lee-pharma-begins-first-in-human-trial-for-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Dr Andreas Amrein joins Advanced Clinical to lead global development and expansion in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/34/19825/dr-andreas-amrein-joins-advanced-clinical-to-lead-global-development-and-expansion-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19825/dr-andreas-amrein-joins-advanced-clinical-to-lead-global-development-and-expansion-in-apac.html</link>
			<pubDate>Thu, 10 Mar 2022 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amrein-19825.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19825/dr-andreas-amrein-joins-advanced-clinical-to-lead-global-development-and-expansion-in-apac.html</guid>
		</item>	
				<item>
			<title>China approves phase II trial of Akeso&#039;s cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/19808/china-approves-phase-ii-trial-of-akesos-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19808/china-approves-phase-ii-trial-of-akesos-cancer-drug.html</link>
			<pubDate>Tue, 08 Mar 2022 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-19808.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19808/china-approves-phase-ii-trial-of-akesos-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Swiss firm BC Platforms opens Singapore R&amp;D Center</title>
			<atom:link href="https://biospectrumasia.com/news/34/19784/swiss-firm-bc-platforms-opens-singapore-rd-center.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19784/swiss-firm-bc-platforms-opens-singapore-rd-center.html</link>
			<pubDate>Fri, 04 Mar 2022 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19784/swiss-firm-bc-platforms-opens-singapore-rd-center.html</guid>
		</item>	
				<item>
			<title>I-Mab receives FDA orphan drug designation for cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/19782/i-mab-receives-fda-orphan-drug-designation-for-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19782/i-mab-receives-fda-orphan-drug-designation-for-cancer-drug-.html</link>
			<pubDate>Fri, 04 Mar 2022 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/12-19782.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19782/i-mab-receives-fda-orphan-drug-designation-for-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>China-based startup InxMed raises $50 M in Series B Financing</title>
			<atom:link href="https://biospectrumasia.com/news/34/19781/china-based-startup-inxmed-raises-50-m-in-series-b-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19781/china-based-startup-inxmed-raises-50-m-in-series-b-financing.html</link>
			<pubDate>Fri, 04 Mar 2022 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-19781.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19781/china-based-startup-inxmed-raises-50-m-in-series-b-financing.html</guid>
		</item>	
				<item>
			<title>China&#039;s Adagene partners with French firm Sanofi for Immuno-Oncology </title>
			<atom:link href="https://biospectrumasia.com/news/34/19772/chinas-adagene-partners-with-french-firm-sanofi-for-immuno-oncology-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19772/chinas-adagene-partners-with-french-firm-sanofi-for-immuno-oncology-.html</link>
			<pubDate>Thu, 03 Mar 2022 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-19772.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19772/chinas-adagene-partners-with-french-firm-sanofi-for-immuno-oncology-.html</guid>
		</item>	
				<item>
			<title>China approves Phase II clinical trial of InnoCare&#039;s cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/19771/china-approves-phase-ii-clinical-trial-of-innocares-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19771/china-approves-phase-ii-clinical-trial-of-innocares-cancer-drug-.html</link>
			<pubDate>Thu, 03 Mar 2022 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19771.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19771/china-approves-phase-ii-clinical-trial-of-innocares-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>China-based Fosun Pharma and Insilico Medicine advance AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/19575/china-based-fosun-pharma-and-insilico-medicine-advance-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19575/china-based-fosun-pharma-and-insilico-medicine-advance-ai-driven-drug-discovery.html</link>
			<pubDate>Wed, 12 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2022_01_12_at_11_35_48_am-19575.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19575/china-based-fosun-pharma-and-insilico-medicine-advance-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s GoldenBiotech suggests 100% recovery with oral drug Antroquinonol in COVID-19 patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/19566/taiwans-goldenbiotech-suggests-100-recovery-with-oral-drug-antroquinonol-in-covid-19-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19566/taiwans-goldenbiotech-suggests-100-recovery-with-oral-drug-antroquinonol-in-covid-19-patients.html</link>
			<pubDate>Mon, 10 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2022_01_10_at_5_13_57_pm-19566.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19566/taiwans-goldenbiotech-suggests-100-recovery-with-oral-drug-antroquinonol-in-covid-19-patients.html</guid>
		</item>	
				<item>
			<title>Korean startup Astrogen to use AI for drug design against Parkinson&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/19554/korean-startup-astrogen-to-use-ai-for-drug-design-against-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19554/korean-startup-astrogen-to-use-ai-for-drug-design-against-parkinsons-disease.html</link>
			<pubDate>Thu, 06 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19554.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19554/korean-startup-astrogen-to-use-ai-for-drug-design-against-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s PRISM BioLab partners with Roche and Genentech for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html</link>
			<pubDate>Wed, 05 Jan 2022 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-19548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19548/japans-prism-biolab-partners-with-roche-and-genentech-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>China&#039;s BeiGene expands collaboration with Novartis for oncology medicines</title>
			<atom:link href="https://biospectrumasia.com/news/34/19527/chinas-beigene-expands-collaboration-with-novartis-for-oncology-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19527/chinas-beigene-expands-collaboration-with-novartis-for-oncology-medicines.html</link>
			<pubDate>Tue, 28 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications_342462_1920-19527.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19527/chinas-beigene-expands-collaboration-with-novartis-for-oncology-medicines.html</guid>
		</item>	
				<item>
			<title>Merck and Ridgeback&#039;s COVID-19 pill receives â€˜special approval&#039; in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html</link>
			<pubDate>Mon, 27 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19523.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19523/merck-and-ridgebacks-covid-19-pill-receives-special-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Korea offers niclosamide-based drug as possible cure for COVID-19 variants</title>
			<atom:link href="https://biospectrumasia.com/news/34/19456/korea-offers-niclosamide-based-drug-as-possible-cure-for-covid-19-variants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19456/korea-offers-niclosamide-based-drug-as-possible-cure-for-covid-19-variants.html</link>
			<pubDate>Wed, 08 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19456.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19456/korea-offers-niclosamide-based-drug-as-possible-cure-for-covid-19-variants.html</guid>
		</item>	
				<item>
			<title>Tackling Onerousness Drug Development Process Through Cost-Effective Genomic Analysis Platforms</title>
			<atom:link href="https://biospectrumasia.com/news/34/19429/tackling-onerousness-drug-development-process-through-cost-effective-genomic-analysis-platforms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19429/tackling-onerousness-drug-development-process-through-cost-effective-genomic-analysis-platforms.html</link>
			<pubDate>Thu, 02 Dec 2021 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bertrand_adanve-19429.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19429/tackling-onerousness-drug-development-process-through-cost-effective-genomic-analysis-platforms.html</guid>
		</item>	
				<item>
			<title>Standigm, Institut Pasteur Korea team up for AI-based drug discovery research on TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/19436/standigm-institut-pasteur-korea-team-up-for-ai-based-drug-discovery-research-on-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19436/standigm-institut-pasteur-korea-team-up-for-ai-based-drug-discovery-research-on-tb.html</link>
			<pubDate>Thu, 02 Dec 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_12_02_at_4_08_08_pm-19436.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19436/standigm-institut-pasteur-korea-team-up-for-ai-based-drug-discovery-research-on-tb.html</guid>
		</item>	
				<item>
			<title>Holistic drug development strategy improves probability of success in oncology therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/19377/holistic-drug-development-strategy-improves-probability-of-success-in-oncology-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19377/holistic-drug-development-strategy-improves-probability-of-success-in-oncology-therapeutics.html</link>
			<pubDate>Mon, 22 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vishal_doshi__aum_biosciences-19377.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19377/holistic-drug-development-strategy-improves-probability-of-success-in-oncology-therapeutics.html</guid>
		</item>	
				<item>
			<title>Pfizer inks deal worth $5.29 B with US government for COVID-19 pill</title>
			<atom:link href="https://biospectrumasia.com/news/34/19373/pfizer-inks-deal-worth-5-29-b-with-us-government-for-covid-19-pill.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19373/pfizer-inks-deal-worth-5-29-b-with-us-government-for-covid-19-pill.html</link>
			<pubDate>Fri, 19 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_120064627-19373.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19373/pfizer-inks-deal-worth-5-29-b-with-us-government-for-covid-19-pill.html</guid>
		</item>	
				<item>
			<title>Pfizer seeks EUA for novel oral COVID-19 pill</title>
			<atom:link href="https://biospectrumasia.com/news/34/19362/pfizer-seeks-eua-for-novel-oral-covid-19-pill.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19362/pfizer-seeks-eua-for-novel-oral-covid-19-pill.html</link>
			<pubDate>Wed, 17 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-19362.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19362/pfizer-seeks-eua-for-novel-oral-covid-19-pill.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s GI Innovation inks MoU with Merck for bio drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/19335/koreas-gi-innovation-inks-mou-with-merck-for-bio-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19335/koreas-gi-innovation-inks-mou-with-merck-for-bio-drug-development.html</link>
			<pubDate>Wed, 10 Nov 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_11_10_at_3_21_26_pm-19335.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19335/koreas-gi-innovation-inks-mou-with-merck-for-bio-drug-development.html</guid>
		</item>	
				<item>
			<title>AUM Biosciences raises $27M â€œSeries Aâ€ fund to advance precision cancer therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/19202/aum-biosciences-raises-27m-series-a-fund-to-advance-precision-cancer-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19202/aum-biosciences-raises-27m-series-a-fund-to-advance-precision-cancer-therapies.html</link>
			<pubDate>Wed, 13 Oct 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_7-19202.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19202/aum-biosciences-raises-27m-series-a-fund-to-advance-precision-cancer-therapies.html</guid>
		</item>	
				<item>
			<title>Israel&#039;s CytoReason introduces AI clinical drug development platform to Japan&#039;s pharma market</title>
			<atom:link href="https://biospectrumasia.com/news/34/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html</link>
			<pubDate>Thu, 30 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-19155.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19155/israels-cytoreason-introduces-ai-clinical-drug-development-platform-to-japans-pharma-market.html</guid>
		</item>	
				<item>
			<title>Japan sets eyes on rare pediatric liver diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html</link>
			<pubDate>Wed, 22 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/11-19082.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19082/japan-sets-eyes-on-rare-pediatric-liver-diseases.html</guid>
		</item>	
				<item>
			<title>U.S. NIH supports an Australian Biopharma to develop antibiotics against crucial drug-resistant bacteria</title>
			<atom:link href="https://biospectrumasia.com/news/34/19057/u-s-nih-supports-an-australian-biopharma-to-develop-antibiotics-against-crucial-drug-resistant-bacteria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19057/u-s-nih-supports-an-australian-biopharma-to-develop-antibiotics-against-crucial-drug-resistant-bacteria.html</link>
			<pubDate>Fri, 17 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/news_medical_net-19057.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19057/u-s-nih-supports-an-australian-biopharma-to-develop-antibiotics-against-crucial-drug-resistant-bacteria.html</guid>
		</item>	
				<item>
			<title>BC Platforms to enable longitudinal RWD and Genomics access for drug development in Africa</title>
			<atom:link href="https://biospectrumasia.com/news/34/19020/bc-platforms-to-enable-longitudinal-rwd-and-genomics-access-for-drug-development-in-africa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19020/bc-platforms-to-enable-longitudinal-rwd-and-genomics-access-for-drug-development-in-africa.html</link>
			<pubDate>Mon, 13 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-19020.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19020/bc-platforms-to-enable-longitudinal-rwd-and-genomics-access-for-drug-development-in-africa.html</guid>
		</item>	
				<item>
			<title>French firm Poxel launches type 2 diabetes drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html</link>
			<pubDate>Fri, 10 Sep 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/which_medications_are_best_for_anxiety_disorders_1440x810-19009.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/19009/french-firm-poxel-launches-type-2-diabetes-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>â€œWith an array of partners, we are tackling some of the biggest unmet needs in mental health diseasesâ€</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/18973/with-an-array-of-partners-we-are-tackling-some-of-the-biggest-unmet-needs-in-mental-health-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/18973/with-an-array-of-partners-we-are-tackling-some-of-the-biggest-unmet-needs-in-mental-health-diseases.html</link>
			<pubDate>Mon, 06 Sep 2021 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_luke_holtham_reid_-18973.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/18973/with-an-array-of-partners-we-are-tackling-some-of-the-biggest-unmet-needs-in-mental-health-diseases.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s Centre for Drug Evaluation initiates new drug trial against COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/34/18826/taiwans-centre-for-drug-evaluation-initiates-new-drug-trial-against-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18826/taiwans-centre-for-drug-evaluation-initiates-new-drug-trial-against-covid-19.html</link>
			<pubDate>Mon, 16 Aug 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-18826.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18826/taiwans-centre-for-drug-evaluation-initiates-new-drug-trial-against-covid-19.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka Pharma receives $17.8 M grant for TB drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html</link>
			<pubDate>Tue, 10 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_198282422-18786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18786/japans-otsuka-pharma-receives-17-8-m-grant-for-tb-drug-trial.html</guid>
		</item>	
				<item>
			<title>Healx&#039;s AI-platform to create world&#039;s most detailed rare disease biomedical knowledge graph</title>
			<atom:link href="https://biospectrumasia.com/news/34/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html</link>
			<pubDate>Tue, 10 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/adobestock_182431295_convertedv5_2x-18790.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18790/healxs-ai-platform-to-create-worlds-most-detailed-rare-disease-biomedical-knowledge-graph.html</guid>
		</item>	
				<item>
			<title>Chinese firms to advance drug development for hard-to-drug molecular targets</title>
			<atom:link href="https://biospectrumasia.com/news/34/18778/chinese-firms-to-advance-drug-development-for-hard-to-drug-molecular-targets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18778/chinese-firms-to-advance-drug-development-for-hard-to-drug-molecular-targets.html</link>
			<pubDate>Mon, 09 Aug 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cyborg_hand_holding_devices_with_medical_iconnd_stethoscope_3d_rendering_110893_576-18778.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18778/chinese-firms-to-advance-drug-development-for-hard-to-drug-molecular-targets.html</guid>
		</item>	
				<item>
			<title>Chinese startups accelerate innovative drugs R&amp;D for novel coronavirus</title>
			<atom:link href="https://biospectrumasia.com/news/34/18733/chinese-startups-accelerate-innovative-drugs-rd-for-novel-coronavirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18733/chinese-startups-accelerate-innovative-drugs-rd-for-novel-coronavirus.html</link>
			<pubDate>Tue, 03 Aug 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-18733.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18733/chinese-startups-accelerate-innovative-drugs-rd-for-novel-coronavirus.html</guid>
		</item>	
				<item>
			<title>Taiwan brings hope for breast cancer patients with new epigenetic drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/18683/taiwan-brings-hope-for-breast-cancer-patients-with-new-epigenetic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18683/taiwan-brings-hope-for-breast-cancer-patients-with-new-epigenetic-drug.html</link>
			<pubDate>Wed, 28 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_07_27_at_4_32_32_pm-18683.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18683/taiwan-brings-hope-for-breast-cancer-patients-with-new-epigenetic-drug.html</guid>
		</item>	
				<item>
			<title>China emphasizes on self-replicating, conventional mRNA therapeutics and vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/34/18633/china-emphasizes-on-self-replicating-conventional-mrna-therapeutics-and-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18633/china-emphasizes-on-self-replicating-conventional-mrna-therapeutics-and-vaccines.html</link>
			<pubDate>Wed, 21 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biology_lab_46706_648-18633.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18633/china-emphasizes-on-self-replicating-conventional-mrna-therapeutics-and-vaccines.html</guid>
		</item>	
				<item>
			<title>Product launches by Asian pharma cos can benefit antiviral drug makers in APAC: Graphical Research</title>
			<atom:link href="https://biospectrumasia.com/news/34/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html</link>
			<pubDate>Mon, 19 Jul 2021 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines-18620.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18620/product-launches-by-asian-pharma-cos-can-benefit-antiviral-drug-makers-in-apac-graphical-research.html</guid>
		</item>	
				<item>
			<title>Korean firm Celltrion&#039;s mAb candidate effective against Delta variant</title>
			<atom:link href="https://biospectrumasia.com/news/34/18605/korean-firm-celltrions-mab-candidate-effective-against-delta-variant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18605/korean-firm-celltrions-mab-candidate-effective-against-delta-variant.html</link>
			<pubDate>Fri, 16 Jul 2021 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/covid_blue_620x342-18605.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18605/korean-firm-celltrions-mab-candidate-effective-against-delta-variant.html</guid>
		</item>	
				<item>
			<title>Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs</title>
			<atom:link href="https://biospectrumasia.com/news/34/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html</link>
			<pubDate>Thu, 15 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money_dollar_rolled_up_with_pills_flowing_out_isolated_blue_background_high_costs_expensive_medication_concept_copy_space_130265_1928-18593.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18593/adlai-nortye-raises-100-m-series-d-to-accelerate-clinical-and-drug-development-programs.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares partners InveniAI to launch multi-target AI-powered drug discovery platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html</link>
			<pubDate>Tue, 06 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fmcna-18521.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18521/sosei-heptares-partners-inveniai-to-launch-multi-target-ai-powered-drug-discovery-platform.html</guid>
		</item>	
				<item>
			<title>Five arrows invest in Sygnature Discovery supporting drug discovery services in the UK</title>
			<atom:link href="https://biospectrumasia.com/news/34/18488/five-arrows-invest-in-sygnature-discovery-supporting-drug-discovery-services-in-the-uk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18488/five-arrows-invest-in-sygnature-discovery-supporting-drug-discovery-services-in-the-uk.html</link>
			<pubDate>Thu, 01 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/discovery_building_in_nottingham_headquarters_of_sygnature_discovery-18488.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18488/five-arrows-invest-in-sygnature-discovery-supporting-drug-discovery-services-in-the-uk.html</guid>
		</item>	
				<item>
			<title>US FDA grants VICO therapeutics Orphan-Drug Designation for anti-neurodegenerative drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/18489/us-fda-grants-vico-therapeutics-orphan-drug-designation-for-anti-neurodegenerative-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18489/us-fda-grants-vico-therapeutics-orphan-drug-designation-for-anti-neurodegenerative-drug.html</link>
			<pubDate>Thu, 01 Jul 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_brain_with_some_pills_58466_2262-18489.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18489/us-fda-grants-vico-therapeutics-orphan-drug-designation-for-anti-neurodegenerative-drug.html</guid>
		</item>	
				<item>
			<title>New antibiotic from Australia to combat bacterial superbugs enters clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/18427/new-antibiotic-from-australia-to-combat-bacterial-superbugs-enters-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18427/new-antibiotic-from-australia-to-combat-bacterial-superbugs-enters-clinical-trials.html</link>
			<pubDate>Wed, 23 Jun 2021 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_06_23_at_2_09_58_pm-18427.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18427/new-antibiotic-from-australia-to-combat-bacterial-superbugs-enters-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Fujitsu Japan deploys world&#039;s fastest supercomputer for COVID-19 therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html</link>
			<pubDate>Tue, 22 Jun 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depositphotos0-18417.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18417/fujitsu-japan-deploys-worlds-fastest-supercomputer-for-covid-19-therapies.html</guid>
		</item>	
				<item>
			<title>Aptamer Group collaborates with Takeda Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/18253/aptamer-group-collaborates-with-takeda-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18253/aptamer-group-collaborates-with-takeda-pharma.html</link>
			<pubDate>Fri, 28 May 2021 17:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/e1reprwwuau2zfq-18253.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18253/aptamer-group-collaborates-with-takeda-pharma.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares and Pfizer collaborate for multi-target drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html</link>
			<pubDate>Mon, 24 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik_7-18213.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18213/sosei-heptares-and-pfizer-collaborate-for-multi-target-drug-discovery.html</guid>
		</item>	
				<item>
			<title>China-based Shineco to pick 51% stake in Taiwan&#039;s Mayah Biological </title>
			<atom:link href="https://biospectrumasia.com/news/34/18129/china-based-shineco-to-pick-51-stake-in-taiwans-mayah-biological-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18129/china-based-shineco-to-pick-51-stake-in-taiwans-mayah-biological-.html</link>
			<pubDate>Wed, 05 May 2021 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_05_05_at_1_49_02_pm-18129.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18129/china-based-shineco-to-pick-51-stake-in-taiwans-mayah-biological-.html</guid>
		</item>	
				<item>
			<title>Korean firm Pharmcadd plans expansion in India, US &amp; France</title>
			<atom:link href="https://biospectrumasia.com/news/34/18122/korean-firm-pharmcadd-plans-expansion-in-india-us-france.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18122/korean-firm-pharmcadd-plans-expansion-in-india-us-france.html</link>
			<pubDate>Tue, 04 May 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik8765-18122.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18122/korean-firm-pharmcadd-plans-expansion-in-india-us-france.html</guid>
		</item>	
				<item>
			<title>RNAimmune accelerates R&amp;D into mRNA vaccine, drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/18049/rnaimmune-accelerates-rd-into-mrna-vaccine-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18049/rnaimmune-accelerates-rd-into-mrna-vaccine-drug-discovery.html</link>
			<pubDate>Fri, 23 Apr 2021 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/screen_shot_2021_04_23_at_12_42_22_pm-18049.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18049/rnaimmune-accelerates-rd-into-mrna-vaccine-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Pureos Bioventures closes first fund with committed capital of $205 M</title>
			<atom:link href="https://biospectrumasia.com/news/34/18043/pureos-bioventures-closes-first-fund-with-committed-capital-of-205-m.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/18043/pureos-bioventures-closes-first-fund-with-committed-capital-of-205-m.html</link>
			<pubDate>Thu, 22 Apr 2021 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_16325-18043.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/18043/pureos-bioventures-closes-first-fund-with-committed-capital-of-205-m.html</guid>
		</item>	
				<item>
			<title>CAR-T therapy leads Singapore medical tourism within APAC </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/17963/car-t-therapy-leads-singapore-medical-tourism-within-apac-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/17963/car-t-therapy-leads-singapore-medical-tourism-within-apac-.html</link>
			<pubDate>Mon, 12 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_3_-17963.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/17963/car-t-therapy-leads-singapore-medical-tourism-within-apac-.html</guid>
		</item>	
				<item>
			<title>Hitachi uses digital technology for creation of next-generation biopharmaceuticals</title>
			<atom:link href="https://biospectrumasia.com/news/34/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html</link>
			<pubDate>Wed, 07 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_259174286-17935.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17935/hitachi-uses-digital-technology-for-creation-of-next-generation-biopharmaceuticals.html</guid>
		</item>	
				<item>
			<title>Shanghai Genchem announces global collaboration with I-Mab on Bispecific antibodies </title>
			<atom:link href="https://biospectrumasia.com/news/34/17927/shanghai-genchem-announces-global-collaboration-with-i-mab-on-bispecific-antibodies-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17927/shanghai-genchem-announces-global-collaboration-with-i-mab-on-bispecific-antibodies-.html</link>
			<pubDate>Tue, 06 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/virus_particles_background_concept_52683_41982-17927.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17927/shanghai-genchem-announces-global-collaboration-with-i-mab-on-bispecific-antibodies-.html</guid>
		</item>	
				<item>
			<title>Peptone to scale its AI-driven protein engineering system PeOS in Iceland</title>
			<atom:link href="https://biospectrumasia.com/news/34/17915/peptone-to-scale-its-ai-driven-protein-engineering-system-peos-in-iceland.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17915/peptone-to-scale-its-ai-driven-protein-engineering-system-peos-in-iceland.html</link>
			<pubDate>Mon, 05 Apr 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nvid-17915.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17915/peptone-to-scale-its-ai-driven-protein-engineering-system-peos-in-iceland.html</guid>
		</item>	
				<item>
			<title>Industry accelerates R&amp;D of innovative antibody drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/17852/industry-accelerates-rd-of-innovative-antibody-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17852/industry-accelerates-rd-of-innovative-antibody-drugs.html</link>
			<pubDate>Fri, 26 Mar 2021 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_31369030-17852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17852/industry-accelerates-rd-of-innovative-antibody-drugs.html</guid>
		</item>	
				<item>
			<title>PerkinElmer expands computing capabilities for biological drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/17805/perkinelmer-expands-computing-capabilities-for-biological-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17805/perkinelmer-expands-computing-capabilities-for-biological-drug-discovery.html</link>
			<pubDate>Mon, 22 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/laboratory_interior_with_microscope_digital_image_portable_computer_87646_2503-17805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17805/perkinelmer-expands-computing-capabilities-for-biological-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Fujitsu, NCC to create new services for clinical trials, drug development in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html</link>
			<pubDate>Thu, 18 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_231530785-17786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17786/fujitsu-ncc-to-create-new-services-for-clinical-trials-drug-development-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai aims for novel drug discovery for neurodegenerative disorders</title>
			<atom:link href="https://biospectrumasia.com/news/34/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html</link>
			<pubDate>Wed, 17 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_472971505_zpsttwkyiau_1000x480_2x-17778.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17778/eisai-aims-for-novel-drug-discovery-for-neurodegenerative-disorders.html</guid>
		</item>	
				<item>
			<title>QBiotics joins TDM Growth Partners to accelerate drug development timelines</title>
			<atom:link href="https://biospectrumasia.com/news/34/17770/qbiotics-joins-tdm-growth-partners-to-accelerate-drug-development-timelines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17770/qbiotics-joins-tdm-growth-partners-to-accelerate-drug-development-timelines.html</link>
			<pubDate>Tue, 16 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/close_up_pharmacist_man_hand_shaking_counter_with_patient_customer_42708_27-17770.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17770/qbiotics-joins-tdm-growth-partners-to-accelerate-drug-development-timelines.html</guid>
		</item>	
				<item>
			<title>HitGen, UPPTHERA collaborate for drug discovery research</title>
			<atom:link href="https://biospectrumasia.com/news/34/17683/hitgen-uppthera-collaborate-for-drug-discovery-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17683/hitgen-uppthera-collaborate-for-drug-discovery-research.html</link>
			<pubDate>Tue, 02 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_312999893-17683.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17683/hitgen-uppthera-collaborate-for-drug-discovery-research.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim to developÂ innovative PeptidesÂ to treat Obesity</title>
			<atom:link href="https://biospectrumasia.com/news/34/17686/boehringer-ingelheim-to-developinnovative-peptidesto-treat-obesity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17686/boehringer-ingelheim-to-developinnovative-peptidesto-treat-obesity.html</link>
			<pubDate>Mon, 01 Mar 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diet_pills_measuring_tape_gray_surface_175682_4893-17686.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17686/boehringer-ingelheim-to-developinnovative-peptidesto-treat-obesity.html</guid>
		</item>	
				<item>
			<title>Insilico Medicine discovers industry first preclinical drug candidate using AI  </title>
			<atom:link href="https://biospectrumasia.com/news/34/17661/insilico-medicine-discovers-industry-first-preclinical-drug-candidate-using-ai-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17661/insilico-medicine-discovers-industry-first-preclinical-drug-candidate-using-ai-.html</link>
			<pubDate>Thu, 25 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-17661.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17661/insilico-medicine-discovers-industry-first-preclinical-drug-candidate-using-ai-.html</guid>
		</item>	
				<item>
			<title>China&#039;s Suntrap discovers LeSoleil to fight COVID-19 and future epidemics</title>
			<atom:link href="https://biospectrumasia.com/news/34/17602/chinas-suntrap-discovers-lesoleil-to-fight-covid-19-and-future-epidemics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17602/chinas-suntrap-discovers-lesoleil-to-fight-covid-19-and-future-epidemics.html</link>
			<pubDate>Mon, 15 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/low_suntrap20210210-17602.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17602/chinas-suntrap-discovers-lesoleil-to-fight-covid-19-and-future-epidemics.html</guid>
		</item>	
				<item>
			<title>The Next-generation antimalarial treatment designed to tackle the drug-resistance challenge</title>
			<atom:link href="https://biospectrumasia.com/news/34/17569/the-next-generation-antimalarial-treatment-designed-to-tackle-the-drug-resistance-challenge.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17569/the-next-generation-antimalarial-treatment-designed-to-tackle-the-drug-resistance-challenge.html</link>
			<pubDate>Tue, 09 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_caroline_boulton_global_program_head_for_malaria_novartis-17569.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17569/the-next-generation-antimalarial-treatment-designed-to-tackle-the-drug-resistance-challenge.html</guid>
		</item>	
				<item>
			<title>Korea approves first anti-COVID-19 monoclonal antibody treatment </title>
			<atom:link href="https://biospectrumasia.com/news/34/17560/korea-approves-first-anti-covid-19-monoclonal-antibody-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17560/korea-approves-first-anti-covid-19-monoclonal-antibody-treatment-.html</link>
			<pubDate>Mon, 08 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikewadsf-17560.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17560/korea-approves-first-anti-covid-19-monoclonal-antibody-treatment-.html</guid>
		</item>	
				<item>
			<title>Hong Kong develops formula for treating Alzheimer&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/17549/hong-kong-develops-formula-for-treating-alzheimers-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17549/hong-kong-develops-formula-for-treating-alzheimers-disease.html</link>
			<pubDate>Fri, 05 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_13_-17549.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17549/hong-kong-develops-formula-for-treating-alzheimers-disease.html</guid>
		</item>	
				<item>
			<title>India&#039;s Biocon Biologics to offer Oncology Biosimilars in over 30 countries</title>
			<atom:link href="https://biospectrumasia.com/news/34/17556/indias-biocon-biologics-to-offer-oncology-biosimilars-in-over-30-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17556/indias-biocon-biologics-to-offer-oncology-biosimilars-in-over-30-countries.html</link>
			<pubDate>Fri, 05 Feb 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/100-17556.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17556/indias-biocon-biologics-to-offer-oncology-biosimilars-in-over-30-countries.html</guid>
		</item>	
				<item>
			<title>Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/17461/genesis-medtech-collaborates-with-penumbra-to-expand-neurovascular-market-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17461/genesis-medtech-collaborates-with-penumbra-to-expand-neurovascular-market-in-china.html</link>
			<pubDate>Wed, 20 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/active_nerve_cells_151689_44-17461.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17461/genesis-medtech-collaborates-with-penumbra-to-expand-neurovascular-market-in-china.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe &amp; Takeda to accelerate data-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html</link>
			<pubDate>Tue, 19 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medgadget-17457.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17457/mitsubishi-tanabe-takeda-to-accelerate-data-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html</link>
			<pubDate>Tue, 12 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_rendering_medical_artificial_intelligence_robot_31965_5171-17412.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17412/sosei-and-pharmenable-enter-technology-collaboration-for-ai-driven-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Fujifilm injects $2B into large-scale cell culture manufacturing site in US</title>
			<atom:link href="https://biospectrumasia.com/news/34/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html</link>
			<pubDate>Fri, 08 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstoc5k-17384.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17384/fujifilm-injects-2b-into-large-scale-cell-culture-manufacturing-site-in-us.html</guid>
		</item>	
				<item>
			<title>Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China</title>
			<atom:link href="https://biospectrumasia.com/news/34/17370/y-biologics-3d-medicines-collaborate-to-develop-novel-cancer-therapeutics-for-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17370/y-biologics-3d-medicines-collaborate-to-develop-novel-cancer-therapeutics-for-china.html</link>
			<pubDate>Wed, 06 Jan 2021 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_309940142-17370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17370/y-biologics-3d-medicines-collaborate-to-develop-novel-cancer-therapeutics-for-china.html</guid>
		</item>	
				<item>
			<title>Singapore launches spin-off to develop treatment for intractable diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/17324/singapore-launches-spin-off-to-develop-treatment-for-intractable-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17324/singapore-launches-spin-off-to-develop-treatment-for-intractable-diseases.html</link>
			<pubDate>Thu, 24 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/experimental_drug_development_centre_launches_1200x630_1_-17324.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17324/singapore-launches-spin-off-to-develop-treatment-for-intractable-diseases.html</guid>
		</item>	
				<item>
			<title>Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets</title>
			<atom:link href="https://biospectrumasia.com/news/34/17228/antengene-submits-ndas-for-xpovio-selinexor-in-multiple-apac-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17228/antengene-submits-ndas-for-xpovio-selinexor-in-multiple-apac-markets.html</link>
			<pubDate>Fri, 04 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/colorful_capsule_pills_stainless_steel_drug_tray_white_background_33867_24-17228.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17228/antengene-submits-ndas-for-xpovio-selinexor-in-multiple-apac-markets.html</guid>
		</item>	
				<item>
			<title>Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies</title>
			<atom:link href="https://biospectrumasia.com/news/34/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html</link>
			<pubDate>Tue, 01 Dec 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3d_render_medical_background_with_brain_being_attacked_by_virus_cells_1048_6355-17195.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17195/eisai-and-wren-therapeutics-collaborate-for-potential-treatment-of-synucleinopathies.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s OliPass advisory board to evaluate osteoarthritis pain killer drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/17173/koreas-olipass-advisory-board-to-evaluate-osteoarthritis-pain-killer-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17173/koreas-olipass-advisory-board-to-evaluate-osteoarthritis-pain-killer-drug-development.html</link>
			<pubDate>Wed, 25 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/closeup_therapist_explaining_arthritis_symptoms_1098_18695-17173.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17173/koreas-olipass-advisory-board-to-evaluate-osteoarthritis-pain-killer-drug-development.html</guid>
		</item>	
				<item>
			<title>Koru Lifescience identifies drug compounds beneficial for COVID-19 trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/17167/koru-lifescience-identifies-drug-compounds-beneficial-for-covid-19-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17167/koru-lifescience-identifies-drug-compounds-beneficial-for-covid-19-trials.html</link>
			<pubDate>Tue, 24 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/koru-17167.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17167/koru-lifescience-identifies-drug-compounds-beneficial-for-covid-19-trials.html</guid>
		</item>	
				<item>
			<title>Insilico announces AI-powered drug discovery collaboration with Janssen </title>
			<atom:link href="https://biospectrumasia.com/news/34/17102/insilico-announces-ai-powered-drug-discovery-collaboration-with-janssen-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17102/insilico-announces-ai-powered-drug-discovery-collaboration-with-janssen-.html</link>
			<pubDate>Wed, 11 Nov 2020 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma_shutter-17102.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17102/insilico-announces-ai-powered-drug-discovery-collaboration-with-janssen-.html</guid>
		</item>	
				<item>
			<title>Australia evaluates hyperimmune immunoglobulin treatment for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/34/17089/australia-evaluates-hyperimmune-immunoglobulin-treatment-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17089/australia-evaluates-hyperimmune-immunoglobulin-treatment-for-covid-19.html</link>
			<pubDate>Mon, 09 Nov 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_1700617951_1-17089.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17089/australia-evaluates-hyperimmune-immunoglobulin-treatment-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Cerecin&#039;s Tricaprilin receives ODD in the Treatment of infantile spasms</title>
			<atom:link href="https://biospectrumasia.com/news/34/17025/cerecins-tricaprilin-receives-odd-in-the-treatment-of-infantile-spasms.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17025/cerecins-tricaprilin-receives-odd-in-the-treatment-of-infantile-spasms.html</link>
			<pubDate>Fri, 30 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/67447640_fda_approved_stamp_sign_seal-17025.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17025/cerecins-tricaprilin-receives-odd-in-the-treatment-of-infantile-spasms.html</guid>
		</item>	
				<item>
			<title>CStone inks deal worth $353.5M for new antibody drug conjugate</title>
			<atom:link href="https://biospectrumasia.com/news/34/17017/cstone-inks-deal-worth-353-5m-for-new-antibody-drug-conjugate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/17017/cstone-inks-deal-worth-353-5m-for-new-antibody-drug-conjugate.html</link>
			<pubDate>Thu, 29 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_212432119-17017.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/17017/cstone-inks-deal-worth-353-5m-for-new-antibody-drug-conjugate.html</guid>
		</item>	
				<item>
			<title>Aslan Pharma offers new treatment for autoimmune conditions</title>
			<atom:link href="https://biospectrumasia.com/news/34/16959/aslan-pharma-offers-new-treatment-for-autoimmune-conditions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16959/aslan-pharma-offers-new-treatment-for-autoimmune-conditions.html</link>
			<pubDate>Tue, 20 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/20180308_lab_scientist_research_shutterstock_16513-16959.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16959/aslan-pharma-offers-new-treatment-for-autoimmune-conditions.html</guid>
		</item>	
				<item>
			<title>ASLAN to develop next-gen DHODH inhibitor in autoimmune conditions</title>
			<atom:link href="https://biospectrumasia.com/news/34/16942/aslan-to-develop-next-gen-dhodh-inhibitor-in-autoimmune-conditions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16942/aslan-to-develop-next-gen-dhodh-inhibitor-in-autoimmune-conditions.html</link>
			<pubDate>Fri, 16 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor_with_augmented_reality_1134_133-16942.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16942/aslan-to-develop-next-gen-dhodh-inhibitor-in-autoimmune-conditions.html</guid>
		</item>	
				<item>
			<title>Antengene partners with WuXi Biologics for innovative oncology medicines</title>
			<atom:link href="https://biospectrumasia.com/news/34/16913/antengene-partners-with-wuxi-biologics-for-innovative-oncology-medicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16913/antengene-partners-with-wuxi-biologics-for-innovative-oncology-medicines.html</link>
			<pubDate>Wed, 14 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-16913.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16913/antengene-partners-with-wuxi-biologics-for-innovative-oncology-medicines.html</guid>
		</item>	
				<item>
			<title>Prestige Biopharma receives ODD to its Pancreatic Cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/16916/prestige-biopharma-receives-odd-to-its-pancreatic-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16916/prestige-biopharma-receives-odd-to-its-pancreatic-cancer-drug.html</link>
			<pubDate>Wed, 14 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikliukyjhtgr-16916.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16916/prestige-biopharma-receives-odd-to-its-pancreatic-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Eisai collaborates with University of Tokyo for protein degradation drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html</link>
			<pubDate>Tue, 13 Oct 2020 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_691546588-16904.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16904/eisai-collaborates-with-university-of-tokyo-for-protein-degradation-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Antengene establishes new drug discovery centre in Shanghai</title>
			<atom:link href="https://biospectrumasia.com/news/34/16903/antengene-establishes-new-drug-discovery-centre-in-shanghai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16903/antengene-establishes-new-drug-discovery-centre-in-shanghai.html</link>
			<pubDate>Tue, 13 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2946428_1-16903.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16903/antengene-establishes-new-drug-discovery-centre-in-shanghai.html</guid>
		</item>	
				<item>
			<title>Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis</title>
			<atom:link href="https://biospectrumasia.com/news/34/16892/marinomed-biotech-develops-novel-drug-for-the-treatment-of-autoimmune-gastritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16892/marinomed-biotech-develops-novel-drug-for-the-treatment-of-autoimmune-gastritis.html</link>
			<pubDate>Fri, 09 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gastritis_related_documents_medications_53419_3825-16892.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16892/marinomed-biotech-develops-novel-drug-for-the-treatment-of-autoimmune-gastritis.html</guid>
		</item>	
				<item>
			<title>Standigm releases AI-based target identification platform for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/16833/standigm-releases-ai-based-target-identification-platform-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16833/standigm-releases-ai-based-target-identification-platform-for-drug-discovery.html</link>
			<pubDate>Thu, 01 Oct 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_13570075191_750x500_1-16833.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16833/standigm-releases-ai-based-target-identification-platform-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Standigm partners with Excelra to enhance AI-driven drug discovery process</title>
			<atom:link href="https://biospectrumasia.com/news/34/16717/standigm-partners-with-excelra-to-enhance-ai-driven-drug-discovery-process.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16717/standigm-partners-with-excelra-to-enhance-ai-driven-drug-discovery-process.html</link>
			<pubDate>Tue, 15 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepik8765-16717.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16717/standigm-partners-with-excelra-to-enhance-ai-driven-drug-discovery-process.html</guid>
		</item>	
				<item>
			<title>Japan designs method to create drugs â€œbuilding blocksâ€ for multiple diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html</link>
			<pubDate>Thu, 03 Sep 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/infographic_aug_06_2020_768x432_1_-16652.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16652/japan-designs-method-to-create-drugs-building-blocks-for-multiple-diseases.html</guid>
		</item>	
				<item>
			<title>Eisai takes Counter-Measures to tackle COVID-19 spread in Africa</title>
			<atom:link href="https://biospectrumasia.com/news/34/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html</link>
			<pubDate>Wed, 10 Jun 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1200px_eisai_logo_svg-16089.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/16089/eisai-takes-counter-measures-to-tackle-covid-19-spread-in-africa.html</guid>
		</item>	
				<item>
			<title>India&#039;s Sun Pharma to start nafamostat mesylate trial for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/16042/indias-sun-pharma-to-start-nafamostat-mesylate-trial-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/16042/indias-sun-pharma-to-start-nafamostat-mesylate-trial-for-covid-19.html</link>
			<pubDate>Wed, 03 Jun 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freepikq36-16042.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/16042/indias-sun-pharma-to-start-nafamostat-mesylate-trial-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Roche&#039;s Tecentriq approved for extensive-stage small cell lung cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/15968/roches-tecentriq-approved-for-extensive-stage-small-cell-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15968/roches-tecentriq-approved-for-extensive-stage-small-cell-lung-cancer.html</link>
			<pubDate>Tue, 19 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/theepharmatechnicians-15968.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15968/roches-tecentriq-approved-for-extensive-stage-small-cell-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Exyte and Univercells combine forces for rapid deployment of COVID-19 vaccine </title>
			<atom:link href="https://biospectrumasia.com/news/34/15945/exyte-and-univercells-combine-forces-for-rapid-deployment-of-covid-19-vaccine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15945/exyte-and-univercells-combine-forces-for-rapid-deployment-of-covid-19-vaccine-.html</link>
			<pubDate>Thu, 14 May 2020 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15945.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15945/exyte-and-univercells-combine-forces-for-rapid-deployment-of-covid-19-vaccine-.html</guid>
		</item>	
				<item>
			<title>Astellas, Insilico Medicine bank on AI for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html</link>
			<pubDate>Mon, 04 May 2020 08:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15874.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15874/astellas-insilico-medicine-bank-on-ai-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Senhwa Biosciences, NIH to co-develop COVID-19 drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15848/senhwa-biosciences-nih-to-co-develop-covid-19-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15848/senhwa-biosciences-nih-to-co-develop-covid-19-drug.html</link>
			<pubDate>Mon, 27 Apr 2020 08:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15848.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15848/senhwa-biosciences-nih-to-co-develop-covid-19-drug.html</guid>
		</item>	
				<item>
			<title>Esperion &amp; Otsuka to develop treatment for hypercholesterolemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html</link>
			<pubDate>Thu, 23 Apr 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15836/esperion-otsuka-to-develop-treatment-for-hypercholesterolemia.html</guid>
		</item>	
				<item>
			<title>Insilico collaborates with BI for discovering therapeutic targets</title>
			<atom:link href="https://biospectrumasia.com/news/34/15828/insilico-collaborates-with-bi-for-discovering-therapeutic-targets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15828/insilico-collaborates-with-bi-for-discovering-therapeutic-targets.html</link>
			<pubDate>Thu, 23 Apr 2020 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shutterstock_676738099_1024x614-15828.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15828/insilico-collaborates-with-bi-for-discovering-therapeutic-targets.html</guid>
		</item>	
				<item>
			<title>Combined treatment from existing drugs might combat COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/34/15810/combined-treatment-from-existing-drugs-might-combat-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15810/combined-treatment-from-existing-drugs-might-combat-covid-19.html</link>
			<pubDate>Fri, 17 Apr 2020 03:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_insider-15810.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15810/combined-treatment-from-existing-drugs-might-combat-covid-19.html</guid>
		</item>	
				<item>
			<title>Fujifilm accelerates favipiravir production for COVID-19 treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html</link>
			<pubDate>Thu, 16 Apr 2020 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-15801.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15801/fujifilm-accelerates-favipiravir-production-for-covid-19-treatment.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s CDD Cures Crohn&#039;s Disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/15792/australias-cdd-cures-crohns-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15792/australias-cdd-cures-crohns-disease.html</link>
			<pubDate>Wed, 15 Apr 2020 05:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medgadget-15792.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15792/australias-cdd-cures-crohns-disease.html</guid>
		</item>	
				<item>
			<title>Pfizer Advances Battle Against COVID-19 on Multiple Fronts </title>
			<atom:link href="https://biospectrumasia.com/news/34/15777/pfizer-advances-battle-against-covid-19-on-multiple-fronts-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15777/pfizer-advances-battle-against-covid-19-on-multiple-fronts-.html</link>
			<pubDate>Fri, 10 Apr 2020 18:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stat-15777.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15777/pfizer-advances-battle-against-covid-19-on-multiple-fronts-.html</guid>
		</item>	
				<item>
			<title>Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html</link>
			<pubDate>Fri, 10 Apr 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/xconomy-15766.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15766/takeda-and-csl-behring-to-develop-potential-covid-19-hyperimmune-therapy.html</guid>
		</item>	
				<item>
			<title>I-Mab to develop TJM2 for treatment of COVID-19 related illness</title>
			<atom:link href="https://biospectrumasia.com/news/34/15667/i-mab-to-develop-tjm2-for-treatment-of-covid-19-related-illness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15667/i-mab-to-develop-tjm2-for-treatment-of-covid-19-related-illness.html</link>
			<pubDate>Thu, 26 Mar 2020 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_15348-15667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15667/i-mab-to-develop-tjm2-for-treatment-of-covid-19-related-illness.html</guid>
		</item>	
				<item>
			<title>CytomX, Astellas to find cure for cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/15651/cytomx-astellas-to-find-cure-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15651/cytomx-astellas-to-find-cure-for-cancer.html</link>
			<pubDate>Wed, 25 Mar 2020 07:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1063442_1920-15651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15651/cytomx-astellas-to-find-cure-for-cancer.html</guid>
		</item>	
				<item>
			<title>China clears Taletrectinib IND, issues clinical trial authorizations</title>
			<atom:link href="https://biospectrumasia.com/news/34/15650/china-clears-taletrectinib-ind-issues-clinical-trial-authorizations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15650/china-clears-taletrectinib-ind-issues-clinical-trial-authorizations.html</link>
			<pubDate>Tue, 24 Mar 2020 17:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15650.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15650/china-clears-taletrectinib-ind-issues-clinical-trial-authorizations.html</guid>
		</item>	
				<item>
			<title>Bayer, Curadev ink â‚¬250M deal for novel STING antagonists</title>
			<atom:link href="https://biospectrumasia.com/news/34/15648/bayer-curadev-ink-250m-deal-for-novel-sting-antagonists.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15648/bayer-curadev-ink-250m-deal-for-novel-sting-antagonists.html</link>
			<pubDate>Tue, 24 Mar 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15648.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15648/bayer-curadev-ink-250m-deal-for-novel-sting-antagonists.html</guid>
		</item>	
				<item>
			<title>Japan approves Novartis&#039; SMA drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/15622/japan-approves-novartis-sma-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15622/japan-approves-novartis-sma-drug-.html</link>
			<pubDate>Thu, 19 Mar 2020 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15622.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15622/japan-approves-novartis-sma-drug-.html</guid>
		</item>	
				<item>
			<title>Beijing Tide Pharma collaborates with Insilico for cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/15606/beijing-tide-pharma-collaborates-with-insilico-for-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15606/beijing-tide-pharma-collaborates-with-insilico-for-cancer-therapy.html</link>
			<pubDate>Wed, 18 Mar 2020 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/02_blog_immunotherapy_drug_l-15606.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15606/beijing-tide-pharma-collaborates-with-insilico-for-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Atomwise, Bridge Bio sign $1B Deal </title>
			<atom:link href="https://biospectrumasia.com/news/34/15569/atomwise-bridge-bio-sign-1b-deal-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15569/atomwise-bridge-bio-sign-1b-deal-.html</link>
			<pubDate>Thu, 12 Mar 2020 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1063442_1920-15569.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15569/atomwise-bridge-bio-sign-1b-deal-.html</guid>
		</item>	
				<item>
			<title>Japan to test AIM ImmunoTech&#039;s Ampligen for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/34/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html</link>
			<pubDate>Tue, 10 Mar 2020 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_15348-15570.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15570/japan-to-test-aim-immunotechs-ampligen-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Takeda initiates development of Plasma-Derived Therapy for COVID-19</title>
			<atom:link href="https://biospectrumasia.com/news/34/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html</link>
			<pubDate>Thu, 05 Mar 2020 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/coronavirus_blood_sample-15535.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15535/takeda-initiates-development-of-plasma-derived-therapy-for-covid-19.html</guid>
		</item>	
				<item>
			<title>Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html</link>
			<pubDate>Thu, 27 Feb 2020 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15500.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15500/eisai-fuji-yakuhin-to-work-on-hyperuricemia-and-gout-treatment.html</guid>
		</item>	
				<item>
			<title>Arctoris launches BioTarget 2020 to support biotech company innovations</title>
			<atom:link href="https://biospectrumasia.com/news/34/15470/arctoris-launches-biotarget-2020-to-support-biotech-company-innovations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15470/arctoris-launches-biotarget-2020-to-support-biotech-company-innovations.html</link>
			<pubDate>Fri, 21 Feb 2020 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/unnamed_1_-15470.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15470/arctoris-launches-biotarget-2020-to-support-biotech-company-innovations.html</guid>
		</item>	
				<item>
			<title>China&#039;s Borui Biomedical imitates Gilead&#039;s Coronavirus drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15432/chinas-borui-biomedical-imitates-gileads-coronavirus-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15432/chinas-borui-biomedical-imitates-gileads-coronavirus-drug.html</link>
			<pubDate>Fri, 14 Feb 2020 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15432.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15432/chinas-borui-biomedical-imitates-gileads-coronavirus-drug.html</guid>
		</item>	
				<item>
			<title>Codagenix &amp; Serum Institute to co-develop vaccine against Novel Coronavirus</title>
			<atom:link href="https://biospectrumasia.com/news/34/15436/codagenix-serum-institute-to-co-develop-vaccine-against-novel-coronavirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15436/codagenix-serum-institute-to-co-develop-vaccine-against-novel-coronavirus.html</link>
			<pubDate>Fri, 14 Feb 2020 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe_3359627_1280-15436.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15436/codagenix-serum-institute-to-co-develop-vaccine-against-novel-coronavirus.html</guid>
		</item>	
				<item>
			<title>Gilead begins trial for coronavirus drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/15409/gilead-begins-trial-for-coronavirus-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15409/gilead-begins-trial-for-coronavirus-drug-.html</link>
			<pubDate>Wed, 12 Feb 2020 06:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15409.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15409/gilead-begins-trial-for-coronavirus-drug-.html</guid>
		</item>	
				<item>
			<title>Bridge Biotherapeutics acquires new candidate for back-eye diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/15384/bridge-biotherapeutics-acquires-new-candidate-for-back-eye-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15384/bridge-biotherapeutics-acquires-new-candidate-for-back-eye-diseases.html</link>
			<pubDate>Thu, 06 Feb 2020 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15384.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15384/bridge-biotherapeutics-acquires-new-candidate-for-back-eye-diseases.html</guid>
		</item>	
				<item>
			<title>Astellas submits sNDA in Japan for Evrenzo to treat Anemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/15343/astellas-submits-snda-in-japan-for-evrenzo-to-treat-anemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15343/astellas-submits-snda-in-japan-for-evrenzo-to-treat-anemia.html</link>
			<pubDate>Thu, 30 Jan 2020 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anemia_medgadget-15343.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15343/astellas-submits-snda-in-japan-for-evrenzo-to-treat-anemia.html</guid>
		</item>	
				<item>
			<title>Noxopharm to transform cancer treatment space</title>
			<atom:link href="https://biospectrumasia.com/news/34/15336/noxopharm-to-transform-cancer-treatment-space.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15336/noxopharm-to-transform-cancer-treatment-space.html</link>
			<pubDate>Wed, 29 Jan 2020 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15336.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15336/noxopharm-to-transform-cancer-treatment-space.html</guid>
		</item>	
				<item>
			<title>PerkinElmer unveils Advanced Drug Discovery and Disease Research Solutions</title>
			<atom:link href="https://biospectrumasia.com/news/34/15322/perkinelmer-unveils-advanced-drug-discovery-and-disease-research-solutions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15322/perkinelmer-unveils-advanced-drug-discovery-and-disease-research-solutions.html</link>
			<pubDate>Tue, 28 Jan 2020 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wwwwwwwwwwwwwwwwwwwwwww-15322.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15322/perkinelmer-unveils-advanced-drug-discovery-and-disease-research-solutions.html</guid>
		</item>	
				<item>
			<title>CEPI selects Inovio to develop vaccine against coronavirus</title>
			<atom:link href="https://biospectrumasia.com/news/34/15313/cepi-selects-inovio-to-develop-vaccine-against-coronavirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15313/cepi-selects-inovio-to-develop-vaccine-against-coronavirus.html</link>
			<pubDate>Tue, 28 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15313.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15313/cepi-selects-inovio-to-develop-vaccine-against-coronavirus.html</guid>
		</item>	
				<item>
			<title>Darolutamide gets marketing authorization in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/15301/darolutamide-gets-marketing-authorization-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15301/darolutamide-gets-marketing-authorization-in-japan.html</link>
			<pubDate>Fri, 24 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15301.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15301/darolutamide-gets-marketing-authorization-in-japan.html</guid>
		</item>	
				<item>
			<title>Hitachi Chemical inks pact with Ori Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/34/15287/hitachi-chemical-inks-pact-with-ori-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15287/hitachi-chemical-inks-pact-with-ori-biotech.html</link>
			<pubDate>Thu, 23 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15287.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15287/hitachi-chemical-inks-pact-with-ori-biotech.html</guid>
		</item>	
				<item>
			<title>RegeneRx Biopharma receives patent in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/34/15291/regenerx-biopharma-receives-patent-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15291/regenerx-biopharma-receives-patent-in-korea.html</link>
			<pubDate>Thu, 23 Jan 2020 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15291.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15291/regenerx-biopharma-receives-patent-in-korea.html</guid>
		</item>	
				<item>
			<title>PhoreMost, Otsuka collaborate for multi drug discovery projects</title>
			<atom:link href="https://biospectrumasia.com/news/34/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html</link>
			<pubDate>Wed, 22 Jan 2020 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15286.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15286/phoremost-otsuka-collaborate-for-multi-drug-discovery-projects.html</guid>
		</item>	
				<item>
			<title>ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1</title>
			<atom:link href="https://biospectrumasia.com/news/34/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html</link>
			<pubDate>Mon, 20 Jan 2020 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiv-15273.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15273/viiv-healthcare-wins-japanese-approval-for-dovato-to-treat-hiv-1.html</guid>
		</item>	
				<item>
			<title>InterVenn Biosciences advances glycoproteomics for complex disease therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/15267/intervenn-biosciences-advances-glycoproteomics-for-complex-disease-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15267/intervenn-biosciences-advances-glycoproteomics-for-complex-disease-therapies.html</link>
			<pubDate>Fri, 17 Jan 2020 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-15267.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15267/intervenn-biosciences-advances-glycoproteomics-for-complex-disease-therapies.html</guid>
		</item>	
				<item>
			<title>Charles River inks scientific collaboration with Takeda </title>
			<atom:link href="https://biospectrumasia.com/news/34/15259/charles-river-inks-scientific-collaboration-with-takeda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15259/charles-river-inks-scientific-collaboration-with-takeda-.html</link>
			<pubDate>Thu, 16 Jan 2020 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15259.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15259/charles-river-inks-scientific-collaboration-with-takeda-.html</guid>
		</item>	
				<item>
			<title>Hitachi starts commercial manufacturing of Zynteglo</title>
			<atom:link href="https://biospectrumasia.com/news/34/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html</link>
			<pubDate>Wed, 15 Jan 2020 06:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15241.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15241/hitachi-starts-commercial-manufacturing-of-zynteglo.html</guid>
		</item>	
				<item>
			<title>FDA approves sNDA for Astellas&#039;s antifungal drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15230/fda-approves-snda-for-astellass-antifungal-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15230/fda-approves-snda-for-astellass-antifungal-drug.html</link>
			<pubDate>Mon, 13 Jan 2020 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15230.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15230/fda-approves-snda-for-astellass-antifungal-drug.html</guid>
		</item>	
				<item>
			<title>China approves AstraZeneca&#039;s Lokelma to treat hyperkalaemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/15198/china-approves-astrazenecas-lokelma-to-treat-hyperkalaemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15198/china-approves-astrazenecas-lokelma-to-treat-hyperkalaemia.html</link>
			<pubDate>Tue, 07 Jan 2020 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicines-15198.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15198/china-approves-astrazenecas-lokelma-to-treat-hyperkalaemia.html</guid>
		</item>	
				<item>
			<title>China grants priority review to Luye Pharma&#039;s schizophrenia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15177/china-grants-priority-review-to-luye-pharmas-schizophrenia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15177/china-grants-priority-review-to-luye-pharmas-schizophrenia-drug.html</link>
			<pubDate>Thu, 02 Jan 2020 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15177.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15177/china-grants-priority-review-to-luye-pharmas-schizophrenia-drug.html</guid>
		</item>	
				<item>
			<title>AstraZeneca&#039;s triple-combination therapy gets approval in China for COPD</title>
			<atom:link href="https://biospectrumasia.com/news/34/15170/astrazenecas-triple-combination-therapy-gets-approval-in-china-for-copd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15170/astrazenecas-triple-combination-therapy-gets-approval-in-china-for-copd.html</link>
			<pubDate>Wed, 01 Jan 2020 05:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15170.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15170/astrazenecas-triple-combination-therapy-gets-approval-in-china-for-copd.html</guid>
		</item>	
				<item>
			<title>Starpharma commences Ph 1 Trial for AZD0466</title>
			<atom:link href="https://biospectrumasia.com/news/34/15153/starpharma-commences-ph-1-trial-for-azd0466.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15153/starpharma-commences-ph-1-trial-for-azd0466.html</link>
			<pubDate>Mon, 30 Dec 2019 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15153/starpharma-commences-ph-1-trial-for-azd0466.html</guid>
		</item>	
				<item>
			<title>Luye Pharma seeks USFDA approval for antidepressant drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15152/luye-pharma-seeks-usfda-approval-for-antidepressant-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15152/luye-pharma-seeks-usfda-approval-for-antidepressant-drug.html</link>
			<pubDate>Mon, 30 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15152/luye-pharma-seeks-usfda-approval-for-antidepressant-drug.html</guid>
		</item>	
				<item>
			<title>USFDA approves Daiichi Sankyo and AstraZeneca&#039;s breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html</link>
			<pubDate>Thu, 26 Dec 2019 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi_sankyo_enhertu_anchor_12-15141.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15141/usfda-approves-daiichi-sankyo-and-astrazenecas-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Eisai gets USFDA nod for insomnia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15128/eisai-gets-usfda-nod-for-insomnia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15128/eisai-gets-usfda-nod-for-insomnia-drug.html</link>
			<pubDate>Tue, 24 Dec 2019 21:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_2928254-15128.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15128/eisai-gets-usfda-nod-for-insomnia-drug.html</guid>
		</item>	
				<item>
			<title>Allergan gets FDA nod for acute migraine treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/15134/allergan-gets-fda-nod-for-acute-migraine-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15134/allergan-gets-fda-nod-for-acute-migraine-treatment.html</link>
			<pubDate>Tue, 24 Dec 2019 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets_2-15134.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15134/allergan-gets-fda-nod-for-acute-migraine-treatment.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Bridge Biotherapeutics Files IND for lung cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15122/koreas-bridge-biotherapeutics-files-ind-for-lung-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15122/koreas-bridge-biotherapeutics-files-ind-for-lung-cancer-drug.html</link>
			<pubDate>Mon, 23 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_257930-15122.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15122/koreas-bridge-biotherapeutics-files-ind-for-lung-cancer-drug.html</guid>
		</item>	
				<item>
			<title>BeiGene cancer drug misses mark in Phase III study</title>
			<atom:link href="https://biospectrumasia.com/news/34/15107/beigene-cancer-drug-misses-mark-in-phase-iii-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15107/beigene-cancer-drug-misses-mark-in-phase-iii-study.html</link>
			<pubDate>Fri, 20 Dec 2019 15:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sign_1719892_1920-15107.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15107/beigene-cancer-drug-misses-mark-in-phase-iii-study.html</guid>
		</item>	
				<item>
			<title>Takeda, Turnstone Biologics to develop novel viral immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html</link>
			<pubDate>Fri, 20 Dec 2019 07:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15106.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15106/takeda-turnstone-biologics-to-develop-novel-viral-immunotherapies.html</guid>
		</item>	
				<item>
			<title>European Commission approves Roche&#039;s breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/15102/european-commission-approves-roches-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15102/european-commission-approves-roches-breast-cancer-drug.html</link>
			<pubDate>Thu, 19 Dec 2019 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast_cancer-15102.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15102/european-commission-approves-roches-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Pfizer, Astellas&#039; Xtandi Gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/15089/pfizer-astellas-xtandi-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15089/pfizer-astellas-xtandi-gets-fda-nod.html</link>
			<pubDate>Tue, 17 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/board_3700116_1920-15089.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15089/pfizer-astellas-xtandi-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, Daiichi Sankyo&#039;s trastuzumab shows promise in Phase II Trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html</link>
			<pubDate>Mon, 16 Dec 2019 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/board_3700116_1920-15072.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15072/astrazeneca-daiichi-sankyos-trastuzumab-shows-promise-in-phase-ii-trial-.html</guid>
		</item>	
				<item>
			<title>Brii Biosciences expands focus to neurosciences</title>
			<atom:link href="https://biospectrumasia.com/news/34/15017/brii-biosciences-expands-focus-to-neurosciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15017/brii-biosciences-expands-focus-to-neurosciences.html</link>
			<pubDate>Wed, 04 Dec 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-15017.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15017/brii-biosciences-expands-focus-to-neurosciences.html</guid>
		</item>	
				<item>
			<title>Astellas to Acquire Audentes Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/15008/astellas-to-acquire-audentes-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15008/astellas-to-acquire-audentes-therapeutics.html</link>
			<pubDate>Tue, 03 Dec 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people_woman_coffee_meeting-15008.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15008/astellas-to-acquire-audentes-therapeutics.html</guid>
		</item>	
				<item>
			<title>Chugai Pharma&#039;s study on satralizumab published in The New England Journal of Medicine </title>
			<atom:link href="https://biospectrumasia.com/news/34/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html</link>
			<pubDate>Mon, 02 Dec 2019 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ubwcaq8z1qwxuszlplu6xps9pjml8mpkcwjuysvs-15000.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15000/chugai-pharmas-study-on-satralizumab-published-in-the-new-england-journal-of-medicine-.html</guid>
		</item>	
				<item>
			<title>Innovent, Eli Lilly presents co-developed cancer-fighting Tyvyt at CIIE 2019</title>
			<atom:link href="https://biospectrumasia.com/news/34/15001/innovent-eli-lilly-presents-co-developed-cancer-fighting-tyvyt-at-ciie-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/15001/innovent-eli-lilly-presents-co-developed-cancer-fighting-tyvyt-at-ciie-2019.html</link>
			<pubDate>Mon, 02 Dec 2019 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment_3-15001.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/15001/innovent-eli-lilly-presents-co-developed-cancer-fighting-tyvyt-at-ciie-2019.html</guid>
		</item>	
				<item>
			<title>Astellas to treat men with metastatic castration-resistant prostate cancer in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/14967/astellas-to-treat-men-with-metastatic-castration-resistant-prostate-cancer-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14967/astellas-to-treat-men-with-metastatic-castration-resistant-prostate-cancer-in-china.html</link>
			<pubDate>Tue, 26 Nov 2019 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prostate_cancer-14967.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14967/astellas-to-treat-men-with-metastatic-castration-resistant-prostate-cancer-in-china.html</guid>
		</item>	
				<item>
			<title>Pfizer Unveils Positive Results for VIZIMPROÂ® as first-line monotherapy in NSCLC patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/14965/pfizer-unveils-positive-results-for-vizimpro-as-first-line-monotherapy-in-nsclc-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14965/pfizer-unveils-positive-results-for-vizimpro-as-first-line-monotherapy-in-nsclc-patients.html</link>
			<pubDate>Tue, 26 Nov 2019 01:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/express_co_uk-14965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14965/pfizer-unveils-positive-results-for-vizimpro-as-first-line-monotherapy-in-nsclc-patients.html</guid>
		</item>	
				<item>
			<title>Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019</title>
			<atom:link href="https://biospectrumasia.com/news/34/14964/merck-presented-data-on-tepotinib-for-nsclc-at-esmo-asia-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14964/merck-presented-data-on-tepotinib-for-nsclc-at-esmo-asia-2019.html</link>
			<pubDate>Mon, 25 Nov 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daily_express-14964.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14964/merck-presented-data-on-tepotinib-for-nsclc-at-esmo-asia-2019.html</guid>
		</item>	
				<item>
			<title>BeiGene receives its first FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/14901/beigene-receives-its-first-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14901/beigene-receives-its-first-fda-approval.html</link>
			<pubDate>Mon, 18 Nov 2019 06:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14901/beigene-receives-its-first-fda-approval.html</guid>
		</item>	
				<item>
			<title>Yuhan Pharmaceuticals partners with Cyclica</title>
			<atom:link href="https://biospectrumasia.com/news/34/14876/yuhan-pharmaceuticals-partners-with-cyclica.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14876/yuhan-pharmaceuticals-partners-with-cyclica.html</link>
			<pubDate>Wed, 13 Nov 2019 06:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14876.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14876/yuhan-pharmaceuticals-partners-with-cyclica.html</guid>
		</item>	
				<item>
			<title>China approves Alzheimer&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/14860/china-approves-alzheimers-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14860/china-approves-alzheimers-drug.html</link>
			<pubDate>Mon, 11 Nov 2019 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14860.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14860/china-approves-alzheimers-drug.html</guid>
		</item>	
				<item>
			<title>Samsung Biologics collaborates with Ichnos Sciences in derma space</title>
			<atom:link href="https://biospectrumasia.com/news/34/14818/samsung-biologics-collaborates-with-ichnos-sciences-in-derma-space.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14818/samsung-biologics-collaborates-with-ichnos-sciences-in-derma-space.html</link>
			<pubDate>Wed, 06 Nov 2019 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14818.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14818/samsung-biologics-collaborates-with-ichnos-sciences-in-derma-space.html</guid>
		</item>	
				<item>
			<title>EU approves BAVENCIOÂ® (avelumab) Plus Axitinib to treat RCC</title>
			<atom:link href="https://biospectrumasia.com/news/34/14774/eu-approves-bavencio-avelumab-plus-axitinib-to-treat-rcc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14774/eu-approves-bavencio-avelumab-plus-axitinib-to-treat-rcc.html</link>
			<pubDate>Tue, 29 Oct 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/outsourcing_pharma-14774.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14774/eu-approves-bavencio-avelumab-plus-axitinib-to-treat-rcc.html</guid>
		</item>	
				<item>
			<title>Biogen plans regulatory filing for Aducanumab for Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/34/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html</link>
			<pubDate>Wed, 23 Oct 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzeimer-14748.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14748/biogen-plans-regulatory-filing-for-aducanumab-for-alzheimers.html</guid>
		</item>	
				<item>
			<title>Takeda acquires license for celiac disease therapy </title>
			<atom:link href="https://biospectrumasia.com/news/34/14735/takeda-acquires-license-for-celiac-disease-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14735/takeda-acquires-license-for-celiac-disease-therapy-.html</link>
			<pubDate>Tue, 22 Oct 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14735.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14735/takeda-acquires-license-for-celiac-disease-therapy-.html</guid>
		</item>	
				<item>
			<title>NeuClone announces First Human dose of StelaraÂ® (Ustekinumab) Biosimilar candidate </title>
			<atom:link href="https://biospectrumasia.com/news/34/14727/neuclone-announces-first-human-dose-of-stelara-ustekinumab-biosimilar-candidate-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14727/neuclone-announces-first-human-dose-of-stelara-ustekinumab-biosimilar-candidate-.html</link>
			<pubDate>Mon, 21 Oct 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/selectscience-14727.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14727/neuclone-announces-first-human-dose-of-stelara-ustekinumab-biosimilar-candidate-.html</guid>
		</item>	
				<item>
			<title>Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer </title>
			<atom:link href="https://biospectrumasia.com/news/34/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html</link>
			<pubDate>Fri, 18 Oct 2019 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast_cancer-14713.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14713/trastuzumab-deruxtecan-gets-fda-priority-review-to-treat-metastatic-breast-cancer-.html</guid>
		</item>	
				<item>
			<title>Lilly&#039;s Migraine drug receives FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/14676/lillys-migraine-drug-receives-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14676/lillys-migraine-drug-receives-fda-approval.html</link>
			<pubDate>Mon, 14 Oct 2019 13:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/migrane-14676.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14676/lillys-migraine-drug-receives-fda-approval.html</guid>
		</item>	
				<item>
			<title>Mayne Pharma signs exclusive license for novel oral contraceptive </title>
			<atom:link href="https://biospectrumasia.com/news/34/14653/mayne-pharma-signs-exclusive-license-for-novel-oral-contraceptive-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14653/mayne-pharma-signs-exclusive-license-for-novel-oral-contraceptive-.html</link>
			<pubDate>Wed, 09 Oct 2019 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/legal_agreement-14653.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14653/mayne-pharma-signs-exclusive-license-for-novel-oral-contraceptive-.html</guid>
		</item>	
				<item>
			<title>Gilead Sciences submits NDA to treat RA in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html</link>
			<pubDate>Wed, 09 Oct 2019 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rheumatoid_arthritis-14650.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14650/gilead-sciences-submits-nda-to-treat-ra-in-japan.html</guid>
		</item>	
				<item>
			<title>Bayer and RIKEN establish partnership for novel drug discovery </title>
			<atom:link href="https://biospectrumasia.com/news/34/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html</link>
			<pubDate>Wed, 09 Oct 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/azemews_az-14638.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14638/bayer-and-riken-establish-partnership-for-novel-drug-discovery-.html</guid>
		</item>	
				<item>
			<title>Report: China&#039;s Henlius raises $410 million in Hong Kong IPO</title>
			<atom:link href="https://biospectrumasia.com/news/34/14554/report-chinas-henlius-raises-410-million-in-hong-kong-ipo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14554/report-chinas-henlius-raises-410-million-in-hong-kong-ipo.html</link>
			<pubDate>Mon, 23 Sep 2019 17:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14554/report-chinas-henlius-raises-410-million-in-hong-kong-ipo.html</guid>
		</item>	
				<item>
			<title>FDA Approves Merck &amp; Eisai&#039;s combination drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/14551/fda-approves-merck-eisais-combination-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14551/fda-approves-merck-eisais-combination-drug-.html</link>
			<pubDate>Mon, 23 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_nss2erzqwgw_unsplash-14551.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14551/fda-approves-merck-eisais-combination-drug-.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk set to bring innovative treatment for type 2 diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/34/14555/novo-nordisk-set-to-bring-innovative-treatment-for-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14555/novo-nordisk-set-to-bring-innovative-treatment-for-type-2-diabetes.html</link>
			<pubDate>Mon, 23 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetis_3-14555.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14555/novo-nordisk-set-to-bring-innovative-treatment-for-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>SMART announces a revolutionary tech to study cell nanomechanics </title>
			<atom:link href="https://biospectrumasia.com/news/34/14544/smart-announces-a-revolutionary-tech-to-study-cell-nanomechanics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14544/smart-announces-a-revolutionary-tech-to-study-cell-nanomechanics-.html</link>
			<pubDate>Fri, 20 Sep 2019 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/0-14544.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14544/smart-announces-a-revolutionary-tech-to-study-cell-nanomechanics-.html</guid>
		</item>	
				<item>
			<title>FDA approves combo drug to treat endometrial carcinoma</title>
			<atom:link href="https://biospectrumasia.com/news/34/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html</link>
			<pubDate>Thu, 19 Sep 2019 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-14525.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14525/fda-approves-combo-drug-to-treat-endometrial-carcinoma.html</guid>
		</item>	
				<item>
			<title>FDA Grants Breakthrough Therapy Designation for Genentech&#039;s Gazyva (Obinutuzumab) </title>
			<atom:link href="https://biospectrumasia.com/news/34/14513/fda-grants-breakthrough-therapy-designation-for-genentechs-gazyva-obinutuzumab-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14513/fda-grants-breakthrough-therapy-designation-for-genentechs-gazyva-obinutuzumab-.html</link>
			<pubDate>Wed, 18 Sep 2019 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/louis_reed_pwckf7l4_no_unsplash-14513.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14513/fda-grants-breakthrough-therapy-designation-for-genentechs-gazyva-obinutuzumab-.html</guid>
		</item>	
				<item>
			<title>FDA grants priority review for Merck&#039;s Ebola Vaccine </title>
			<atom:link href="https://biospectrumasia.com/influencers/34/14504/fda-grants-priority-review-for-mercks-ebola-vaccine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/14504/fda-grants-priority-review-for-mercks-ebola-vaccine-.html</link>
			<pubDate>Tue, 17 Sep 2019 17:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/louis_reed_pwckf7l4_no_unsplash-14504.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/14504/fda-grants-priority-review-for-mercks-ebola-vaccine-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Sumitomo Dainippon Pharma forms Strategic Alliance with Swiss  Roivant Sciences</title>
			<atom:link href="https://biospectrumasia.com/news/34/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html</link>
			<pubDate>Mon, 16 Sep 2019 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_1162968-14484.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14484/japans-sumitomo-dainippon-pharma-forms-strategic-alliance-with-swiss-roivant-sciences.html</guid>
		</item>	
				<item>
			<title>Certara launches V8.2 of Phoenix PK/PD modeling &amp; simulation software for drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/14474/certara-launches-v8-2-of-phoenix-pk-pd-modeling-simulation-software-for-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14474/certara-launches-v8-2-of-phoenix-pk-pd-modeling-simulation-software-for-drugs.html</link>
			<pubDate>Sun, 15 Sep 2019 22:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phoenix_8_2_screenshot-14474.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14474/certara-launches-v8-2-of-phoenix-pk-pd-modeling-simulation-software-for-drugs.html</guid>
		</item>	
				<item>
			<title>Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab</title>
			<atom:link href="https://biospectrumasia.com/news/34/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html</link>
			<pubDate>Thu, 12 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pexels_photo_1282270-14455.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14455/chugai-presents-results-from-second-positive-global-phase-iii-clinical-study-of-satralizumab.html</guid>
		</item>	
				<item>
			<title>Hansoh Pharma, Atomwise partner for AI Drug Discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/14454/hansoh-pharma-atomwise-partner-for-ai-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14454/hansoh-pharma-atomwise-partner-for-ai-drug-discovery.html</link>
			<pubDate>Thu, 12 Sep 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14454.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14454/hansoh-pharma-atomwise-partner-for-ai-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html</link>
			<pubDate>Tue, 10 Sep 2019 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kelly_sikkema_fvegjucmmzi_unsplash-14435.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14435/daiichi-sankyo-advances-fam-trastuzumab-in-japan-.html</guid>
		</item>	
				<item>
			<title>WuXi AppTec Launches DNA Encoded Library (DEL) Service Package</title>
			<atom:link href="https://biospectrumasia.com/news/34/14427/wuxi-apptec-launches-dna-encoded-library-del-service-package.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14427/wuxi-apptec-launches-dna-encoded-library-del-service-package.html</link>
			<pubDate>Mon, 09 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14427/wuxi-apptec-launches-dna-encoded-library-del-service-package.html</guid>
		</item>	
				<item>
			<title>Zhilin Group announces the development of new drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/14431/zhilin-group-announces-the-development-of-new-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14431/zhilin-group-announces-the-development-of-new-drugs.html</link>
			<pubDate>Mon, 09 Sep 2019 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/freestocks_org_nss2erzqwgw_unsplash-14431.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14431/zhilin-group-announces-the-development-of-new-drugs.html</guid>
		</item>	
				<item>
			<title>SchrÃ¶dinger partners with AstraZeneca</title>
			<atom:link href="https://biospectrumasia.com/news/34/14411/schrdinger-partners-with-astrazeneca.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14411/schrdinger-partners-with-astrazeneca.html</link>
			<pubDate>Thu, 05 Sep 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14411/schrdinger-partners-with-astrazeneca.html</guid>
		</item>	
				<item>
			<title>Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html</link>
			<pubDate>Fri, 30 Aug 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/seshimo_hidenori-14364.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14364/invicro-appoints-hidenori-seshimo-as-vice-president-of-biomarker-services-japan.html</guid>
		</item>	
				<item>
			<title>FDA fast tracks AstraZeneca&#039;s FARXIGA </title>
			<atom:link href="https://biospectrumasia.com/news/34/14352/fda-fast-tracks-astrazenecas-farxiga-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14352/fda-fast-tracks-astrazenecas-farxiga-.html</link>
			<pubDate>Wed, 28 Aug 2019 14:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14352.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14352/fda-fast-tracks-astrazenecas-farxiga-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s BioWa extends partnership with Cantargia </title>
			<atom:link href="https://biospectrumasia.com/news/34/14327/japans-biowa-extends-partnership-with-cantargia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14327/japans-biowa-extends-partnership-with-cantargia-.html</link>
			<pubDate>Tue, 27 Aug 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14327.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14327/japans-biowa-extends-partnership-with-cantargia-.html</guid>
		</item>	
				<item>
			<title>Roxadustat approved in China for the treatment of anaemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/14330/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14330/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html</link>
			<pubDate>Mon, 26 Aug 2019 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicalnewsbulletin-14330.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14330/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html</guid>
		</item>	
				<item>
			<title>Roxadustat approved in China for the treatment of anaemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/14331/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14331/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html</link>
			<pubDate>Mon, 26 Aug 2019 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicalnewsbulletin-14331.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14331/roxadustat-approved-in-china-for-the-treatment-of-anaemia.html</guid>
		</item>	
				<item>
			<title>Voronoi selects CDD Vault platform to manage Drug Discovery Data</title>
			<atom:link href="https://biospectrumasia.com/news/34/14311/voronoi-selects-cdd-vault-platform-to-manage-drug-discovery-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14311/voronoi-selects-cdd-vault-platform-to-manage-drug-discovery-data.html</link>
			<pubDate>Fri, 23 Aug 2019 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/technologynetwork-14311.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14311/voronoi-selects-cdd-vault-platform-to-manage-drug-discovery-data.html</guid>
		</item>	
				<item>
			<title>THC Global Groups&#039; Australalia&#039;s Facility Opened by Federal Minister for Health</title>
			<atom:link href="https://biospectrumasia.com/news/34/14360/thc-global-groups-australalias-facility-opened-by-federal-minister-for-health.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14360/thc-global-groups-australalias-facility-opened-by-federal-minister-for-health.html</link>
			<pubDate>Thu, 22 Aug 2019 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14360/thc-global-groups-australalias-facility-opened-by-federal-minister-for-health.html</guid>
		</item>	
				<item>
			<title>Innovent to develop &amp; commercialize a novel diabetes medicine in China </title>
			<atom:link href="https://biospectrumasia.com/news/34/14297/innovent-to-develop-commercialize-a-novel-diabetes-medicine-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14297/innovent-to-develop-commercialize-a-novel-diabetes-medicine-in-china-.html</link>
			<pubDate>Thu, 22 Aug 2019 09:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/uib-14297.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14297/innovent-to-develop-commercialize-a-novel-diabetes-medicine-in-china-.html</guid>
		</item>	
				<item>
			<title>FDA approves new antibiotic to treat community-acquired bacterial pneumonia</title>
			<atom:link href="https://biospectrumasia.com/news/34/14272/fda-approves-new-antibiotic-to-treat-community-acquired-bacterial-pneumonia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14272/fda-approves-new-antibiotic-to-treat-community-acquired-bacterial-pneumonia.html</link>
			<pubDate>Tue, 20 Aug 2019 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/docwirenews-14272.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14272/fda-approves-new-antibiotic-to-treat-community-acquired-bacterial-pneumonia.html</guid>
		</item>	
				<item>
			<title>FDA approves novel treatment for highly drug-resistant forms of TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/14258/fda-approves-novel-treatment-for-highly-drug-resistant-forms-of-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14258/fda-approves-novel-treatment-for-highly-drug-resistant-forms-of-tb.html</link>
			<pubDate>Mon, 19 Aug 2019 17:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tb_alliance-14258.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14258/fda-approves-novel-treatment-for-highly-drug-resistant-forms-of-tb.html</guid>
		</item>	
				<item>
			<title>Roche gets approval for oncology drug, Rozlytrek</title>
			<atom:link href="https://biospectrumasia.com/news/34/14242/roche-gets-approval-for-oncology-drug-rozlytrek.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14242/roche-gets-approval-for-oncology-drug-rozlytrek.html</link>
			<pubDate>Fri, 16 Aug 2019 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-14242.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14242/roche-gets-approval-for-oncology-drug-rozlytrek.html</guid>
		</item>	
				<item>
			<title>Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/14237/certara-introduces-version-19-6-of-its-d360-scientific-informatics-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14237/certara-introduces-version-19-6-of-its-d360-scientific-informatics-platform.html</link>
			<pubDate>Thu, 15 Aug 2019 22:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/multiple_alignment_identity_matrix_with_cursor_1_-14237.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14237/certara-introduces-version-19-6-of-its-d360-scientific-informatics-platform.html</guid>
		</item>	
				<item>
			<title>Bayer acquires BlueRock Therapeutics to build leading position in cell therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/14229/bayer-acquires-bluerock-therapeutics-to-build-leading-position-in-cell-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14229/bayer-acquires-bluerock-therapeutics-to-build-leading-position-in-cell-therapy.html</link>
			<pubDate>Wed, 14 Aug 2019 18:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/istockphoto_1010456164_1024x1024-14229.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14229/bayer-acquires-bluerock-therapeutics-to-build-leading-position-in-cell-therapy.html</guid>
		</item>	
				<item>
			<title>GE Healthcare Partnership with Fujitsu to tackle Brain Aneurysms with AI</title>
			<atom:link href="https://biospectrumasia.com/news/34/14226/ge-healthcare-partnership-with-fujitsu-to-tackle-brain-aneurysms-with-ai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14226/ge-healthcare-partnership-with-fujitsu-to-tackle-brain-aneurysms-with-ai.html</link>
			<pubDate>Wed, 14 Aug 2019 14:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/4891-14226.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14226/ge-healthcare-partnership-with-fujitsu-to-tackle-brain-aneurysms-with-ai.html</guid>
		</item>	
				<item>
			<title>Lilly Announces Leadership Changes </title>
			<atom:link href="https://biospectrumasia.com/news/34/14197/lilly-announces-leadership-changes-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14197/lilly-announces-leadership-changes-.html</link>
			<pubDate>Sat, 10 Aug 2019 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14197/lilly-announces-leadership-changes-.html</guid>
		</item>	
				<item>
			<title>Innovent, Shenogen to evaluate TyvytÂ® with SNG1005 to treat advanced cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/14174/innovent-shenogen-to-evaluate-tyvyt-with-sng1005-to-treat-advanced-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14174/innovent-shenogen-to-evaluate-tyvyt-with-sng1005-to-treat-advanced-cancer.html</link>
			<pubDate>Wed, 07 Aug 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-14174.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14174/innovent-shenogen-to-evaluate-tyvyt-with-sng1005-to-treat-advanced-cancer.html</guid>
		</item>	
				<item>
			<title>Sun Pharma announces regulatory filing of Tildrakizumab in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html</link>
			<pubDate>Thu, 01 Aug 2019 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-14125.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14125/sun-pharma-announces-regulatory-filing-of-tildrakizumab-in-japan-.html</guid>
		</item>	
				<item>
			<title>Pfizer completes acquisition of Array Biopharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/14109/pfizer-completes-acquisition-of-array-biopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14109/pfizer-completes-acquisition-of-array-biopharma.html</link>
			<pubDate>Wed, 31 Jul 2019 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14109.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14109/pfizer-completes-acquisition-of-array-biopharma.html</guid>
		</item>	
				<item>
			<title>3SBio to bring first self-developed pre-filled fusion protein injection solution</title>
			<atom:link href="https://biospectrumasia.com/news/34/14102/3sbio-to-bring-first-self-developed-pre-filled-fusion-protein-injection-solution.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14102/3sbio-to-bring-first-self-developed-pre-filled-fusion-protein-injection-solution.html</link>
			<pubDate>Tue, 30 Jul 2019 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-14102.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14102/3sbio-to-bring-first-self-developed-pre-filled-fusion-protein-injection-solution.html</guid>
		</item>	
				<item>
			<title>AstraZeneca&#039;s roxadustat reveals positive results against anaemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/14072/astrazenecas-roxadustat-reveals-positive-results-against-anaemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14072/astrazenecas-roxadustat-reveals-positive-results-against-anaemia.html</link>
			<pubDate>Thu, 25 Jul 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anemea-14072.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14072/astrazenecas-roxadustat-reveals-positive-results-against-anaemia.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares teams up with Genentech for multi-target R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/34/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html</link>
			<pubDate>Wed, 17 Jul 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership-14007.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/14007/sosei-heptares-teams-up-with-genentech-for-multi-target-rd.html</guid>
		</item>	
				<item>
			<title>Eisai collaborates with University of Dundee for cancer drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html</link>
			<pubDate>Tue, 09 Jul 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13936/eisai-collaborates-with-university-of-dundee-for-cancer-drug-discovery.html</guid>
		</item>	
				<item>
			<title> New Vaccine in the Treatment of Rheumatoid Arthritis </title>
			<atom:link href="https://biospectrumasia.com/news/34/13933/-new-vaccine-in-the-treatment-of-rheumatoid-arthritis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13933/-new-vaccine-in-the-treatment-of-rheumatoid-arthritis-.html</link>
			<pubDate>Tue, 09 Jul 2019 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/35884897_m_1_-13933.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13933/-new-vaccine-in-the-treatment-of-rheumatoid-arthritis-.html</guid>
		</item>	
				<item>
			<title>Singapore HSA approves Vosevi to treat Chronic Hepatitis C Virus</title>
			<atom:link href="https://biospectrumasia.com/news/34/13805/singapore-hsa-approves-vosevi-to-treat-chronic-hepatitis-c-virus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13805/singapore-hsa-approves-vosevi-to-treat-chronic-hepatitis-c-virus.html</link>
			<pubDate>Tue, 25 Jun 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmazeutische_zeitung-13805.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13805/singapore-hsa-approves-vosevi-to-treat-chronic-hepatitis-c-virus.html</guid>
		</item>	
				<item>
			<title>Gilead collaborates with Nurix to develop new cancer therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/13770/gilead-collaborates-with-nurix-to-develop-new-cancer-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13770/gilead-collaborates-with-nurix-to-develop-new-cancer-therapies.html</link>
			<pubDate>Fri, 21 Jun 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-13770.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13770/gilead-collaborates-with-nurix-to-develop-new-cancer-therapies.html</guid>
		</item>	
				<item>
			<title>Zydus&#039; Nesher Pharma gets final USFDA nod for Lovaza capsules </title>
			<atom:link href="https://biospectrumasia.com/news/34/13727/zydus-nesher-pharma-gets-final-usfda-nod-for-lovaza-capsules-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13727/zydus-nesher-pharma-gets-final-usfda-nod-for-lovaza-capsules-.html</link>
			<pubDate>Mon, 17 Jun 2019 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approval-13727.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13727/zydus-nesher-pharma-gets-final-usfda-nod-for-lovaza-capsules-.html</guid>
		</item>	
				<item>
			<title>Acucela gets EMA approval for Emixustat to treat Stargardt disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html</link>
			<pubDate>Tue, 11 Jun 2019 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye_problem_1-13686.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13686/acucela-gets-ema-approval-for-emixustat-to-treat-stargardt-disease.html</guid>
		</item>	
				<item>
			<title>CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib</title>
			<atom:link href="https://biospectrumasia.com/news/34/13669/cstone-and-bayer-to-evaluate-pd-l1-monoclonal-antibody-cs1001-in-combination-with-regorafenib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13669/cstone-and-bayer-to-evaluate-pd-l1-monoclonal-antibody-cs1001-in-combination-with-regorafenib.html</link>
			<pubDate>Mon, 10 Jun 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/every_day_health-13669.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13669/cstone-and-bayer-to-evaluate-pd-l1-monoclonal-antibody-cs1001-in-combination-with-regorafenib.html</guid>
		</item>	
				<item>
			<title>Sosei Heptares to receive new $3 million milestone payment from Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/34/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html</link>
			<pubDate>Mon, 10 Jun 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition-13673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13673/sosei-heptares-to-receive-new-3-million-milestone-payment-from-pfizer.html</guid>
		</item>	
				<item>
			<title>Luye Pharma&#039;s Rykindo gets NDA filing acceptance by USFDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/13577/luye-pharmas-rykindo-gets-nda-filing-acceptance-by-usfda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13577/luye-pharmas-rykindo-gets-nda-filing-acceptance-by-usfda.html</link>
			<pubDate>Thu, 30 May 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzeimers-13577.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13577/luye-pharmas-rykindo-gets-nda-filing-acceptance-by-usfda.html</guid>
		</item>	
				<item>
			<title>European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma&#039;s Trastuzumab Biosimilar HD201 for Review</title>
			<atom:link href="https://biospectrumasia.com/news/34/13560/european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharmas-trastuzumab-biosimilar-hd201-for-review.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13560/european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharmas-trastuzumab-biosimilar-hd201-for-review.html</link>
			<pubDate>Tue, 28 May 2019 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prestige_biopharma-13560.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13560/european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharmas-trastuzumab-biosimilar-hd201-for-review.html</guid>
		</item>	
				<item>
			<title>Sihuan Pharm achieves new grant approval </title>
			<atom:link href="https://biospectrumasia.com/news/34/13559/sihuan-pharm-achieves-new-grant-approval-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13559/sihuan-pharm-achieves-new-grant-approval-.html</link>
			<pubDate>Tue, 28 May 2019 18:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sihuan_pharmaceutical_holdings_group_ltd-13559.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13559/sihuan-pharm-achieves-new-grant-approval-.html</guid>
		</item>	
				<item>
			<title>BGU introduces Novel Combination Therapy for treating neurological disorders</title>
			<atom:link href="https://biospectrumasia.com/news/34/13444/bgu-introduces-novel-combination-therapy-for-treating-neurological-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13444/bgu-introduces-novel-combination-therapy-for-treating-neurological-disorders.html</link>
			<pubDate>Mon, 13 May 2019 17:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stroke-13444.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13444/bgu-introduces-novel-combination-therapy-for-treating-neurological-disorders.html</guid>
		</item>	
				<item>
			<title>Taiwan Health Ministry approves Vemlidy for chronic hepatitis B</title>
			<atom:link href="https://biospectrumasia.com/news/34/13347/taiwan-health-ministry-approves-vemlidy-for-chronic-hepatitis-b.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13347/taiwan-health-ministry-approves-vemlidy-for-chronic-hepatitis-b.html</link>
			<pubDate>Tue, 30 Apr 2019 09:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13347.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13347/taiwan-health-ministry-approves-vemlidy-for-chronic-hepatitis-b.html</guid>
		</item>	
				<item>
			<title>ADC Therapeutics and Adagene announce discovery collaboration agreement</title>
			<atom:link href="https://biospectrumasia.com/news/34/13316/adc-therapeutics-and-adagene-announce-discovery-collaboration-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13316/adc-therapeutics-and-adagene-announce-discovery-collaboration-agreement.html</link>
			<pubDate>Thu, 25 Apr 2019 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_small_9065-13316.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13316/adc-therapeutics-and-adagene-announce-discovery-collaboration-agreement.html</guid>
		</item>	
				<item>
			<title>Roche launches Emicizumab in India</title>
			<atom:link href="https://biospectrumasia.com/news/34/13265/roche-launches-emicizumab-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13265/roche-launches-emicizumab-in-india.html</link>
			<pubDate>Sun, 21 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13265.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13265/roche-launches-emicizumab-in-india.html</guid>
		</item>	
				<item>
			<title>Japan grants Sakigake designation to Eisai&#039;s novel FGFR</title>
			<atom:link href="https://biospectrumasia.com/news/34/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html</link>
			<pubDate>Mon, 08 Apr 2019 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_2-13201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13201/japan-grants-sakigake-designation-to-eisais-novel-fgfr.html</guid>
		</item>	
				<item>
			<title>Takeda takes step towards EU Entyvio extension </title>
			<atom:link href="https://biospectrumasia.com/news/34/13162/takeda-takes-step-towards-eu-entyvio-extension-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13162/takeda-takes-step-towards-eu-entyvio-extension-.html</link>
			<pubDate>Tue, 02 Apr 2019 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1_1_-13162.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13162/takeda-takes-step-towards-eu-entyvio-extension-.html</guid>
		</item>	
				<item>
			<title>Standigm raises $11.5M in Series B Round </title>
			<atom:link href="https://biospectrumasia.com/news/34/13146/standigm-raises-11-5m-in-series-b-round-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13146/standigm-raises-11-5m-in-series-b-round-.html</link>
			<pubDate>Tue, 02 Apr 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding1-13146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13146/standigm-raises-11-5m-in-series-b-round-.html</guid>
		</item>	
				<item>
			<title>Takeda, StrideBio to advance novel gene therapies for neuro diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html</link>
			<pubDate>Mon, 01 Apr 2019 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13144.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13144/takeda-stridebio-to-advance-novel-gene-therapies-for-neuro-diseases.html</guid>
		</item>	
				<item>
			<title>HitGen, Almirall to identify novel drug targets</title>
			<atom:link href="https://biospectrumasia.com/news/34/13104/hitgen-almirall-to-identify-novel-drug-targets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13104/hitgen-almirall-to-identify-novel-drug-targets.html</link>
			<pubDate>Tue, 26 Mar 2019 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/optimisedfemale_scientist_microscop_smaller-13104.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13104/hitgen-almirall-to-identify-novel-drug-targets.html</guid>
		</item>	
				<item>
			<title>BioInvent developes Anti-TNFR2 programme for cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/13078/bioinvent-developes-anti-tnfr2-programme-for-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13078/bioinvent-developes-anti-tnfr2-programme-for-cancer-treatment.html</link>
			<pubDate>Thu, 21 Mar 2019 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-13078.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13078/bioinvent-developes-anti-tnfr2-programme-for-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>EC approves Roche&#039;s MabThera for a rare autoimmune disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/13058/ec-approves-roches-mabthera-for-a-rare-autoimmune-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13058/ec-approves-roches-mabthera-for-a-rare-autoimmune-disease.html</link>
			<pubDate>Tue, 19 Mar 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13058.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13058/ec-approves-roches-mabthera-for-a-rare-autoimmune-disease.html</guid>
		</item>	
				<item>
			<title>Ono Pharma, twoXAR announce drug discovery research collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/34/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html</link>
			<pubDate>Tue, 19 Mar 2019 10:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-13055.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13055/ono-pharma-twoxar-announce-drug-discovery-research-collaboration.html</guid>
		</item>	
				<item>
			<title>Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma </title>
			<atom:link href="https://biospectrumasia.com/news/34/13027/janssen-seeks-usfda-nod-for-darzalex-to-treat-asct-multiple-myeloma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/13027/janssen-seeks-usfda-nod-for-darzalex-to-treat-asct-multiple-myeloma-.html</link>
			<pubDate>Thu, 14 Mar 2019 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_treatment-13027.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/13027/janssen-seeks-usfda-nod-for-darzalex-to-treat-asct-multiple-myeloma-.html</guid>
		</item>	
				<item>
			<title>FDA approves new nasal spray for treatment-resistant depression</title>
			<atom:link href="https://biospectrumasia.com/news/34/12949/fda-approves-new-nasal-spray-for-treatment-resistant-depression.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12949/fda-approves-new-nasal-spray-for-treatment-resistant-depression.html</link>
			<pubDate>Wed, 06 Mar 2019 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/depression-12949.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12949/fda-approves-new-nasal-spray-for-treatment-resistant-depression.html</guid>
		</item>	
				<item>
			<title>Glenmark announces presentation of New Subtype Analysis of GBR 830</title>
			<atom:link href="https://biospectrumasia.com/news/34/12933/glenmark-announces-presentation-of-new-subtype-analysis-of-gbr-830.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12933/glenmark-announces-presentation-of-new-subtype-analysis-of-gbr-830.html</link>
			<pubDate>Mon, 04 Mar 2019 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/analyse-12933.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12933/glenmark-announces-presentation-of-new-subtype-analysis-of-gbr-830.html</guid>
		</item>	
				<item>
			<title>USFDA accepts Merck and Pfizer&#039;s sBLA for Renal Cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/12784/usfda-accepts-merck-and-pfizers-sbla-for-renal-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12784/usfda-accepts-merck-and-pfizers-sbla-for-renal-cancer-drug-.html</link>
			<pubDate>Tue, 12 Feb 2019 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12784.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12784/usfda-accepts-merck-and-pfizers-sbla-for-renal-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Teva announces US launch of Vigabatrin</title>
			<atom:link href="https://biospectrumasia.com/news/34/12759/teva-announces-us-launch-of-vigabatrin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12759/teva-announces-us-launch-of-vigabatrin.html</link>
			<pubDate>Fri, 08 Feb 2019 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets-12759.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12759/teva-announces-us-launch-of-vigabatrin.html</guid>
		</item>	
				<item>
			<title>Perrigo to launch its AB rated generic Zovirax cream</title>
			<atom:link href="https://biospectrumasia.com/news/34/12750/perrigo-to-launch-its-ab-rated-generic-zovirax-cream.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12750/perrigo-to-launch-its-ab-rated-generic-zovirax-cream.html</link>
			<pubDate>Thu, 07 Feb 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/zovirax-12750.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12750/perrigo-to-launch-its-ab-rated-generic-zovirax-cream.html</guid>
		</item>	
				<item>
			<title>BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/12740/biolinerx-gets-orphan-drug-designation-for-its-pancreatic-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12740/biolinerx-gets-orphan-drug-designation-for-its-pancreatic-cancer-drug.html</link>
			<pubDate>Thu, 07 Feb 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12740.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12740/biolinerx-gets-orphan-drug-designation-for-its-pancreatic-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Reaction Biology Corporation buys ProQinase GmbH</title>
			<atom:link href="https://biospectrumasia.com/news/34/12729/reaction-biology-corporation-buys-proqinase-gmbh.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12729/reaction-biology-corporation-buys-proqinase-gmbh.html</link>
			<pubDate>Tue, 05 Feb 2019 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquisition_2-12729.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12729/reaction-biology-corporation-buys-proqinase-gmbh.html</guid>
		</item>	
				<item>
			<title>I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study</title>
			<atom:link href="https://biospectrumasia.com/news/34/12710/i-mab-bct-to-work-on-arginine-depletion-therapy-and-biomarker-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12710/i-mab-bct-to-work-on-arginine-depletion-therapy-and-biomarker-study.html</link>
			<pubDate>Mon, 04 Feb 2019 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-12710.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12710/i-mab-bct-to-work-on-arginine-depletion-therapy-and-biomarker-study.html</guid>
		</item>	
				<item>
			<title>FDA expands Lilly&#039;s ALIMTA Label</title>
			<atom:link href="https://biospectrumasia.com/news/34/12694/fda-expands-lillys-alimta-label.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12694/fda-expands-lillys-alimta-label.html</link>
			<pubDate>Fri, 01 Feb 2019 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anexxa_672957196_900x-12694.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12694/fda-expands-lillys-alimta-label.html</guid>
		</item>	
				<item>
			<title>Neurocrine Biosciences collaborates with Voyager Therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/34/12687/neurocrine-biosciences-collaborates-with-voyager-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12687/neurocrine-biosciences-collaborates-with-voyager-therapeutics-.html</link>
			<pubDate>Thu, 31 Jan 2019 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12687.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12687/neurocrine-biosciences-collaborates-with-voyager-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Pfizer and Lilly announce top-line results of Tanezumab</title>
			<atom:link href="https://biospectrumasia.com/news/34/12682/pfizer-and-lilly-announce-top-line-results-of-tanezumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12682/pfizer-and-lilly-announce-top-line-results-of-tanezumab.html</link>
			<pubDate>Thu, 31 Jan 2019 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/quarterly_results_bg-12682.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12682/pfizer-and-lilly-announce-top-line-results-of-tanezumab.html</guid>
		</item>	
				<item>
			<title>J&amp;J announces USFDA approval of IMBRUVICA</title>
			<atom:link href="https://biospectrumasia.com/news/34/12655/jj-announces-usfda-approval-of-imbruvica.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12655/jj-announces-usfda-approval-of-imbruvica.html</link>
			<pubDate>Tue, 29 Jan 2019 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-12655.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12655/jj-announces-usfda-approval-of-imbruvica.html</guid>
		</item>	
				<item>
			<title>Basilea announces collaboration with Roche</title>
			<atom:link href="https://biospectrumasia.com/news/34/12633/basilea-announces-collaboration-with-roche.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12633/basilea-announces-collaboration-with-roche.html</link>
			<pubDate>Fri, 25 Jan 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration_words_quoates-12633.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12633/basilea-announces-collaboration-with-roche.html</guid>
		</item>	
				<item>
			<title>Wren Therapeutics completes Â£18M Series A Financing</title>
			<atom:link href="https://biospectrumasia.com/news/34/12602/wren-therapeutics-completes-18m-series-a-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12602/wren-therapeutics-completes-18m-series-a-financing.html</link>
			<pubDate>Wed, 23 Jan 2019 12:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/717x360_revealed_how_to_get_protection_growth_and_tax_saving_from_one_investment-12602.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12602/wren-therapeutics-completes-18m-series-a-financing.html</guid>
		</item>	
				<item>
			<title>AbbVie provides update on Phase 3 Study of IMBRUVICA </title>
			<atom:link href="https://biospectrumasia.com/news/34/12593/abbvie-provides-update-on-phase-3-study-of-imbruvica-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12593/abbvie-provides-update-on-phase-3-study-of-imbruvica-.html</link>
			<pubDate>Tue, 22 Jan 2019 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mutation_analysis_overview-12593.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12593/abbvie-provides-update-on-phase-3-study-of-imbruvica-.html</guid>
		</item>	
				<item>
			<title>Everest Medicines signs new deal targeting drug resistance</title>
			<atom:link href="https://biospectrumasia.com/news/34/12517/everest-medicines-signs-new-deal-targeting-drug-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12517/everest-medicines-signs-new-deal-targeting-drug-resistance.html</link>
			<pubDate>Mon, 14 Jan 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12517.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12517/everest-medicines-signs-new-deal-targeting-drug-resistance.html</guid>
		</item>	
				<item>
			<title>Denali Therapeutics announces Phase 1B Study of DNL747</title>
			<atom:link href="https://biospectrumasia.com/news/34/12510/denali-therapeutics-announces-phase-1b-study-of-dnl747.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12510/denali-therapeutics-announces-phase-1b-study-of-dnl747.html</link>
			<pubDate>Fri, 11 Jan 2019 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patients_slider_8842-12510.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12510/denali-therapeutics-announces-phase-1b-study-of-dnl747.html</guid>
		</item>	
				<item>
			<title>Janssen submits application to EMA seeking approval of STELARA</title>
			<atom:link href="https://biospectrumasia.com/news/34/12512/janssen-submits-application-to-ema-seeking-approval-of-stelara.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12512/janssen-submits-application-to-ema-seeking-approval-of-stelara.html</link>
			<pubDate>Fri, 11 Jan 2019 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule_158568__340-12512.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12512/janssen-submits-application-to-ema-seeking-approval-of-stelara.html</guid>
		</item>	
				<item>
			<title>Japan approves Amgen&#039;s osteoporosis drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/12502/japan-approves-amgens-osteoporosis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12502/japan-approves-amgens-osteoporosis-drug.html</link>
			<pubDate>Thu, 10 Jan 2019 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12502.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12502/japan-approves-amgens-osteoporosis-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo receives regulatory approval for hypertension tablets</title>
			<atom:link href="https://biospectrumasia.com/news/34/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html</link>
			<pubDate>Thu, 10 Jan 2019 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12493.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12493/daiichi-sankyo-receives-regulatory-approval-for-hypertension-tablets.html</guid>
		</item>	
				<item>
			<title>Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/12492/cellular-biomedicine-initiates-clinical-trial-in-anti-bcma-car-t-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12492/cellular-biomedicine-initiates-clinical-trial-in-anti-bcma-car-t-therapy.html</link>
			<pubDate>Wed, 09 Jan 2019 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibodies-12492.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12492/cellular-biomedicine-initiates-clinical-trial-in-anti-bcma-car-t-therapy.html</guid>
		</item>	
				<item>
			<title>Oculis raises CHF 15.5 million</title>
			<atom:link href="https://biospectrumasia.com/news/34/12471/oculis-raises-chf-15-5-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12471/oculis-raises-chf-15-5-million.html</link>
			<pubDate>Tue, 08 Jan 2019 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fund-12471.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12471/oculis-raises-chf-15-5-million.html</guid>
		</item>	
				<item>
			<title>Oculis enters into an agreement with Novartis</title>
			<atom:link href="https://biospectrumasia.com/news/34/12465/oculis-enters-into-an-agreement-with-novartis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12465/oculis-enters-into-an-agreement-with-novartis.html</link>
			<pubDate>Mon, 07 Jan 2019 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collab-12465.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12465/oculis-enters-into-an-agreement-with-novartis.html</guid>
		</item>	
				<item>
			<title>AbbVie and Tizona Therapeutics announce strategic collaboration </title>
			<atom:link href="https://biospectrumasia.com/news/34/12445/abbvie-and-tizona-therapeutics-announce-strategic-collaboration-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12445/abbvie-and-tizona-therapeutics-announce-strategic-collaboration-.html</link>
			<pubDate>Fri, 04 Jan 2019 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration_words_quoates-12445.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12445/abbvie-and-tizona-therapeutics-announce-strategic-collaboration-.html</guid>
		</item>	
				<item>
			<title>Bristol-Myers Squibb&#039;s SprycelÂ® tablets now approved for pediatric patients </title>
			<atom:link href="https://biospectrumasia.com/news/34/12442/bristol-myers-squibbs-sprycel-tablets-now-approved-for-pediatric-patients-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12442/bristol-myers-squibbs-sprycel-tablets-now-approved-for-pediatric-patients-.html</link>
			<pubDate>Fri, 04 Jan 2019 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets-12442.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12442/bristol-myers-squibbs-sprycel-tablets-now-approved-for-pediatric-patients-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca announces phase III trials for roxadustat</title>
			<atom:link href="https://biospectrumasia.com/news/34/12426/astrazeneca-announces-phase-iii-trials-for-roxadustat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12426/astrazeneca-announces-phase-iii-trials-for-roxadustat.html</link>
			<pubDate>Thu, 03 Jan 2019 09:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/role_of_pharmacy_in_a_state_of_the_art_phase_i_clinical_research_unit_pt_2-12426.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12426/astrazeneca-announces-phase-iii-trials-for-roxadustat.html</guid>
		</item>	
				<item>
			<title>Lupin gets FDA approval for Clobazam oral suspension</title>
			<atom:link href="https://biospectrumasia.com/news/34/12413/lupin-gets-fda-approval-for-clobazam-oral-suspension.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12413/lupin-gets-fda-approval-for-clobazam-oral-suspension.html</link>
			<pubDate>Tue, 01 Jan 2019 16:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_2_-12413.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12413/lupin-gets-fda-approval-for-clobazam-oral-suspension.html</guid>
		</item>	
				<item>
			<title>Teva brings Generic Elidel Cream, 1% in US market</title>
			<atom:link href="https://biospectrumasia.com/news/34/12410/teva-brings-generic-elidel-cream-1-in-us-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12410/teva-brings-generic-elidel-cream-1-in-us-market.html</link>
			<pubDate>Tue, 01 Jan 2019 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/product_launch1-12410.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12410/teva-brings-generic-elidel-cream-1-in-us-market.html</guid>
		</item>	
				<item>
			<title>BeiGene initiates clinical trial of Tislelizumab with cancer patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/12402/beigene-initiates-clinical-trial-of-tislelizumab-with-cancer-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12402/beigene-initiates-clinical-trial-of-tislelizumab-with-cancer-patients.html</link>
			<pubDate>Mon, 31 Dec 2018 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-12402.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12402/beigene-initiates-clinical-trial-of-tislelizumab-with-cancer-patients.html</guid>
		</item>	
				<item>
			<title>Chugai obtains approval for Genomic Mutation Analysis Program </title>
			<atom:link href="https://biospectrumasia.com/news/34/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html</link>
			<pubDate>Thu, 27 Dec 2018 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mutation_analysis_overview-12385.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12385/chugai-obtains-approval-for-genomic-mutation-analysis-program-.html</guid>
		</item>	
				<item>
			<title>Cannabics files patent for personalized cannabimetic compositions modeling, production</title>
			<atom:link href="https://biospectrumasia.com/news/34/12383/cannabics-files-patent-for-personalized-cannabimetic-compositions-modeling-production.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12383/cannabics-files-patent-for-personalized-cannabimetic-compositions-modeling-production.html</link>
			<pubDate>Thu, 27 Dec 2018 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-12383.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12383/cannabics-files-patent-for-personalized-cannabimetic-compositions-modeling-production.html</guid>
		</item>	
				<item>
			<title>I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2</title>
			<atom:link href="https://biospectrumasia.com/company-results/34/12370/i-mab-gets-udfda-ind-nod-for-exclusive-monoclonal-antibody-tjm2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/34/12370/i-mab-gets-udfda-ind-nod-for-exclusive-monoclonal-antibody-tjm2.html</link>
			<pubDate>Mon, 24 Dec 2018 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibody-12370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/34/12370/i-mab-gets-udfda-ind-nod-for-exclusive-monoclonal-antibody-tjm2.html</guid>
		</item>	
				<item>
			<title>Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership</title>
			<atom:link href="https://biospectrumasia.com/news/34/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html</link>
			<pubDate>Thu, 20 Dec 2018 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership_small_9065-12351.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12351/roivant-sciences-daiichi-sankyo-enter-into-broad-pipeline-partnership.html</guid>
		</item>	
				<item>
			<title>Lexicon Pharma announces positive topline clinical data for LX9211</title>
			<atom:link href="https://biospectrumasia.com/news/34/12335/lexicon-pharma-announces-positive-topline-clinical-data-for-lx9211.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12335/lexicon-pharma-announces-positive-topline-clinical-data-for-lx9211.html</link>
			<pubDate>Wed, 19 Dec 2018 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clincl_dta-12335.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12335/lexicon-pharma-announces-positive-topline-clinical-data-for-lx9211.html</guid>
		</item>	
				<item>
			<title>Bridge Bio signs $40M license agreement with Daewoong Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/12334/bridge-bio-signs-40m-license-agreement-with-daewoong-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12334/bridge-bio-signs-40m-license-agreement-with-daewoong-pharma.html</link>
			<pubDate>Wed, 19 Dec 2018 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12334.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12334/bridge-bio-signs-40m-license-agreement-with-daewoong-pharma.html</guid>
		</item>	
				<item>
			<title>FibroGen&#039;s roxadustat OK&#039;d in China </title>
			<atom:link href="https://biospectrumasia.com/news/34/12328/fibrogens-roxadustat-okd-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12328/fibrogens-roxadustat-okd-in-china-.html</link>
			<pubDate>Tue, 18 Dec 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_18_-12328.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12328/fibrogens-roxadustat-okd-in-china-.html</guid>
		</item>	
				<item>
			<title>Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation</title>
			<atom:link href="https://biospectrumasia.com/news/34/12293/avacta-lg-chem-life-sciences-to-develop-novel-drugs-for-cancer-inflammation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12293/avacta-lg-chem-life-sciences-to-develop-novel-drugs-for-cancer-inflammation.html</link>
			<pubDate>Thu, 13 Dec 2018 22:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915424__340-12293.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12293/avacta-lg-chem-life-sciences-to-develop-novel-drugs-for-cancer-inflammation.html</guid>
		</item>	
				<item>
			<title>Innovent declares positive result of IBI305, biosimilar to Avastin</title>
			<atom:link href="https://biospectrumasia.com/news/34/12290/innovent-declares-positive-result-of-ibi305-biosimilar-to-avastin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12290/innovent-declares-positive-result-of-ibi305-biosimilar-to-avastin.html</link>
			<pubDate>Thu, 13 Dec 2018 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lung_cancer-12290.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12290/innovent-declares-positive-result-of-ibi305-biosimilar-to-avastin.html</guid>
		</item>	
				<item>
			<title>APLIDIN gets world-first approval for Multiple Myeloma </title>
			<atom:link href="https://biospectrumasia.com/news/34/12265/aplidin-gets-world-first-approval-for-multiple-myeloma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12265/aplidin-gets-world-first-approval-for-multiple-myeloma-.html</link>
			<pubDate>Tue, 11 Dec 2018 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-12265.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12265/aplidin-gets-world-first-approval-for-multiple-myeloma-.html</guid>
		</item>	
				<item>
			<title>TauRx&#039;s LMTXs gets FDA Orphan-drug Designation</title>
			<atom:link href="https://biospectrumasia.com/news/34/12254/taurxs-lmtxs-gets-fda-orphan-drug-designation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12254/taurxs-lmtxs-gets-fda-orphan-drug-designation.html</link>
			<pubDate>Mon, 10 Dec 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neurodenerative_disease-12254.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12254/taurxs-lmtxs-gets-fda-orphan-drug-designation.html</guid>
		</item>	
				<item>
			<title>Diamyd Medical raises SEK 58.4 million through redemption of warrants</title>
			<atom:link href="https://biospectrumasia.com/news/34/12234/diamyd-medical-raises-sek-58-4-million-through-redemption-of-warrants.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12234/diamyd-medical-raises-sek-58-4-million-through-redemption-of-warrants.html</link>
			<pubDate>Thu, 06 Dec 2018 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding_1_-12234.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12234/diamyd-medical-raises-sek-58-4-million-through-redemption-of-warrants.html</guid>
		</item>	
				<item>
			<title>EC Approves Takeda&#039;s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html</link>
			<pubDate>Wed, 28 Nov 2018 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lung_cancer-12175.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12175/ec-approves-takedas-alunbrig-for-alk-non-small-cell-lung-cancer.html</guid>
		</item>	
				<item>
			<title>HitGen, Biogen initiate drug discovery collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/34/12130/hitgen-biogen-initiate-drug-discovery-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12130/hitgen-biogen-initiate-drug-discovery-collaboration.html</link>
			<pubDate>Thu, 22 Nov 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12130.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12130/hitgen-biogen-initiate-drug-discovery-collaboration.html</guid>
		</item>	
				<item>
			<title>World&#039;s first migraine-specific prevention treatment available in Singapore </title>
			<atom:link href="https://biospectrumasia.com/news/34/12128/worlds-first-migraine-specific-prevention-treatment-available-in-singapore-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12128/worlds-first-migraine-specific-prevention-treatment-available-in-singapore-.html</link>
			<pubDate>Thu, 22 Nov 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/migraine-12128.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12128/worlds-first-migraine-specific-prevention-treatment-available-in-singapore-.html</guid>
		</item>	
				<item>
			<title>OBI Pharma granted FDA ODD for OBI-888</title>
			<atom:link href="https://biospectrumasia.com/news/34/12126/obi-pharma-granted-fda-odd-for-obi-888.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12126/obi-pharma-granted-fda-odd-for-obi-888.html</link>
			<pubDate>Wed, 21 Nov 2018 23:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12126.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12126/obi-pharma-granted-fda-odd-for-obi-888.html</guid>
		</item>	
				<item>
			<title>Exscientia acquires Kinetic Discovery to build &#039;full stack&#039; AI-driven drug discovery capabilities </title>
			<atom:link href="https://biospectrumasia.com/news/34/12080/exscientia-acquires-kinetic-discovery-to-build-full-stack-ai-driven-drug-discovery-capabilities-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12080/exscientia-acquires-kinetic-discovery-to-build-full-stack-ai-driven-drug-discovery-capabilities-.html</link>
			<pubDate>Thu, 15 Nov 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-12080.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12080/exscientia-acquires-kinetic-discovery-to-build-full-stack-ai-driven-drug-discovery-capabilities-.html</guid>
		</item>	
				<item>
			<title>MEI Pharma, KHK to develop and commercialize ME-401</title>
			<atom:link href="https://biospectrumasia.com/news/34/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html</link>
			<pubDate>Mon, 05 Nov 2018 22:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-12026.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12026/mei-pharma-khk-to-develop-and-commercialize-me-401.html</guid>
		</item>	
				<item>
			<title>FDA OKs Pfizer&#039;s lorlatinib for lung cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/12019/fda-oks-pfizers-lorlatinib-for-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/12019/fda-oks-pfizers-lorlatinib-for-lung-cancer.html</link>
			<pubDate>Mon, 05 Nov 2018 11:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_17_-12019.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/12019/fda-oks-pfizers-lorlatinib-for-lung-cancer.html</guid>
		</item>	
				<item>
			<title>FDA OKs J&amp;J&#039;s Invokana for heart conditions</title>
			<atom:link href="https://biospectrumasia.com/news/34/11988/fda-oks-jjs-invokana-for-heart-conditions.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11988/fda-oks-jjs-invokana-for-heart-conditions.html</link>
			<pubDate>Wed, 31 Oct 2018 00:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/johnson___johnson_offices_in_madrid__spain__01-11988.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11988/fda-oks-jjs-invokana-for-heart-conditions.html</guid>
		</item>	
				<item>
			<title>Halozyme licenses $25M drug delivery technology to Roche </title>
			<atom:link href="https://biospectrumasia.com/news/34/11987/halozyme-licenses-25m-drug-delivery-technology-to-roche-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11987/halozyme-licenses-25m-drug-delivery-technology-to-roche-.html</link>
			<pubDate>Tue, 30 Oct 2018 23:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/17123250059_5479539f4f_b-11987.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11987/halozyme-licenses-25m-drug-delivery-technology-to-roche-.html</guid>
		</item>	
				<item>
			<title>Pfizer, Eli Lilly&#039;s non-opioid drug helps reduce osteoarthritis pain</title>
			<atom:link href="https://biospectrumasia.com/news/34/11947/pfizer-eli-lillys-non-opioid-drug-helps-reduce-osteoarthritis-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11947/pfizer-eli-lillys-non-opioid-drug-helps-reduce-osteoarthritis-pain.html</link>
			<pubDate>Wed, 24 Oct 2018 19:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2000px_pfizer_logo_svg_2_-11947.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11947/pfizer-eli-lillys-non-opioid-drug-helps-reduce-osteoarthritis-pain.html</guid>
		</item>	
				<item>
			<title>FDA approves Regeneron, Sanofi&#039;s Dupixent for asthma treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/11924/fda-approves-regeneron-sanofis-dupixent-for-asthma-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11924/fda-approves-regeneron-sanofis-dupixent-for-asthma-treatment.html</link>
			<pubDate>Mon, 22 Oct 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_16_-11924.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11924/fda-approves-regeneron-sanofis-dupixent-for-asthma-treatment.html</guid>
		</item>	
				<item>
			<title>Roche&#039;s Tecentriq extends progression-free survival in TNBC</title>
			<atom:link href="https://biospectrumasia.com/news/34/11923/roches-tecentriq-extends-progression-free-survival-in-tnbc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11923/roches-tecentriq-extends-progression-free-survival-in-tnbc.html</link>
			<pubDate>Mon, 22 Oct 2018 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2000px_hoffmann_la_roche_logo_svg-11923.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11923/roches-tecentriq-extends-progression-free-survival-in-tnbc.html</guid>
		</item>	
				<item>
			<title>Ostrich antibody as dengue fever solution ready for commercialization</title>
			<atom:link href="https://biospectrumasia.com/news/34/11922/ostrich-antibody-as-dengue-fever-solution-ready-for-commercialization.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11922/ostrich-antibody-as-dengue-fever-solution-ready-for-commercialization.html</link>
			<pubDate>Mon, 22 Oct 2018 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/animal_animal_photography_beak_752035-11922.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11922/ostrich-antibody-as-dengue-fever-solution-ready-for-commercialization.html</guid>
		</item>	
				<item>
			<title> Strides Pharma gets USFDA nod for its anti-epileptic drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/11921/-strides-pharma-gets-usfda-nod-for-its-anti-epileptic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11921/-strides-pharma-gets-usfda-nod-for-its-anti-epileptic-drug.html</link>
			<pubDate>Mon, 22 Oct 2018 13:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approved-11921.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11921/-strides-pharma-gets-usfda-nod-for-its-anti-epileptic-drug.html</guid>
		</item>	
				<item>
			<title>Eisai discovers new compound to treat Parkinson&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html</link>
			<pubDate>Fri, 19 Oct 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/parkinson-11912.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11912/eisai-discovers-new-compound-to-treat-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Axsome receives FDA Orphan Drug designation for narcolepsy drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/11904/axsome-receives-fda-orphan-drug-designation-for-narcolepsy-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11904/axsome-receives-fda-orphan-drug-designation-for-narcolepsy-drug.html</link>
			<pubDate>Wed, 17 Oct 2018 21:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11904.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11904/axsome-receives-fda-orphan-drug-designation-for-narcolepsy-drug.html</guid>
		</item>	
				<item>
			<title>FDA issues new guidance for developers of complex generics</title>
			<atom:link href="https://biospectrumasia.com/news/34/11853/fda-issues-new-guidance-for-developers-of-complex-generics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11853/fda-issues-new-guidance-for-developers-of-complex-generics.html</link>
			<pubDate>Wed, 10 Oct 2018 12:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11853.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11853/fda-issues-new-guidance-for-developers-of-complex-generics.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; crizanlizumab relieves patients from sickle cell pain crisis</title>
			<atom:link href="https://biospectrumasia.com/news/34/11849/novartis-crizanlizumab-relieves-patients-from-sickle-cell-pain-crisis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11849/novartis-crizanlizumab-relieves-patients-from-sickle-cell-pain-crisis.html</link>
			<pubDate>Wed, 10 Oct 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sickle_cell-11849.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11849/novartis-crizanlizumab-relieves-patients-from-sickle-cell-pain-crisis.html</guid>
		</item>	
				<item>
			<title>J&amp;J abandons partnership for Geron&#039;s cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/11813/jj-abandons-partnership-for-gerons-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11813/jj-abandons-partnership-for-gerons-cancer-drug.html</link>
			<pubDate>Thu, 04 Oct 2018 00:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/19916066779_1a281ebca0_b-11813.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11813/jj-abandons-partnership-for-gerons-cancer-drug.html</guid>
		</item>	
				<item>
			<title>New drug blocks pancreatic cancer growth </title>
			<atom:link href="https://biospectrumasia.com/news/34/11786/new-drug-blocks-pancreatic-cancer-growth-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11786/new-drug-blocks-pancreatic-cancer-growth-.html</link>
			<pubDate>Fri, 28 Sep 2018 10:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pancreas-11786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11786/new-drug-blocks-pancreatic-cancer-growth-.html</guid>
		</item>	
				<item>
			<title>Alexion to acquire Syntimmune</title>
			<atom:link href="https://biospectrumasia.com/news/34/11775/alexion-to-acquire-syntimmune.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11775/alexion-to-acquire-syntimmune.html</link>
			<pubDate>Wed, 26 Sep 2018 22:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11775.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11775/alexion-to-acquire-syntimmune.html</guid>
		</item>	
				<item>
			<title>Anaeropharma Science signs research agreement with Astellas</title>
			<atom:link href="https://biospectrumasia.com/news/34/11757/anaeropharma-science-signs-research-agreement-with-astellas.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11757/anaeropharma-science-signs-research-agreement-with-astellas.html</link>
			<pubDate>Tue, 25 Sep 2018 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11757.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11757/anaeropharma-science-signs-research-agreement-with-astellas.html</guid>
		</item>	
				<item>
			<title>Accenture, Merck, Amazon partner to advance drug innovation and research</title>
			<atom:link href="https://biospectrumasia.com/news/34/11705/accenture-merck-amazon-partner-to-advance-drug-innovation-and-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11705/accenture-merck-amazon-partner-to-advance-drug-innovation-and-research.html</link>
			<pubDate>Tue, 18 Sep 2018 01:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement_3489902_960_720-11705.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11705/accenture-merck-amazon-partner-to-advance-drug-innovation-and-research.html</guid>
		</item>	
				<item>
			<title>Pfizer receives Breakthrough Therapy designation for inhibitor drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/11644/pfizer-receives-breakthrough-therapy-designation-for-inhibitor-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11644/pfizer-receives-breakthrough-therapy-designation-for-inhibitor-drug.html</link>
			<pubDate>Thu, 06 Sep 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/food_and_drug_administration_logo_svg_3_-11644.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11644/pfizer-receives-breakthrough-therapy-designation-for-inhibitor-drug.html</guid>
		</item>	
				<item>
			<title>China approves first &quot;Made in China&quot; cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/11641/china-approves-first-made-in-china-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11641/china-approves-first-made-in-china-cancer-drug.html</link>
			<pubDate>Thu, 06 Sep 2018 02:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_29149__340-11641.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11641/china-approves-first-made-in-china-cancer-drug.html</guid>
		</item>	
				<item>
			<title>BeiGene Announces Acceptance of its First NDA for Zanubrutinib</title>
			<atom:link href="https://biospectrumasia.com/news/34/11589/beigene-announces-acceptance-of-its-first-nda-for-zanubrutinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11589/beigene-announces-acceptance-of-its-first-nda-for-zanubrutinib.html</link>
			<pubDate>Tue, 28 Aug 2018 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine_296966__340-11589.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11589/beigene-announces-acceptance-of-its-first-nda-for-zanubrutinib.html</guid>
		</item>	
				<item>
			<title>FDA approves first drug for neurotrophic keratitis</title>
			<atom:link href="https://biospectrumasia.com/news/34/11561/fda-approves-first-drug-for-neurotrophic-keratitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11561/fda-approves-first-drug-for-neurotrophic-keratitis.html</link>
			<pubDate>Thu, 23 Aug 2018 20:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/food_and_drug_administration_logo_svg_2_-11561.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11561/fda-approves-first-drug-for-neurotrophic-keratitis.html</guid>
		</item>	
				<item>
			<title>Strides Pharma receives USFDA nod for two key ANDAs </title>
			<atom:link href="https://biospectrumasia.com/news/34/11552/strides-pharma-receives-usfda-nod-for-two-key-andas-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11552/strides-pharma-receives-usfda-nod-for-two-key-andas-.html</link>
			<pubDate>Wed, 22 Aug 2018 16:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/capsule_158568__340-11552.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11552/strides-pharma-receives-usfda-nod-for-two-key-andas-.html</guid>
		</item>	
				<item>
			<title>GIC receives govt funding for immuno-oncology project</title>
			<atom:link href="https://biospectrumasia.com/news/34/11549/gic-receives-govt-funding-for-immuno-oncology-project.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11549/gic-receives-govt-funding-for-immuno-oncology-project.html</link>
			<pubDate>Wed, 22 Aug 2018 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11549.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11549/gic-receives-govt-funding-for-immuno-oncology-project.html</guid>
		</item>	
				<item>
			<title>Roche&#039;s Alecensa receives &#039;priority review&#039; designation from CNDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/11538/roches-alecensa-receives-priority-review-designation-from-cnda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11538/roches-alecensa-receives-priority-review-designation-from-cnda.html</link>
			<pubDate>Tue, 21 Aug 2018 02:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11538.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11538/roches-alecensa-receives-priority-review-designation-from-cnda.html</guid>
		</item>	
				<item>
			<title>HitGen collaborates with LG Chem</title>
			<atom:link href="https://biospectrumasia.com/news/34/11528/hitgen-collaborates-with-lg-chem.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11528/hitgen-collaborates-with-lg-chem.html</link>
			<pubDate>Mon, 20 Aug 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration_1_-11528.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11528/hitgen-collaborates-with-lg-chem.html</guid>
		</item>	
				<item>
			<title>Blueberry Therapeutics raises Â£10M funding to develop nanomedicines</title>
			<atom:link href="https://biospectrumasia.com/news/34/11516/blueberry-therapeutics-raises-10m-funding-to-develop-nanomedicines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11516/blueberry-therapeutics-raises-10m-funding-to-develop-nanomedicines.html</link>
			<pubDate>Thu, 16 Aug 2018 17:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medicine-11516.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11516/blueberry-therapeutics-raises-10m-funding-to-develop-nanomedicines.html</guid>
		</item>	
				<item>
			<title>Multi- institutional alliance to develop anti-aging drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/11509/multi-institutional-alliance-to-develop-anti-aging-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11509/multi-institutional-alliance-to-develop-anti-aging-drugs.html</link>
			<pubDate>Thu, 16 Aug 2018 10:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11509.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11509/multi-institutional-alliance-to-develop-anti-aging-drugs.html</guid>
		</item>	
				<item>
			<title>FDA approves Amicus&#039; Galafold for Fabry disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/11499/fda-approves-amicus-galafold-for-fabry-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11499/fda-approves-amicus-galafold-for-fabry-disease.html</link>
			<pubDate>Mon, 13 Aug 2018 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/food_and_drug_administration_logo_svg_1_-11499.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11499/fda-approves-amicus-galafold-for-fabry-disease.html</guid>
		</item>	
				<item>
			<title>Pfizer&#039;s Innovative drug IBRANCE gets China approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/11466/pfizers-innovative-drug-ibrance-gets-china-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11466/pfizers-innovative-drug-ibrance-gets-china-approval.html</link>
			<pubDate>Wed, 08 Aug 2018 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-11466.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11466/pfizers-innovative-drug-ibrance-gets-china-approval.html</guid>
		</item>	
				<item>
			<title>DotBio successfully raises $2.3 M in seed financing </title>
			<atom:link href="https://biospectrumasia.com/news/34/11455/dotbio-successfully-raises-2-3-m-in-seed-financing-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11455/dotbio-successfully-raises-2-3-m-in-seed-financing-.html</link>
			<pubDate>Tue, 07 Aug 2018 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cash_box_with_money-11455.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11455/dotbio-successfully-raises-2-3-m-in-seed-financing-.html</guid>
		</item>	
				<item>
			<title>Medpacto inks deal with AstraZeneca</title>
			<atom:link href="https://biospectrumasia.com/news/34/11439/medpacto-inks-deal-with-astrazeneca.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11439/medpacto-inks-deal-with-astrazeneca.html</link>
			<pubDate>Thu, 02 Aug 2018 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bless_you_2070774__340-11439.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11439/medpacto-inks-deal-with-astrazeneca.html</guid>
		</item>	
				<item>
			<title>Breakthrough therapy for endometrial cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/11415/breakthrough-therapy-for-endometrial-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11415/breakthrough-therapy-for-endometrial-cancer.html</link>
			<pubDate>Tue, 31 Jul 2018 19:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/optimized_dollarphotoclub_66078421crop-11415.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11415/breakthrough-therapy-for-endometrial-cancer.html</guid>
		</item>	
				<item>
			<title>Pfizer&#039;s Herceptin biosimilar approved in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/11414/pfizers-herceptin-biosimilar-approved-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11414/pfizers-herceptin-biosimilar-approved-in-europe.html</link>
			<pubDate>Tue, 31 Jul 2018 19:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_94_-11414.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11414/pfizers-herceptin-biosimilar-approved-in-europe.html</guid>
		</item>	
				<item>
			<title>Nektar&#039;s back pain opioid gets approval for FDA review</title>
			<atom:link href="https://biospectrumasia.com/news/34/11404/nektars-back-pain-opioid-gets-approval-for-fda-review.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11404/nektars-back-pain-opioid-gets-approval-for-fda-review.html</link>
			<pubDate>Mon, 30 Jul 2018 23:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11404.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11404/nektars-back-pain-opioid-gets-approval-for-fda-review.html</guid>
		</item>	
				<item>
			<title>Innovent receives IND approval for clinical trials in China </title>
			<atom:link href="https://biospectrumasia.com/news/34/11383/innovent-receives-ind-approval-for-clinical-trials-in-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11383/innovent-receives-ind-approval-for-clinical-trials-in-china-.html</link>
			<pubDate>Thu, 26 Jul 2018 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_10_-11383.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11383/innovent-receives-ind-approval-for-clinical-trials-in-china-.html</guid>
		</item>	
				<item>
			<title>FDA approves Pfizer&#039;s biosimilar</title>
			<atom:link href="https://biospectrumasia.com/news/34/11350/fda-approves-pfizers-biosimilar.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11350/fda-approves-pfizers-biosimilar.html</link>
			<pubDate>Mon, 23 Jul 2018 17:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/optimized_dollarphotoclub_66078421crop-11350.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11350/fda-approves-pfizers-biosimilar.html</guid>
		</item>	
				<item>
			<title>Agios receives nod for ivosidenib </title>
			<atom:link href="https://biospectrumasia.com/news/34/11353/agios-receives-nod-for-ivosidenib-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11353/agios-receives-nod-for-ivosidenib-.html</link>
			<pubDate>Mon, 23 Jul 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-11353.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11353/agios-receives-nod-for-ivosidenib-.html</guid>
		</item>	
				<item>
			<title>FDA approves first drug indicating treatment of smallpox</title>
			<atom:link href="https://biospectrumasia.com/news/34/11295/fda-approves-first-drug-indicating-treatment-of-smallpox.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11295/fda-approves-first-drug-indicating-treatment-of-smallpox.html</link>
			<pubDate>Mon, 16 Jul 2018 19:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-11295.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11295/fda-approves-first-drug-indicating-treatment-of-smallpox.html</guid>
		</item>	
				<item>
			<title>HSA approves Novartis Kisqali for treating metastatic breast cancer </title>
			<atom:link href="https://biospectrumasia.com/news/34/11291/hsa-approves-novartis-kisqali-for-treating-metastatic-breast-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11291/hsa-approves-novartis-kisqali-for-treating-metastatic-breast-cancer-.html</link>
			<pubDate>Mon, 16 Jul 2018 16:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/health_sciences_authority_2008-11291.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11291/hsa-approves-novartis-kisqali-for-treating-metastatic-breast-cancer-.html</guid>
		</item>	
				<item>
			<title>Immatics, Genmab to develop bispecific cancer immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/11267/immatics-genmab-to-develop-bispecific-cancer-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11267/immatics-genmab-to-develop-bispecific-cancer-immunotherapies.html</link>
			<pubDate>Thu, 12 Jul 2018 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership2-11267.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11267/immatics-genmab-to-develop-bispecific-cancer-immunotherapies.html</guid>
		</item>	
				<item>
			<title>FDA grants 7-year orphan drug exclusivity to Eagle</title>
			<atom:link href="https://biospectrumasia.com/news/34/11249/fda-grants-7-year-orphan-drug-exclusivity-to-eagle.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11249/fda-grants-7-year-orphan-drug-exclusivity-to-eagle.html</link>
			<pubDate>Mon, 09 Jul 2018 21:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_11_-11249.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11249/fda-grants-7-year-orphan-drug-exclusivity-to-eagle.html</guid>
		</item>	
				<item>
			<title>FDA grants ODD to OBI Pharma&#039;s lead investigational drug candidate </title>
			<atom:link href="https://biospectrumasia.com/news/34/11244/fda-grants-odd-to-obi-pharmas-lead-investigational-drug-candidate-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11244/fda-grants-odd-to-obi-pharmas-lead-investigational-drug-candidate-.html</link>
			<pubDate>Mon, 09 Jul 2018 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11244.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11244/fda-grants-odd-to-obi-pharmas-lead-investigational-drug-candidate-.html</guid>
		</item>	
				<item>
			<title>Biogen&#039;s Alzheimer&#039;s drug succeeds in trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/11234/biogens-alzheimers-drug-succeeds-in-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11234/biogens-alzheimers-drug-succeeds-in-trial.html</link>
			<pubDate>Fri, 06 Jul 2018 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chemiluminiscence_with_the_scientist_1_-11234.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11234/biogens-alzheimers-drug-succeeds-in-trial.html</guid>
		</item>	
				<item>
			<title>Roche onto another win in front-line cancer setting</title>
			<atom:link href="https://biospectrumasia.com/news/34/11216/roche-onto-another-win-in-front-line-cancer-setting.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11216/roche-onto-another-win-in-front-line-cancer-setting.html</link>
			<pubDate>Wed, 04 Jul 2018 18:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/2000px_hoffmann_la_roche_logo_svg-11216.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11216/roche-onto-another-win-in-front-line-cancer-setting.html</guid>
		</item>	
				<item>
			<title>Roche announces positive results of lung cancer drug Tecentriq</title>
			<atom:link href="https://biospectrumasia.com/news/34/11208/roche-announces-positive-results-of-lung-cancer-drug-tecentriq.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11208/roche-announces-positive-results-of-lung-cancer-drug-tecentriq.html</link>
			<pubDate>Wed, 04 Jul 2018 09:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_163464__340-11208.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11208/roche-announces-positive-results-of-lung-cancer-drug-tecentriq.html</guid>
		</item>	
				<item>
			<title>Singapore institutes collaborate with ROK to develop innovative drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/11206/singapore-institutes-collaborate-with-rok-to-develop-innovative-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11206/singapore-institutes-collaborate-with-rok-to-develop-innovative-drugs.html</link>
			<pubDate>Tue, 03 Jul 2018 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_2_-11206.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11206/singapore-institutes-collaborate-with-rok-to-develop-innovative-drugs.html</guid>
		</item>	
				<item>
			<title>Lumicks teams up with AZ, UC to set up CoE</title>
			<atom:link href="https://biospectrumasia.com/news/34/11171/lumicks-teams-up-with-az-uc-to-set-up-coe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11171/lumicks-teams-up-with-az-uc-to-set-up-coe.html</link>
			<pubDate>Thu, 28 Jun 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11171.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11171/lumicks-teams-up-with-az-uc-to-set-up-coe.html</guid>
		</item>	
				<item>
			<title>Ascletis, CR Pharma sign strategic cooperation agreement</title>
			<atom:link href="https://biospectrumasia.com/news/34/11160/ascletis-cr-pharma-sign-strategic-cooperation-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11160/ascletis-cr-pharma-sign-strategic-cooperation-agreement.html</link>
			<pubDate>Wed, 27 Jun 2018 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11160.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11160/ascletis-cr-pharma-sign-strategic-cooperation-agreement.html</guid>
		</item>	
				<item>
			<title>MiRXES provides support to advance research of RNA treatment  at BIDMC</title>
			<atom:link href="https://biospectrumasia.com/news/34/11152/mirxes-provides-support-to-advance-research-of-rna-treatment-at-bidmc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11152/mirxes-provides-support-to-advance-research-of-rna-treatment-at-bidmc.html</link>
			<pubDate>Tue, 26 Jun 2018 17:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image_24-11152.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11152/mirxes-provides-support-to-advance-research-of-rna-treatment-at-bidmc.html</guid>
		</item>	
				<item>
			<title>AUM Biosciences to drive commercial innovation in oncology</title>
			<atom:link href="https://biospectrumasia.com/news/34/11139/aum-biosciences-to-drive-commercial-innovation-in-oncology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11139/aum-biosciences-to-drive-commercial-innovation-in-oncology.html</link>
			<pubDate>Mon, 25 Jun 2018 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-11139.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11139/aum-biosciences-to-drive-commercial-innovation-in-oncology.html</guid>
		</item>	
				<item>
			<title>Mylan announces US launch of Bivalirudin for Injection</title>
			<atom:link href="https://biospectrumasia.com/news/34/11108/mylan-announces-us-launch-of-bivalirudin-for-injection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11108/mylan-announces-us-launch-of-bivalirudin-for-injection.html</link>
			<pubDate>Tue, 19 Jun 2018 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11108.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11108/mylan-announces-us-launch-of-bivalirudin-for-injection.html</guid>
		</item>	
				<item>
			<title>Ganovo approval marks a milestone for MAH policy in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/11088/ganovo-approval-marks-a-milestone-for-mah-policy-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11088/ganovo-approval-marks-a-milestone-for-mah-policy-in-china.html</link>
			<pubDate>Thu, 14 Jun 2018 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hepatitis_c-11088.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11088/ganovo-approval-marks-a-milestone-for-mah-policy-in-china.html</guid>
		</item>	
				<item>
			<title>WuXi AppTec, Insilico unite to integrate AI with Drug Discovery </title>
			<atom:link href="https://biospectrumasia.com/news/34/11074/wuxi-apptec-insilico-unite-to-integrate-ai-with-drug-discovery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11074/wuxi-apptec-insilico-unite-to-integrate-ai-with-drug-discovery-.html</link>
			<pubDate>Tue, 12 Jun 2018 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fullerton-11074.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11074/wuxi-apptec-insilico-unite-to-integrate-ai-with-drug-discovery-.html</guid>
		</item>	
				<item>
			<title>TESARO, Roche to evaluate triplet therapy for ovarian cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/11043/tesaro-roche-to-evaluate-triplet-therapy-for-ovarian-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11043/tesaro-roche-to-evaluate-triplet-therapy-for-ovarian-cancer.html</link>
			<pubDate>Wed, 06 Jun 2018 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_78_-11043.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11043/tesaro-roche-to-evaluate-triplet-therapy-for-ovarian-cancer.html</guid>
		</item>	
				<item>
			<title>USFDA grants Priority Review to Astellas&#039;s NDA for Gilteritinib</title>
			<atom:link href="https://biospectrumasia.com/news/34/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html</link>
			<pubDate>Tue, 05 Jun 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fish_oil_1915423__340-11028.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11028/usfda-grants-priority-review-to-astellass-nda-for-gilteritinib.html</guid>
		</item>	
				<item>
			<title>Versartis, Aravive enter into merger agreement </title>
			<atom:link href="https://biospectrumasia.com/news/34/11023/versartis-aravive-enter-into-merger-agreement-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11023/versartis-aravive-enter-into-merger-agreement-.html</link>
			<pubDate>Mon, 04 Jun 2018 19:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_64_-11023.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11023/versartis-aravive-enter-into-merger-agreement-.html</guid>
		</item>	
				<item>
			<title>Blueprint inks deal on oncology therapies with CStone </title>
			<atom:link href="https://biospectrumasia.com/news/34/11021/blueprint-inks-deal-on-oncology-therapies-with-cstone-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11021/blueprint-inks-deal-on-oncology-therapies-with-cstone-.html</link>
			<pubDate>Mon, 04 Jun 2018 18:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-11021.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11021/blueprint-inks-deal-on-oncology-therapies-with-cstone-.html</guid>
		</item>	
				<item>
			<title>Lilly and Incyte&#039;s drug gets FDA approval </title>
			<atom:link href="https://biospectrumasia.com/news/34/11019/lilly-and-incytes-drug-gets-fda-approval-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11019/lilly-and-incytes-drug-gets-fda-approval-.html</link>
			<pubDate>Mon, 04 Jun 2018 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_6_-11019.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11019/lilly-and-incytes-drug-gets-fda-approval-.html</guid>
		</item>	
				<item>
			<title>Amgen&#039;s Biosimilar fails to get FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/11018/amgens-biosimilar-fails-to-get-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11018/amgens-biosimilar-fails-to-get-fda-approval.html</link>
			<pubDate>Mon, 04 Jun 2018 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_9_-11018.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11018/amgens-biosimilar-fails-to-get-fda-approval.html</guid>
		</item>	
				<item>
			<title>EC approves Roche&#039;s Perjeta for HER2-positive early breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/11009/ec-approves-roches-perjeta-for-her2-positive-early-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/11009/ec-approves-roches-perjeta-for-her2-positive-early-breast-cancer.html</link>
			<pubDate>Sun, 03 Jun 2018 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1966719__340-11009.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/11009/ec-approves-roches-perjeta-for-her2-positive-early-breast-cancer.html</guid>
		</item>	
				<item>
			<title>LUYE pharma Joins US Firm to Develop Immuno-oncology Treatments</title>
			<atom:link href="https://biospectrumasia.com/news/34/10982/luye-pharma-joins-us-firm-to-develop-immuno-oncology-treatments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10982/luye-pharma-joins-us-firm-to-develop-immuno-oncology-treatments.html</link>
			<pubDate>Tue, 29 May 2018 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/contract-10982.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10982/luye-pharma-joins-us-firm-to-develop-immuno-oncology-treatments.html</guid>
		</item>	
				<item>
			<title>FDA approves BioMarin&#039;s metabolic disorder treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/10968/fda-approves-biomarins-metabolic-disorder-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10968/fda-approves-biomarins-metabolic-disorder-treatment.html</link>
			<pubDate>Fri, 25 May 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_8_-10968.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10968/fda-approves-biomarins-metabolic-disorder-treatment.html</guid>
		</item>	
				<item>
			<title>Eisai, Merck provide Update on sNDA for Lenvatinib</title>
			<atom:link href="https://biospectrumasia.com/news/34/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html</link>
			<pubDate>Fri, 25 May 2018 11:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_1-10965.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10965/eisai-merck-provide-update-on-snda-for-lenvatinib.html</guid>
		</item>	
				<item>
			<title>Pfizer&#039;s Tafamidis breakthrough therapy for rare heart disorder</title>
			<atom:link href="https://biospectrumasia.com/news/34/10959/pfizers-tafamidis-breakthrough-therapy-for-rare-heart-disorder.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10959/pfizers-tafamidis-breakthrough-therapy-for-rare-heart-disorder.html</link>
			<pubDate>Thu, 24 May 2018 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ogco_fda_1006-10959.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10959/pfizers-tafamidis-breakthrough-therapy-for-rare-heart-disorder.html</guid>
		</item>	
				<item>
			<title>Celgene, Evotec team up on cancer treatments</title>
			<atom:link href="https://biospectrumasia.com/news/34/10939/celgene-evotec-team-up-on-cancer-treatments.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10939/celgene-evotec-team-up-on-cancer-treatments.html</link>
			<pubDate>Tue, 22 May 2018 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_14_-10939.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10939/celgene-evotec-team-up-on-cancer-treatments.html</guid>
		</item>	
				<item>
			<title>AstraZeneca submits sNDA in Japan for Forxiga in T1D</title>
			<atom:link href="https://biospectrumasia.com/news/34/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html</link>
			<pubDate>Tue, 22 May 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_68_-10938.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10938/astrazeneca-submits-snda-in-japan-for-forxiga-in-t1d.html</guid>
		</item>	
				<item>
			<title>AstraZeneca submits sNDA for Forxiga in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html</link>
			<pubDate>Tue, 22 May 2018 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_1106934_960_720-10936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10936/astrazeneca-submits-snda-for-forxiga-in-japan.html</guid>
		</item>	
				<item>
			<title>Regeneron, Sanofi&#039;s drug shows positive effect in lung cancer study</title>
			<atom:link href="https://biospectrumasia.com/news/34/10910/regeneron-sanofis-drug-shows-positive-effect-in-lung-cancer-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10910/regeneron-sanofis-drug-shows-positive-effect-in-lung-cancer-study.html</link>
			<pubDate>Fri, 18 May 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_66_-10910.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10910/regeneron-sanofis-drug-shows-positive-effect-in-lung-cancer-study.html</guid>
		</item>	
				<item>
			<title>Cabometyx gets approval in Europe for first-line kidney cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/10911/cabometyx-gets-approval-in-europe-for-first-line-kidney-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10911/cabometyx-gets-approval-in-europe-for-first-line-kidney-cancer.html</link>
			<pubDate>Fri, 18 May 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/14800299007_e371a51ee9_b-10911.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10911/cabometyx-gets-approval-in-europe-for-first-line-kidney-cancer.html</guid>
		</item>	
				<item>
			<title>Minerva&#039;s drug shows treatment effect in schizophrenia patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/10912/minervas-drug-shows-treatment-effect-in-schizophrenia-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10912/minervas-drug-shows-treatment-effect-in-schizophrenia-patients.html</link>
			<pubDate>Fri, 18 May 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/schizophreniabrain-10912.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10912/minervas-drug-shows-treatment-effect-in-schizophrenia-patients.html</guid>
		</item>	
				<item>
			<title>Dicerna&#039;s hyperoxaluria treatment gets orphan status from FDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/10908/dicernas-hyperoxaluria-treatment-gets-orphan-status-from-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10908/dicernas-hyperoxaluria-treatment-gets-orphan-status-from-fda.html</link>
			<pubDate>Fri, 18 May 2018 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ogco_fda_1006-10908.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10908/dicernas-hyperoxaluria-treatment-gets-orphan-status-from-fda.html</guid>
		</item>	
				<item>
			<title>FDA approves first non-opioid treatment for opioid withdrawal</title>
			<atom:link href="https://biospectrumasia.com/news/34/10901/fda-approves-first-non-opioid-treatment-for-opioid-withdrawal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10901/fda-approves-first-non-opioid-treatment-for-opioid-withdrawal.html</link>
			<pubDate>Thu, 17 May 2018 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ogco_fda_1006-10901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10901/fda-approves-first-non-opioid-treatment-for-opioid-withdrawal.html</guid>
		</item>	
				<item>
			<title>Duke-NUS, Novo join hands to study therapy for heart and eye diseases </title>
			<atom:link href="https://biospectrumasia.com/news/34/10900/duke-nus-novo-join-hands-to-study-therapy-for-heart-and-eye-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10900/duke-nus-novo-join-hands-to-study-therapy-for-heart-and-eye-diseases-.html</link>
			<pubDate>Thu, 17 May 2018 18:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_64_-10900.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10900/duke-nus-novo-join-hands-to-study-therapy-for-heart-and-eye-diseases-.html</guid>
		</item>	
				<item>
			<title>DarÃ© to merge with Pear Tree Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/10828/dar-to-merge-with-pear-tree-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10828/dar-to-merge-with-pear-tree-pharma.html</link>
			<pubDate>Tue, 08 May 2018 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merger-10828.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10828/dar-to-merge-with-pear-tree-pharma.html</guid>
		</item>	
				<item>
			<title>Kindred Biosciences Receives FDA Approval of Mirataz</title>
			<atom:link href="https://biospectrumasia.com/news/34/10824/kindred-biosciences-receives-fda-approval-of-mirataz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10824/kindred-biosciences-receives-fda-approval-of-mirataz.html</link>
			<pubDate>Mon, 07 May 2018 18:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kinder_bio-10824.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10824/kindred-biosciences-receives-fda-approval-of-mirataz.html</guid>
		</item>	
				<item>
			<title>Starpharma completes US New Drug Application for VivaGel BV</title>
			<atom:link href="https://biospectrumasia.com/news/34/10791/starpharma-completes-us-new-drug-application-for-vivagel-bv.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10791/starpharma-completes-us-new-drug-application-for-vivagel-bv.html</link>
			<pubDate>Mon, 30 Apr 2018 15:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1049259_960_720-10791.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10791/starpharma-completes-us-new-drug-application-for-vivagel-bv.html</guid>
		</item>	
				<item>
			<title>Zai Lab in-licenses Entasis&#039;s broad-spectrum antibiotic in APAC</title>
			<atom:link href="https://biospectrumasia.com/news/34/10778/zai-lab-in-licenses-entasiss-broad-spectrum-antibiotic-in-apac.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10778/zai-lab-in-licenses-entasiss-broad-spectrum-antibiotic-in-apac.html</link>
			<pubDate>Thu, 26 Apr 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_41_-10778.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10778/zai-lab-in-licenses-entasiss-broad-spectrum-antibiotic-in-apac.html</guid>
		</item>	
				<item>
			<title>Pfizer vaccine receives FDA&#039;s breakthrough therapy designation</title>
			<atom:link href="https://biospectrumasia.com/news/34/10767/pfizer-vaccine-receives-fdas-breakthrough-therapy-designation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10767/pfizer-vaccine-receives-fdas-breakthrough-therapy-designation.html</link>
			<pubDate>Wed, 25 Apr 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_151676__340-10767.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10767/pfizer-vaccine-receives-fdas-breakthrough-therapy-designation.html</guid>
		</item>	
				<item>
			<title>Zymeworks, Celgene expand bispecific antibody partnership</title>
			<atom:link href="https://biospectrumasia.com/news/34/10756/zymeworks-celgene-expand-bispecific-antibody-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10756/zymeworks-celgene-expand-bispecific-antibody-partnership.html</link>
			<pubDate>Tue, 24 Apr 2018 17:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_50_-10756.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10756/zymeworks-celgene-expand-bispecific-antibody-partnership.html</guid>
		</item>	
				<item>
			<title>UCB to acquire Proximagen&#039;s midazolam nasal spray </title>
			<atom:link href="https://biospectrumasia.com/news/34/10738/ucb-to-acquire-proximagens-midazolam-nasal-spray-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10738/ucb-to-acquire-proximagens-midazolam-nasal-spray-.html</link>
			<pubDate>Fri, 20 Apr 2018 19:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_35_-10738.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10738/ucb-to-acquire-proximagens-midazolam-nasal-spray-.html</guid>
		</item>	
				<item>
			<title>J&amp;J ramps up pricing for Imbruvica </title>
			<atom:link href="https://biospectrumasia.com/news/34/10723/jj-ramps-up-pricing-for-imbruvica-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10723/jj-ramps-up-pricing-for-imbruvica-.html</link>
			<pubDate>Thu, 19 Apr 2018 22:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_7_-10723.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10723/jj-ramps-up-pricing-for-imbruvica-.html</guid>
		</item>	
				<item>
			<title>OBI Pharma gets FDA clearance for new drug application</title>
			<atom:link href="https://biospectrumasia.com/news/34/10722/obi-pharma-gets-fda-clearance-for-new-drug-application.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10722/obi-pharma-gets-fda-clearance-for-new-drug-application.html</link>
			<pubDate>Thu, 19 Apr 2018 15:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-10722.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10722/obi-pharma-gets-fda-clearance-for-new-drug-application.html</guid>
		</item>	
				<item>
			<title>Telix Pharmaceuticals inks deal with two institutes to advance radiopharmaceutical research</title>
			<atom:link href="https://biospectrumasia.com/news/34/10696/telix-pharmaceuticals-inks-deal-with-two-institutes-to-advance-radiopharmaceutical-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10696/telix-pharmaceuticals-inks-deal-with-two-institutes-to-advance-radiopharmaceutical-research.html</link>
			<pubDate>Mon, 16 Apr 2018 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/image002-10696.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10696/telix-pharmaceuticals-inks-deal-with-two-institutes-to-advance-radiopharmaceutical-research.html</guid>
		</item>	
				<item>
			<title>Perrigo launches medication for Frequent Heartburn</title>
			<atom:link href="https://biospectrumasia.com/news/34/10686/perrigo-launches-medication-for-frequent-heartburn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10686/perrigo-launches-medication-for-frequent-heartburn.html</link>
			<pubDate>Fri, 13 Apr 2018 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heart_burn-10686.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10686/perrigo-launches-medication-for-frequent-heartburn.html</guid>
		</item>	
				<item>
			<title>Pfizer initiates Phase I trials for DMD</title>
			<atom:link href="https://biospectrumasia.com/news/34/10684/pfizer-initiates-phase-i-trials-for-dmd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10684/pfizer-initiates-phase-i-trials-for-dmd.html</link>
			<pubDate>Fri, 13 Apr 2018 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/family_2073604__340-10684.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10684/pfizer-initiates-phase-i-trials-for-dmd.html</guid>
		</item>	
				<item>
			<title>Strides Shasun&#039;s allergy relief drug gets USFDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/10677/strides-shasuns-allergy-relief-drug-gets-usfda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10677/strides-shasuns-allergy-relief-drug-gets-usfda-approval.html</link>
			<pubDate>Thu, 12 Apr 2018 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-10677.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10677/strides-shasuns-allergy-relief-drug-gets-usfda-approval.html</guid>
		</item>	
				<item>
			<title>Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/10670/alexion-pharmaceuticals-to-acquire-wilson-therapeutics-for-855mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10670/alexion-pharmaceuticals-to-acquire-wilson-therapeutics-for-855mn.html</link>
			<pubDate>Thu, 12 Apr 2018 10:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_32833__340-10670.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10670/alexion-pharmaceuticals-to-acquire-wilson-therapeutics-for-855mn.html</guid>
		</item>	
				<item>
			<title>USFDA approves Perrigo&#039;s OTC heartburn medicine </title>
			<atom:link href="https://biospectrumasia.com/news/34/10662/usfda-approves-perrigos-otc-heartburn-medicine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10662/usfda-approves-perrigos-otc-heartburn-medicine-.html</link>
			<pubDate>Wed, 11 Apr 2018 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images_3_-10662.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10662/usfda-approves-perrigos-otc-heartburn-medicine-.html</guid>
		</item>	
				<item>
			<title>Ionis Pharma, AstraZeneca to advance new drug for NASH</title>
			<atom:link href="https://biospectrumasia.com/news/34/10661/ionis-pharma-astrazeneca-to-advance-new-drug-for-nash.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10661/ionis-pharma-astrazeneca-to-advance-new-drug-for-nash.html</link>
			<pubDate>Wed, 11 Apr 2018 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-10661.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10661/ionis-pharma-astrazeneca-to-advance-new-drug-for-nash.html</guid>
		</item>	
				<item>
			<title>Australian university UNSW research holds out hope for thalassemia patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/10658/australian-university-unsw-research-holds-out-hope-for-thalassemia-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10658/australian-university-unsw-research-holds-out-hope-for-thalassemia-patients.html</link>
			<pubDate>Tue, 10 Apr 2018 23:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-10658.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10658/australian-university-unsw-research-holds-out-hope-for-thalassemia-patients.html</guid>
		</item>	
				<item>
			<title>Yuhan Corporation collaborates with Syntekabio for AI platform</title>
			<atom:link href="https://biospectrumasia.com/news/34/10651/yuhan-corporation-collaborates-with-syntekabio-for-ai-platform.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10651/yuhan-corporation-collaborates-with-syntekabio-for-ai-platform.html</link>
			<pubDate>Tue, 10 Apr 2018 09:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fax_1889028_960_720-10651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10651/yuhan-corporation-collaborates-with-syntekabio-for-ai-platform.html</guid>
		</item>	
				<item>
			<title>AstraZeneca&#039;s oncology drugs receive regulatory boost</title>
			<atom:link href="https://biospectrumasia.com/news/34/10632/astrazenecas-oncology-drugs-receive-regulatory-boost.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10632/astrazenecas-oncology-drugs-receive-regulatory-boost.html</link>
			<pubDate>Fri, 06 Apr 2018 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_151676__340-10632.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10632/astrazenecas-oncology-drugs-receive-regulatory-boost.html</guid>
		</item>	
				<item>
			<title>Aleafia steps-up battle against opioid crisis</title>
			<atom:link href="https://biospectrumasia.com/news/34/10623/aleafia-steps-up-battle-against-opioid-crisis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10623/aleafia-steps-up-battle-against-opioid-crisis.html</link>
			<pubDate>Fri, 06 Apr 2018 00:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/170105_f_rb000_001-10623.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10623/aleafia-steps-up-battle-against-opioid-crisis.html</guid>
		</item>	
				<item>
			<title>USFDA approves Proteostasis&#039;s triple combination program for CF</title>
			<atom:link href="https://biospectrumasia.com/news/34/10614/usfda-approves-proteostasiss-triple-combination-program-for-cf.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10614/usfda-approves-proteostasiss-triple-combination-program-for-cf.html</link>
			<pubDate>Wed, 04 Apr 2018 22:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-10614.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10614/usfda-approves-proteostasiss-triple-combination-program-for-cf.html</guid>
		</item>	
				<item>
			<title>Strides Shasun&#039;s generic Ibuprofen receives USFDA approval </title>
			<atom:link href="https://biospectrumasia.com/news/34/10594/strides-shasuns-generic-ibuprofen-receives-usfda-approval-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10594/strides-shasuns-generic-ibuprofen-receives-usfda-approval-.html</link>
			<pubDate>Mon, 02 Apr 2018 17:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-10594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10594/strides-shasuns-generic-ibuprofen-receives-usfda-approval-.html</guid>
		</item>	
				<item>
			<title>C4X Discovery signs licensing agreement with Indivior </title>
			<atom:link href="https://biospectrumasia.com/news/34/10592/c4x-discovery-signs-licensing-agreement-with-indivior-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10592/c4x-discovery-signs-licensing-agreement-with-indivior-.html</link>
			<pubDate>Mon, 02 Apr 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pcd_pharma_franchise_agreement_1-10592.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10592/c4x-discovery-signs-licensing-agreement-with-indivior-.html</guid>
		</item>	
				<item>
			<title>Breckenridge announces approval of Hep B virus tablets </title>
			<atom:link href="https://biospectrumasia.com/news/34/10588/breckenridge-announces-approval-of-hep-b-virus-tablets-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10588/breckenridge-announces-approval-of-hep-b-virus-tablets-.html</link>
			<pubDate>Mon, 02 Apr 2018 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_9_-10588.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10588/breckenridge-announces-approval-of-hep-b-virus-tablets-.html</guid>
		</item>	
				<item>
			<title>Esco, Max Planck cooperate on research of flavivirus vaccines</title>
			<atom:link href="https://biospectrumasia.com/news/34/10586/esco-max-planck-cooperate-on-research-of-flavivirus-vaccines.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10586/esco-max-planck-cooperate-on-research-of-flavivirus-vaccines.html</link>
			<pubDate>Mon, 02 Apr 2018 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/38709078151_20a1b2b59f_b-10586.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10586/esco-max-planck-cooperate-on-research-of-flavivirus-vaccines.html</guid>
		</item>	
				<item>
			<title>Merck to launch three new products at INTERPHEX 2018</title>
			<atom:link href="https://biospectrumasia.com/news/34/10579/merck-to-launch-three-new-products-at-interphex-2018.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10579/merck-to-launch-three-new-products-at-interphex-2018.html</link>
			<pubDate>Thu, 29 Mar 2018 18:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-10579.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10579/merck-to-launch-three-new-products-at-interphex-2018.html</guid>
		</item>	
				<item>
			<title>Ablynx&#039; vobarilizumab fails in lupus trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/10573/ablynx-vobarilizumab-fails-in-lupus-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10573/ablynx-vobarilizumab-fails-in-lupus-trial.html</link>
			<pubDate>Wed, 28 Mar 2018 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_8_-10573.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10573/ablynx-vobarilizumab-fails-in-lupus-trial.html</guid>
		</item>	
				<item>
			<title>Carna Bio, Sumitomo collaborate for neurological drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html</link>
			<pubDate>Wed, 28 Mar 2018 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10568.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10568/carna-bio-sumitomo-collaborate-for-neurological-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Syngene inks drug discovery agreement with GSK</title>
			<atom:link href="https://biospectrumasia.com/news/34/10560/syngene-inks-drug-discovery-agreement-with-gsk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10560/syngene-inks-drug-discovery-agreement-with-gsk.html</link>
			<pubDate>Tue, 27 Mar 2018 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-10560.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10560/syngene-inks-drug-discovery-agreement-with-gsk.html</guid>
		</item>	
				<item>
			<title>Male birth control pill shows promise</title>
			<atom:link href="https://biospectrumasia.com/news/34/10551/male-birth-control-pill-shows-promise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10551/male-birth-control-pill-shows-promise.html</link>
			<pubDate>Tue, 27 Mar 2018 09:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_437968_960_720-10551.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10551/male-birth-control-pill-shows-promise.html</guid>
		</item>	
				<item>
			<title>Suven Life Sciences secures 3 product patents</title>
			<atom:link href="https://biospectrumasia.com/news/34/10535/suven-life-sciences-secures-3-product-patents.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10535/suven-life-sciences-secures-3-product-patents.html</link>
			<pubDate>Thu, 22 Mar 2018 18:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thermometer_1539191_960_720-10535.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10535/suven-life-sciences-secures-3-product-patents.html</guid>
		</item>	
				<item>
			<title>Allergan launches Ozurdex in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/10533/allergan-launches-ozurdex-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10533/allergan-launches-ozurdex-in-china.html</link>
			<pubDate>Thu, 22 Mar 2018 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/intravitreal_injection-10533.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10533/allergan-launches-ozurdex-in-china.html</guid>
		</item>	
				<item>
			<title>Inovio Pharma, Apollo Bio ink deal for cervical cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/10512/inovio-pharma-apollo-bio-ink-deal-for-cervical-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10512/inovio-pharma-apollo-bio-ink-deal-for-cervical-cancer-drug-.html</link>
			<pubDate>Wed, 21 Mar 2018 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10512.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10512/inovio-pharma-apollo-bio-ink-deal-for-cervical-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>USFDA grants priority to XTANDI&#039;s sNDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/10507/usfda-grants-priority-to-xtandis-snda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10507/usfda-grants-priority-to-xtandis-snda.html</link>
			<pubDate>Tue, 20 Mar 2018 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/court_hammer_648x430-10507.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10507/usfda-grants-priority-to-xtandis-snda.html</guid>
		</item>	
				<item>
			<title>Biogen acquires Schizophrenia investigational drug candidate form Pfizer </title>
			<atom:link href="https://biospectrumasia.com/news/34/10489/biogen-acquires-schizophrenia-investigational-drug-candidate-form-pfizer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10489/biogen-acquires-schizophrenia-investigational-drug-candidate-form-pfizer-.html</link>
			<pubDate>Fri, 16 Mar 2018 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_1012459__340-10489.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10489/biogen-acquires-schizophrenia-investigational-drug-candidate-form-pfizer-.html</guid>
		</item>	
				<item>
			<title>JW Pharma develops tablet formulation for hair loss and BPH</title>
			<atom:link href="https://biospectrumasia.com/news/34/10476/jw-pharma-develops-tablet-formulation-for-hair-loss-and-bph.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10476/jw-pharma-develops-tablet-formulation-for-hair-loss-and-bph.html</link>
			<pubDate>Tue, 13 Mar 2018 18:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs_206150__340-10476.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10476/jw-pharma-develops-tablet-formulation-for-hair-loss-and-bph.html</guid>
		</item>	
				<item>
			<title>&#039;Cancer is an increasingly important health issue in the APAC region&#039;</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/10466/cancer-is-an-increasingly-important-health-issue-in-the-apac-region.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/10466/cancer-is-an-increasingly-important-health-issue-in-the-apac-region.html</link>
			<pubDate>Fri, 09 Mar 2018 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_shintaro_nishimura_photo-10466.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/10466/cancer-is-an-increasingly-important-health-issue-in-the-apac-region.html</guid>
		</item>	
				<item>
			<title>USFDA approves Taiwan&#039;s HIV drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/10454/usfda-approves-taiwans-hiv-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10454/usfda-approves-taiwans-hiv-drug.html</link>
			<pubDate>Thu, 08 Mar 2018 13:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10454.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10454/usfda-approves-taiwans-hiv-drug.html</guid>
		</item>	
				<item>
			<title>FDA approves Prometic&#039;s inter-alpha-inhibitor-proteins </title>
			<atom:link href="https://biospectrumasia.com/news/34/10427/fda-approves-prometics-inter-alpha-inhibitor-proteins-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10427/fda-approves-prometics-inter-alpha-inhibitor-proteins-.html</link>
			<pubDate>Tue, 06 Mar 2018 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_29149_960_720-10427.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10427/fda-approves-prometics-inter-alpha-inhibitor-proteins-.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk&#039;s diabetes pill presents the first successful data </title>
			<atom:link href="https://biospectrumasia.com/news/34/10391/novo-nordisks-diabetes-pill-presents-the-first-successful-data-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10391/novo-nordisks-diabetes-pill-presents-the-first-successful-data-.html</link>
			<pubDate>Mon, 26 Feb 2018 18:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novo_nordisk-10391.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10391/novo-nordisks-diabetes-pill-presents-the-first-successful-data-.html</guid>
		</item>	
				<item>
			<title>STA Pharma, Regulus team up for mRNA targeting drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/10380/sta-pharma-regulus-team-up-for-mrna-targeting-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10380/sta-pharma-regulus-team-up-for-mrna-targeting-drugs.html</link>
			<pubDate>Fri, 23 Feb 2018 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10380/sta-pharma-regulus-team-up-for-mrna-targeting-drugs.html</guid>
		</item>	
				<item>
			<title>Asia needs a legal framework to combat rare diseases</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/10293/asia-needs-a-legal-framework-to-combat-rare-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/10293/asia-needs-a-legal-framework-to-combat-rare-diseases.html</link>
			<pubDate>Thu, 08 Feb 2018 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/court_hammer_648x430-10293.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/10293/asia-needs-a-legal-framework-to-combat-rare-diseases.html</guid>
		</item>	
				<item>
			<title>DL Medicine teams up with Pfizer for new drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/10275/dl-medicine-teams-up-with-pfizer-for-new-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10275/dl-medicine-teams-up-with-pfizer-for-new-drug-discovery.html</link>
			<pubDate>Wed, 07 Feb 2018 11:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10275.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10275/dl-medicine-teams-up-with-pfizer-for-new-drug-discovery.html</guid>
		</item>	
				<item>
			<title>New study shows baldness and prostate cancer may be interrelated </title>
			<atom:link href="https://biospectrumasia.com/news/34/10206/new-study-shows-baldness-and-prostate-cancer-may-be-interrelated-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10206/new-study-shows-baldness-and-prostate-cancer-may-be-interrelated-.html</link>
			<pubDate>Thu, 25 Jan 2018 11:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/men_1574607_960_720-10206.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10206/new-study-shows-baldness-and-prostate-cancer-may-be-interrelated-.html</guid>
		</item>	
				<item>
			<title>XtalPi secures $15 M funding</title>
			<atom:link href="https://biospectrumasia.com/news/34/10198/xtalpi-secures-15-m-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10198/xtalpi-secures-15-m-funding.html</link>
			<pubDate>Wed, 24 Jan 2018 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10198.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10198/xtalpi-secures-15-m-funding.html</guid>
		</item>	
				<item>
			<title>OBI Pharma receives FDA nod for Phase I study of its cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/10170/obi-pharma-receives-fda-nod-for-phase-i-study-of-its-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10170/obi-pharma-receives-fda-nod-for-phase-i-study-of-its-cancer-drug.html</link>
			<pubDate>Thu, 18 Jan 2018 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fax_1889028_960_720-10170.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10170/obi-pharma-receives-fda-nod-for-phase-i-study-of-its-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer </title>
			<atom:link href="https://biospectrumasia.com/news/34/10157/forty-seven-collaborates-with-merck-kgaa-on-a-novel-combination-for-ovarian-cancer-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10157/forty-seven-collaborates-with-merck-kgaa-on-a-novel-combination-for-ovarian-cancer-.html</link>
			<pubDate>Tue, 16 Jan 2018 23:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10157.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10157/forty-seven-collaborates-with-merck-kgaa-on-a-novel-combination-for-ovarian-cancer-.html</guid>
		</item>	
				<item>
			<title>FDA approves first treatment for breast cancer with a certain inherited genetic mutation </title>
			<atom:link href="https://biospectrumasia.com/news/34/10150/fda-approves-first-treatment-for-breast-cancer-with-a-certain-inherited-genetic-mutation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10150/fda-approves-first-treatment-for-breast-cancer-with-a-certain-inherited-genetic-mutation-.html</link>
			<pubDate>Mon, 15 Jan 2018 23:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/6237594287_aba5344dbc-10150.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10150/fda-approves-first-treatment-for-breast-cancer-with-a-certain-inherited-genetic-mutation-.html</guid>
		</item>	
				<item>
			<title>Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives</title>
			<atom:link href="https://biospectrumasia.com/news/34/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html</link>
			<pubDate>Mon, 15 Jan 2018 09:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_1012459__340-10143.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10143/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives.html</guid>
		</item>	
				<item>
			<title>BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324</title>
			<atom:link href="https://biospectrumasia.com/news/34/10123/bergenbio-meets-first-efficacy-endpoint-in-phase-ii-trial-evaluating-bgb324.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10123/bergenbio-meets-first-efficacy-endpoint-in-phase-ii-trial-evaluating-bgb324.html</link>
			<pubDate>Wed, 10 Jan 2018 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bergenbio_710_265-10123.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10123/bergenbio-meets-first-efficacy-endpoint-in-phase-ii-trial-evaluating-bgb324.html</guid>
		</item>	
				<item>
			<title>Intec Pharma acknowledged with patent </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/10116/intec-pharma-acknowledged-with-patent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/10116/intec-pharma-acknowledged-with-patent-.html</link>
			<pubDate>Mon, 08 Jan 2018 18:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-10116.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/10116/intec-pharma-acknowledged-with-patent-.html</guid>
		</item>	
				<item>
			<title>Pfizer to launch a new venture fund to invest in neuroscience research projects</title>
			<atom:link href="https://biospectrumasia.com/news/34/10115/pfizer-to-launch-a-new-venture-fund-to-invest-in-neuroscience-research-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10115/pfizer-to-launch-a-new-venture-fund-to-invest-in-neuroscience-research-projects.html</link>
			<pubDate>Mon, 08 Jan 2018 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bullying_2778163_960_720-10115.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10115/pfizer-to-launch-a-new-venture-fund-to-invest-in-neuroscience-research-projects.html</guid>
		</item>	
				<item>
			<title>Drug for diabetes type 2 shows potential in treating Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/34/10103/drug-for-diabetes-type-2-shows-potential-in-treating-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10103/drug-for-diabetes-type-2-shows-potential-in-treating-alzheimers.html</link>
			<pubDate>Thu, 04 Jan 2018 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzheimers_3034960_960_720-10103.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10103/drug-for-diabetes-type-2-shows-potential-in-treating-alzheimers.html</guid>
		</item>	
				<item>
			<title>Biocon &amp; Mylan&#039;s biosimilar gets Brazilian approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/10074/biocon-mylans-biosimilar-gets-brazilian-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10074/biocon-mylans-biosimilar-gets-brazilian-approval.html</link>
			<pubDate>Fri, 29 Dec 2017 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10074.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10074/biocon-mylans-biosimilar-gets-brazilian-approval.html</guid>
		</item>	
				<item>
			<title>FDA approves drug to treat dangerously low blood pressure </title>
			<atom:link href="https://biospectrumasia.com/news/34/10064/fda-approves-drug-to-treat-dangerously-low-blood-pressure-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10064/fda-approves-drug-to-treat-dangerously-low-blood-pressure-.html</link>
			<pubDate>Wed, 27 Dec 2017 20:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-10064.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10064/fda-approves-drug-to-treat-dangerously-low-blood-pressure-.html</guid>
		</item>	
				<item>
			<title>Dr. Reddy&#039;s launches Melphalan Hydrochloride for Injection in the U.S. Market</title>
			<atom:link href="https://biospectrumasia.com/news/34/10062/dr-reddys-launches-melphalan-hydrochloride-for-injection-in-the-u-s-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10062/dr-reddys-launches-melphalan-hydrochloride-for-injection-in-the-u-s-market.html</link>
			<pubDate>Wed, 27 Dec 2017 17:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hormonetherapy-10062.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10062/dr-reddys-launches-melphalan-hydrochloride-for-injection-in-the-u-s-market.html</guid>
		</item>	
				<item>
			<title>CANbridge submits investigational new drug application for cancer treatment </title>
			<atom:link href="https://biospectrumasia.com/news/34/10059/canbridge-submits-investigational-new-drug-application-for-cancer-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10059/canbridge-submits-investigational-new-drug-application-for-cancer-treatment-.html</link>
			<pubDate>Wed, 27 Dec 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibodies-10059.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10059/canbridge-submits-investigational-new-drug-application-for-cancer-treatment-.html</guid>
		</item>	
				<item>
			<title>Otsuka collaborates with X-Chem for new drug compounds</title>
			<atom:link href="https://biospectrumasia.com/news/34/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html</link>
			<pubDate>Tue, 26 Dec 2017 12:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-10054.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10054/otsuka-collaborates-with-x-chem-for-new-drug-compounds.html</guid>
		</item>	
				<item>
			<title>Adaptive Phase II Study of BAN2401 in Early Alzheimer&#039;s Disease Continues toward 18-Month Endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/34/10048/adaptive-phase-ii-study-of-ban2401-in-early-alzheimers-disease-continues-toward-18-month-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10048/adaptive-phase-ii-study-of-ban2401-in-early-alzheimers-disease-continues-toward-18-month-endpoint.html</link>
			<pubDate>Fri, 22 Dec 2017 18:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzheimers_paper_1-10048.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10048/adaptive-phase-ii-study-of-ban2401-in-early-alzheimers-disease-continues-toward-18-month-endpoint.html</guid>
		</item>	
				<item>
			<title>Confo Therapeutics enters into collaboration with Roche</title>
			<atom:link href="https://biospectrumasia.com/news/34/10020/confo-therapeutics-enters-into-collaboration-with-roche.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/10020/confo-therapeutics-enters-into-collaboration-with-roche.html</link>
			<pubDate>Wed, 20 Dec 2017 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration1-10020.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/10020/confo-therapeutics-enters-into-collaboration-with-roche.html</guid>
		</item>	
				<item>
			<title>Researchers show patients&#039; own immune cells can fight deadly cancers</title>
			<atom:link href="https://biospectrumasia.com/news/34/9987/researchers-show-patients-own-immune-cells-can-fight-deadly-cancers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9987/researchers-show-patients-own-immune-cells-can-fight-deadly-cancers.html</link>
			<pubDate>Fri, 15 Dec 2017 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9987.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9987/researchers-show-patients-own-immune-cells-can-fight-deadly-cancers.html</guid>
		</item>	
				<item>
			<title>Bioelectronic medicine to treat lupus </title>
			<atom:link href="https://biospectrumasia.com/news/34/9986/bioelectronic-medicine-to-treat-lupus-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9986/bioelectronic-medicine-to-treat-lupus-.html</link>
			<pubDate>Fri, 15 Dec 2017 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/images-9986.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9986/bioelectronic-medicine-to-treat-lupus-.html</guid>
		</item>	
				<item>
			<title>Sirenas receives $1.68 M research grant to accelerate ATLANTIS </title>
			<atom:link href="https://biospectrumasia.com/news/34/9975/sirenas-receives-1-68-m-research-grant-to-accelerate-atlantis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9975/sirenas-receives-1-68-m-research-grant-to-accelerate-atlantis-.html</link>
			<pubDate>Wed, 13 Dec 2017 22:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business_money_pink_coins-9975.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9975/sirenas-receives-1-68-m-research-grant-to-accelerate-atlantis-.html</guid>
		</item>	
				<item>
			<title>Kenalog-40 Injection approved and available through Amneal Biosciences</title>
			<atom:link href="https://biospectrumasia.com/news/34/9974/kenalog-40-injection-approved-and-available-through-amneal-biosciences.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9974/kenalog-40-injection-approved-and-available-through-amneal-biosciences.html</link>
			<pubDate>Wed, 13 Dec 2017 22:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe_866550_960_720-9974.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9974/kenalog-40-injection-approved-and-available-through-amneal-biosciences.html</guid>
		</item>	
				<item>
			<title>FDA approves Sanofi&#039;s Admelog </title>
			<atom:link href="https://biospectrumasia.com/news/34/9969/fda-approves-sanofis-admelog-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9969/fda-approves-sanofis-admelog-.html</link>
			<pubDate>Wed, 13 Dec 2017 00:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download_1_-9969.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9969/fda-approves-sanofis-admelog-.html</guid>
		</item>	
				<item>
			<title>JW Pharma releases cancer treatment trial results</title>
			<atom:link href="https://biospectrumasia.com/news/34/9962/jw-pharma-releases-cancer-treatment-trial-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9962/jw-pharma-releases-cancer-treatment-trial-results.html</link>
			<pubDate>Tue, 12 Dec 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9962.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9962/jw-pharma-releases-cancer-treatment-trial-results.html</guid>
		</item>	
				<item>
			<title>Sanofi ends development of Clostridium difficile vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/34/9932/sanofi-ends-development-of-clostridium-difficile-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9932/sanofi-ends-development-of-clostridium-difficile-vaccine.html</link>
			<pubDate>Tue, 05 Dec 2017 22:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/800x_1-9932.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9932/sanofi-ends-development-of-clostridium-difficile-vaccine.html</guid>
		</item>	
				<item>
			<title>Pfizer to develop and commercialize CRESEMBA in China and Asia Pacific </title>
			<atom:link href="https://biospectrumasia.com/news/34/9906/pfizer-to-develop-and-commercialize-cresemba-in-china-and-asia-pacific-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9906/pfizer-to-develop-and-commercialize-cresemba-in-china-and-asia-pacific-.html</link>
			<pubDate>Tue, 05 Dec 2017 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9906.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9906/pfizer-to-develop-and-commercialize-cresemba-in-china-and-asia-pacific-.html</guid>
		</item>	
				<item>
			<title>Pfizer inks drug development and commercialization deal with Basilea Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/9903/pfizer-inks-drug-development-and-commercialization-deal-with-basilea-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9903/pfizer-inks-drug-development-and-commercialization-deal-with-basilea-pharma.html</link>
			<pubDate>Fri, 01 Dec 2017 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1923185__340-9903.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9903/pfizer-inks-drug-development-and-commercialization-deal-with-basilea-pharma.html</guid>
		</item>	
				<item>
			<title>Achievement of Biotech Company: Treat Burns with Pineapples</title>
			<atom:link href="https://biospectrumasia.com/news/34/9860/achievement-of-biotech-company-treat-burns-with-pineapples.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9860/achievement-of-biotech-company-treat-burns-with-pineapples.html</link>
			<pubDate>Mon, 27 Nov 2017 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotech-9860.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9860/achievement-of-biotech-company-treat-burns-with-pineapples.html</guid>
		</item>	
				<item>
			<title>Khondrion presents Phase II KHENERGY trial data</title>
			<atom:link href="https://biospectrumasia.com/news/34/9845/khondrion-presents-phase-ii-khenergy-trial-data.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9845/khondrion-presents-phase-ii-khenergy-trial-data.html</link>
			<pubDate>Thu, 23 Nov 2017 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical_trial-9845.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9845/khondrion-presents-phase-ii-khenergy-trial-data.html</guid>
		</item>	
				<item>
			<title>Novel in vitro model investigates drug candidates for cancer metastasis</title>
			<atom:link href="https://biospectrumasia.com/news/34/9836/novel-in-vitro-model-investigates-drug-candidates-for-cancer-metastasis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9836/novel-in-vitro-model-investigates-drug-candidates-for-cancer-metastasis.html</link>
			<pubDate>Wed, 22 Nov 2017 16:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/435029196_1280x720-9836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9836/novel-in-vitro-model-investigates-drug-candidates-for-cancer-metastasis.html</guid>
		</item>	
				<item>
			<title>Gamida Cell appoints Julian Adams as chairman and CEO</title>
			<atom:link href="https://biospectrumasia.com/news/34/9821/gamida-cell-appoints-julian-adams-as-chairman-and-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9821/gamida-cell-appoints-julian-adams-as-chairman-and-ceo.html</link>
			<pubDate>Tue, 21 Nov 2017 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/julian_adams_l-9821.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9821/gamida-cell-appoints-julian-adams-as-chairman-and-ceo.html</guid>
		</item>	
				<item>
			<title>NDA submission for Starpharma&#039;s VivaGel BV </title>
			<atom:link href="https://biospectrumasia.com/news/34/9815/nda-submission-for-starpharmas-vivagel-bv-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9815/nda-submission-for-starpharmas-vivagel-bv-.html</link>
			<pubDate>Tue, 21 Nov 2017 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blausen_0732_pid_sites-9815.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9815/nda-submission-for-starpharmas-vivagel-bv-.html</guid>
		</item>	
				<item>
			<title>Mitsubhishi Tanabe Pharma&#039;s ALS drug treats more than 1000 people in three months</title>
			<atom:link href="https://biospectrumasia.com/news/34/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html</link>
			<pubDate>Fri, 17 Nov 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs_206150__340-9812.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9812/mitsubhishi-tanabe-pharmas-als-drug-treats-more-than-1000-people-in-three-months.html</guid>
		</item>	
				<item>
			<title>Seres Therapeutics, MD Anderson Cancer Center and Parker Institute for Cancer Immunotherapy collaborates</title>
			<atom:link href="https://biospectrumasia.com/news/34/9798/seres-therapeutics-md-anderson-cancer-center-and-parker-institute-for-cancer-immunotherapy-collaborates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9798/seres-therapeutics-md-anderson-cancer-center-and-parker-institute-for-cancer-immunotherapy-collaborates.html</link>
			<pubDate>Wed, 15 Nov 2017 16:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-9798.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9798/seres-therapeutics-md-anderson-cancer-center-and-parker-institute-for-cancer-immunotherapy-collaborates.html</guid>
		</item>	
				<item>
			<title>Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/9796/bayer-and-loxo-oncology-to-develop-and-commercialize-two-novel-oncology-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9796/bayer-and-loxo-oncology-to-develop-and-commercialize-two-novel-oncology-therapies.html</link>
			<pubDate>Wed, 15 Nov 2017 15:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tcellhead_0-9796.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9796/bayer-and-loxo-oncology-to-develop-and-commercialize-two-novel-oncology-therapies.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s Dongsung Pharmaceuticals opens a new cancer research center in Seoul</title>
			<atom:link href="https://biospectrumasia.com/news/34/9786/koreas-dongsung-pharmaceuticals-opens-a-new-cancer-research-center-in-seoul.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9786/koreas-dongsung-pharmaceuticals-opens-a-new-cancer-research-center-in-seoul.html</link>
			<pubDate>Tue, 14 Nov 2017 13:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna_profiling_human_bill-9786.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9786/koreas-dongsung-pharmaceuticals-opens-a-new-cancer-research-center-in-seoul.html</guid>
		</item>	
				<item>
			<title>Helperby Therapeutics develops sustainable solution for antibiotic resistance</title>
			<atom:link href="https://biospectrumasia.com/news/34/9780/helperby-therapeutics-develops-sustainable-solution-for-antibiotic-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9780/helperby-therapeutics-develops-sustainable-solution-for-antibiotic-resistance.html</link>
			<pubDate>Mon, 13 Nov 2017 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibiotic_resistance-9780.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9780/helperby-therapeutics-develops-sustainable-solution-for-antibiotic-resistance.html</guid>
		</item>	
				<item>
			<title>Amgen And Novartis announce expanded collaboration with Banner Alzheimer&#039;s Institute</title>
			<atom:link href="https://biospectrumasia.com/news/34/9721/amgen-and-novartis-announce-expanded-collaboration-with-banner-alzheimers-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9721/amgen-and-novartis-announce-expanded-collaboration-with-banner-alzheimers-institute.html</link>
			<pubDate>Fri, 03 Nov 2017 20:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alzheimers_brain-9721.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9721/amgen-and-novartis-announce-expanded-collaboration-with-banner-alzheimers-institute.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim and Dicerna collaborate to develop treatments for chronic liver diseases </title>
			<atom:link href="https://biospectrumasia.com/news/34/9714/boehringer-ingelheim-and-dicerna-collaborate-to-develop-treatments-for-chronic-liver-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9714/boehringer-ingelheim-and-dicerna-collaborate-to-develop-treatments-for-chronic-liver-diseases-.html</link>
			<pubDate>Thu, 02 Nov 2017 17:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/consolidation-9714.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9714/boehringer-ingelheim-and-dicerna-collaborate-to-develop-treatments-for-chronic-liver-diseases-.html</guid>
		</item>	
				<item>
			<title>Evolution of drug delivery system for better patient safety</title>
			<atom:link href="https://biospectrumasia.com/news/34/9710/evolution-of-drug-delivery-system-for-better-patient-safety.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9710/evolution-of-drug-delivery-system-for-better-patient-safety.html</link>
			<pubDate>Wed, 01 Nov 2017 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/subramaniam_alagu_0324_2-9710.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9710/evolution-of-drug-delivery-system-for-better-patient-safety.html</guid>
		</item>	
				<item>
			<title>CFDA accepts Eisai&#039;s NDA for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/9690/cfda-accepts-eisais-nda-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9690/cfda-accepts-eisais-nda-for-cancer-drug.html</link>
			<pubDate>Tue, 31 Oct 2017 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9690.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9690/cfda-accepts-eisais-nda-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccineÂ </title>
			<atom:link href="https://biospectrumasia.com/news/34/9659/alopexx-completes-first-in-man-trial-of-its-novel-broad-spectrum-anti-microbial-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9659/alopexx-completes-first-in-man-trial-of-its-novel-broad-spectrum-anti-microbial-vaccine.html</link>
			<pubDate>Thu, 26 Oct 2017 16:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/3042791963_b342ec8872_b-9659.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9659/alopexx-completes-first-in-man-trial-of-its-novel-broad-spectrum-anti-microbial-vaccine.html</guid>
		</item>	
				<item>
			<title>New &#039;Double Decker&#039; Antibody Technology Fights CancerÂ </title>
			<atom:link href="https://biospectrumasia.com/news/34/9661/new-double-decker-antibody-technology-fights-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9661/new-double-decker-antibody-technology-fights-cancer.html</link>
			<pubDate>Thu, 26 Oct 2017 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientist_2141259_960_720-9661.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9661/new-double-decker-antibody-technology-fights-cancer.html</guid>
		</item>	
				<item>
			<title>Incyte and MacroGenics collaborates for anti-PD-1 monoclonal antibody</title>
			<atom:link href="https://biospectrumasia.com/news/34/9658/incyte-and-macrogenics-collaborates-for-anti-pd-1-monoclonal-antibody.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9658/incyte-and-macrogenics-collaborates-for-anti-pd-1-monoclonal-antibody.html</link>
			<pubDate>Thu, 26 Oct 2017 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect_20333_1920-9658.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9658/incyte-and-macrogenics-collaborates-for-anti-pd-1-monoclonal-antibody.html</guid>
		</item>	
				<item>
			<title>AbbVie plows $205M upfront Into Alector&#039;s Alzheimer&#039;s Program</title>
			<atom:link href="https://biospectrumasia.com/news/34/9651/abbvie-plows-205m-upfront-into-alectors-alzheimers-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9651/abbvie-plows-205m-upfront-into-alectors-alzheimers-program.html</link>
			<pubDate>Wed, 25 Oct 2017 15:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/maxresdefault_1_-9651.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9651/abbvie-plows-205m-upfront-into-alectors-alzheimers-program.html</guid>
		</item>	
				<item>
			<title>Eisai, Biogen expand their agreement to codevelop and commercialize AD drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html</link>
			<pubDate>Tue, 24 Oct 2017 20:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-9644.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9644/eisai-biogen-expand-their-agreement-to-codevelop-and-commercialize-ad-drug.html</guid>
		</item>	
				<item>
			<title>â€œWith the new blood testing technology, the laboratories can better focus their resources and expertise.â€</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/9587/with-the-new-blood-testing-technology-the-laboratories-can-better-focus-their-resources-and-expertise-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/9587/with-the-new-blood-testing-technology-the-laboratories-can-better-focus-their-resources-and-expertise-.html</link>
			<pubDate>Fri, 13 Oct 2017 11:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/picture1-9587.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/9587/with-the-new-blood-testing-technology-the-laboratories-can-better-focus-their-resources-and-expertise-.html</guid>
		</item>	
				<item>
			<title>Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection </title>
			<atom:link href="https://biospectrumasia.com/news/34/9581/novel-bi-specific-antibody-shows-strong-therapeutic-potential-to-treat-zika-virus-infection-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9581/novel-bi-specific-antibody-shows-strong-therapeutic-potential-to-treat-zika-virus-infection-.html</link>
			<pubDate>Thu, 12 Oct 2017 00:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9581.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9581/novel-bi-specific-antibody-shows-strong-therapeutic-potential-to-treat-zika-virus-infection-.html</guid>
		</item>	
				<item>
			<title>Adult patients with Schizophrenia in Singapore to benefit from the first three-monthly long-acting treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/9567/adult-patients-with-schizophrenia-in-singapore-to-benefit-from-the-first-three-monthly-long-acting-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9567/adult-patients-with-schizophrenia-in-singapore-to-benefit-from-the-first-three-monthly-long-acting-treatment.html</link>
			<pubDate>Tue, 10 Oct 2017 11:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brain_2676370_960_720-9567.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9567/adult-patients-with-schizophrenia-in-singapore-to-benefit-from-the-first-three-monthly-long-acting-treatment.html</guid>
		</item>	
				<item>
			<title>Chiome Bioscience selects ProBioGen for GlymaxX antibody manufacturing program</title>
			<atom:link href="https://biospectrumasia.com/news/34/9548/chiome-bioscience-selects-probiogen-for-glymaxx-antibody-manufacturing-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9548/chiome-bioscience-selects-probiogen-for-glymaxx-antibody-manufacturing-program.html</link>
			<pubDate>Thu, 05 Oct 2017 14:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership-9548.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9548/chiome-bioscience-selects-probiogen-for-glymaxx-antibody-manufacturing-program.html</guid>
		</item>	
				<item>
			<title>Regulatory approval in Europe granted for Synthon&#039;s Glatiramer Acetate</title>
			<atom:link href="https://biospectrumasia.com/news/34/9547/regulatory-approval-in-europe-granted-for-synthons-glatiramer-acetate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9547/regulatory-approval-in-europe-granted-for-synthons-glatiramer-acetate.html</link>
			<pubDate>Thu, 05 Oct 2017 14:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prefilled_syringe-9547.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9547/regulatory-approval-in-europe-granted-for-synthons-glatiramer-acetate.html</guid>
		</item>	
				<item>
			<title>Newly approved cancer drugs do not extend survival, says a study</title>
			<atom:link href="https://biospectrumasia.com/news/34/9546/newly-approved-cancer-drugs-do-not-extend-survival-says-a-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9546/newly-approved-cancer-drugs-do-not-extend-survival-says-a-study.html</link>
			<pubDate>Thu, 05 Oct 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer2-9546.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9546/newly-approved-cancer-drugs-do-not-extend-survival-says-a-study.html</guid>
		</item>	
				<item>
			<title>Sato And Eisai Pharma co-promote antifungal agent in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html</link>
			<pubDate>Tue, 03 Oct 2017 12:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1-9530.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9530/sato-and-eisai-pharma-co-promote-antifungal-agent-in-japan.html</guid>
		</item>	
				<item>
			<title>Korea to inject 500 billion won into pharma sector; aims to launch 100 new drugs by 2026</title>
			<atom:link href="https://biospectrumasia.com/news/34/9527/korea-to-inject-500-billion-won-into-pharma-sector-aims-to-launch-100-new-drugs-by-2026.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9527/korea-to-inject-500-billion-won-into-pharma-sector-aims-to-launch-100-new-drugs-by-2026.html</link>
			<pubDate>Sat, 30 Sep 2017 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/won-9527.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9527/korea-to-inject-500-billion-won-into-pharma-sector-aims-to-launch-100-new-drugs-by-2026.html</guid>
		</item>	
				<item>
			<title>Indivumed partners with cancer research specialist Helomics </title>
			<atom:link href="https://biospectrumasia.com/news/34/9502/indivumed-partners-with-cancer-research-specialist-helomics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9502/indivumed-partners-with-cancer-research-specialist-helomics-.html</link>
			<pubDate>Fri, 22 Sep 2017 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal-9502.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9502/indivumed-partners-with-cancer-research-specialist-helomics-.html</guid>
		</item>	
				<item>
			<title>GSK receives FDA nod for its triple drug inhaler</title>
			<atom:link href="https://biospectrumasia.com/news/34/9500/gsk-receives-fda-nod-for-its-triple-drug-inhaler.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9500/gsk-receives-fda-nod-for-its-triple-drug-inhaler.html</link>
			<pubDate>Thu, 21 Sep 2017 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_stamp-9500.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9500/gsk-receives-fda-nod-for-its-triple-drug-inhaler.html</guid>
		</item>	
				<item>
			<title>Nacimbio signs agreement with MYLAN Laboratories</title>
			<atom:link href="https://biospectrumasia.com/news/34/9484/nacimbio-signs-agreement-with-mylan-laboratories.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9484/nacimbio-signs-agreement-with-mylan-laboratories.html</link>
			<pubDate>Tue, 19 Sep 2017 16:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/document_428335_960_720-9484.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9484/nacimbio-signs-agreement-with-mylan-laboratories.html</guid>
		</item>	
				<item>
			<title>CSL Behring announces FDA approval of Privigen for the treatment of CIDP in adults</title>
			<atom:link href="https://biospectrumasia.com/news/34/9472/csl-behring-announces-fda-approval-of-privigen-for-the-treatment-of-cidp-in-adults.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9472/csl-behring-announces-fda-approval-of-privigen-for-the-treatment-of-cidp-in-adults.html</link>
			<pubDate>Fri, 15 Sep 2017 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rubber_stamp_1560306_960_720-9472.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9472/csl-behring-announces-fda-approval-of-privigen-for-the-treatment-of-cidp-in-adults.html</guid>
		</item>	
				<item>
			<title>Bristol-Myers Squibb collaborates with ENHANZE technology</title>
			<atom:link href="https://biospectrumasia.com/news/34/9467/bristol-myers-squibb-collaborates-with-enhanze-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9467/bristol-myers-squibb-collaborates-with-enhanze-technology.html</link>
			<pubDate>Fri, 15 Sep 2017 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-9467.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9467/bristol-myers-squibb-collaborates-with-enhanze-technology.html</guid>
		</item>	
				<item>
			<title>Invicro acquires Imanova to Expand Global Imaging Capabilities</title>
			<atom:link href="https://biospectrumasia.com/news/34/9456/invicro-acquires-imanova-to-expand-global-imaging-capabilities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9456/invicro-acquires-imanova-to-expand-global-imaging-capabilities.html</link>
			<pubDate>Tue, 12 Sep 2017 18:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal-9456.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9456/invicro-acquires-imanova-to-expand-global-imaging-capabilities.html</guid>
		</item>	
				<item>
			<title>Boehringer collaborates with Gubra to develop next generation obesity treatments </title>
			<atom:link href="https://biospectrumasia.com/news/34/9449/boehringer-collaborates-with-gubra-to-develop-next-generation-obesity-treatments-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9449/boehringer-collaborates-with-gubra-to-develop-next-generation-obesity-treatments-.html</link>
			<pubDate>Mon, 11 Sep 2017 15:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect_20333_1920-9449.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9449/boehringer-collaborates-with-gubra-to-develop-next-generation-obesity-treatments-.html</guid>
		</item>	
				<item>
			<title>Targeted therapy for acute myeloid leukemia </title>
			<atom:link href="https://biospectrumasia.com/news/34/9413/targeted-therapy-for-acute-myeloid-leukemia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9413/targeted-therapy-for-acute-myeloid-leukemia-.html</link>
			<pubDate>Mon, 04 Sep 2017 15:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/food_and_drug_administration_logo_svg-9413.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9413/targeted-therapy-for-acute-myeloid-leukemia-.html</guid>
		</item>	
				<item>
			<title>Korean companies mull on using AI for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/9406/korean-companies-mull-on-using-ai-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9406/korean-companies-mull-on-using-ai-for-drug-discovery.html</link>
			<pubDate>Fri, 01 Sep 2017 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/microscope_275984_960_720-9406.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9406/korean-companies-mull-on-using-ai-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>FDA approved revolutionary immunotherapy for blood cancer patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/9401/fda-approved-revolutionary-immunotherapy-for-blood-cancer-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9401/fda-approved-revolutionary-immunotherapy-for-blood-cancer-patients.html</link>
			<pubDate>Fri, 01 Sep 2017 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-9401.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9401/fda-approved-revolutionary-immunotherapy-for-blood-cancer-patients.html</guid>
		</item>	
				<item>
			<title>Samsung Bioepis jumps into drug development;inks deal with Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/34/9352/samsung-bioepis-jumps-into-drug-developmentinks-deal-with-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9352/samsung-bioepis-jumps-into-drug-developmentinks-deal-with-takeda.html</link>
			<pubDate>Mon, 21 Aug 2017 14:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-9352.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9352/samsung-bioepis-jumps-into-drug-developmentinks-deal-with-takeda.html</guid>
		</item>	
				<item>
			<title>New treatment for adults with relapsed or refractory acute lymphoblastic leukemia </title>
			<atom:link href="https://biospectrumasia.com/news/34/9341/new-treatment-for-adults-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9341/new-treatment-for-adults-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-.html</link>
			<pubDate>Fri, 18 Aug 2017 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/food_and_drug_administration_logo_svg-9341.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9341/new-treatment-for-adults-with-relapsed-or-refractory-acute-lymphoblastic-leukemia-.html</guid>
		</item>	
				<item>
			<title>Swift announces the highest throughput single-cell methyl-seq library preparation method </title>
			<atom:link href="https://biospectrumasia.com/news/34/9321/swift-announces-the-highest-throughput-single-cell-methyl-seq-library-preparation-method-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9321/swift-announces-the-highest-throughput-single-cell-methyl-seq-library-preparation-method-.html</link>
			<pubDate>Mon, 14 Aug 2017 11:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/single_cell-9321.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9321/swift-announces-the-highest-throughput-single-cell-methyl-seq-library-preparation-method-.html</guid>
		</item>	
				<item>
			<title>Speeding up drug discovery process with Artificial Intelligence</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/9314/speeding-up-drug-discovery-process-with-artificial-intelligence.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/9314/speeding-up-drug-discovery-process-with-artificial-intelligence.html</link>
			<pubDate>Thu, 10 Aug 2017 14:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/a_team_photo_no_logo-9314.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/9314/speeding-up-drug-discovery-process-with-artificial-intelligence.html</guid>
		</item>	
				<item>
			<title>Breakthrough immunotherapy for Chronic Hepatitis B virus infection</title>
			<atom:link href="https://biospectrumasia.com/news/34/9301/breakthrough-immunotherapy-for-chronic-hepatitis-b-virus-infection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9301/breakthrough-immunotherapy-for-chronic-hepatitis-b-virus-infection.html</link>
			<pubDate>Tue, 08 Aug 2017 14:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/healthy_human_t_cell-9301.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9301/breakthrough-immunotherapy-for-chronic-hepatitis-b-virus-infection.html</guid>
		</item>	
				<item>
			<title>Xarelto proven to be highly effective stroke prevention in patients with AF</title>
			<atom:link href="https://biospectrumasia.com/news/34/9278/xarelto-proven-to-be-highly-effective-stroke-prevention-in-patients-with-af.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9278/xarelto-proven-to-be-highly-effective-stroke-prevention-in-patients-with-af.html</link>
			<pubDate>Tue, 01 Aug 2017 23:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/10_15_20_3-9278.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9278/xarelto-proven-to-be-highly-effective-stroke-prevention-in-patients-with-af.html</guid>
		</item>	
				<item>
			<title>Takeda, Tesaro ink strategic deal to co-develop and commercialize cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/9273/takeda-tesaro-ink-strategic-deal-to-co-develop-and-commercialize-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9273/takeda-tesaro-ink-strategic-deal-to-co-develop-and-commercialize-cancer-drug.html</link>
			<pubDate>Tue, 01 Aug 2017 16:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947__340-9273.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9273/takeda-tesaro-ink-strategic-deal-to-co-develop-and-commercialize-cancer-drug.html</guid>
		</item>	
				<item>
			<title>CARB-X announces funding to speed treatments for the world&#039;s deadliest super bugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/9267/carb-x-announces-funding-to-speed-treatments-for-the-worlds-deadliest-super-bugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9267/carb-x-announces-funding-to-speed-treatments-for-the-worlds-deadliest-super-bugs.html</link>
			<pubDate>Tue, 01 Aug 2017 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibiotic_sensitvity_and_resistance-9267.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9267/carb-x-announces-funding-to-speed-treatments-for-the-worlds-deadliest-super-bugs.html</guid>
		</item>	
				<item>
			<title>Jim Spavins appointed to the advisory board of Catalent Applied Drug Delivery Institute</title>
			<atom:link href="https://biospectrumasia.com/news/34/9264/jim-spavins-appointed-to-the-advisory-board-of-catalent-applied-drug-delivery-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9264/jim-spavins-appointed-to-the-advisory-board-of-catalent-applied-drug-delivery-institute.html</link>
			<pubDate>Mon, 31 Jul 2017 17:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/appointment-9264.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9264/jim-spavins-appointed-to-the-advisory-board-of-catalent-applied-drug-delivery-institute.html</guid>
		</item>	
				<item>
			<title>FROM TRADITIONAL TO ADVANCED: Drug delivery market on the growth curve in Asia</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/9245/from-traditional-to-advanced-drug-delivery-market-on-the-growth-curve-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/9245/from-traditional-to-advanced-drug-delivery-market-on-the-growth-curve-in-asia.html</link>
			<pubDate>Wed, 26 Jul 2017 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug_delivery_systems_combination_products_design_considerations-9245.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/9245/from-traditional-to-advanced-drug-delivery-market-on-the-growth-curve-in-asia.html</guid>
		</item>	
				<item>
			<title>Korean Pharma Association mulls on use of AI to speed drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/9233/korean-pharma-association-mulls-on-use-of-ai-to-speed-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9233/korean-pharma-association-mulls-on-use-of-ai-to-speed-drug-discovery.html</link>
			<pubDate>Tue, 25 Jul 2017 00:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands_1903104__340-9233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9233/korean-pharma-association-mulls-on-use-of-ai-to-speed-drug-discovery.html</guid>
		</item>	
				<item>
			<title>FDA approves GSK&#039;s new self-injectable formulation for systemic lupus erythematosus</title>
			<atom:link href="https://biospectrumasia.com/news/34/9229/fda-approves-gsks-new-self-injectable-formulation-for-systemic-lupus-erythematosus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9229/fda-approves-gsks-new-self-injectable-formulation-for-systemic-lupus-erythematosus.html</link>
			<pubDate>Mon, 24 Jul 2017 13:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/announce-9229.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9229/fda-approves-gsks-new-self-injectable-formulation-for-systemic-lupus-erythematosus.html</guid>
		</item>	
				<item>
			<title>FDA approves new treatment to reduce the risk of breast cancer returning</title>
			<atom:link href="https://biospectrumasia.com/news/34/9201/fda-approves-new-treatment-to-reduce-the-risk-of-breast-cancer-returning.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9201/fda-approves-new-treatment-to-reduce-the-risk-of-breast-cancer-returning.html</link>
			<pubDate>Tue, 18 Jul 2017 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breakthrough_breast_cancer_logo-9201.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9201/fda-approves-new-treatment-to-reduce-the-risk-of-breast-cancer-returning.html</guid>
		</item>	
				<item>
			<title>U.S. FDA approves Janssen&#039;s TREMFYA for the treatment of moderate to severe plaque psoriasis</title>
			<atom:link href="https://biospectrumasia.com/news/34/9195/u-s-fda-approves-janssens-tremfya-for-the-treatment-of-moderate-to-severe-plaque-psoriasis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9195/u-s-fda-approves-janssens-tremfya-for-the-treatment-of-moderate-to-severe-plaque-psoriasis.html</link>
			<pubDate>Mon, 17 Jul 2017 17:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/640px_unternehmenssitz_janssen_cilag-9195.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9195/u-s-fda-approves-janssens-tremfya-for-the-treatment-of-moderate-to-severe-plaque-psoriasis.html</guid>
		</item>	
				<item>
			<title>Kolon Life Science wins license for gene therapy drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/9192/kolon-life-science-wins-license-for-gene-therapy-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9192/kolon-life-science-wins-license-for-gene-therapy-drug.html</link>
			<pubDate>Mon, 17 Jul 2017 13:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills-9192.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9192/kolon-life-science-wins-license-for-gene-therapy-drug.html</guid>
		</item>	
				<item>
			<title>GSK inks a strategic drug development deal with Exscientia</title>
			<atom:link href="https://biospectrumasia.com/news/34/9136/gsk-inks-a-strategic-drug-development-deal-with-exscientia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9136/gsk-inks-a-strategic-drug-development-deal-with-exscientia.html</link>
			<pubDate>Tue, 04 Jul 2017 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/laboratory_421064__340-9136.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9136/gsk-inks-a-strategic-drug-development-deal-with-exscientia.html</guid>
		</item>	
				<item>
			<title>Exscientia inks â‚¬37m contract with GSK</title>
			<atom:link href="https://biospectrumasia.com/news/34/9130/exscientia-inks-37m-contract-with-gsk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9130/exscientia-inks-37m-contract-with-gsk.html</link>
			<pubDate>Mon, 03 Jul 2017 15:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/deal_1457947_960_720-9130.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9130/exscientia-inks-37m-contract-with-gsk.html</guid>
		</item>	
				<item>
			<title>Promethazine by Strides Shasun approved by USFDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/9129/promethazine-by-strides-shasun-approved-by-usfda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9129/promethazine-by-strides-shasun-approved-by-usfda.html</link>
			<pubDate>Mon, 03 Jul 2017 14:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_151676_960_720-9129.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9129/promethazine-by-strides-shasun-approved-by-usfda.html</guid>
		</item>	
				<item>
			<title>Amgen&#039;s uncontrolled LDL cholesterol lowering drug available in Singapore </title>
			<atom:link href="https://biospectrumasia.com/news/34/9125/amgens-uncontrolled-ldl-cholesterol-lowering-drug-available-in-singapore-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9125/amgens-uncontrolled-ldl-cholesterol-lowering-drug-available-in-singapore-.html</link>
			<pubDate>Mon, 03 Jul 2017 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/human_heart_and_circulatory_system-9125.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9125/amgens-uncontrolled-ldl-cholesterol-lowering-drug-available-in-singapore-.html</guid>
		</item>	
				<item>
			<title>Strategic alliance between Alma Bio Therapeutics and Delphi Genetics on Plasmid DNA drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/9109/strategic-alliance-between-alma-bio-therapeutics-and-delphi-genetics-on-plasmid-dna-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9109/strategic-alliance-between-alma-bio-therapeutics-and-delphi-genetics-on-plasmid-dna-drugs.html</link>
			<pubDate>Tue, 27 Jun 2017 18:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/network_1020332_960_720-9109.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9109/strategic-alliance-between-alma-bio-therapeutics-and-delphi-genetics-on-plasmid-dna-drugs.html</guid>
		</item>	
				<item>
			<title>J&amp;J&#039;s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS program</title>
			<atom:link href="https://biospectrumasia.com/news/34/9103/jjs-type-2-diabetes-drug-invokana-significantly-reduces-major-heart-complications-in-canvas-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9103/jjs-type-2-diabetes-drug-invokana-significantly-reduces-major-heart-complications-in-canvas-program.html</link>
			<pubDate>Tue, 27 Jun 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/download-9103.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9103/jjs-type-2-diabetes-drug-invokana-significantly-reduces-major-heart-complications-in-canvas-program.html</guid>
		</item>	
				<item>
			<title>BioAuxilium completes development of its 100th TR-FRET assay kit </title>
			<atom:link href="https://biospectrumasia.com/news/34/9096/bioauxilium-completes-development-of-its-100th-tr-fret-assay-kit-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9096/bioauxilium-completes-development-of-its-100th-tr-fret-assay-kit-.html</link>
			<pubDate>Fri, 23 Jun 2017 16:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/science_1029385_1280-9096.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9096/bioauxilium-completes-development-of-its-100th-tr-fret-assay-kit-.html</guid>
		</item>	
				<item>
			<title>Major advancement in cell-based influenza vaccine technology by Seqirus</title>
			<atom:link href="https://biospectrumasia.com/news/34/9095/major-advancement-in-cell-based-influenza-vaccine-technology-by-seqirus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9095/major-advancement-in-cell-based-influenza-vaccine-technology-by-seqirus.html</link>
			<pubDate>Fri, 23 Jun 2017 16:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccination_1215279_960_720-9095.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9095/major-advancement-in-cell-based-influenza-vaccine-technology-by-seqirus.html</guid>
		</item>	
				<item>
			<title>New patent issuance for Zyga&#039;s SImmetry Sacroiliac Joint Fusion System</title>
			<atom:link href="https://biospectrumasia.com/news/34/9090/new-patent-issuance-for-zygas-simmetry-sacroiliac-joint-fusion-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9090/new-patent-issuance-for-zygas-simmetry-sacroiliac-joint-fusion-system.html</link>
			<pubDate>Thu, 22 Jun 2017 15:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/knee_bones_lateral-9090.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9090/new-patent-issuance-for-zygas-simmetry-sacroiliac-joint-fusion-system.html</guid>
		</item>	
				<item>
			<title>New antibody for effective blood cancer treatment using two-pronged approach</title>
			<atom:link href="https://biospectrumasia.com/news/34/9089/new-antibody-for-effective-blood-cancer-treatment-using-two-pronged-approach.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9089/new-antibody-for-effective-blood-cancer-treatment-using-two-pronged-approach.html</link>
			<pubDate>Thu, 22 Jun 2017 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer_vs_alzheimer_1080x810-9089.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9089/new-antibody-for-effective-blood-cancer-treatment-using-two-pronged-approach.html</guid>
		</item>	
				<item>
			<title>Sunless tan now a reality!</title>
			<atom:link href="https://biospectrumasia.com/news/34/9085/sunless-tan-now-a-reality.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9085/sunless-tan-now-a-reality.html</link>
			<pubDate>Wed, 21 Jun 2017 13:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vacation_2218989_960_720-9085.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9085/sunless-tan-now-a-reality.html</guid>
		</item>	
				<item>
			<title>A type-2 diabetes drug found to reduce heart and kidney risk</title>
			<atom:link href="https://biospectrumasia.com/news/34/9084/a-type-2-diabetes-drug-found-to-reduce-heart-and-kidney-risk.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9084/a-type-2-diabetes-drug-found-to-reduce-heart-and-kidney-risk.html</link>
			<pubDate>Wed, 21 Jun 2017 13:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes_1326964__340-9084.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9084/a-type-2-diabetes-drug-found-to-reduce-heart-and-kidney-risk.html</guid>
		</item>	
				<item>
			<title>Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)</title>
			<atom:link href="https://biospectrumasia.com/news/34/9075/enzychem-lifesciences-announces-global-phase-2-trial-inititation-of-ec-18-in-patients-with-chemotherapy-induced-neutropeniacin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9075/enzychem-lifesciences-announces-global-phase-2-trial-inititation-of-ec-18-in-patients-with-chemotherapy-induced-neutropeniacin.html</link>
			<pubDate>Tue, 20 Jun 2017 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/announcement_1019756_960_720-9075.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9075/enzychem-lifesciences-announces-global-phase-2-trial-inititation-of-ec-18-in-patients-with-chemotherapy-induced-neutropeniacin.html</guid>
		</item>	
				<item>
			<title>NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine </title>
			<atom:link href="https://biospectrumasia.com/news/34/9074/nanobio-and-porton-biopharma-receive-approval-to-advance-anthrax-vaccine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9074/nanobio-and-porton-biopharma-receive-approval-to-advance-anthrax-vaccine-.html</link>
			<pubDate>Tue, 20 Jun 2017 15:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anthrax_spores-9074.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9074/nanobio-and-porton-biopharma-receive-approval-to-advance-anthrax-vaccine-.html</guid>
		</item>	
				<item>
			<title>New, long-acting insulin therapy demonstrates Cardiovascular Safety</title>
			<atom:link href="https://biospectrumasia.com/news/34/9038/new-long-acting-insulin-therapy-demonstrates-cardiovascular-safety.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9038/new-long-acting-insulin-therapy-demonstrates-cardiovascular-safety.html</link>
			<pubDate>Tue, 13 Jun 2017 01:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes_528678_960_720-9038.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9038/new-long-acting-insulin-therapy-demonstrates-cardiovascular-safety.html</guid>
		</item>	
				<item>
			<title>A translational research collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/34/9029/a-translational-research-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9029/a-translational-research-collaboration.html</link>
			<pubDate>Fri, 09 Jun 2017 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-9029.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9029/a-translational-research-collaboration.html</guid>
		</item>	
				<item>
			<title>BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.</title>
			<atom:link href="https://biospectrumasia.com/news/34/9012/bd-receives-fda-510k-clearance-for-molecular-test-of-acute-gastroenteritis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/9012/bd-receives-fda-510k-clearance-for-molecular-test-of-acute-gastroenteritis-.html</link>
			<pubDate>Mon, 05 Jun 2017 20:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved_1_-9012.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/9012/bd-receives-fda-510k-clearance-for-molecular-test-of-acute-gastroenteritis-.html</guid>
		</item>	
				<item>
			<title>Trends in Drug Discovery Outsourcing: A Perspective</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/8998/trends-in-drug-discovery-outsourcing-a-perspective.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/8998/trends-in-drug-discovery-outsourcing-a-perspective.html</link>
			<pubDate>Fri, 02 Jun 2017 14:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr_subir_gvk_bio-8998.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/8998/trends-in-drug-discovery-outsourcing-a-perspective.html</guid>
		</item>	
				<item>
			<title>FDA approves new Novo Nordisk treatment for patients with Hemophilia</title>
			<atom:link href="https://biospectrumasia.com/news/34/8989/fda-approves-new-novo-nordisk-treatment-for-patients-with-hemophilia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8989/fda-approves-new-novo-nordisk-treatment-for-patients-with-hemophilia.html</link>
			<pubDate>Thu, 01 Jun 2017 12:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/1024px_variouspills-8989.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8989/fda-approves-new-novo-nordisk-treatment-for-patients-with-hemophilia.html</guid>
		</item>	
				<item>
			<title>Biogen acquires Remedy Pharmaceuticals&#039; late stage drug CIRARA</title>
			<atom:link href="https://biospectrumasia.com/news/34/8950/biogen-acquires-remedy-pharmaceuticals-late-stage-drug-cirara.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8950/biogen-acquires-remedy-pharmaceuticals-late-stage-drug-cirara.html</link>
			<pubDate>Tue, 23 May 2017 17:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/acquire-8950.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8950/biogen-acquires-remedy-pharmaceuticals-late-stage-drug-cirara.html</guid>
		</item>	
				<item>
			<title>Symic Bio Secures $30 Million Series B financingÂ </title>
			<atom:link href="https://biospectrumasia.com/news/34/8947/symic-bio-secures-30-million-series-b-financing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8947/symic-bio-secures-30-million-series-b-financing.html</link>
			<pubDate>Tue, 23 May 2017 15:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fund-8947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8947/symic-bio-secures-30-million-series-b-financing.html</guid>
		</item>	
				<item>
			<title>FDA approves first new drug for ALS  in 2 decades</title>
			<atom:link href="https://biospectrumasia.com/news/34/8880/fda-approves-first-new-drug-for-als-in-2-decades.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8880/fda-approves-first-new-drug-for-als-in-2-decades.html</link>
			<pubDate>Thu, 11 May 2017 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_logo-8880.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8880/fda-approves-first-new-drug-for-als-in-2-decades.html</guid>
		</item>	
				<item>
			<title>Sanofi enters into a $273 mn research deal with Exscientia</title>
			<atom:link href="https://biospectrumasia.com/news/34/8881/sanofi-enters-into-a-273-mn-research-deal-with-exscientia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8881/sanofi-enters-into-a-273-mn-research-deal-with-exscientia.html</link>
			<pubDate>Wed, 10 May 2017 16:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-8881.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8881/sanofi-enters-into-a-273-mn-research-deal-with-exscientia.html</guid>
		</item>	
				<item>
			<title>A new drug for diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/34/8855/a-new-drug-for-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8855/a-new-drug-for-diabetes.html</link>
			<pubDate>Tue, 02 May 2017 16:28:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hand_1106934_960_720-8855.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8855/a-new-drug-for-diabetes.html</guid>
		</item>	
				<item>
			<title>Foamix Pharmaceuticals Ltd. completed Phase 3 trials for FMX101 </title>
			<atom:link href="https://biospectrumasia.com/news/34/8854/foamix-pharmaceuticals-ltd-completed-phase-3-trials-for-fmx101-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8854/foamix-pharmaceuticals-ltd-completed-phase-3-trials-for-fmx101-.html</link>
			<pubDate>Tue, 02 May 2017 16:11:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe_1884784_960_720-8854.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8854/foamix-pharmaceuticals-ltd-completed-phase-3-trials-for-fmx101-.html</guid>
		</item>	
				<item>
			<title>Novel antibiotic resistance gene found in milk </title>
			<atom:link href="https://biospectrumasia.com/news/34/8845/novel-antibiotic-resistance-gene-found-in-milk-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8845/novel-antibiotic-resistance-gene-found-in-milk-.html</link>
			<pubDate>Mon, 01 May 2017 18:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cowpills-8845.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8845/novel-antibiotic-resistance-gene-found-in-milk-.html</guid>
		</item>	
				<item>
			<title>Glenmark initiates clinical investigation for respiratory drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/8836/glenmark-initiates-clinical-investigation-for-respiratory-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8836/glenmark-initiates-clinical-investigation-for-respiratory-drug.html</link>
			<pubDate>Fri, 28 Apr 2017 12:20:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/glenmark1-8836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8836/glenmark-initiates-clinical-investigation-for-respiratory-drug.html</guid>
		</item>	
				<item>
			<title>Asceneuron gets regulatory approval to initiate clinical trial of new drug candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/8803/asceneuron-gets-regulatory-approval-to-initiate-clinical-trial-of-new-drug-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8803/asceneuron-gets-regulatory-approval-to-initiate-clinical-trial-of-new-drug-candidate.html</link>
			<pubDate>Fri, 07 Apr 2017 12:19:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8803/asceneuron-gets-regulatory-approval-to-initiate-clinical-trial-of-new-drug-candidate.html</guid>
		</item>	
				<item>
			<title>Licensing agreement announced for sutezolid drug for TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/8785/licensing-agreement-announced-for-sutezolid-drug-for-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8785/licensing-agreement-announced-for-sutezolid-drug-for-tb.html</link>
			<pubDate>Fri, 24 Mar 2017 16:04:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tuberculosis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8785/licensing-agreement-announced-for-sutezolid-drug-for-tb.html</guid>
		</item>	
				<item>
			<title> Astex Pharma cancer drug receives US marketing approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/8768/-astex-pharma-cancer-drug-receives-us-marketing-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8768/-astex-pharma-cancer-drug-receives-us-marketing-approval.html</link>
			<pubDate>Tue, 14 Mar 2017 15:25:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approved-160120-150.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8768/-astex-pharma-cancer-drug-receives-us-marketing-approval.html</guid>
		</item>	
				<item>
			<title>Chugai receives Taiwan nod for Alecensa</title>
			<atom:link href="https://biospectrumasia.com/news/34/8739/chugai-receives-taiwan-nod-for-alecensa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8739/chugai-receives-taiwan-nod-for-alecensa.html</link>
			<pubDate>Mon, 27 Feb 2017 14:15:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/thumb-108660-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8739/chugai-receives-taiwan-nod-for-alecensa.html</guid>
		</item>	
				<item>
			<title>Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102</title>
			<atom:link href="https://biospectrumasia.com/news/34/64/minoryx-therapeutics-receives-orphan-drug-designation-for-its-lead-candidate-min-102.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/64/minoryx-therapeutics-receives-orphan-drug-designation-for-its-lead-candidate-min-102.html</link>
			<pubDate>Wed, 22 Feb 2017 16:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda_approved-64.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/64/minoryx-therapeutics-receives-orphan-drug-designation-for-its-lead-candidate-min-102.html</guid>
		</item>	
				<item>
			<title>Apollo Therapeutics launched the first drug discovery programme</title>
			<atom:link href="https://biospectrumasia.com/news/34/63/apollo-therapeutics-launched-the-first-drug-discovery-programme.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/63/apollo-therapeutics-launched-the-first-drug-discovery-programme.html</link>
			<pubDate>Wed, 22 Feb 2017 14:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-63.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/63/apollo-therapeutics-launched-the-first-drug-discovery-programme.html</guid>
		</item>	
				<item>
			<title>TimeBlock - to reverse biological ageing launches in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/8732/timeblock-to-reverse-biological-ageing-launches-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8732/timeblock-to-reverse-biological-ageing-launches-in-singapore.html</link>
			<pubDate>Mon, 20 Feb 2017 12:49:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aging-hands.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8732/timeblock-to-reverse-biological-ageing-launches-in-singapore.html</guid>
		</item>	
				<item>
			<title>New CoolPal Vertos Advance launched by Pelican BioThermal</title>
			<atom:link href="https://biospectrumasia.com/news/34/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html</link>
			<pubDate>Thu, 19 Jan 2017 15:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pelican_biothermal_logo_262x174-55.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/55/new-coolpal-vertos-advance-launched-by-pelican-biothermal.html</guid>
		</item>	
				<item>
			<title>According to GBI Research, the growth will primarily be driven by the emergence of novel therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/54/according-to-gbi-research-the-growth-will-primarily-be-driven-by-the-emergence-of-novel-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/54/according-to-gbi-research-the-growth-will-primarily-be-driven-by-the-emergence-of-novel-therapeutics.html</link>
			<pubDate>Thu, 19 Jan 2017 13:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scan_262x174-54.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/54/according-to-gbi-research-the-growth-will-primarily-be-driven-by-the-emergence-of-novel-therapeutics.html</guid>
		</item>	
				<item>
			<title>Australia approves drug that can &#039;melt away&#039; cancer cells</title>
			<atom:link href="https://biospectrumasia.com/news/34/8682/australia-approves-drug-that-can-melt-away-cancer-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8682/australia-approves-drug-that-can-melt-away-cancer-cells.html</link>
			<pubDate>Tue, 10 Jan 2017 18:17:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100279666.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8682/australia-approves-drug-that-can-melt-away-cancer-cells.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin</title>
			<atom:link href="https://biospectrumasia.com/news/34/8647/boehringer-ingelheim-bevacizumab-biosimilar-candidate-demonstrates-bioequivalence-to-avastin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8647/boehringer-ingelheim-bevacizumab-biosimilar-candidate-demonstrates-bioequivalence-to-avastin.html</link>
			<pubDate>Wed, 23 Nov 2016 13:20:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100187469.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8647/boehringer-ingelheim-bevacizumab-biosimilar-candidate-demonstrates-bioequivalence-to-avastin.html</guid>
		</item>	
				<item>
			<title>NUS scientists discover the switch that makes breast cancer cells aggressive</title>
			<atom:link href="https://biospectrumasia.com/news/34/8623/nus-scientists-discover-the-switch-that-makes-breast-cancer-cells-aggressive.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8623/nus-scientists-discover-the-switch-that-makes-breast-cancer-cells-aggressive.html</link>
			<pubDate>Wed, 02 Nov 2016 13:46:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100288979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8623/nus-scientists-discover-the-switch-that-makes-breast-cancer-cells-aggressive.html</guid>
		</item>	
				<item>
			<title>&quot;Prevalence of COPD in Asia is similar to western countries&quot;</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/8619/prevalence-of-copd-in-asia-is-similar-to-western-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/8619/prevalence-of-copd-in-asia-is-similar-to-western-countries.html</link>
			<pubDate>Thu, 27 Oct 2016 11:31:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prof-norbert-berend-cropped.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/8619/prevalence-of-copd-in-asia-is-similar-to-western-countries.html</guid>
		</item>	
				<item>
			<title>Singapore develops oral-anti-diabetic drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/8609/singapore-develops-oral-anti-diabetic-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8609/singapore-develops-oral-anti-diabetic-drug-.html</link>
			<pubDate>Fri, 21 Oct 2016 09:13:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13593-np0cnt.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8609/singapore-develops-oral-anti-diabetic-drug-.html</guid>
		</item>	
				<item>
			<title>South Korea&#039;s Hanmi pharmaceuticals in troubled waters!</title>
			<atom:link href="https://biospectrumasia.com/news/34/8591/south-koreas-hanmi-pharmaceuticals-in-troubled-waters.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8591/south-koreas-hanmi-pharmaceuticals-in-troubled-waters.html</link>
			<pubDate>Fri, 14 Oct 2016 14:02:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/road-sign-1274312-960-720.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8591/south-koreas-hanmi-pharmaceuticals-in-troubled-waters.html</guid>
		</item>	
				<item>
			<title>Renowned neurologist, Allen Roses, passes away</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/8580/renowned-neurologist-allen-roses-passes-away.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/8580/renowned-neurologist-allen-roses-passes-away.html</link>
			<pubDate>Wed, 05 Oct 2016 09:58:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13113-2-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/8580/renowned-neurologist-allen-roses-passes-away.html</guid>
		</item>	
				<item>
			<title>&quot;We are looking to collaborate with visionary research institutes to develop new methods of discovering cancer&quot;</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/8581/we-are-looking-to-collaborate-with-visionary-research-institutes-to-develop-new-methods-of-discovering-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/8581/we-are-looking-to-collaborate-with-visionary-research-institutes-to-develop-new-methods-of-discovering-cancer.html</link>
			<pubDate>Tue, 04 Oct 2016 09:59:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/castro-perez-cropped.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/8581/we-are-looking-to-collaborate-with-visionary-research-institutes-to-develop-new-methods-of-discovering-cancer.html</guid>
		</item>	
				<item>
			<title>Australia changes drug approval norms to speed up approval process</title>
			<atom:link href="https://biospectrumasia.com/news/34/8558/australia-changes-drug-approval-norms-to-speed-up-approval-process.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8558/australia-changes-drug-approval-norms-to-speed-up-approval-process.html</link>
			<pubDate>Wed, 21 Sep 2016 14:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10082836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8558/australia-changes-drug-approval-norms-to-speed-up-approval-process.html</guid>
		</item>	
				<item>
			<title>Semaglutide reduces risk of cardiovascular problems among type 2 Diabetic patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/8550/semaglutide-reduces-risk-of-cardiovascular-problems-among-type-2-diabetic-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8550/semaglutide-reduces-risk-of-cardiovascular-problems-among-type-2-diabetic-patients.html</link>
			<pubDate>Mon, 19 Sep 2016 16:30:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-american-college-of-cardiology-educational-program-to-rectify-misunderstandings-on-stroke-prevention-in-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8550/semaglutide-reduces-risk-of-cardiovascular-problems-among-type-2-diabetic-patients.html</guid>
		</item>	
				<item>
			<title>Eisai receives license for new indication for anticancer agent Kisplyx </title>
			<atom:link href="https://biospectrumasia.com/news/34/8546/eisai-receives-license-for-new-indication-for-anticancer-agent-kisplyx-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8546/eisai-receives-license-for-new-indication-for-anticancer-agent-kisplyx-.html</link>
			<pubDate>Thu, 15 Sep 2016 10:03:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/green-156711-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8546/eisai-receives-license-for-new-indication-for-anticancer-agent-kisplyx-.html</guid>
		</item>	
				<item>
			<title>Singapore develops new protein to alter DNA in living cells</title>
			<atom:link href="https://biospectrumasia.com/news/34/8542/singapore-develops-new-protein-to-alter-dna-in-living-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8542/singapore-develops-new-protein-to-alter-dna-in-living-cells.html</link>
			<pubDate>Wed, 14 Sep 2016 13:03:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/doctor-563429-1920.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8542/singapore-develops-new-protein-to-alter-dna-in-living-cells.html</guid>
		</item>	
				<item>
			<title>Bayer recognizes innovation by Korean start-up</title>
			<atom:link href="https://biospectrumasia.com/news/34/1159/bayer-recognizes-innovation-by-korean-start-up.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1159/bayer-recognizes-innovation-by-korean-start-up.html</link>
			<pubDate>Tue, 30 Aug 2016 10:46:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vital-smith-grants4apps-accelerator-award-event1-002.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1159/bayer-recognizes-innovation-by-korean-start-up.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher Scientific celebrates 20th year in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/1113/thermo-fisher-scientific-celebrates-20th-year-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1113/thermo-fisher-scientific-celebrates-20th-year-in-singapore.html</link>
			<pubDate>Tue, 30 Aug 2016 10:16:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/13593-np0cnt.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1113/thermo-fisher-scientific-celebrates-20th-year-in-singapore.html</guid>
		</item>	
				<item>
			<title>Glenmark receives ANDA approval for Nystatin, Triamcinolone Acetonide ointment</title>
			<atom:link href="https://biospectrumasia.com/news/34/8492/glenmark-receives-anda-approval-for-nystatin-triamcinolone-acetonide-ointment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8492/glenmark-receives-anda-approval-for-nystatin-triamcinolone-acetonide-ointment.html</link>
			<pubDate>Mon, 08 Aug 2016 12:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approved-logo-blue11.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8492/glenmark-receives-anda-approval-for-nystatin-triamcinolone-acetonide-ointment.html</guid>
		</item>	
				<item>
			<title>Systems Toxicology Computational Challenge explores toxicant prediction </title>
			<atom:link href="https://biospectrumasia.com/news/34/8230/systems-toxicology-computational-challenge-explores-toxicant-prediction-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8230/systems-toxicology-computational-challenge-explores-toxicant-prediction-.html</link>
			<pubDate>Wed, 20 Jul 2016 14:13:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100288979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8230/systems-toxicology-computational-challenge-explores-toxicant-prediction-.html</guid>
		</item>	
				<item>
			<title>Hironic to begin world&#039;s first HIFU Urinary Incontinence treatment study in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/4482/hironic-to-begin-worlds-first-hifu-urinary-incontinence-treatment-study-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4482/hironic-to-begin-worlds-first-hifu-urinary-incontinence-treatment-study-in-japan.html</link>
			<pubDate>Mon, 27 Jun 2016 11:06:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100288979.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4482/hironic-to-begin-worlds-first-hifu-urinary-incontinence-treatment-study-in-japan.html</guid>
		</item>	
				<item>
			<title>FDA approves Lupin&#039;s new generic</title>
			<atom:link href="https://biospectrumasia.com/news/34/8417/fda-approves-lupins-new-generic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8417/fda-approves-lupins-new-generic.html</link>
			<pubDate>Thu, 23 Jun 2016 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100271228.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8417/fda-approves-lupins-new-generic.html</guid>
		</item>	
				<item>
			<title>San Diego&#039;s TNK Therapeutics inks deal with a Chinese firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/42/san-diegos-tnk-therapeutics-inks-deal-with-a-chinese-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/42/san-diegos-tnk-therapeutics-inks-deal-with-a-chinese-firm.html</link>
			<pubDate>Sat, 18 Jun 2016 06:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id_100110956_100x71-42.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/42/san-diegos-tnk-therapeutics-inks-deal-with-a-chinese-firm.html</guid>
		</item>	
				<item>
			<title>Charleston Laboratories, Daiichi Sankyo receives FDA acceptance for CL-108 NDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/7773/charleston-laboratories-daiichi-sankyo-receives-fda-acceptance-for-cl-108-nda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7773/charleston-laboratories-daiichi-sankyo-receives-fda-acceptance-for-cl-108-nda.html</link>
			<pubDate>Tue, 14 Jun 2016 11:50:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-accepts-ind-of-jubilant-biosys-and-endo-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7773/charleston-laboratories-daiichi-sankyo-receives-fda-acceptance-for-cl-108-nda.html</guid>
		</item>	
				<item>
			<title>Excelra, H M Pharma to expand Drug Repurposing Solutions outreach in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/4126/excelra-h-m-pharma-to-expand-drug-repurposing-solutions-outreach-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4126/excelra-h-m-pharma-to-expand-drug-repurposing-solutions-outreach-in-europe.html</link>
			<pubDate>Tue, 24 May 2016 12:10:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-342481-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4126/excelra-h-m-pharma-to-expand-drug-repurposing-solutions-outreach-in-europe.html</guid>
		</item>	
				<item>
			<title>Australian researchers find key gene behind Type 2 Diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/34/7768/australian-researchers-find-key-gene-behind-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7768/australian-researchers-find-key-gene-behind-type-2-diabetes.html</link>
			<pubDate>Mon, 23 May 2016 11:27:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100253650-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7768/australian-researchers-find-key-gene-behind-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>Regeneus clears procedures to initiate Progenza trial for osteoarthritis treatment </title>
			<atom:link href="https://biospectrumasia.com/news/34/6222/regeneus-clears-procedures-to-initiate-progenza-trial-for-osteoarthritis-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6222/regeneus-clears-procedures-to-initiate-progenza-trial-for-osteoarthritis-treatment-.html</link>
			<pubDate>Tue, 17 May 2016 11:27:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10016847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6222/regeneus-clears-procedures-to-initiate-progenza-trial-for-osteoarthritis-treatment-.html</guid>
		</item>	
				<item>
			<title>FDA approves additional indication of Eisai&#039;s anticancer agent Lenvima </title>
			<atom:link href="https://biospectrumasia.com/news/34/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html</link>
			<pubDate>Tue, 17 May 2016 11:23:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7092/fda-approves-additional-indication-of-eisais-anticancer-agent-lenvima-.html</guid>
		</item>	
				<item>
			<title>Chugai gets positive outcome from Actemra Subcutaneous Injection trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html</link>
			<pubDate>Tue, 17 May 2016 11:20:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mark-43729-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8428/chugai-gets-positive-outcome-from-actemra-subcutaneous-injection-trials.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Invitrocue initiates research on Malaria </title>
			<atom:link href="https://biospectrumasia.com/news/34/7035/australias-invitrocue-initiates-research-on-malaria-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7035/australias-invitrocue-initiates-research-on-malaria-.html</link>
			<pubDate>Mon, 16 May 2016 11:07:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10052603.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7035/australias-invitrocue-initiates-research-on-malaria-.html</guid>
		</item>	
				<item>
			<title>Rock Creek granted Japanese, European, US Patent for lead compound</title>
			<atom:link href="https://biospectrumasia.com/news/34/8047/rock-creek-granted-japanese-european-us-patent-for-lead-compound.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8047/rock-creek-granted-japanese-european-us-patent-for-lead-compound.html</link>
			<pubDate>Fri, 06 May 2016 09:46:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/israel-based-d-pharm-recieved-patent-in-the-us-and-china-for-thr-18-a-synthetic-therapeutic-peptide-used-in-thromboembolic-diseases-and-pathological-conditions-associated-with-neurological-damage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8047/rock-creek-granted-japanese-european-us-patent-for-lead-compound.html</guid>
		</item>	
				<item>
			<title>Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html</link>
			<pubDate>Tue, 03 May 2016 10:01:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8421/prosetta-biosciences-takeda-to-co-discover-drugs-for-neurodegenerative-diseases.html</guid>
		</item>	
				<item>
			<title>Prima BioMed&#039;s immunotherapeutic drug secures Japanese patent</title>
			<atom:link href="https://biospectrumasia.com/news/34/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html</link>
			<pubDate>Tue, 03 May 2016 09:58:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/resmed-wins-patent-case-against-china-firm-in-germany.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6514/prima-biomeds-immunotherapeutic-drug-secures-japanese-patent.html</guid>
		</item>	
				<item>
			<title>Novogen&#039;s ovarian cancer drug set for trials in H1 2016 </title>
			<atom:link href="https://biospectrumasia.com/news/34/8258/novogens-ovarian-cancer-drug-set-for-trials-in-h1-2016-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8258/novogens-ovarian-cancer-drug-set-for-trials-in-h1-2016-.html</link>
			<pubDate>Tue, 03 May 2016 09:53:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-257344-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8258/novogens-ovarian-cancer-drug-set-for-trials-in-h1-2016-.html</guid>
		</item>	
				<item>
			<title>Ignyta acquires Teva&#039;s upcoming oncology program at $41.6 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/5359/ignyta-acquires-tevas-upcoming-oncology-program-at-41-6-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5359/ignyta-acquires-tevas-upcoming-oncology-program-at-41-6-mn.html</link>
			<pubDate>Sun, 24 Apr 2016 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/waters.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5359/ignyta-acquires-tevas-upcoming-oncology-program-at-41-6-mn.html</guid>
		</item>	
				<item>
			<title>Asia&#039;s lung cancer burden</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/8213/asias-lung-cancer-burden.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/8213/asias-lung-cancer-burden.html</link>
			<pubDate>Fri, 08 Apr 2016 11:23:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/8213/asias-lung-cancer-burden.html</guid>
		</item>	
				<item>
			<title>Glenmark receives two ANDA approvals from the FDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/2588/glenmark-receives-two-anda-approvals-from-the-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2588/glenmark-receives-two-anda-approvals-from-the-fda.html</link>
			<pubDate>Tue, 29 Mar 2016 12:09:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100294534.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2588/glenmark-receives-two-anda-approvals-from-the-fda.html</guid>
		</item>	
				<item>
			<title>HUYA Bioscience partners with Fudan University</title>
			<atom:link href="https://biospectrumasia.com/news/34/5812/huya-bioscience-partners-with-fudan-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5812/huya-bioscience-partners-with-fudan-university.html</link>
			<pubDate>Tue, 15 Mar 2016 14:51:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/connect-20333-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5812/huya-bioscience-partners-with-fudan-university.html</guid>
		</item>	
				<item>
			<title>Gilead&#039;s cancer drug under FDA scrutiny</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/8289/gileads-cancer-drug-under-fda-scrutiny.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/8289/gileads-cancer-drug-under-fda-scrutiny.html</link>
			<pubDate>Tue, 15 Mar 2016 14:50:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/8289/gileads-cancer-drug-under-fda-scrutiny.html</guid>
		</item>	
				<item>
			<title>Korea&#039;s ImmunoMet raises $5.2 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/7421/koreas-immunomet-raises-5-2-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7421/koreas-immunomet-raises-5-2-mn.html</link>
			<pubDate>Mon, 14 Mar 2016 11:29:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7421/koreas-immunomet-raises-5-2-mn.html</guid>
		</item>	
				<item>
			<title>Celsion launches cancer drug trial in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/7926/celsion-launches-cancer-drug-trial-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7926/celsion-launches-cancer-drug-trial-in-china.html</link>
			<pubDate>Tue, 08 Mar 2016 15:04:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7926/celsion-launches-cancer-drug-trial-in-china.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s constipation drug phase III study shows significant improvement </title>
			<atom:link href="https://biospectrumasia.com/news/34/7993/shionogis-constipation-drug-phase-iii-study-shows-significant-improvement-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7993/shionogis-constipation-drug-phase-iii-study-shows-significant-improvement-.html</link>
			<pubDate>Mon, 22 Feb 2016 11:56:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10030917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7993/shionogis-constipation-drug-phase-iii-study-shows-significant-improvement-.html</guid>
		</item>	
				<item>
			<title>FDA breakthrough for Roche&#039;s MS drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6540/fda-breakthrough-for-roches-ms-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6540/fda-breakthrough-for-roches-ms-drug.html</link>
			<pubDate>Fri, 19 Feb 2016 12:36:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6540/fda-breakthrough-for-roches-ms-drug.html</guid>
		</item>	
				<item>
			<title>Sosei&#039; subsidiary Heptares records positive outcome of Schizophrenia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/8158/sosei-subsidiary-heptares-records-positive-outcome-of-schizophrenia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8158/sosei-subsidiary-heptares-records-positive-outcome-of-schizophrenia-drug.html</link>
			<pubDate>Fri, 12 Feb 2016 12:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8158/sosei-subsidiary-heptares-records-positive-outcome-of-schizophrenia-drug.html</guid>
		</item>	
				<item>
			<title>University of Dundee, Ono Pharma to collaborate on drug research</title>
			<atom:link href="https://biospectrumasia.com/news/34/8229/university-of-dundee-ono-pharma-to-collaborate-on-drug-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8229/university-of-dundee-ono-pharma-to-collaborate-on-drug-research.html</link>
			<pubDate>Thu, 11 Feb 2016 11:30:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8229/university-of-dundee-ono-pharma-to-collaborate-on-drug-research.html</guid>
		</item>	
				<item>
			<title>Minerva derives positive outcome of Insomnia drug study in Japanese patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/7862/minerva-derives-positive-outcome-of-insomnia-drug-study-in-japanese-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7862/minerva-derives-positive-outcome-of-insomnia-drug-study-in-japanese-patients.html</link>
			<pubDate>Tue, 02 Feb 2016 11:29:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100128764.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7862/minerva-derives-positive-outcome-of-insomnia-drug-study-in-japanese-patients.html</guid>
		</item>	
				<item>
			<title>China&#039;s Adagene raises $28 million</title>
			<atom:link href="https://biospectrumasia.com/news/34/6473/chinas-adagene-raises-28-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6473/chinas-adagene-raises-28-million.html</link>
			<pubDate>Mon, 01 Feb 2016 13:59:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211120.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6473/chinas-adagene-raises-28-million.html</guid>
		</item>	
				<item>
			<title>Takeda gets NDA approval for VAXEM Hib vaccine in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/8242/takeda-gets-nda-approval-for-vaxem-hib-vaccine-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8242/takeda-gets-nda-approval-for-vaxem-hib-vaccine-in-japan.html</link>
			<pubDate>Mon, 01 Feb 2016 11:31:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10030917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8242/takeda-gets-nda-approval-for-vaxem-hib-vaccine-in-japan.html</guid>
		</item>	
				<item>
			<title>Eisai submits Lenvatinib&#039;s new application in Europe </title>
			<atom:link href="https://biospectrumasia.com/news/34/7166/eisai-submits-lenvatinibs-new-application-in-europe-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7166/eisai-submits-lenvatinibs-new-application-in-europe-.html</link>
			<pubDate>Wed, 13 Jan 2016 12:13:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7166/eisai-submits-lenvatinibs-new-application-in-europe-.html</guid>
		</item>	
				<item>
			<title>China&#039;s Zai Lab raises $100mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/8275/chinas-zai-lab-raises-100mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8275/chinas-zai-lab-raises-100mn.html</link>
			<pubDate>Mon, 11 Jan 2016 12:22:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100170733.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8275/chinas-zai-lab-raises-100mn.html</guid>
		</item>	
				<item>
			<title>Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/7887/jubilant-biosys-collaborates-with-sanofi-to-develop-metabolic-disorders-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7887/jubilant-biosys-collaborates-with-sanofi-to-develop-metabolic-disorders-therapy.html</link>
			<pubDate>Mon, 11 Jan 2016 12:21:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088852.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7887/jubilant-biosys-collaborates-with-sanofi-to-develop-metabolic-disorders-therapy.html</guid>
		</item>	
				<item>
			<title>Takeda, Enterome ink drug discovery collaboration </title>
			<atom:link href="https://biospectrumasia.com/news/34/7093/takeda-enterome-ink-drug-discovery-collaboration-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7093/takeda-enterome-ink-drug-discovery-collaboration-.html</link>
			<pubDate>Fri, 08 Jan 2016 12:11:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-liposome-company-nce.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7093/takeda-enterome-ink-drug-discovery-collaboration-.html</guid>
		</item>	
				<item>
			<title>ASLAN raises $43 mn in series C financing round</title>
			<atom:link href="https://biospectrumasia.com/news/34/4479/aslan-raises-43-mn-in-series-c-financing-round.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4479/aslan-raises-43-mn-in-series-c-financing-round.html</link>
			<pubDate>Thu, 07 Jan 2016 10:47:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100183758.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4479/aslan-raises-43-mn-in-series-c-financing-round.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s Gordagen forays into Japan with Matsumoto&#039;s support </title>
			<atom:link href="https://biospectrumasia.com/news/34/8244/australias-gordagen-forays-into-japan-with-matsumotos-support-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8244/australias-gordagen-forays-into-japan-with-matsumotos-support-.html</link>
			<pubDate>Wed, 06 Jan 2016 11:26:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8244/australias-gordagen-forays-into-japan-with-matsumotos-support-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Korea, Daewoong Pharma to co-promote oral anti-coagulant in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/34/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html</link>
			<pubDate>Mon, 28 Dec 2015 10:28:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-big-question-to-collaborate-or-not-to.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6979/daiichi-sankyo-korea-daewoong-pharma-to-co-promote-oral-anti-coagulant-in-korea.html</guid>
		</item>	
				<item>
			<title>Pluristem secures Japan&#039;s PMDA nod on regenerative drug trial protocol</title>
			<atom:link href="https://biospectrumasia.com/news/34/8464/pluristem-secures-japans-pmda-nod-on-regenerative-drug-trial-protocol.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8464/pluristem-secures-japans-pmda-nod-on-regenerative-drug-trial-protocol.html</link>
			<pubDate>Tue, 22 Dec 2015 12:28:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10016847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8464/pluristem-secures-japans-pmda-nod-on-regenerative-drug-trial-protocol.html</guid>
		</item>	
				<item>
			<title>CSL Behring seeks Japan PMDA approval for Hemophilia drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html</link>
			<pubDate>Tue, 22 Dec 2015 12:18:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7781/csl-behring-seeks-japan-pmda-approval-for-hemophilia-drug-.html</guid>
		</item>	
				<item>
			<title>Singapore scientists find new clues on cervical cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/5237/singapore-scientists-find-new-clues-on-cervical-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5237/singapore-scientists-find-new-clues-on-cervical-cancer.html</link>
			<pubDate>Wed, 09 Dec 2015 10:46:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5237/singapore-scientists-find-new-clues-on-cervical-cancer.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s Aslan secures $34 mn funding</title>
			<atom:link href="https://biospectrumasia.com/news/34/4774/singapores-aslan-secures-34-mn-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4774/singapores-aslan-secures-34-mn-funding.html</link>
			<pubDate>Wed, 09 Dec 2015 10:44:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4774/singapores-aslan-secures-34-mn-funding.html</guid>
		</item>	
				<item>
			<title>Japanese stem cell company ReproCELL acquires Biopta</title>
			<atom:link href="https://biospectrumasia.com/news/34/7970/japanese-stem-cell-company-reprocell-acquires-biopta.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7970/japanese-stem-cell-company-reprocell-acquires-biopta.html</link>
			<pubDate>Thu, 26 Nov 2015 11:28:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-acquires-costim.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7970/japanese-stem-cell-company-reprocell-acquires-biopta.html</guid>
		</item>	
				<item>
			<title>Strides Shasun receives USFDA approval for  Dutasteride Softgel Capsule</title>
			<atom:link href="https://biospectrumasia.com/news/34/7515/strides-shasun-receives-usfda-approval-for-dutasteride-softgel-capsule.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7515/strides-shasun-receives-usfda-approval-for-dutasteride-softgel-capsule.html</link>
			<pubDate>Mon, 23 Nov 2015 12:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approved-logo-blue11.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7515/strides-shasun-receives-usfda-approval-for-dutasteride-softgel-capsule.html</guid>
		</item>	
				<item>
			<title>Mochida seeks Ulcerative Colitis drug approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html</link>
			<pubDate>Fri, 06 Nov 2015 10:29:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5015/mochida-seeks-ulcerative-colitis-drug-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese scientist inch closer to Toxoplasma vaccine discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/8251/japanese-scientist-inch-closer-to-toxoplasma-vaccine-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8251/japanese-scientist-inch-closer-to-toxoplasma-vaccine-discovery.html</link>
			<pubDate>Wed, 04 Nov 2015 11:48:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe-417786-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8251/japanese-scientist-inch-closer-to-toxoplasma-vaccine-discovery.html</guid>
		</item>	
				<item>
			<title>Invion completes patient enrolment for asthma drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/5923/invion-completes-patient-enrolment-for-asthma-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5923/invion-completes-patient-enrolment-for-asthma-drug-trial.html</link>
			<pubDate>Mon, 02 Nov 2015 11:57:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5923/invion-completes-patient-enrolment-for-asthma-drug-trial.html</guid>
		</item>	
				<item>
			<title>Celgene gets Europe&#039;s nod for acute myeloid leukaemia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7045/celgene-gets-europes-nod-for-acute-myeloid-leukaemia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7045/celgene-gets-europes-nod-for-acute-myeloid-leukaemia-drug.html</link>
			<pubDate>Fri, 30 Oct 2015 14:02:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7045/celgene-gets-europes-nod-for-acute-myeloid-leukaemia-drug.html</guid>
		</item>	
				<item>
			<title>Japanese scientists identify genes associated with peripheral artery disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/5070/japanese-scientists-identify-genes-associated-with-peripheral-artery-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5070/japanese-scientists-identify-genes-associated-with-peripheral-artery-disease.html</link>
			<pubDate>Mon, 26 Oct 2015 10:18:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dana-farber-cancer-institute-and-the-broad-institute-conduct-the-largest-analysis-to-date-that-evaluates-the-role-of-dna-copy-number-alterations-across-several-types-of-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5070/japanese-scientists-identify-genes-associated-with-peripheral-artery-disease.html</guid>
		</item>	
				<item>
			<title>Nemus&#039; glaucoma drug secures patent in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/5036/nemus-glaucoma-drug-secures-patent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5036/nemus-glaucoma-drug-secures-patent-in-japan.html</link>
			<pubDate>Mon, 26 Oct 2015 10:11:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5036/nemus-glaucoma-drug-secures-patent-in-japan.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s PharmaEngine gets TFDA nod for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5762/taiwans-pharmaengine-gets-tfda-nod-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5762/taiwans-pharmaengine-gets-tfda-nod-for-cancer-drug.html</link>
			<pubDate>Fri, 23 Oct 2015 12:19:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5762/taiwans-pharmaengine-gets-tfda-nod-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Aussie firm to begin human trial of cancer detecting antibody</title>
			<atom:link href="https://biospectrumasia.com/news/34/7350/aussie-firm-to-begin-human-trial-of-cancer-detecting-antibody.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7350/aussie-firm-to-begin-human-trial-of-cancer-detecting-antibody.html</link>
			<pubDate>Fri, 23 Oct 2015 11:50:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7350/aussie-firm-to-begin-human-trial-of-cancer-detecting-antibody.html</guid>
		</item>	
				<item>
			<title>3SBio, Alteogen to develop antibody for metastatic cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/7434/3sbio-alteogen-to-develop-antibody-for-metastatic-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7434/3sbio-alteogen-to-develop-antibody-for-metastatic-cancer.html</link>
			<pubDate>Tue, 13 Oct 2015 14:23:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191614-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7434/3sbio-alteogen-to-develop-antibody-for-metastatic-cancer.html</guid>
		</item>	
				<item>
			<title>J&amp;J starts clinical trial of Ebola vaccine in Sierra Leone</title>
			<atom:link href="https://biospectrumasia.com/news/34/7244/jj-starts-clinical-trial-of-ebola-vaccine-in-sierra-leone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7244/jj-starts-clinical-trial-of-ebola-vaccine-in-sierra-leone.html</link>
			<pubDate>Mon, 12 Oct 2015 11:46:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ebola.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7244/jj-starts-clinical-trial-of-ebola-vaccine-in-sierra-leone.html</guid>
		</item>	
				<item>
			<title>Singapore develops animal-free screening platform to predict nephrotoxicity</title>
			<atom:link href="https://biospectrumasia.com/news/34/7994/singapore-develops-animal-free-screening-platform-to-predict-nephrotoxicity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7994/singapore-develops-animal-free-screening-platform-to-predict-nephrotoxicity.html</link>
			<pubDate>Fri, 09 Oct 2015 11:23:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ibn.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7994/singapore-develops-animal-free-screening-platform-to-predict-nephrotoxicity.html</guid>
		</item>	
				<item>
			<title>TauRx pumps $135mn to advance treatment for Alzheimer&#039;s disease </title>
			<atom:link href="https://biospectrumasia.com/news/34/6267/taurx-pumps-135mn-to-advance-treatment-for-alzheimers-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6267/taurx-pumps-135mn-to-advance-treatment-for-alzheimers-disease-.html</link>
			<pubDate>Fri, 09 Oct 2015 11:22:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6267/taurx-pumps-135mn-to-advance-treatment-for-alzheimers-disease-.html</guid>
		</item>	
				<item>
			<title>FDA approves Merck&#039;s Keytruda for advanced lung cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/3593/fda-approves-mercks-keytruda-for-advanced-lung-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3593/fda-approves-mercks-keytruda-for-advanced-lung-cancer.html</link>
			<pubDate>Wed, 07 Oct 2015 17:18:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/keytruda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3593/fda-approves-mercks-keytruda-for-advanced-lung-cancer.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo initiates TaNeDS drug discovery program in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html</link>
			<pubDate>Thu, 01 Oct 2015 12:54:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biorx-venture-advisors-biorx-bio-acceleration-program-will-be-held-from-september-21-23-2013-at-new-delhi-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4894/daiichi-sankyo-initiates-taneds-drug-discovery-program-in-europe.html</guid>
		</item>	
				<item>
			<title>CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/7985/carsgen-partners-with-shanghai-cancer-institute-to-develop-cancer-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7985/carsgen-partners-with-shanghai-cancer-institute-to-develop-cancer-immunotherapies.html</link>
			<pubDate>Wed, 30 Sep 2015 13:06:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7985/carsgen-partners-with-shanghai-cancer-institute-to-develop-cancer-immunotherapies.html</guid>
		</item>	
				<item>
			<title>PeptiDream, Teijin to co-discover peptide-based therapeutics </title>
			<atom:link href="https://biospectrumasia.com/news/34/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html</link>
			<pubDate>Wed, 30 Sep 2015 10:26:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exchange-of-ideas-81822-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7446/peptidream-teijin-to-co-discover-peptide-based-therapeutics-.html</guid>
		</item>	
				<item>
			<title>Gene therapy pipeline in oncology is rich but at early stage&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7492/gene-therapy-pipeline-in-oncology-is-rich-but-at-early-stage.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7492/gene-therapy-pipeline-in-oncology-is-rich-but-at-early-stage.html</link>
			<pubDate>Tue, 29 Sep 2015 11:38:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7492/gene-therapy-pipeline-in-oncology-is-rich-but-at-early-stage.html</guid>
		</item>	
				<item>
			<title>Aussie firm trials combination therapy for melanoma</title>
			<atom:link href="https://biospectrumasia.com/news/34/7177/aussie-firm-trials-combination-therapy-for-melanoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7177/aussie-firm-trials-combination-therapy-for-melanoma.html</link>
			<pubDate>Tue, 29 Sep 2015 11:29:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ime.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7177/aussie-firm-trials-combination-therapy-for-melanoma.html</guid>
		</item>	
				<item>
			<title>Aslan recieves Singapore, Taiwan nod for Ph II trial of bile duct cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6994/aslan-recieves-singapore-taiwan-nod-for-ph-ii-trial-of-bile-duct-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6994/aslan-recieves-singapore-taiwan-nod-for-ph-ii-trial-of-bile-duct-cancer-drug.html</link>
			<pubDate>Wed, 23 Sep 2015 11:48:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/me.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6994/aslan-recieves-singapore-taiwan-nod-for-ph-ii-trial-of-bile-duct-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Australia&#039;s TransBio, DendroCyte to develop antibody for transplant rejection</title>
			<atom:link href="https://biospectrumasia.com/news/34/8103/australias-transbio-dendrocyte-to-develop-antibody-for-transplant-rejection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8103/australias-transbio-dendrocyte-to-develop-antibody-for-transplant-rejection.html</link>
			<pubDate>Tue, 22 Sep 2015 14:02:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/p.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8103/australias-transbio-dendrocyte-to-develop-antibody-for-transplant-rejection.html</guid>
		</item>	
				<item>
			<title>NZ gets drug that glows brain tumour </title>
			<atom:link href="https://biospectrumasia.com/news/34/8029/nz-gets-drug-that-glows-brain-tumour-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8029/nz-gets-drug-that-glows-brain-tumour-.html</link>
			<pubDate>Mon, 21 Sep 2015 15:12:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8029/nz-gets-drug-that-glows-brain-tumour-.html</guid>
		</item>	
				<item>
			<title>Singapore cancer genome scientists win President&#039;s Science Award</title>
			<atom:link href="https://biospectrumasia.com/news/34/7849/singapore-cancer-genome-scientists-win-presidents-science-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7849/singapore-cancer-genome-scientists-win-presidents-science-award.html</link>
			<pubDate>Thu, 17 Sep 2015 13:14:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/psa-2015-winners-singapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7849/singapore-cancer-genome-scientists-win-presidents-science-award.html</guid>
		</item>	
				<item>
			<title>FDA designates Chugai&#039;s bispecific antibody as breakthrough therapy </title>
			<atom:link href="https://biospectrumasia.com/news/34/8035/fda-designates-chugais-bispecific-antibody-as-breakthrough-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8035/fda-designates-chugais-bispecific-antibody-as-breakthrough-therapy-.html</link>
			<pubDate>Mon, 14 Sep 2015 11:37:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/green-156711-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8035/fda-designates-chugais-bispecific-antibody-as-breakthrough-therapy-.html</guid>
		</item>	
				<item>
			<title>FDA warns against Mitshubi Tanabe&#039;s type 2 diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/8153/fda-warns-against-mitshubi-tanabes-type-2-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8153/fda-warns-against-mitshubi-tanabes-type-2-diabetes-drug.html</link>
			<pubDate>Mon, 14 Sep 2015 10:58:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-issues-warning-against-nizoral-tablets.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8153/fda-warns-against-mitshubi-tanabes-type-2-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>AstraZeneca purchases Amgen&#039;s biologic site</title>
			<atom:link href="https://biospectrumasia.com/news/34/6923/astrazeneca-purchases-amgens-biologic-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6923/astrazeneca-purchases-amgens-biologic-site.html</link>
			<pubDate>Mon, 14 Sep 2015 10:32:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064000.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6923/astrazeneca-purchases-amgens-biologic-site.html</guid>
		</item>	
				<item>
			<title>Dengue can soon be treated!</title>
			<atom:link href="https://biospectrumasia.com/news/34/7408/dengue-can-soon-be-treated.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7408/dengue-can-soon-be-treated.html</link>
			<pubDate>Fri, 11 Sep 2015 14:07:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10064229-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7408/dengue-can-soon-be-treated.html</guid>
		</item>	
				<item>
			<title>Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html</link>
			<pubDate>Fri, 11 Sep 2015 12:13:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10041896.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7264/biogen-inks-autoimmune-deal-with-mitsubhishi-tanabe-pharma.html</guid>
		</item>	
				<item>
			<title>China&#039;s Yabao pharma inks deal with Australian University</title>
			<atom:link href="https://biospectrumasia.com/news/34/7048/chinas-yabao-pharma-inks-deal-with-australian-university.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7048/chinas-yabao-pharma-inks-deal-with-australian-university.html</link>
			<pubDate>Wed, 09 Sep 2015 11:32:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7048/chinas-yabao-pharma-inks-deal-with-australian-university.html</guid>
		</item>	
				<item>
			<title>Genticel secures patent for a targeted therapy for cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/7406/genticel-secures-patent-for-a-targeted-therapy-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7406/genticel-secures-patent-for-a-targeted-therapy-for-cancer.html</link>
			<pubDate>Tue, 08 Sep 2015 16:57:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100261337.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7406/genticel-secures-patent-for-a-targeted-therapy-for-cancer.html</guid>
		</item>	
				<item>
			<title>Wockhardt increases investment in R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/34/8171/wockhardt-increases-investment-in-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8171/wockhardt-increases-investment-in-rd.html</link>
			<pubDate>Mon, 07 Sep 2015 12:38:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/c.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8171/wockhardt-increases-investment-in-rd.html</guid>
		</item>	
				<item>
			<title>Singapore researchers get access to AstraZeneca drug compounds</title>
			<atom:link href="https://biospectrumasia.com/news/34/6117/singapore-researchers-get-access-to-astrazeneca-drug-compounds.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6117/singapore-researchers-get-access-to-astrazeneca-drug-compounds.html</link>
			<pubDate>Fri, 04 Sep 2015 12:11:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6117/singapore-researchers-get-access-to-astrazeneca-drug-compounds.html</guid>
		</item>	
				<item>
			<title>FDA approves new drug for chemo induced vomiting</title>
			<atom:link href="https://biospectrumasia.com/news/34/7582/fda-approves-new-drug-for-chemo-induced-vomiting.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7582/fda-approves-new-drug-for-chemo-induced-vomiting.html</link>
			<pubDate>Thu, 03 Sep 2015 12:59:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7582/fda-approves-new-drug-for-chemo-induced-vomiting.html</guid>
		</item>	
				<item>
			<title>Sanofi terminates NaP2b inhibitors development deal with Ardelyx</title>
			<atom:link href="https://biospectrumasia.com/news/34/4992/sanofi-terminates-nap2b-inhibitors-development-deal-with-ardelyx.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4992/sanofi-terminates-nap2b-inhibitors-development-deal-with-ardelyx.html</link>
			<pubDate>Thu, 03 Sep 2015 12:58:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4992/sanofi-terminates-nap2b-inhibitors-development-deal-with-ardelyx.html</guid>
		</item>	
				<item>
			<title>Abbott marks success with naturally dissolving stent in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html</link>
			<pubDate>Wed, 02 Sep 2015 12:10:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gene-therapy-virus-encapsulated.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7909/abbott-marks-success-with-naturally-dissolving-stent-in-japan-.html</guid>
		</item>	
				<item>
			<title>PharmaMar seeks Japan PMDA approval for tissue sarcoma drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html</link>
			<pubDate>Wed, 02 Sep 2015 12:06:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-colorectal-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7075/pharmamar-seeks-japan-pmda-approval-for-tissue-sarcoma-drug-.html</guid>
		</item>	
				<item>
			<title>Taiwan FDA nods Ph II trial of Hep C drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4710/taiwan-fda-nods-ph-ii-trial-of-hep-c-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4710/taiwan-fda-nods-ph-ii-trial-of-hep-c-drug.html</link>
			<pubDate>Wed, 02 Sep 2015 11:41:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100186667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4710/taiwan-fda-nods-ph-ii-trial-of-hep-c-drug.html</guid>
		</item>	
				<item>
			<title>Bionomics to initiate trial for antibody targeting cancer stem cell</title>
			<atom:link href="https://biospectrumasia.com/news/34/7025/bionomics-to-initiate-trial-for-antibody-targeting-cancer-stem-cell.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7025/bionomics-to-initiate-trial-for-antibody-targeting-cancer-stem-cell.html</link>
			<pubDate>Mon, 31 Aug 2015 15:00:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/s.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7025/bionomics-to-initiate-trial-for-antibody-targeting-cancer-stem-cell.html</guid>
		</item>	
				<item>
			<title>LBT Innovations inks partnership with French tech firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/7992/lbt-innovations-inks-partnership-with-french-tech-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7992/lbt-innovations-inks-partnership-with-french-tech-firm.html</link>
			<pubDate>Thu, 27 Aug 2015 12:42:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7992/lbt-innovations-inks-partnership-with-french-tech-firm.html</guid>
		</item>	
				<item>
			<title>Janssen terminates R&amp;D alliance with Hutchison Medipharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/7130/janssen-terminates-rd-alliance-with-hutchison-medipharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7130/janssen-terminates-rd-alliance-with-hutchison-medipharma.html</link>
			<pubDate>Wed, 26 Aug 2015 14:08:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/b.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7130/janssen-terminates-rd-alliance-with-hutchison-medipharma.html</guid>
		</item>	
				<item>
			<title>NMT Pharma and CAO Pharma in licensing agreement for anti-cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7108/nmt-pharma-and-cao-pharma-in-licensing-agreement-for-anti-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7108/nmt-pharma-and-cao-pharma-in-licensing-agreement-for-anti-cancer-drug.html</link>
			<pubDate>Wed, 26 Aug 2015 14:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7108/nmt-pharma-and-cao-pharma-in-licensing-agreement-for-anti-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Paradigm gets US patent  for bone marrow drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/7057/paradigm-gets-us-patent-for-bone-marrow-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7057/paradigm-gets-us-patent-for-bone-marrow-drug-.html</link>
			<pubDate>Wed, 26 Aug 2015 12:38:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7057/paradigm-gets-us-patent-for-bone-marrow-drug-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo Espha&#039;s TB drugs approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html</link>
			<pubDate>Tue, 25 Aug 2015 14:37:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6875/daiichi-sankyo-esphas-tb-drugs-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Japanese researchers discover potential drug target for muscle disease </title>
			<atom:link href="https://biospectrumasia.com/news/34/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html</link>
			<pubDate>Mon, 24 Aug 2015 10:35:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-received-29-reports-of-problems-associated-with-use-of-the-product-including-fatigue-muscle-cramping-muscle-pain-abnormal-liver-and-thyroid-and-cholesterol-tests.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7692/japanese-researchers-discover-potential-drug-target-for-muscle-disease-.html</guid>
		</item>	
				<item>
			<title>Novartis buys GSK&#039;s antibody drug, Ofatumumab</title>
			<atom:link href="https://biospectrumasia.com/news/34/7756/novartis-buys-gsks-antibody-drug-ofatumumab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7756/novartis-buys-gsks-antibody-drug-ofatumumab.html</link>
			<pubDate>Fri, 21 Aug 2015 12:16:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ime.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7756/novartis-buys-gsks-antibody-drug-ofatumumab.html</guid>
		</item>	
				<item>
			<title>Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html</link>
			<pubDate>Fri, 21 Aug 2015 12:15:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10071146.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7757/multiple-myeloma-treatment-market-to-reach-8-9-bn-by-2021-analyst.html</guid>
		</item>	
				<item>
			<title>ASLAN&#039;s bile duct cancer drug receives orphan drug status</title>
			<atom:link href="https://biospectrumasia.com/news/34/7238/aslans-bile-duct-cancer-drug-receives-orphan-drug-status.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7238/aslans-bile-duct-cancer-drug-receives-orphan-drug-status.html</link>
			<pubDate>Fri, 21 Aug 2015 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7238/aslans-bile-duct-cancer-drug-receives-orphan-drug-status.html</guid>
		</item>	
				<item>
			<title>USFDA approves &#039;Female Viagra&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/7348/usfda-approves-female-viagra.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7348/usfda-approves-female-viagra.html</link>
			<pubDate>Wed, 19 Aug 2015 14:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sprout3-bz-080515-hll.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7348/usfda-approves-female-viagra.html</guid>
		</item>	
				<item>
			<title>CrystalGenomics partners with Dong-A for Acelex commercialization</title>
			<atom:link href="https://biospectrumasia.com/news/34/7719/crystalgenomics-partners-with-dong-a-for-acelex-commercialization.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7719/crystalgenomics-partners-with-dong-a-for-acelex-commercialization.html</link>
			<pubDate>Fri, 14 Aug 2015 12:46:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100256617.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7719/crystalgenomics-partners-with-dong-a-for-acelex-commercialization.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim, Circuit Therapeutics to invest in obesity diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/7094/boehringer-ingelheim-circuit-therapeutics-to-invest-in-obesity-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7094/boehringer-ingelheim-circuit-therapeutics-to-invest-in-obesity-diseases.html</link>
			<pubDate>Fri, 14 Aug 2015 12:45:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7094/boehringer-ingelheim-circuit-therapeutics-to-invest-in-obesity-diseases.html</guid>
		</item>	
				<item>
			<title>AOP Orphan launches drug for Lipodystrophy in HIV patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/7461/aop-orphan-launches-drug-for-lipodystrophy-in-hiv-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7461/aop-orphan-launches-drug-for-lipodystrophy-in-hiv-patients.html</link>
			<pubDate>Thu, 13 Aug 2015 14:12:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7461/aop-orphan-launches-drug-for-lipodystrophy-in-hiv-patients.html</guid>
		</item>	
				<item>
			<title>ASLAN receives orphan drug designation for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6865/aslan-receives-orphan-drug-designation-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6865/aslan-receives-orphan-drug-designation-for-cancer-drug.html</link>
			<pubDate>Thu, 13 Aug 2015 13:08:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ime.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6865/aslan-receives-orphan-drug-designation-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Sphaera Pharma, DDRC, Wellcome Trust collaborate to foster TB research</title>
			<atom:link href="https://biospectrumasia.com/news/34/5345/sphaera-pharma-ddrc-wellcome-trust-collaborate-to-foster-tb-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5345/sphaera-pharma-ddrc-wellcome-trust-collaborate-to-foster-tb-research.html</link>
			<pubDate>Mon, 10 Aug 2015 12:43:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ime.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5345/sphaera-pharma-ddrc-wellcome-trust-collaborate-to-foster-tb-research.html</guid>
		</item>	
				<item>
			<title>Oncology drug pipeline is the most robust&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7012/oncology-drug-pipeline-is-the-most-robust.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7012/oncology-drug-pipeline-is-the-most-robust.html</link>
			<pubDate>Thu, 06 Aug 2015 14:01:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7012/oncology-drug-pipeline-is-the-most-robust.html</guid>
		</item>	
				<item>
			<title>Pharmaxis, Synairgen to develop drugs for fatal lung disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/5818/pharmaxis-synairgen-to-develop-drugs-for-fatal-lung-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5818/pharmaxis-synairgen-to-develop-drugs-for-fatal-lung-disease.html</link>
			<pubDate>Thu, 06 Aug 2015 14:00:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5818/pharmaxis-synairgen-to-develop-drugs-for-fatal-lung-disease.html</guid>
		</item>	
				<item>
			<title>Shionogi&#039;s constipation medicine proves effective in trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/5822/shionogis-constipation-medicine-proves-effective-in-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5822/shionogis-constipation-medicine-proves-effective-in-trials.html</link>
			<pubDate>Tue, 04 Aug 2015 11:56:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5822/shionogis-constipation-medicine-proves-effective-in-trials.html</guid>
		</item>	
				<item>
			<title>Pfizer launches targeted therapy for lung cancer in Singapore</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7937/pfizer-launches-targeted-therapy-for-lung-cancer-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7937/pfizer-launches-targeted-therapy-for-lung-cancer-in-singapore.html</link>
			<pubDate>Tue, 04 Aug 2015 11:52:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100186667.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7937/pfizer-launches-targeted-therapy-for-lung-cancer-in-singapore.html</guid>
		</item>	
				<item>
			<title>Pharma sales is getting strong&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2148/pharma-sales-is-getting-strong.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2148/pharma-sales-is-getting-strong.html</link>
			<pubDate>Tue, 04 Aug 2015 11:48:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2148/pharma-sales-is-getting-strong.html</guid>
		</item>	
				<item>
			<title>TWi&#039;s diabetes drug recieves patent allowance from Europe, Russia</title>
			<atom:link href="https://biospectrumasia.com/news/34/7977/twis-diabetes-drug-recieves-patent-allowance-from-europe-russia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7977/twis-diabetes-drug-recieves-patent-allowance-from-europe-russia.html</link>
			<pubDate>Mon, 03 Aug 2015 14:31:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/c.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7977/twis-diabetes-drug-recieves-patent-allowance-from-europe-russia.html</guid>
		</item>	
				<item>
			<title>AstraZeneca invests in antisense therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/7271/astrazeneca-invests-in-antisense-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7271/astrazeneca-invests-in-antisense-therapies.html</link>
			<pubDate>Mon, 03 Aug 2015 13:16:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/v.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7271/astrazeneca-invests-in-antisense-therapies.html</guid>
		</item>	
				<item>
			<title>Network Verfication Challenge gains momentum</title>
			<atom:link href="https://biospectrumasia.com/news/34/6391/network-verfication-challenge-gains-momentum.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6391/network-verfication-challenge-gains-momentum.html</link>
			<pubDate>Fri, 31 Jul 2015 13:14:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/r.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6391/network-verfication-challenge-gains-momentum.html</guid>
		</item>	
				<item>
			<title>China firms Shuwen, Hengrui to build companion diagnostics</title>
			<atom:link href="https://biospectrumasia.com/news/34/7638/china-firms-shuwen-hengrui-to-build-companion-diagnostics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7638/china-firms-shuwen-hengrui-to-build-companion-diagnostics.html</link>
			<pubDate>Fri, 31 Jul 2015 11:00:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/h.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7638/china-firms-shuwen-hengrui-to-build-companion-diagnostics.html</guid>
		</item>	
				<item>
			<title>Novartis partners with Mereo BioPharma to enhance novel drug portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/34/7891/novartis-partners-with-mereo-biopharma-to-enhance-novel-drug-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7891/novartis-partners-with-mereo-biopharma-to-enhance-novel-drug-portfolio.html</link>
			<pubDate>Fri, 31 Jul 2015 10:33:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7891/novartis-partners-with-mereo-biopharma-to-enhance-novel-drug-portfolio.html</guid>
		</item>	
				<item>
			<title>CSL progresses on Novartis influenza vaccine biz acquisition</title>
			<atom:link href="https://biospectrumasia.com/news/34/6006/csl-progresses-on-novartis-influenza-vaccine-biz-acquisition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6006/csl-progresses-on-novartis-influenza-vaccine-biz-acquisition.html</link>
			<pubDate>Fri, 31 Jul 2015 10:28:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/meeting.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6006/csl-progresses-on-novartis-influenza-vaccine-biz-acquisition.html</guid>
		</item>	
				<item>
			<title>BMS, Japan firm collaborate to develop new immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html</link>
			<pubDate>Thu, 30 Jul 2015 14:15:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6850/bms-japan-firm-collaborate-to-develop-new-immunotherapies.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim, Hanmi to co-develop lung cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7780/boehringer-ingelheim-hanmi-to-co-develop-lung-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7780/boehringer-ingelheim-hanmi-to-co-develop-lung-cancer-drug.html</link>
			<pubDate>Thu, 30 Jul 2015 14:05:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7780/boehringer-ingelheim-hanmi-to-co-develop-lung-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Takeda, DND to accelerate drug discovery for parasite infection</title>
			<atom:link href="https://biospectrumasia.com/news/34/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html</link>
			<pubDate>Wed, 29 Jul 2015 15:11:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7918/takeda-dnd-to-accelerate-drug-discovery-for-parasite-infection.html</guid>
		</item>	
				<item>
			<title>Novartis gets EU nod for combination therapy for skin cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/7654/novartis-gets-eu-nod-for-combination-therapy-for-skin-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7654/novartis-gets-eu-nod-for-combination-therapy-for-skin-cancer.html</link>
			<pubDate>Mon, 27 Jul 2015 12:43:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7654/novartis-gets-eu-nod-for-combination-therapy-for-skin-cancer.html</guid>
		</item>	
				<item>
			<title>Kowa, Chugai to market liver cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7675/kowa-chugai-to-market-liver-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7675/kowa-chugai-to-market-liver-cancer-drug.html</link>
			<pubDate>Tue, 21 Jul 2015 14:06:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7675/kowa-chugai-to-market-liver-cancer-drug.html</guid>
		</item>	
				<item>
			<title>AMRI acquires spanish API firm at $174 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/7688/amri-acquires-spanish-api-firm-at-174-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7688/amri-acquires-spanish-api-firm-at-174-mn.html</link>
			<pubDate>Mon, 20 Jul 2015 15:56:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7688/amri-acquires-spanish-api-firm-at-174-mn.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s ASLAN pharma inks MoU with NCCS</title>
			<atom:link href="https://biospectrumasia.com/news/34/7597/singapores-aslan-pharma-inks-mou-with-nccs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7597/singapores-aslan-pharma-inks-mou-with-nccs.html</link>
			<pubDate>Mon, 20 Jul 2015 12:17:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7597/singapores-aslan-pharma-inks-mou-with-nccs.html</guid>
		</item>	
				<item>
			<title>Singapore develops novel cancer drug candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/5619/singapore-develops-novel-cancer-drug-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5619/singapore-develops-novel-cancer-drug-candidate.html</link>
			<pubDate>Thu, 16 Jul 2015 14:09:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5619/singapore-develops-novel-cancer-drug-candidate.html</guid>
		</item>	
				<item>
			<title>Novogen develops drug to enhance chemotherapy effect</title>
			<atom:link href="https://biospectrumasia.com/news/34/6341/novogen-develops-drug-to-enhance-chemotherapy-effect.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6341/novogen-develops-drug-to-enhance-chemotherapy-effect.html</link>
			<pubDate>Wed, 15 Jul 2015 15:20:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100179874.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6341/novogen-develops-drug-to-enhance-chemotherapy-effect.html</guid>
		</item>	
				<item>
			<title>Pancreatic cancer drug pipeline rich but slow&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/7594/pancreatic-cancer-drug-pipeline-rich-but-slow.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7594/pancreatic-cancer-drug-pipeline-rich-but-slow.html</link>
			<pubDate>Thu, 18 Jun 2015 12:25:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7594/pancreatic-cancer-drug-pipeline-rich-but-slow.html</guid>
		</item>	
				<item>
			<title>SCIEX expands lipidomics portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/34/7671/sciex-expands-lipidomics-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7671/sciex-expands-lipidomics-portfolio.html</link>
			<pubDate>Wed, 17 Jun 2015 13:59:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/microscope.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7671/sciex-expands-lipidomics-portfolio.html</guid>
		</item>	
				<item>
			<title>Queensland to get a new drug development center</title>
			<atom:link href="https://biospectrumasia.com/news/34/1628/queensland-to-get-a-new-drug-development-center.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1628/queensland-to-get-a-new-drug-development-center.html</link>
			<pubDate>Wed, 17 Jun 2015 10:34:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancerous-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1628/queensland-to-get-a-new-drug-development-center.html</guid>
		</item>	
				<item>
			<title>Bionomics files patent application for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7748/bionomics-files-patent-application-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7748/bionomics-files-patent-application-for-cancer-drug.html</link>
			<pubDate>Tue, 16 Jun 2015 12:00:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7748/bionomics-files-patent-application-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Taiwan research centre to develop dengue vaccine with Janssen</title>
			<atom:link href="https://biospectrumasia.com/news/34/3808/taiwan-research-centre-to-develop-dengue-vaccine-with-janssen.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3808/taiwan-research-centre-to-develop-dengue-vaccine-with-janssen.html</link>
			<pubDate>Mon, 15 Jun 2015 11:52:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100169573.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3808/taiwan-research-centre-to-develop-dengue-vaccine-with-janssen.html</guid>
		</item>	
				<item>
			<title>Aussie firm gets FDA nod to inititate trial of wet AMD drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4536/aussie-firm-gets-fda-nod-to-inititate-trial-of-wet-amd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4536/aussie-firm-gets-fda-nod-to-inititate-trial-of-wet-amd-drug.html</link>
			<pubDate>Mon, 15 Jun 2015 11:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ct-talk-aj-huppke-eye-contact-1010-jpg-20131009.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4536/aussie-firm-gets-fda-nod-to-inititate-trial-of-wet-amd-drug.html</guid>
		</item>	
				<item>
			<title>FDA approves Novartis&#039; drug for rare blood disorder </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7735/fda-approves-novartis-drug-for-rare-blood-disorder-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7735/fda-approves-novartis-drug-for-rare-blood-disorder-.html</link>
			<pubDate>Sat, 13 Jun 2015 09:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100211390.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7735/fda-approves-novartis-drug-for-rare-blood-disorder-.html</guid>
		</item>	
				<item>
			<title>BI shows afatinib to be effective in advanced squamous cell carcinoma of lung</title>
			<atom:link href="https://biospectrumasia.com/news/34/7895/bi-shows-afatinib-to-be-effective-in-advanced-squamous-cell-carcinoma-of-lung.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7895/bi-shows-afatinib-to-be-effective-in-advanced-squamous-cell-carcinoma-of-lung.html</link>
			<pubDate>Thu, 11 Jun 2015 14:28:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7895/bi-shows-afatinib-to-be-effective-in-advanced-squamous-cell-carcinoma-of-lung.html</guid>
		</item>	
				<item>
			<title>Roche to develop companion diagnostic test for Acute Coronary Syndrome</title>
			<atom:link href="https://biospectrumasia.com/news/34/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html</link>
			<pubDate>Wed, 10 Jun 2015 12:32:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people-219985-640-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6944/roche-to-develop-companion-diagnostic-test-for-acute-coronary-syndrome.html</guid>
		</item>	
				<item>
			<title>FDA slams NIH for non-compliance issues</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5878/fda-slams-nih-for-non-compliance-issues.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5878/fda-slams-nih-for-non-compliance-issues.html</link>
			<pubDate>Fri, 05 Jun 2015 12:47:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinicaltrials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5878/fda-slams-nih-for-non-compliance-issues.html</guid>
		</item>	
				<item>
			<title>Chemistry Nobel winner, Dr Irwin Rose, dies at 88</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/7647/chemistry-nobel-winner-dr-irwin-rose-dies-at-88.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/7647/chemistry-nobel-winner-dr-irwin-rose-dies-at-88.html</link>
			<pubDate>Thu, 04 Jun 2015 12:20:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rose.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/7647/chemistry-nobel-winner-dr-irwin-rose-dies-at-88.html</guid>
		</item>	
				<item>
			<title>German, Korean firm join hands to discover cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/5454/german-korean-firm-join-hands-to-discover-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5454/german-korean-firm-join-hands-to-discover-cancer-drugs.html</link>
			<pubDate>Thu, 04 Jun 2015 12:20:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5454/german-korean-firm-join-hands-to-discover-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>German firm proceeds on ebola vaccine trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/7769/german-firm-proceeds-on-ebola-vaccine-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7769/german-firm-proceeds-on-ebola-vaccine-trial.html</link>
			<pubDate>Thu, 04 Jun 2015 12:17:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinicaltrials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7769/german-firm-proceeds-on-ebola-vaccine-trial.html</guid>
		</item>	
				<item>
			<title>FDA to review MSD&#039;s next blockbuster drug, Keytruda</title>
			<atom:link href="https://biospectrumasia.com/news/34/5944/fda-to-review-msds-next-blockbuster-drug-keytruda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5944/fda-to-review-msds-next-blockbuster-drug-keytruda.html</link>
			<pubDate>Wed, 03 Jun 2015 10:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5944/fda-to-review-msds-next-blockbuster-drug-keytruda.html</guid>
		</item>	
				<item>
			<title>PharmaEngine files NDA for metastatic cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7489/pharmaengine-files-nda-for-metastatic-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7489/pharmaengine-files-nda-for-metastatic-cancer-drug.html</link>
			<pubDate>Tue, 02 Jun 2015 14:12:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7489/pharmaengine-files-nda-for-metastatic-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Novocure launches Optune in 23 brain cancer centers in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html</link>
			<pubDate>Mon, 01 Jun 2015 12:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7560/novocure-launches-optune-in-23-brain-cancer-centers-in-japan.html</guid>
		</item>	
				<item>
			<title>Bayer conducts Xarelto trials on cancer patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/7627/bayer-conducts-xarelto-trials-on-cancer-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7627/bayer-conducts-xarelto-trials-on-cancer-patients.html</link>
			<pubDate>Fri, 29 May 2015 13:43:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7627/bayer-conducts-xarelto-trials-on-cancer-patients.html</guid>
		</item>	
				<item>
			<title>French firm successfully completes Ph I trial of diabetes drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html</link>
			<pubDate>Thu, 28 May 2015 12:31:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7292/french-firm-successfully-completes-ph-i-trial-of-diabetes-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>EMA recommends MSD&#039;s melanoma drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2006/ema-recommends-msds-melanoma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2006/ema-recommends-msds-melanoma-drug.html</link>
			<pubDate>Wed, 27 May 2015 15:14:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2006/ema-recommends-msds-melanoma-drug.html</guid>
		</item>	
				<item>
			<title>Swedish firm partners with Sanofi to expand in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/34/5069/swedish-firm-partners-with-sanofi-to-expand-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5069/swedish-firm-partners-with-sanofi-to-expand-in-asia.html</link>
			<pubDate>Wed, 27 May 2015 15:14:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/person.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5069/swedish-firm-partners-with-sanofi-to-expand-in-asia.html</guid>
		</item>	
				<item>
			<title>Amgen terminates AstraZeneca psoriasis drug partnership</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1837/amgen-terminates-astrazeneca-psoriasis-drug-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1837/amgen-terminates-astrazeneca-psoriasis-drug-partnership.html</link>
			<pubDate>Wed, 27 May 2015 14:11:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1837/amgen-terminates-astrazeneca-psoriasis-drug-partnership.html</guid>
		</item>	
				<item>
			<title>Re-engineered antibiotic could fight drug-resistant bacteria</title>
			<atom:link href="https://biospectrumasia.com/news/34/4520/re-engineered-antibiotic-could-fight-drug-resistant-bacteria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4520/re-engineered-antibiotic-could-fight-drug-resistant-bacteria.html</link>
			<pubDate>Tue, 26 May 2015 16:23:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100279018.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4520/re-engineered-antibiotic-could-fight-drug-resistant-bacteria.html</guid>
		</item>	
				<item>
			<title>Japanese GHIT Fund to include diagnostics and drugs for leishmaniasis</title>
			<atom:link href="https://biospectrumasia.com/news/34/4480/japanese-ghit-fund-to-include-diagnostics-and-drugs-for-leishmaniasis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4480/japanese-ghit-fund-to-include-diagnostics-and-drugs-for-leishmaniasis.html</link>
			<pubDate>Fri, 22 May 2015 11:53:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-first-set-of-nih-broadening-experience-in-scientific-training-best-awards-are-supported-through-the-nih-common-fund-s-strengthening-the-biomedical-research-workforce-program.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4480/japanese-ghit-fund-to-include-diagnostics-and-drugs-for-leishmaniasis.html</guid>
		</item>	
				<item>
			<title>Eisai launches In-house anticancer agent in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/7279/eisai-launches-in-house-anticancer-agent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7279/eisai-launches-in-house-anticancer-agent-in-japan.html</link>
			<pubDate>Thu, 21 May 2015 10:36:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7279/eisai-launches-in-house-anticancer-agent-in-japan.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim acquires Pharmaxis&#039; anti-inflammatory drug candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/4542/boehringer-ingelheim-acquires-pharmaxis-anti-inflammatory-drug-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4542/boehringer-ingelheim-acquires-pharmaxis-anti-inflammatory-drug-candidate.html</link>
			<pubDate>Mon, 18 May 2015 13:04:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100227380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4542/boehringer-ingelheim-acquires-pharmaxis-anti-inflammatory-drug-candidate.html</guid>
		</item>	
				<item>
			<title>OccuRx kick starts with $5.21 mn investment</title>
			<atom:link href="https://biospectrumasia.com/news/34/5293/occurx-kick-starts-with-5-21-mn-investment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5293/occurx-kick-starts-with-5-21-mn-investment.html</link>
			<pubDate>Mon, 18 May 2015 11:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100272217.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5293/occurx-kick-starts-with-5-21-mn-investment.html</guid>
		</item>	
				<item>
			<title>SCIEX, NUS to jointly develop oncology biomarkers</title>
			<atom:link href="https://biospectrumasia.com/news/34/7079/sciex-nus-to-jointly-develop-oncology-biomarkers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7079/sciex-nus-to-jointly-develop-oncology-biomarkers.html</link>
			<pubDate>Mon, 18 May 2015 11:49:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people-219985-640-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7079/sciex-nus-to-jointly-develop-oncology-biomarkers.html</guid>
		</item>	
				<item>
			<title>Amgen progresses on Ph II study of migraine drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5313/amgen-progresses-on-ph-ii-study-of-migraine-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5313/amgen-progresses-on-ph-ii-study-of-migraine-drug.html</link>
			<pubDate>Mon, 18 May 2015 11:48:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10022370.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5313/amgen-progresses-on-ph-ii-study-of-migraine-drug.html</guid>
		</item>	
				<item>
			<title>Novogen drug candidate effective as anti-cancer agent in preclinical studies</title>
			<atom:link href="https://biospectrumasia.com/news/34/6446/novogen-drug-candidate-effective-as-anti-cancer-agent-in-preclinical-studies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6446/novogen-drug-candidate-effective-as-anti-cancer-agent-in-preclinical-studies.html</link>
			<pubDate>Thu, 14 May 2015 12:00:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014426.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6446/novogen-drug-candidate-effective-as-anti-cancer-agent-in-preclinical-studies.html</guid>
		</item>	
				<item>
			<title>TB Alliance starts clinical trial of drug resistant TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/5360/tb-alliance-starts-clinical-trial-of-drug-resistant-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5360/tb-alliance-starts-clinical-trial-of-drug-resistant-tb.html</link>
			<pubDate>Thu, 14 May 2015 09:57:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/network-665237-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5360/tb-alliance-starts-clinical-trial-of-drug-resistant-tb.html</guid>
		</item>	
				<item>
			<title>Baxter expands oncology pipeline through acquisition</title>
			<atom:link href="https://biospectrumasia.com/news/34/7159/baxter-expands-oncology-pipeline-through-acquisition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7159/baxter-expands-oncology-pipeline-through-acquisition.html</link>
			<pubDate>Wed, 13 May 2015 13:07:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95715-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7159/baxter-expands-oncology-pipeline-through-acquisition.html</guid>
		</item>	
				<item>
			<title>Journey of the Dengue Vaccine</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7122/journey-of-the-dengue-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7122/journey-of-the-dengue-vaccine.html</link>
			<pubDate>Wed, 13 May 2015 07:59:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-anh-wartel-senior-director-clinical-development-r-d-sanofi-pasteur.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7122/journey-of-the-dengue-vaccine.html</guid>
		</item>	
				<item>
			<title>Eli Lilly partners with BioNTech to develop cancer immunotherapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/6678/eli-lilly-partners-with-biontech-to-develop-cancer-immunotherapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6678/eli-lilly-partners-with-biontech-to-develop-cancer-immunotherapies.html</link>
			<pubDate>Tue, 12 May 2015 10:28:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/personal-95715-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6678/eli-lilly-partners-with-biontech-to-develop-cancer-immunotherapies.html</guid>
		</item>	
				<item>
			<title>Australia supports budding medical researchers</title>
			<atom:link href="https://biospectrumasia.com/news/34/6323/australia-supports-budding-medical-researchers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6323/australia-supports-budding-medical-researchers.html</link>
			<pubDate>Mon, 11 May 2015 13:41:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10031183.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6323/australia-supports-budding-medical-researchers.html</guid>
		</item>	
				<item>
			<title>Australia grants $7 mn to uplift cancer research</title>
			<atom:link href="https://biospectrumasia.com/news/34/6371/australia-grants-7-mn-to-uplift-cancer-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6371/australia-grants-7-mn-to-uplift-cancer-research.html</link>
			<pubDate>Mon, 11 May 2015 13:40:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100186558.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6371/australia-grants-7-mn-to-uplift-cancer-research.html</guid>
		</item>	
				<item>
			<title>TGA approves chemotherapy-induced nausea and vomiting drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6319/tga-approves-chemotherapy-induced-nausea-and-vomiting-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6319/tga-approves-chemotherapy-induced-nausea-and-vomiting-drug.html</link>
			<pubDate>Mon, 11 May 2015 12:19:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100227380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6319/tga-approves-chemotherapy-induced-nausea-and-vomiting-drug.html</guid>
		</item>	
				<item>
			<title>Novogen progresses on drug for paediatric brain cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/6365/novogen-progresses-on-drug-for-paediatric-brain-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6365/novogen-progresses-on-drug-for-paediatric-brain-cancer.html</link>
			<pubDate>Fri, 08 May 2015 14:24:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100279018.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6365/novogen-progresses-on-drug-for-paediatric-brain-cancer.html</guid>
		</item>	
				<item>
			<title>Clinuvel&#039;s subisidiary develops drug candidate for vitiligo</title>
			<atom:link href="https://biospectrumasia.com/news/34/5097/clinuvels-subisidiary-develops-drug-candidate-for-vitiligo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5097/clinuvels-subisidiary-develops-drug-candidate-for-vitiligo.html</link>
			<pubDate>Wed, 06 May 2015 16:03:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/people-219985-640-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5097/clinuvels-subisidiary-develops-drug-candidate-for-vitiligo.html</guid>
		</item>	
				<item>
			<title>China approves Bayer&#039;s Xarelto</title>
			<atom:link href="https://biospectrumasia.com/news/34/7230/china-approves-bayers-xarelto.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7230/china-approves-bayers-xarelto.html</link>
			<pubDate>Tue, 05 May 2015 15:31:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7230/china-approves-bayers-xarelto.html</guid>
		</item>	
				<item>
			<title>Taiwan&#039;s PharmEngine initiates clinical trial of chemotherapy drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5816/taiwans-pharmengine-initiates-clinical-trial-of-chemotherapy-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5816/taiwans-pharmengine-initiates-clinical-trial-of-chemotherapy-drug.html</link>
			<pubDate>Tue, 05 May 2015 12:52:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5816/taiwans-pharmengine-initiates-clinical-trial-of-chemotherapy-drug.html</guid>
		</item>	
				<item>
			<title>TaiGen initiates clinical trial of leukemia drug in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/7231/taigen-initiates-clinical-trial-of-leukemia-drug-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7231/taigen-initiates-clinical-trial-of-leukemia-drug-in-china.html</link>
			<pubDate>Mon, 04 May 2015 14:10:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7231/taigen-initiates-clinical-trial-of-leukemia-drug-in-china.html</guid>
		</item>	
				<item>
			<title>Perrigo rejects Mylan&#039;s acquisition bid</title>
			<atom:link href="https://biospectrumasia.com/news/34/4577/perrigo-rejects-mylans-acquisition-bid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4577/perrigo-rejects-mylans-acquisition-bid.html</link>
			<pubDate>Tue, 28 Apr 2015 14:29:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100144925.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4577/perrigo-rejects-mylans-acquisition-bid.html</guid>
		</item>	
				<item>
			<title>Eisai, Nihon Medi-Physics to work on dementia intervention </title>
			<atom:link href="https://biospectrumasia.com/news/34/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html</link>
			<pubDate>Tue, 28 Apr 2015 09:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7296/eisai-nihon-medi-physics-to-work-on-dementia-intervention-.html</guid>
		</item>	
				<item>
			<title>Aussie firm likely to get orphan status for its new drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/7300/aussie-firm-likely-to-get-orphan-status-for-its-new-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7300/aussie-firm-likely-to-get-orphan-status-for-its-new-drug-.html</link>
			<pubDate>Tue, 28 Apr 2015 09:53:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100220917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7300/aussie-firm-likely-to-get-orphan-status-for-its-new-drug-.html</guid>
		</item>	
				<item>
			<title>FDA approves Eli Lilly&#039;s combination drug for metastatic colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/8216/fda-approves-eli-lillys-combination-drug-for-metastatic-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/8216/fda-approves-eli-lillys-combination-drug-for-metastatic-colorectal-cancer.html</link>
			<pubDate>Mon, 27 Apr 2015 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/8216/fda-approves-eli-lillys-combination-drug-for-metastatic-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>EU recommends Opdivo as monotherapy for advance melanoma</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7071/eu-recommends-opdivo-as-monotherapy-for-advance-melanoma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7071/eu-recommends-opdivo-as-monotherapy-for-advance-melanoma.html</link>
			<pubDate>Mon, 27 Apr 2015 12:41:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7071/eu-recommends-opdivo-as-monotherapy-for-advance-melanoma.html</guid>
		</item>	
				<item>
			<title>Aussie chemotherapy drug gets orphan designation</title>
			<atom:link href="https://biospectrumasia.com/news/34/7172/aussie-chemotherapy-drug-gets-orphan-designation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7172/aussie-chemotherapy-drug-gets-orphan-designation.html</link>
			<pubDate>Thu, 23 Apr 2015 12:26:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7172/aussie-chemotherapy-drug-gets-orphan-designation.html</guid>
		</item>	
				<item>
			<title>Astella, Potenza partner to enhance immune-oncology programs </title>
			<atom:link href="https://biospectrumasia.com/news/34/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html</link>
			<pubDate>Thu, 23 Apr 2015 12:22:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6999/astella-potenza-partner-to-enhance-immune-oncology-programs-.html</guid>
		</item>	
				<item>
			<title>OTC drug may be key to multiple sclerosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/6315/otc-drug-may-be-key-to-multiple-sclerosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6315/otc-drug-may-be-key-to-multiple-sclerosis.html</link>
			<pubDate>Wed, 22 Apr 2015 14:26:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10013140.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6315/otc-drug-may-be-key-to-multiple-sclerosis.html</guid>
		</item>	
				<item>
			<title>NIH launches clinical trial focused on HIV-related CV disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/7265/nih-launches-clinical-trial-focused-on-hiv-related-cv-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7265/nih-launches-clinical-trial-focused-on-hiv-related-cv-disease.html</link>
			<pubDate>Thu, 16 Apr 2015 11:44:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100220917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7265/nih-launches-clinical-trial-focused-on-hiv-related-cv-disease.html</guid>
		</item>	
				<item>
			<title>Israel firm to develop epilepsy drug in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/5028/israel-firm-to-develop-epilepsy-drug-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5028/israel-firm-to-develop-epilepsy-drug-in-china.html</link>
			<pubDate>Wed, 15 Apr 2015 15:02:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5028/israel-firm-to-develop-epilepsy-drug-in-china.html</guid>
		</item>	
				<item>
			<title>Japan Vaccine seeks approval to sell intradermal seasonal influenza vaccine in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/5706/japan-vaccine-seeks-approval-to-sell-intradermal-seasonal-influenza-vaccine-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5706/japan-vaccine-seeks-approval-to-sell-intradermal-seasonal-influenza-vaccine-in-japan-.html</link>
			<pubDate>Mon, 13 Apr 2015 12:15:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/syringe-417786-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5706/japan-vaccine-seeks-approval-to-sell-intradermal-seasonal-influenza-vaccine-in-japan-.html</guid>
		</item>	
				<item>
			<title>FDA stamps Merck&#039;s Hep C drug as breakthough therapy</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7377/fda-stamps-mercks-hep-c-drug-as-breakthough-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7377/fda-stamps-mercks-hep-c-drug-as-breakthough-therapy.html</link>
			<pubDate>Thu, 09 Apr 2015 11:56:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7377/fda-stamps-mercks-hep-c-drug-as-breakthough-therapy.html</guid>
		</item>	
				<item>
			<title>Progenics initiates Fuji&#039;s Phase 2 Trial for prostate cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html</link>
			<pubDate>Wed, 08 Apr 2015 15:03:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10088885.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6887/progenics-initiates-fujis-phase-2-trial-for-prostate-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>MD Anderson, Astellas collaborate to develop new drug for Acute Myeloid Leukemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html</link>
			<pubDate>Wed, 08 Apr 2015 14:57:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260363.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6502/md-anderson-astellas-collaborate-to-develop-new-drug-for-acute-myeloid-leukemia.html</guid>
		</item>	
				<item>
			<title>Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma </title>
			<atom:link href="https://biospectrumasia.com/news/34/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html</link>
			<pubDate>Sun, 05 Apr 2015 09:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100259719.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4899/neurocrine-biosciences-collaborates-with-mitsubishi-tanabe-pharma-.html</guid>
		</item>	
				<item>
			<title>Aussie firm gets FDA green flag for oncology drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4892/aussie-firm-gets-fda-green-flag-for-oncology-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4892/aussie-firm-gets-fda-green-flag-for-oncology-drug.html</link>
			<pubDate>Thu, 02 Apr 2015 11:37:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4892/aussie-firm-gets-fda-green-flag-for-oncology-drug.html</guid>
		</item>	
				<item>
			<title>Japanese researchers discover gold nanoparticles for cancer drug delivery</title>
			<atom:link href="https://biospectrumasia.com/news/34/7004/japanese-researchers-discover-gold-nanoparticles-for-cancer-drug-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7004/japanese-researchers-discover-gold-nanoparticles-for-cancer-drug-delivery.html</link>
			<pubDate>Wed, 01 Apr 2015 12:20:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-at-astar-s-singapore-immunology-network-sign-discover-a-new-class-of-white-blood-cells-which-are-subsets-of-dendritic-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7004/japanese-researchers-discover-gold-nanoparticles-for-cancer-drug-delivery.html</guid>
		</item>	
				<item>
			<title>Genzyme&#039;s Cerdelga capsules approved in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/5429/genzymes-cerdelga-capsules-approved-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5429/genzymes-cerdelga-capsules-approved-in-japan.html</link>
			<pubDate>Wed, 01 Apr 2015 11:52:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yes-68480-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5429/genzymes-cerdelga-capsules-approved-in-japan.html</guid>
		</item>	
				<item>
			<title>Bayer receives approval for Gadovist injection in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html</link>
			<pubDate>Mon, 30 Mar 2015 11:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100146305.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4210/bayer-receives-approval-for-gadovist-injection-in-japan.html</guid>
		</item>	
				<item>
			<title>Takeda, Immunogen in a cancer drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/6833/takeda-immunogen-in-a-cancer-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6833/takeda-immunogen-in-a-cancer-drug-deal.html</link>
			<pubDate>Wed, 25 Mar 2015 15:04:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellular-biomedicine-launches-a-stromal-adipose-stromal-cell-purification-kit-in-china-and-also-signs-deal-for-proceller-computer-controlled-processing-system-for-mainland-china-and-hong-kong.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6833/takeda-immunogen-in-a-cancer-drug-deal.html</guid>
		</item>	
				<item>
			<title>Japanese scientists discover anti-cancer property in diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html</link>
			<pubDate>Tue, 24 Mar 2015 13:27:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100191233.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5615/japanese-scientists-discover-anti-cancer-property-in-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Companion diagnostic drug for prostate cancer from Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html</link>
			<pubDate>Tue, 17 Mar 2015 10:52:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/symbol-451848-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4835/companion-diagnostic-drug-for-prostate-cancer-from-japan.html</guid>
		</item>	
				<item>
			<title>Are declining Ebola cases a challenge for clinical studies?</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/6696/are-declining-ebola-cases-a-challenge-for-clinical-studies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/6696/are-declining-ebola-cases-a-challenge-for-clinical-studies.html</link>
			<pubDate>Mon, 16 Mar 2015 14:52:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-163711-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/6696/are-declining-ebola-cases-a-challenge-for-clinical-studies.html</guid>
		</item>	
				<item>
			<title>Anti-herpes drug may help control HIV: NIH</title>
			<atom:link href="https://biospectrumasia.com/news/34/4516/anti-herpes-drug-may-help-control-hiv-nih.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4516/anti-herpes-drug-may-help-control-hiv-nih.html</link>
			<pubDate>Mon, 16 Mar 2015 14:49:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/test-214186-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4516/anti-herpes-drug-may-help-control-hiv-nih.html</guid>
		</item>	
				<item>
			<title>TWi&#039;s drug gets rare disease drug designation in Taiwan</title>
			<atom:link href="https://biospectrumasia.com/news/34/7313/twis-drug-gets-rare-disease-drug-designation-in-taiwan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7313/twis-drug-gets-rare-disease-drug-designation-in-taiwan.html</link>
			<pubDate>Wed, 11 Mar 2015 11:39:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-163711-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7313/twis-drug-gets-rare-disease-drug-designation-in-taiwan.html</guid>
		</item>	
				<item>
			<title>Novogen&#039;s drug shows positive result for brain cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/7225/novogens-drug-shows-positive-result-for-brain-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7225/novogens-drug-shows-positive-result-for-brain-cancer.html</link>
			<pubDate>Thu, 05 Mar 2015 13:12:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100220917.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7225/novogens-drug-shows-positive-result-for-brain-cancer.html</guid>
		</item>	
				<item>
			<title>Viral antibody discovered offers hope against flu</title>
			<atom:link href="https://biospectrumasia.com/news/34/5594/viral-antibody-discovered-offers-hope-against-flu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5594/viral-antibody-discovered-offers-hope-against-flu.html</link>
			<pubDate>Mon, 23 Feb 2015 15:02:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibody-web-274x186.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5594/viral-antibody-discovered-offers-hope-against-flu.html</guid>
		</item>	
				<item>
			<title>Suven secures patents in four countries</title>
			<atom:link href="https://biospectrumasia.com/news/34/6825/suven-secures-patents-in-four-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6825/suven-secures-patents-in-four-countries.html</link>
			<pubDate>Sat, 21 Feb 2015 09:53:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6825/suven-secures-patents-in-four-countries.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s multiple myeloma drug meets primary endpoints </title>
			<atom:link href="https://biospectrumasia.com/news/34/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html</link>
			<pubDate>Wed, 11 Feb 2015 11:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5858/takedas-multiple-myeloma-drug-meets-primary-endpoints-.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; Cosentyx receives Japanese nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/5093/novartis-cosentyx-receives-japanese-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5093/novartis-cosentyx-receives-japanese-nod.html</link>
			<pubDate>Fri, 06 Feb 2015 16:32:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bacteria-96601-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5093/novartis-cosentyx-receives-japanese-nod.html</guid>
		</item>	
				<item>
			<title>Bionomics initiaties trial of anxiety drug in France</title>
			<atom:link href="https://biospectrumasia.com/news/34/5998/bionomics-initiaties-trial-of-anxiety-drug-in-france.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5998/bionomics-initiaties-trial-of-anxiety-drug-in-france.html</link>
			<pubDate>Tue, 03 Feb 2015 11:44:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biosimilar.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5998/bionomics-initiaties-trial-of-anxiety-drug-in-france.html</guid>
		</item>	
				<item>
			<title>Abivax initiates Ph IIa clinical trial of HIV drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4507/abivax-initiates-ph-iia-clinical-trial-of-hiv-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4507/abivax-initiates-ph-iia-clinical-trial-of-hiv-drug.html</link>
			<pubDate>Tue, 03 Feb 2015 11:40:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets-193666-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4507/abivax-initiates-ph-iia-clinical-trial-of-hiv-drug.html</guid>
		</item>	
				<item>
			<title>China&#039;s Innovent raises $100 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/6402/chinas-innovent-raises-100-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6402/chinas-innovent-raises-100-mn.html</link>
			<pubDate>Sat, 31 Jan 2015 08:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/man-40094-640.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6402/chinas-innovent-raises-100-mn.html</guid>
		</item>	
				<item>
			<title>APAC ovarian cancer drug market to grow modestly&#039; </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html</link>
			<pubDate>Fri, 30 Jan 2015 11:59:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/150/apac-ovarian-cancer-drug-market-to-grow-modestly-.html</guid>
		</item>	
				<item>
			<title>Japan&#039;s Otsuka expands in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/34/4611/japans-otsuka-expands-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4611/japans-otsuka-expands-in-australia.html</link>
			<pubDate>Thu, 29 Jan 2015 12:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expand.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4611/japans-otsuka-expands-in-australia.html</guid>
		</item>	
				<item>
			<title>VolitionRx to study cancer detection device in Singapore </title>
			<atom:link href="https://biospectrumasia.com/news/34/4617/volitionrx-to-study-cancer-detection-device-in-singapore-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4617/volitionrx-to-study-cancer-detection-device-in-singapore-.html</link>
			<pubDate>Fri, 23 Jan 2015 14:42:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10038442.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4617/volitionrx-to-study-cancer-detection-device-in-singapore-.html</guid>
		</item>	
				<item>
			<title>AMRI receives NIH contract for clinical drug product</title>
			<atom:link href="https://biospectrumasia.com/news/34/4921/amri-receives-nih-contract-for-clinical-drug-product.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4921/amri-receives-nih-contract-for-clinical-drug-product.html</link>
			<pubDate>Fri, 23 Jan 2015 14:40:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/health1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4921/amri-receives-nih-contract-for-clinical-drug-product.html</guid>
		</item>	
				<item>
			<title>Taiwan firm Delta, A*Star launches diagnostics lab in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/5559/taiwan-firm-delta-astar-launches-diagnostics-lab-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5559/taiwan-firm-delta-astar-launches-diagnostics-lab-in-singapore.html</link>
			<pubDate>Fri, 16 Jan 2015 12:38:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lk8a7933.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5559/taiwan-firm-delta-astar-launches-diagnostics-lab-in-singapore.html</guid>
		</item>	
				<item>
			<title>Roche, Meiji Seika Pharma, Fedora collaborate to develop bacterial resistance to antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/34/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html</link>
			<pubDate>Fri, 16 Jan 2015 12:36:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5560/roche-meiji-seika-pharma-fedora-collaborate-to-develop-bacterial-resistance-to-antibiotics.html</guid>
		</item>	
				<item>
			<title>Aussie start-up firm gets MRCF funding</title>
			<atom:link href="https://biospectrumasia.com/news/34/5561/aussie-start-up-firm-gets-mrcf-funding.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5561/aussie-start-up-firm-gets-mrcf-funding.html</link>
			<pubDate>Fri, 16 Jan 2015 12:29:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/invet.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5561/aussie-start-up-firm-gets-mrcf-funding.html</guid>
		</item>	
				<item>
			<title>China&#039;s 3SBio to jointly develop mAB with Korea&#039;s PharmAbcine</title>
			<atom:link href="https://biospectrumasia.com/news/34/4684/chinas-3sbio-to-jointly-develop-mab-with-koreas-pharmabcine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4684/chinas-3sbio-to-jointly-develop-mab-with-koreas-pharmabcine.html</link>
			<pubDate>Fri, 16 Jan 2015 12:27:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/complaint.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4684/chinas-3sbio-to-jointly-develop-mab-with-koreas-pharmabcine.html</guid>
		</item>	
				<item>
			<title>Montreal Heart Institute discovers personalized therapy for cardiovascular disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/5691/montreal-heart-institute-discovers-personalized-therapy-for-cardiovascular-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5691/montreal-heart-institute-discovers-personalized-therapy-for-cardiovascular-disease.html</link>
			<pubDate>Tue, 13 Jan 2015 13:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/health1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5691/montreal-heart-institute-discovers-personalized-therapy-for-cardiovascular-disease.html</guid>
		</item>	
				<item>
			<title>Chipscren Biosciences receives CFDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/5932/chipscren-biosciences-receives-cfda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5932/chipscren-biosciences-receives-cfda-nod.html</link>
			<pubDate>Tue, 13 Jan 2015 11:57:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100246947.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5932/chipscren-biosciences-receives-cfda-nod.html</guid>
		</item>	
				<item>
			<title>Cellmid receive patent approval from Australia</title>
			<atom:link href="https://biospectrumasia.com/news/34/5738/cellmid-receive-patent-approval-from-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5738/cellmid-receive-patent-approval-from-australia.html</link>
			<pubDate>Tue, 13 Jan 2015 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5738/cellmid-receive-patent-approval-from-australia.html</guid>
		</item>	
				<item>
			<title>Finally, Impax&#039;s Parkinson&#039;s drug gets FDA approval</title>
			<atom:link href="https://biospectrumasia.com/news/34/5658/finally-impaxs-parkinsons-drug-gets-fda-approval.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5658/finally-impaxs-parkinsons-drug-gets-fda-approval.html</link>
			<pubDate>Mon, 12 Jan 2015 13:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100265496.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5658/finally-impaxs-parkinsons-drug-gets-fda-approval.html</guid>
		</item>	
				<item>
			<title>US investment firm expands in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/5201/us-investment-firm-expands-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5201/us-investment-firm-expands-in-china.html</link>
			<pubDate>Fri, 09 Jan 2015 11:53:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/expand.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5201/us-investment-firm-expands-in-china.html</guid>
		</item>	
				<item>
			<title>Singapore firm progresses on urinary tract infections drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5208/singapore-firm-progresses-on-urinary-tract-infections-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5208/singapore-firm-progresses-on-urinary-tract-infections-drug.html</link>
			<pubDate>Fri, 09 Jan 2015 11:09:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medications-342481-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5208/singapore-firm-progresses-on-urinary-tract-infections-drug.html</guid>
		</item>	
				<item>
			<title>EU supports Pyridorin drug trial for diabetic nephropathy</title>
			<atom:link href="https://biospectrumasia.com/news/34/5096/eu-supports-pyridorin-drug-trial-for-diabetic-nephropathy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5096/eu-supports-pyridorin-drug-trial-for-diabetic-nephropathy.html</link>
			<pubDate>Fri, 09 Jan 2015 08:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5096/eu-supports-pyridorin-drug-trial-for-diabetic-nephropathy.html</guid>
		</item>	
				<item>
			<title>Japanese, Korean firm to jointly develop breast cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html</link>
			<pubDate>Thu, 08 Jan 2015 14:59:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100257378.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5128/japanese-korean-firm-to-jointly-develop-breast-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Gilead buys liver disease drug candidate at $470 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/5984/gilead-buys-liver-disease-drug-candidate-at-470-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5984/gilead-buys-liver-disease-drug-candidate-at-470-mn.html</link>
			<pubDate>Wed, 07 Jan 2015 12:20:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/money1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5984/gilead-buys-liver-disease-drug-candidate-at-470-mn.html</guid>
		</item>	
				<item>
			<title>BMS to develop anti-fibrotic therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/4657/bms-to-develop-anti-fibrotic-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4657/bms-to-develop-anti-fibrotic-therapies.html</link>
			<pubDate>Tue, 06 Jan 2015 12:07:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100261976.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4657/bms-to-develop-anti-fibrotic-therapies.html</guid>
		</item>	
				<item>
			<title>Researchers discover antibody to prevent dengue</title>
			<atom:link href="https://biospectrumasia.com/news/34/5271/researchers-discover-antibody-to-prevent-dengue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5271/researchers-discover-antibody-to-prevent-dengue.html</link>
			<pubDate>Wed, 31 Dec 2014 11:23:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical-testing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5271/researchers-discover-antibody-to-prevent-dengue.html</guid>
		</item>	
				<item>
			<title>Roivant acquires GSK&#039;s Alzheimer&#039;s drug candidate</title>
			<atom:link href="https://biospectrumasia.com/news/34/7428/roivant-acquires-gsks-alzheimers-drug-candidate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7428/roivant-acquires-gsks-alzheimers-drug-candidate.html</link>
			<pubDate>Tue, 30 Dec 2014 10:16:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7428/roivant-acquires-gsks-alzheimers-drug-candidate.html</guid>
		</item>	
				<item>
			<title>Gilead, Janssen extends HIV drug partnership</title>
			<atom:link href="https://biospectrumasia.com/news/34/5826/gilead-janssen-extends-hiv-drug-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5826/gilead-janssen-extends-hiv-drug-partnership.html</link>
			<pubDate>Tue, 30 Dec 2014 10:14:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232367.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5826/gilead-janssen-extends-hiv-drug-partnership.html</guid>
		</item>	
				<item>
			<title>Phylogica inks a deal with Genentech</title>
			<atom:link href="https://biospectrumasia.com/news/34/5807/phylogica-inks-a-deal-with-genentech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5807/phylogica-inks-a-deal-with-genentech.html</link>
			<pubDate>Mon, 22 Dec 2014 14:37:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-also-entered-into-a-strategic-partnership-with-sverdlovsk-based-drug-manufacturer-medsintez-to-jointly-manufacture-and-commercialize-diagnostic-imaging-products.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5807/phylogica-inks-a-deal-with-genentech.html</guid>
		</item>	
				<item>
			<title>Suven Lifesciences receives five patents from four countries</title>
			<atom:link href="https://biospectrumasia.com/news/34/5261/suven-lifesciences-receives-five-patents-from-four-countries.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5261/suven-lifesciences-receives-five-patents-from-four-countries.html</link>
			<pubDate>Wed, 17 Dec 2014 13:21:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/j.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5261/suven-lifesciences-receives-five-patents-from-four-countries.html</guid>
		</item>	
				<item>
			<title>Brain cancer drug may be effective in melanoma treatment </title>
			<atom:link href="https://biospectrumasia.com/news/34/5247/brain-cancer-drug-may-be-effective-in-melanoma-treatment-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5247/brain-cancer-drug-may-be-effective-in-melanoma-treatment-.html</link>
			<pubDate>Wed, 17 Dec 2014 12:00:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5247/brain-cancer-drug-may-be-effective-in-melanoma-treatment-.html</guid>
		</item>	
				<item>
			<title>Novogen&#039;s chemotherapeutic agent set to enter human trial in 2015</title>
			<atom:link href="https://biospectrumasia.com/news/34/5124/novogens-chemotherapeutic-agent-set-to-enter-human-trial-in-2015.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5124/novogens-chemotherapeutic-agent-set-to-enter-human-trial-in-2015.html</link>
			<pubDate>Tue, 16 Dec 2014 12:48:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5124/novogens-chemotherapeutic-agent-set-to-enter-human-trial-in-2015.html</guid>
		</item>	
				<item>
			<title>Taiwan firm gets FDA nod for ph II trial of gout drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6136/taiwan-firm-gets-fda-nod-for-ph-ii-trial-of-gout-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6136/taiwan-firm-gets-fda-nod-for-ph-ii-trial-of-gout-drug.html</link>
			<pubDate>Mon, 15 Dec 2014 12:11:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100225328.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6136/taiwan-firm-gets-fda-nod-for-ph-ii-trial-of-gout-drug.html</guid>
		</item>	
				<item>
			<title>BMS takes on combination drug for cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/6135/bms-takes-on-combination-drug-for-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6135/bms-takes-on-combination-drug-for-cancer-therapy.html</link>
			<pubDate>Thu, 11 Dec 2014 14:20:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100232464.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6135/bms-takes-on-combination-drug-for-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>BMS releases $3.5 mn fund for Hep B&amp;C in India, China</title>
			<atom:link href="https://biospectrumasia.com/news/34/6691/bms-releases-3-5-mn-fund-for-hep-bc-in-india-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6691/bms-releases-3-5-mn-fund-for-hep-bc-in-india-china.html</link>
			<pubDate>Thu, 04 Dec 2014 14:12:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100183235.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6691/bms-releases-3-5-mn-fund-for-hep-bc-in-india-china.html</guid>
		</item>	
				<item>
			<title>Evotec acquires Sanofi&#039;s drug discovery site</title>
			<atom:link href="https://biospectrumasia.com/news/34/6545/evotec-acquires-sanofis-drug-discovery-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6545/evotec-acquires-sanofis-drug-discovery-site.html</link>
			<pubDate>Thu, 04 Dec 2014 14:11:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100225328.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6545/evotec-acquires-sanofis-drug-discovery-site.html</guid>
		</item>	
				<item>
			<title>China firm Beigene raises $75 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/8305/china-firm-beigene-raises-75-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8305/china-firm-beigene-raises-75-mn.html</link>
			<pubDate>Tue, 18 Nov 2014 12:47:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8305/china-firm-beigene-raises-75-mn.html</guid>
		</item>	
				<item>
			<title>GE to open technology and training centre in Turkey</title>
			<atom:link href="https://biospectrumasia.com/news/34/5425/ge-to-open-technology-and-training-centre-in-turkey.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5425/ge-to-open-technology-and-training-centre-in-turkey.html</link>
			<pubDate>Mon, 17 Nov 2014 11:27:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100183235.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5425/ge-to-open-technology-and-training-centre-in-turkey.html</guid>
		</item>	
				<item>
			<title>Aussie firm to initiate oncology clinical trial in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/4929/aussie-firm-to-initiate-oncology-clinical-trial-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4929/aussie-firm-to-initiate-oncology-clinical-trial-in-europe.html</link>
			<pubDate>Fri, 14 Nov 2014 15:36:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100122536.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4929/aussie-firm-to-initiate-oncology-clinical-trial-in-europe.html</guid>
		</item>	
				<item>
			<title>NSC lung cancer drug pipeline is strong: Analyst</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/6726/nsc-lung-cancer-drug-pipeline-is-strong-analyst.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/6726/nsc-lung-cancer-drug-pipeline-is-strong-analyst.html</link>
			<pubDate>Tue, 11 Nov 2014 13:36:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10039602.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/6726/nsc-lung-cancer-drug-pipeline-is-strong-analyst.html</guid>
		</item>	
				<item>
			<title>NUHS chief gets Singapore President&#039;s award</title>
			<atom:link href="https://biospectrumasia.com/news/34/6137/nuhs-chief-gets-singapore-presidents-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6137/nuhs-chief-gets-singapore-presidents-award.html</link>
			<pubDate>Tue, 11 Nov 2014 13:34:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prof-john-wong.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6137/nuhs-chief-gets-singapore-presidents-award.html</guid>
		</item>	
				<item>
			<title>US firm discovers potential biomarker for malaria</title>
			<atom:link href="https://biospectrumasia.com/news/34/5167/us-firm-discovers-potential-biomarker-for-malaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5167/us-firm-discovers-potential-biomarker-for-malaria.html</link>
			<pubDate>Tue, 11 Nov 2014 13:30:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10065554.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5167/us-firm-discovers-potential-biomarker-for-malaria.html</guid>
		</item>	
				<item>
			<title>Merck partners with Kenya research centre</title>
			<atom:link href="https://biospectrumasia.com/news/34/2648/merck-partners-with-kenya-research-centre.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2648/merck-partners-with-kenya-research-centre.html</link>
			<pubDate>Thu, 30 Oct 2014 15:17:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-kenya-partnership.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2648/merck-partners-with-kenya-research-centre.html</guid>
		</item>	
				<item>
			<title>Alexion files NDA in Japan for Asfotase Alfa</title>
			<atom:link href="https://biospectrumasia.com/news/34/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html</link>
			<pubDate>Tue, 28 Oct 2014 15:26:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-gives-patrys-cancer-drug-orphan-status.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5863/alexion-files-nda-in-japan-for-asfotase-alfa.html</guid>
		</item>	
				<item>
			<title>Auspherix raises $1 mn for antibiotics</title>
			<atom:link href="https://biospectrumasia.com/news/34/5115/auspherix-raises-1-mn-for-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5115/auspherix-raises-1-mn-for-antibiotics.html</link>
			<pubDate>Thu, 23 Oct 2014 11:20:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical-testing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5115/auspherix-raises-1-mn-for-antibiotics.html</guid>
		</item>	
				<item>
			<title>Researchers develop novel solutions to fight the obesity gene</title>
			<atom:link href="https://biospectrumasia.com/news/34/6406/researchers-develop-novel-solutions-to-fight-the-obesity-gene.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6406/researchers-develop-novel-solutions-to-fight-the-obesity-gene.html</link>
			<pubDate>Mon, 20 Oct 2014 15:50:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-obesity-patients-glaxosmithkline-gsk-and-vanderbilt-university-to-use-positive-allosteric-modulators-pams-like-melanocortin-4-receptor-mc4-r-for-treating-severe-obesity.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6406/researchers-develop-novel-solutions-to-fight-the-obesity-gene.html</guid>
		</item>	
				<item>
			<title>Virax to acquire cancer drug developer AKTivate</title>
			<atom:link href="https://biospectrumasia.com/news/34/5625/virax-to-acquire-cancer-drug-developer-aktivate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5625/virax-to-acquire-cancer-drug-developer-aktivate.html</link>
			<pubDate>Fri, 17 Oct 2014 11:57:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10097811.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5625/virax-to-acquire-cancer-drug-developer-aktivate.html</guid>
		</item>	
				<item>
			<title>Green tea for cancer drug delivery </title>
			<atom:link href="https://biospectrumasia.com/news/34/6272/green-tea-for-cancer-drug-delivery-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6272/green-tea-for-cancer-drug-delivery-.html</link>
			<pubDate>Tue, 14 Oct 2014 15:11:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ibn-team.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6272/green-tea-for-cancer-drug-delivery-.html</guid>
		</item>	
				<item>
			<title>Satish Jindal, BMS India R&amp;D head,  to lead US innovation venture</title>
			<atom:link href="https://biospectrumasia.com/news/34/5175/satish-jindal-bms-india-rd-head-to-lead-us-innovation-venture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5175/satish-jindal-bms-india-rd-head-to-lead-us-innovation-venture.html</link>
			<pubDate>Fri, 03 Oct 2014 12:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/human-65924-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5175/satish-jindal-bms-india-rd-head-to-lead-us-innovation-venture.html</guid>
		</item>	
				<item>
			<title>Translation of ideas is Australia&#039;s key to growth&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/6428/translation-of-ideas-is-australias-key-to-growth.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/6428/translation-of-ideas-is-australias-key-to-growth.html</link>
			<pubDate>Tue, 30 Sep 2014 16:46:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mario-pennisi-ceo-qctn-australia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/6428/translation-of-ideas-is-australias-key-to-growth.html</guid>
		</item>	
				<item>
			<title>Pfizer, Japanese firm to jointly asses mAB for tumor</title>
			<atom:link href="https://biospectrumasia.com/news/34/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html</link>
			<pubDate>Tue, 30 Sep 2014 10:01:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gear-403504-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6165/pfizer-japanese-firm-to-jointly-asses-mab-for-tumor.html</guid>
		</item>	
				<item>
			<title>Aussie firm progresses with cancer anorexia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5516/aussie-firm-progresses-with-cancer-anorexia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5516/aussie-firm-progresses-with-cancer-anorexia-drug.html</link>
			<pubDate>Mon, 29 Sep 2014 11:20:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bacteria-96601-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5516/aussie-firm-progresses-with-cancer-anorexia-drug.html</guid>
		</item>	
				<item>
			<title>Zebrafish genes linked to human respiratory diseases&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/5179/zebrafish-genes-linked-to-human-respiratory-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5179/zebrafish-genes-linked-to-human-respiratory-diseases.html</link>
			<pubDate>Mon, 22 Sep 2014 11:30:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neural-pathways-221718-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5179/zebrafish-genes-linked-to-human-respiratory-diseases.html</guid>
		</item>	
				<item>
			<title>Singapore start-up progresses in Alzheimer&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4918/singapore-start-up-progresses-in-alzheimers-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4918/singapore-start-up-progresses-in-alzheimers-drug.html</link>
			<pubDate>Mon, 22 Sep 2014 10:53:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dna-163710-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4918/singapore-start-up-progresses-in-alzheimers-drug.html</guid>
		</item>	
				<item>
			<title>Glioblastoma therapeutics market to double in APAC by 2020</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4527/glioblastoma-therapeutics-market-to-double-in-apac-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4527/glioblastoma-therapeutics-market-to-double-in-apac-by-2020.html</link>
			<pubDate>Fri, 19 Sep 2014 11:29:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neural-pathways-221718-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4527/glioblastoma-therapeutics-market-to-double-in-apac-by-2020.html</guid>
		</item>	
				<item>
			<title>FDA&#039;s call on Rytary delayed by 3 months</title>
			<atom:link href="https://biospectrumasia.com/news/34/4486/fdas-call-on-rytary-delayed-by-3-months.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4486/fdas-call-on-rytary-delayed-by-3-months.html</link>
			<pubDate>Thu, 18 Sep 2014 17:11:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10082836.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4486/fdas-call-on-rytary-delayed-by-3-months.html</guid>
		</item>	
				<item>
			<title>New drug formulation for respiratory system infections</title>
			<atom:link href="https://biospectrumasia.com/news/34/4454/new-drug-formulation-for-respiratory-system-infections.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4454/new-drug-formulation-for-respiratory-system-infections.html</link>
			<pubDate>Thu, 18 Sep 2014 12:56:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-researchers.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4454/new-drug-formulation-for-respiratory-system-infections.html</guid>
		</item>	
				<item>
			<title>3SBio to develop JenKem&#039;s novel drug for cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/4226/3sbio-to-develop-jenkems-novel-drug-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4226/3sbio-to-develop-jenkems-novel-drug-for-cancer.html</link>
			<pubDate>Thu, 18 Sep 2014 11:49:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100279727.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4226/3sbio-to-develop-jenkems-novel-drug-for-cancer.html</guid>
		</item>	
				<item>
			<title>Profits - A stumbling block for Ebola research</title>
			<atom:link href="https://biospectrumasia.com/news/34/4930/profits-a-stumbling-block-for-ebola-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4930/profits-a-stumbling-block-for-ebola-research.html</link>
			<pubDate>Tue, 16 Sep 2014 11:08:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ppps-attract-investment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4930/profits-a-stumbling-block-for-ebola-research.html</guid>
		</item>	
				<item>
			<title>Cadila Healthcare eyeing US, Europe markets</title>
			<atom:link href="https://biospectrumasia.com/news/34/8061/cadila-healthcare-eyeing-us-europe-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8061/cadila-healthcare-eyeing-us-europe-markets.html</link>
			<pubDate>Mon, 15 Sep 2014 12:32:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/business-313592-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8061/cadila-healthcare-eyeing-us-europe-markets.html</guid>
		</item>	
				<item>
			<title>Non-Small Cell Lung Cancer treatment market to touch $7.9 bn by 2020&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5504/non-small-cell-lung-cancer-treatment-market-to-touch-7-9-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5504/non-small-cell-lung-cancer-treatment-market-to-touch-7-9-bn-by-2020.html</link>
			<pubDate>Thu, 11 Sep 2014 12:21:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-390322-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5504/non-small-cell-lung-cancer-treatment-market-to-touch-7-9-bn-by-2020.html</guid>
		</item>	
				<item>
			<title> Ascend to begin PhII trial for skin cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/5209/-ascend-to-begin-phii-trial-for-skin-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5209/-ascend-to-begin-phii-trial-for-skin-cancer.html</link>
			<pubDate>Thu, 11 Sep 2014 12:20:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100283764.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5209/-ascend-to-begin-phii-trial-for-skin-cancer.html</guid>
		</item>	
				<item>
			<title>Minomic, US firm to develop prostrate cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/5839/minomic-us-firm-to-develop-prostrate-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5839/minomic-us-firm-to-develop-prostrate-cancer-drug-.html</link>
			<pubDate>Mon, 08 Sep 2014 12:20:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/virus-174051-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5839/minomic-us-firm-to-develop-prostrate-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Asthma therapy market to touch $23.1 bn by 2023</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html</link>
			<pubDate>Mon, 08 Sep 2014 11:57:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10057221-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5040/asthma-therapy-market-to-touch-23-1-bn-by-2023.html</guid>
		</item>	
				<item>
			<title>Breast cancer boasts of highest drug pipeline&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/5212/breast-cancer-boasts-of-highest-drug-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5212/breast-cancer-boasts-of-highest-drug-pipeline.html</link>
			<pubDate>Mon, 08 Sep 2014 11:56:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100257907.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5212/breast-cancer-boasts-of-highest-drug-pipeline.html</guid>
		</item>	
				<item>
			<title>Taiwan-China to collaborate on new drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/6080/taiwan-china-to-collaborate-on-new-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6080/taiwan-china-to-collaborate-on-new-drug-discovery.html</link>
			<pubDate>Fri, 05 Sep 2014 14:59:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cooperation-384084-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6080/taiwan-china-to-collaborate-on-new-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Roche acquires respiratory therapy firm at $8.3 bn</title>
			<atom:link href="https://biospectrumasia.com/news/34/4906/roche-acquires-respiratory-therapy-firm-at-8-3-bn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4906/roche-acquires-respiratory-therapy-firm-at-8-3-bn.html</link>
			<pubDate>Wed, 27 Aug 2014 12:46:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100175675.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4906/roche-acquires-respiratory-therapy-firm-at-8-3-bn.html</guid>
		</item>	
				<item>
			<title>AB SCIEX, Dalton Pharma to advance antibody drug conjugate analysis</title>
			<atom:link href="https://biospectrumasia.com/news/34/4937/ab-sciex-dalton-pharma-to-advance-antibody-drug-conjugate-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4937/ab-sciex-dalton-pharma-to-advance-antibody-drug-conjugate-analysis.html</link>
			<pubDate>Wed, 27 Aug 2014 12:42:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/faces-63516-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4937/ab-sciex-dalton-pharma-to-advance-antibody-drug-conjugate-analysis.html</guid>
		</item>	
				<item>
			<title>Imugene appoints Mr Charles Walker as CEO</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/4640/imugene-appoints-mr-charles-walker-as-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/4640/imugene-appoints-mr-charles-walker-as-ceo.html</link>
			<pubDate>Tue, 26 Aug 2014 12:02:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10048343.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/4640/imugene-appoints-mr-charles-walker-as-ceo.html</guid>
		</item>	
				<item>
			<title>FDA approves single dosage HIV drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4515/fda-approves-single-dosage-hiv-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4515/fda-approves-single-dosage-hiv-drug.html</link>
			<pubDate>Mon, 25 Aug 2014 17:53:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100145251.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4515/fda-approves-single-dosage-hiv-drug.html</guid>
		</item>	
				<item>
			<title>DNA repair drug could treat leukaemia: Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/4514/dna-repair-drug-could-treat-leukaemia-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4514/dna-repair-drug-could-treat-leukaemia-singapore.html</link>
			<pubDate>Mon, 25 Aug 2014 17:50:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-institute-singapore.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4514/dna-repair-drug-could-treat-leukaemia-singapore.html</guid>
		</item>	
				<item>
			<title>Hope for COPD: Network Verification Challenge </title>
			<atom:link href="https://biospectrumasia.com/news/34/6161/hope-for-copd-network-verification-challenge-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6161/hope-for-copd-network-verification-challenge-.html</link>
			<pubDate>Thu, 21 Aug 2014 12:25:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wave-376969-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6161/hope-for-copd-network-verification-challenge-.html</guid>
		</item>	
				<item>
			<title>Novartis partners with TB alliance  </title>
			<atom:link href="https://biospectrumasia.com/news/34/6156/novartis-partners-with-tb-alliance-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6156/novartis-partners-with-tb-alliance-.html</link>
			<pubDate>Thu, 21 Aug 2014 11:32:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100137959.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6156/novartis-partners-with-tb-alliance-.html</guid>
		</item>	
				<item>
			<title>A*STAR, Japanese bank ink partnership </title>
			<atom:link href="https://biospectrumasia.com/news/34/6105/astar-japanese-bank-ink-partnership-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6105/astar-japanese-bank-ink-partnership-.html</link>
			<pubDate>Wed, 20 Aug 2014 16:14:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-smbcweb2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6105/astar-japanese-bank-ink-partnership-.html</guid>
		</item>	
				<item>
			<title>HUYA, Changzhou to harbour biotech innovation</title>
			<atom:link href="https://biospectrumasia.com/news/34/6015/huya-changzhou-to-harbour-biotech-innovation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6015/huya-changzhou-to-harbour-biotech-innovation.html</link>
			<pubDate>Tue, 19 Aug 2014 12:22:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/exchange-of-ideas-81822-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6015/huya-changzhou-to-harbour-biotech-innovation.html</guid>
		</item>	
				<item>
			<title>Shimadzu launches i-series of HPLC system in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/6019/shimadzu-launches-i-series-of-hplc-system-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6019/shimadzu-launches-i-series-of-hplc-system-in-singapore.html</link>
			<pubDate>Tue, 19 Aug 2014 12:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sandhya-shimadzu.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6019/shimadzu-launches-i-series-of-hplc-system-in-singapore.html</guid>
		</item>	
				<item>
			<title>FDA to review Pfizer&#039;s meningococcal disease drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5722/fda-to-review-pfizers-meningococcal-disease-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5722/fda-to-review-pfizers-meningococcal-disease-drug.html</link>
			<pubDate>Fri, 15 Aug 2014 14:24:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100241307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5722/fda-to-review-pfizers-meningococcal-disease-drug.html</guid>
		</item>	
				<item>
			<title>TNI BioTech, Qianjiang Pharma join hands</title>
			<atom:link href="https://biospectrumasia.com/news/34/5719/tni-biotech-qianjiang-pharma-join-hands.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5719/tni-biotech-qianjiang-pharma-join-hands.html</link>
			<pubDate>Thu, 14 Aug 2014 14:26:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hands-14109-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5719/tni-biotech-qianjiang-pharma-join-hands.html</guid>
		</item>	
				<item>
			<title>3SBio to develop antibody for acute leukemia</title>
			<atom:link href="https://biospectrumasia.com/news/34/5224/3sbio-to-develop-antibody-for-acute-leukemia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5224/3sbio-to-develop-antibody-for-acute-leukemia.html</link>
			<pubDate>Fri, 08 Aug 2014 09:59:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/office-227746-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5224/3sbio-to-develop-antibody-for-acute-leukemia.html</guid>
		</item>	
				<item>
			<title>Taiwan to develop cancer drug with target delivery</title>
			<atom:link href="https://biospectrumasia.com/news/34/5629/taiwan-to-develop-cancer-drug-with-target-delivery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5629/taiwan-to-develop-cancer-drug-with-target-delivery.html</link>
			<pubDate>Tue, 05 Aug 2014 10:55:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100275284.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5629/taiwan-to-develop-cancer-drug-with-target-delivery.html</guid>
		</item>	
				<item>
			<title>Malaria drug may cure asthma: Research</title>
			<atom:link href="https://biospectrumasia.com/news/34/5147/malaria-drug-may-cure-asthma-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5147/malaria-drug-may-cure-asthma-research.html</link>
			<pubDate>Mon, 04 Aug 2014 11:59:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10052603.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5147/malaria-drug-may-cure-asthma-research.html</guid>
		</item>	
				<item>
			<title>Japan gets Certara&#039;s D360 to boost drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html</link>
			<pubDate>Mon, 04 Aug 2014 10:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100241307.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5232/japan-gets-certaras-d360-to-boost-drug-discovery.html</guid>
		</item>	
				<item>
			<title>UK pours $500 mn in genome sequencing</title>
			<atom:link href="https://biospectrumasia.com/news/34/5024/uk-pours-500-mn-in-genome-sequencing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5024/uk-pours-500-mn-in-genome-sequencing.html</link>
			<pubDate>Fri, 01 Aug 2014 11:12:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/david-cameron-official.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5024/uk-pours-500-mn-in-genome-sequencing.html</guid>
		</item>	
				<item>
			<title>Novartis positive with anti-malaria drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4572/novartis-positive-with-anti-malaria-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4572/novartis-positive-with-anti-malaria-drug.html</link>
			<pubDate>Thu, 31 Jul 2014 14:40:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tiger-mosquito-49141-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4572/novartis-positive-with-anti-malaria-drug.html</guid>
		</item>	
				<item>
			<title>Breast cancer drug market to touch $13.1 bn by 2020&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html</link>
			<pubDate>Thu, 24 Jul 2014 10:48:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100190703.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4662/breast-cancer-drug-market-to-touch-13-1-bn-by-2020.html</guid>
		</item>	
				<item>
			<title>Biotron&#039;s HIV drug candidate reverses impaired immune system </title>
			<atom:link href="https://biospectrumasia.com/news/34/3426/biotrons-hiv-drug-candidate-reverses-impaired-immune-system-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3426/biotrons-hiv-drug-candidate-reverses-impaired-immune-system-.html</link>
			<pubDate>Thu, 24 Jul 2014 10:27:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hiv-218541-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3426/biotrons-hiv-drug-candidate-reverses-impaired-immune-system-.html</guid>
		</item>	
				<item>
			<title>BI drug gets &#039;breakthrough therapy designation&#039; </title>
			<atom:link href="https://biospectrumasia.com/news/34/4767/bi-drug-gets-breakthrough-therapy-designation-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4767/bi-drug-gets-breakthrough-therapy-designation-.html</link>
			<pubDate>Wed, 23 Jul 2014 08:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hook-111316-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4767/bi-drug-gets-breakthrough-therapy-designation-.html</guid>
		</item>	
				<item>
			<title>Aussie firm Phosphagenics raises $11.45 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/4425/aussie-firm-phosphagenics-raises-11-45-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4425/aussie-firm-phosphagenics-raises-11-45-mn.html</link>
			<pubDate>Tue, 22 Jul 2014 13:31:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chrome-103695-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4425/aussie-firm-phosphagenics-raises-11-45-mn.html</guid>
		</item>	
				<item>
			<title>Aussie drug delivery firm raises $19.3 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/217/aussie-drug-delivery-firm-raises-19-3-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/217/aussie-drug-delivery-firm-raises-19-3-mn.html</link>
			<pubDate>Tue, 15 Jul 2014 15:08:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccination-67477-640.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/217/aussie-drug-delivery-firm-raises-19-3-mn.html</guid>
		</item>	
				<item>
			<title>Otsuka, Lundbeck files NDA for schizophrenia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html</link>
			<pubDate>Tue, 15 Jul 2014 15:00:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100110567.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/262/otsuka-lundbeck-files-nda-for-schizophrenia-drug.html</guid>
		</item>	
				<item>
			<title>Novartis gets positive result in psoriasis PhIII drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/5602/novartis-gets-positive-result-in-psoriasis-phiii-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5602/novartis-gets-positive-result-in-psoriasis-phiii-drug.html</link>
			<pubDate>Thu, 10 Jul 2014 17:39:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/le-metier-de-beaute-gets-phylogica-license-for-skin-repair-peptide-for-use-in-anti-aging-creams.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5602/novartis-gets-positive-result-in-psoriasis-phiii-drug.html</guid>
		</item>	
				<item>
			<title>Boston Strategics gets rights for Eisai&#039;s cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html</link>
			<pubDate>Thu, 10 Jul 2014 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100234673.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4389/boston-strategics-gets-rights-for-eisais-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Eli Lilly, China firm to co-develop diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/761/eli-lilly-china-firm-to-co-develop-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/761/eli-lilly-china-firm-to-co-develop-diabetes-drug.html</link>
			<pubDate>Mon, 07 Jul 2014 18:30:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100260610.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/761/eli-lilly-china-firm-to-co-develop-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Novotech to support drug development in Korea</title>
			<atom:link href="https://biospectrumasia.com/news/34/960/novotech-to-support-drug-development-in-korea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/960/novotech-to-support-drug-development-in-korea.html</link>
			<pubDate>Sat, 05 Jul 2014 17:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10056679.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/960/novotech-to-support-drug-development-in-korea.html</guid>
		</item>	
				<item>
			<title>Glenmark&#039;s MAb drug enters human trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/4307/glenmarks-mab-drug-enters-human-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4307/glenmarks-mab-drug-enters-human-trials.html</link>
			<pubDate>Fri, 04 Jul 2014 13:14:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100219514.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4307/glenmarks-mab-drug-enters-human-trials.html</guid>
		</item>	
				<item>
			<title>Actavis to acquire Forest Lab</title>
			<atom:link href="https://biospectrumasia.com/news/34/7983/actavis-to-acquire-forest-lab.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7983/actavis-to-acquire-forest-lab.html</link>
			<pubDate>Tue, 01 Jul 2014 13:10:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100110576.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7983/actavis-to-acquire-forest-lab.html</guid>
		</item>	
				<item>
			<title>Gilead files NDA for Hep C drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/424/gilead-files-nda-for-hep-c-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/424/gilead-files-nda-for-hep-c-drug-in-japan.html</link>
			<pubDate>Mon, 30 Jun 2014 11:00:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100108924.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/424/gilead-files-nda-for-hep-c-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>Bionomics, Merck collaborate on drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/5562/bionomics-merck-collaborate-on-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5562/bionomics-merck-collaborate-on-drug-development.html</link>
			<pubDate>Tue, 24 Jun 2014 16:54:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100110567.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5562/bionomics-merck-collaborate-on-drug-development.html</guid>
		</item>	
				<item>
			<title>Takeda terminates prostrate cancer drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/5413/takeda-terminates-prostrate-cancer-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5413/takeda-terminates-prostrate-cancer-drug-trial.html</link>
			<pubDate>Tue, 24 Jun 2014 09:27:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100180747.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5413/takeda-terminates-prostrate-cancer-drug-trial.html</guid>
		</item>	
				<item>
			<title>3SBio, Selecta join hands to develop gout therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/3741/3sbio-selecta-join-hands-to-develop-gout-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3741/3sbio-selecta-join-hands-to-develop-gout-therapy.html</link>
			<pubDate>Fri, 20 Jun 2014 16:02:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaccine-research-and-testing.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3741/3sbio-selecta-join-hands-to-develop-gout-therapy.html</guid>
		</item>	
				<item>
			<title>Dengue incurs annual cost of $950 mn to SE Asia </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/6729/dengue-incurs-annual-cost-of-950-mn-to-se-asia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/6729/dengue-incurs-annual-cost-of-950-mn-to-se-asia-.html</link>
			<pubDate>Fri, 20 Jun 2014 09:14:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/donal-shepard-brandeis-uni.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/6729/dengue-incurs-annual-cost-of-950-mn-to-se-asia-.html</guid>
		</item>	
				<item>
			<title>Ex-Novartis employee arrested for fudging data </title>
			<atom:link href="https://biospectrumasia.com/news/34/4076/ex-novartis-employee-arrested-for-fudging-data-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4076/ex-novartis-employee-arrested-for-fudging-data-.html</link>
			<pubDate>Thu, 12 Jun 2014 16:50:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10032599.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4076/ex-novartis-employee-arrested-for-fudging-data-.html</guid>
		</item>	
				<item>
			<title>Pradaxa gets EU approval for DVT</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2809/pradaxa-gets-eu-approval-for-dvt.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2809/pradaxa-gets-eu-approval-for-dvt.html</link>
			<pubDate>Tue, 10 Jun 2014 12:13:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100129427.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2809/pradaxa-gets-eu-approval-for-dvt.html</guid>
		</item>	
				<item>
			<title>GSK announces failure of cancer drug trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/4146/gsk-announces-failure-of-cancer-drug-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4146/gsk-announces-failure-of-cancer-drug-trial-.html</link>
			<pubDate>Thu, 05 Jun 2014 17:37:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10086051.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4146/gsk-announces-failure-of-cancer-drug-trial-.html</guid>
		</item>	
				<item>
			<title>Teva to acquire migraine drug firm at $825 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html</link>
			<pubDate>Wed, 04 Jun 2014 13:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100230594.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4216/teva-to-acquire-migraine-drug-firm-at-825-mn.html</guid>
		</item>	
				<item>
			<title>Zydus initiates Ph III trial of Lipaglyn for lipodystrophy</title>
			<atom:link href="https://biospectrumasia.com/news/34/4336/zydus-initiates-ph-iii-trial-of-lipaglyn-for-lipodystrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4336/zydus-initiates-ph-iii-trial-of-lipaglyn-for-lipodystrophy.html</link>
			<pubDate>Mon, 02 Jun 2014 12:00:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4336/zydus-initiates-ph-iii-trial-of-lipaglyn-for-lipodystrophy.html</guid>
		</item>	
				<item>
			<title>Mesoblast to set up stem cell drug plant in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/590/mesoblast-to-set-up-stem-cell-drug-plant-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/590/mesoblast-to-set-up-stem-cell-drug-plant-in-singapore.html</link>
			<pubDate>Thu, 29 May 2014 11:51:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/silviu-itescu-chief-executive-mesoblast.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/590/mesoblast-to-set-up-stem-cell-drug-plant-in-singapore.html</guid>
		</item>	
				<item>
			<title>Orient launches prostate cancer drug in SE Asia</title>
			<atom:link href="https://biospectrumasia.com/news/34/8082/orient-launches-prostate-cancer-drug-in-se-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8082/orient-launches-prostate-cancer-drug-in-se-asia.html</link>
			<pubDate>Tue, 27 May 2014 10:59:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100229135.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8082/orient-launches-prostate-cancer-drug-in-se-asia.html</guid>
		</item>	
				<item>
			<title>Singapore firm to launch next-gen cancer study device </title>
			<atom:link href="https://biospectrumasia.com/news/34/2322/singapore-firm-to-launch-next-gen-cancer-study-device-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2322/singapore-firm-to-launch-next-gen-cancer-study-device-.html</link>
			<pubDate>Tue, 27 May 2014 09:52:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clearcell-fx-system.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2322/singapore-firm-to-launch-next-gen-cancer-study-device-.html</guid>
		</item>	
				<item>
			<title>Sanford-Burnham, Daiichi form new alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/581/sanford-burnham-daiichi-form-new-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/581/sanford-burnham-daiichi-form-new-alliance.html</link>
			<pubDate>Mon, 26 May 2014 09:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10048225.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/581/sanford-burnham-daiichi-form-new-alliance.html</guid>
		</item>	
				<item>
			<title>Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/1007/zhejiang-medicine-ambrx-to-develop-antibody-drug-conjugate-for-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1007/zhejiang-medicine-ambrx-to-develop-antibody-drug-conjugate-for-breast-cancer.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1007/zhejiang-medicine-ambrx-to-develop-antibody-drug-conjugate-for-breast-cancer.html</guid>
		</item>	
				<item>
			<title>AbbVie invests $320 mn in bilogics manufacturing in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/1245/abbvie-invests-320-mn-in-bilogics-manufacturing-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1245/abbvie-invests-320-mn-in-bilogics-manufacturing-in-singapore.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1245/abbvie-invests-320-mn-in-bilogics-manufacturing-in-singapore.html</guid>
		</item>	
				<item>
			<title>Cellmid gets positive sign with Midkine antibody for kidney disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/1289/cellmid-gets-positive-sign-with-midkine-antibody-for-kidney-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1289/cellmid-gets-positive-sign-with-midkine-antibody-for-kidney-disease.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1289/cellmid-gets-positive-sign-with-midkine-antibody-for-kidney-disease.html</guid>
		</item>	
				<item>
			<title>QRxPharma to resubmit NDA to FDA for pain relieving drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/1375/qrxpharma-to-resubmit-nda-to-fda-for-pain-relieving-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1375/qrxpharma-to-resubmit-nda-to-fda-for-pain-relieving-drug.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1375/qrxpharma-to-resubmit-nda-to-fda-for-pain-relieving-drug.html</guid>
		</item>	
				<item>
			<title>Australia invests in autoimmune disease start up firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/1420/australia-invests-in-autoimmune-disease-start-up-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1420/australia-invests-in-autoimmune-disease-start-up-firm.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1420/australia-invests-in-autoimmune-disease-start-up-firm.html</guid>
		</item>	
				<item>
			<title>Australia strengthens scientific collaboration with Indonesia</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/1857/australia-strengthens-scientific-collaboration-with-indonesia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/1857/australia-strengthens-scientific-collaboration-with-indonesia.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/1857/australia-strengthens-scientific-collaboration-with-indonesia.html</guid>
		</item>	
				<item>
			<title>Next-Generation Pipetting</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/2414/next-generation-pipetting.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/2414/next-generation-pipetting.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pipetting-2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/2414/next-generation-pipetting.html</guid>
		</item>	
				<item>
			<title>FDA recommends Takeda&#039;s drug for Chrohn&#039;s disease</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2671/fda-recommends-takedas-drug-for-chrohns-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2671/fda-recommends-takedas-drug-for-chrohns-disease.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2671/fda-recommends-takedas-drug-for-chrohns-disease.html</guid>
		</item>	
				<item>
			<title>Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3396/coherus-starts-ph3-trial-of-rheumatoid-arthritis-biosimilar-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3396/coherus-starts-ph3-trial-of-rheumatoid-arthritis-biosimilar-drug.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100180384.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3396/coherus-starts-ph3-trial-of-rheumatoid-arthritis-biosimilar-drug.html</guid>
		</item>	
				<item>
			<title>Clinical trial drugs must adopt highest GMP standards</title>
			<atom:link href="https://biospectrumasia.com/news/34/4138/clinical-trial-drugs-must-adopt-highest-gmp-standards.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4138/clinical-trial-drugs-must-adopt-highest-gmp-standards.html</link>
			<pubDate>Thu, 24 Apr 2014 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4138/clinical-trial-drugs-must-adopt-highest-gmp-standards.html</guid>
		</item>	
				<item>
			<title>FDA approves Merck&#039;s drug for pollen-induced allergic rhinitis</title>
			<atom:link href="https://biospectrumasia.com/news/34/4114/fda-approves-mercks-drug-for-pollen-induced-allergic-rhinitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4114/fda-approves-mercks-drug-for-pollen-induced-allergic-rhinitis.html</link>
			<pubDate>Mon, 21 Apr 2014 10:56:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/are-regeneron-and-sanofi-in-trouble.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4114/fda-approves-mercks-drug-for-pollen-induced-allergic-rhinitis.html</guid>
		</item>	
				<item>
			<title>Women are on greater risk for Alzheimer&#039;s disease: Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3870/women-are-on-greater-risk-for-alzheimers-disease-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3870/women-are-on-greater-risk-for-alzheimers-disease-report.html</link>
			<pubDate>Thu, 17 Apr 2014 14:45:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3870/women-are-on-greater-risk-for-alzheimers-disease-report.html</guid>
		</item>	
				<item>
			<title>Boehringer IngelheimÂ´s Volasertib gets orphan drug designation in EU, US</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3867/boehringer-ingelheims-volasertib-gets-orphan-drug-designation-in-eu-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3867/boehringer-ingelheims-volasertib-gets-orphan-drug-designation-in-eu-us.html</link>
			<pubDate>Thu, 17 Apr 2014 14:04:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100166303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3867/boehringer-ingelheims-volasertib-gets-orphan-drug-designation-in-eu-us.html</guid>
		</item>	
				<item>
			<title>Money churning drugs of 2014: Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3866/money-churning-drugs-of-2014-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3866/money-churning-drugs-of-2014-report.html</link>
			<pubDate>Thu, 17 Apr 2014 12:15:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-s-hepatitis-c-drug-sovaldi-can-cure-the-disease-faster-and-more-reliably-than-previous-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3866/money-churning-drugs-of-2014-report.html</guid>
		</item>	
				<item>
			<title>Merck Millipore appoints Dr Udit Batra as CEO and President</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/6496/merck-millipore-appoints-dr-udit-batra-as-ceo-and-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/6496/merck-millipore-appoints-dr-udit-batra-as-ceo-and-president.html</link>
			<pubDate>Tue, 15 Apr 2014 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-udit-batra.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/6496/merck-millipore-appoints-dr-udit-batra-as-ceo-and-president.html</guid>
		</item>	
				<item>
			<title>Thermo Fisher Scientific to support research in NUS</title>
			<atom:link href="https://biospectrumasia.com/news/34/3535/thermo-fisher-scientific-to-support-research-in-nus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3535/thermo-fisher-scientific-to-support-research-in-nus.html</link>
			<pubDate>Mon, 14 Apr 2014 10:32:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10071144.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3535/thermo-fisher-scientific-to-support-research-in-nus.html</guid>
		</item>	
				<item>
			<title>Merck Serono starts Phase III non-small cell lung cancer drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2829/merck-serono-starts-phase-iii-non-small-cell-lung-cancer-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2829/merck-serono-starts-phase-iii-non-small-cell-lung-cancer-drug-trial.html</link>
			<pubDate>Wed, 09 Apr 2014 08:57:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2829/merck-serono-starts-phase-iii-non-small-cell-lung-cancer-drug-trial.html</guid>
		</item>	
				<item>
			<title> AMRI acquires Cedarburg at $41mn </title>
			<atom:link href="https://biospectrumasia.com/news/34/6689/-amri-acquires-cedarburg-at-41mn-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6689/-amri-acquires-cedarburg-at-41mn-.html</link>
			<pubDate>Tue, 08 Apr 2014 09:47:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6689/-amri-acquires-cedarburg-at-41mn-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca to integrate dendrimer drug delivery technology in oncology portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/34/3659/astrazeneca-to-integrate-dendrimer-drug-delivery-technology-in-oncology-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3659/astrazeneca-to-integrate-dendrimer-drug-delivery-technology-in-oncology-portfolio.html</link>
			<pubDate>Mon, 07 Apr 2014 11:55:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/almac-establishes-regional-hubs-in-singapore-and-japan-to-provide-clinical-trial-solutions.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3659/astrazeneca-to-integrate-dendrimer-drug-delivery-technology-in-oncology-portfolio.html</guid>
		</item>	
				<item>
			<title>Mundipharma to develop cancer pain patch for German firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/3652/mundipharma-to-develop-cancer-pain-patch-for-german-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3652/mundipharma-to-develop-cancer-pain-patch-for-german-firm.html</link>
			<pubDate>Fri, 04 Apr 2014 10:51:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/beijing-eastern-to-give-nutriceuticals-at-internet-cafes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3652/mundipharma-to-develop-cancer-pain-patch-for-german-firm.html</guid>
		</item>	
				<item>
			<title>Evotec, Debiopharm ink drug discovey alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/3639/evotec-debiopharm-ink-drug-discovey-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3639/evotec-debiopharm-ink-drug-discovey-alliance.html</link>
			<pubDate>Wed, 02 Apr 2014 12:37:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3639/evotec-debiopharm-ink-drug-discovey-alliance.html</guid>
		</item>	
				<item>
			<title>AMRI to acquire Cedarburg Pharmaceuticals at $38.2 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/3614/amri-to-acquire-cedarburg-pharmaceuticals-at-38-2-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3614/amri-to-acquire-cedarburg-pharmaceuticals-at-38-2-mn.html</link>
			<pubDate>Wed, 26 Mar 2014 12:17:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3614/amri-to-acquire-cedarburg-pharmaceuticals-at-38-2-mn.html</guid>
		</item>	
				<item>
			<title>Novartis gets FDA approval for chronic idiopathic urticaria drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3603/novartis-gets-fda-approval-for-chronic-idiopathic-urticaria-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3603/novartis-gets-fda-approval-for-chronic-idiopathic-urticaria-drug.html</link>
			<pubDate>Tue, 25 Mar 2014 12:11:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3603/novartis-gets-fda-approval-for-chronic-idiopathic-urticaria-drug.html</guid>
		</item>	
				<item>
			<title>Let&#039;s make India known for innovations&#039;</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/3604/lets-make-india-known-for-innovations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/3604/lets-make-india-known-for-innovations.html</link>
			<pubDate>Tue, 25 Mar 2014 11:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-krishna-ella-chairman-and-managing-director-bharat-biotech-and-member-of-the-scientific-advisory-committee-to-the-prime-minister-india-262x174.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/3604/lets-make-india-known-for-innovations.html</guid>
		</item>	
				<item>
			<title>Global prophylactic HPV vaccine market to reach $2.2bn by 2022&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/4607/global-prophylactic-hpv-vaccine-market-to-reach-2-2bn-by-2022.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4607/global-prophylactic-hpv-vaccine-market-to-reach-2-2bn-by-2022.html</link>
			<pubDate>Thu, 20 Mar 2014 11:22:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4607/global-prophylactic-hpv-vaccine-market-to-reach-2-2bn-by-2022.html</guid>
		</item>	
				<item>
			<title>Charles River to acquire Galapagos at USD 179 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/2024/charles-river-to-acquire-galapagos-at-usd-179-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2024/charles-river-to-acquire-galapagos-at-usd-179-mn.html</link>
			<pubDate>Wed, 19 Mar 2014 09:51:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2024/charles-river-to-acquire-galapagos-at-usd-179-mn.html</guid>
		</item>	
				<item>
			<title>FDA approves SNDA for BMS-Pfizer DVT prevention drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3580/fda-approves-snda-for-bms-pfizer-dvt-prevention-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3580/fda-approves-snda-for-bms-pfizer-dvt-prevention-drug.html</link>
			<pubDate>Wed, 19 Mar 2014 09:36:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3580/fda-approves-snda-for-bms-pfizer-dvt-prevention-drug.html</guid>
		</item>	
				<item>
			<title>Non-small cell lung cancer therapeutics APAC market to touch $2.9 bn by 2019&#039;</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html</link>
			<pubDate>Wed, 19 Mar 2014 09:04:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4165/non-small-cell-lung-cancer-therapeutics-apac-market-to-touch-2-9-bn-by-2019.html</guid>
		</item>	
				<item>
			<title>TaiGen gets TFDA nod for bacterial pneumonia drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1532/taigen-gets-tfda-nod-for-bacterial-pneumonia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1532/taigen-gets-tfda-nod-for-bacterial-pneumonia-drug.html</link>
			<pubDate>Tue, 18 Mar 2014 08:08:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1532/taigen-gets-tfda-nod-for-bacterial-pneumonia-drug.html</guid>
		</item>	
				<item>
			<title>Aussie firm gets TGA approval for pancreatic cancer drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/646/aussie-firm-gets-tga-approval-for-pancreatic-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/646/aussie-firm-gets-tga-approval-for-pancreatic-cancer-drug.html</link>
			<pubDate>Tue, 18 Mar 2014 07:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/646/aussie-firm-gets-tga-approval-for-pancreatic-cancer-drug.html</guid>
		</item>	
				<item>
			<title>BioPharma Asia: Dr Deborah Rathjen wins Life Science Woman Executive of the Year award</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/2108/biopharma-asia-dr-deborah-rathjen-wins-life-science-woman-executive-of-the-year-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/2108/biopharma-asia-dr-deborah-rathjen-wins-life-science-woman-executive-of-the-year-award.html</link>
			<pubDate>Mon, 17 Mar 2014 10:09:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-deborah-rathjen-the-new-chair-of-australia-s-pharmaceuticals-industry-council-pic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/2108/biopharma-asia-dr-deborah-rathjen-wins-life-science-woman-executive-of-the-year-award.html</guid>
		</item>	
				<item>
			<title>BioPharma Asia: Bionomics wins Innovative Asian Biotech of the Year Award</title>
			<atom:link href="https://biospectrumasia.com/news/34/3577/biopharma-asia-bionomics-wins-innovative-asian-biotech-of-the-year-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3577/biopharma-asia-bionomics-wins-innovative-asian-biotech-of-the-year-award.html</link>
			<pubDate>Mon, 17 Mar 2014 10:01:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3577/biopharma-asia-bionomics-wins-innovative-asian-biotech-of-the-year-award.html</guid>
		</item>	
				<item>
			<title>BioPharma Asia: Is Asia ready to boost global drug pipeline?</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4004/biopharma-asia-is-asia-ready-to-boost-global-drug-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4004/biopharma-asia-is-asia-ready-to-boost-global-drug-pipeline.html</link>
			<pubDate>Mon, 17 Mar 2014 09:53:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4004/biopharma-asia-is-asia-ready-to-boost-global-drug-pipeline.html</guid>
		</item>	
				<item>
			<title>Regeneron, Sanofi brain drug has side effects: US FDA </title>
			<atom:link href="https://biospectrumasia.com/news/34/2175/regeneron-sanofi-brain-drug-has-side-effects-us-fda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2175/regeneron-sanofi-brain-drug-has-side-effects-us-fda-.html</link>
			<pubDate>Tue, 11 Mar 2014 17:41:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/are-regeneron-and-sanofi-in-trouble.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2175/regeneron-sanofi-brain-drug-has-side-effects-us-fda-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, KHIDI setup cancer research program </title>
			<atom:link href="https://biospectrumasia.com/news/34/3587/astrazeneca-khidi-setup-cancer-research-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3587/astrazeneca-khidi-setup-cancer-research-program-.html</link>
			<pubDate>Tue, 11 Mar 2014 17:07:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-korean-cancer-patients-astrazeneca-and-korea-health-industry-development-institute-khidi-sig-mou-to-further-oncology-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3587/astrazeneca-khidi-setup-cancer-research-program-.html</guid>
		</item>	
				<item>
			<title>Biostar, Shaanxi Uni to co-develop liver cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3192/biostar-shaanxi-uni-to-co-develop-liver-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3192/biostar-shaanxi-uni-to-co-develop-liver-cancer-drug.html</link>
			<pubDate>Fri, 07 Mar 2014 10:59:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3192/biostar-shaanxi-uni-to-co-develop-liver-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Phosphagenics appoints three new non-executive directors</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/3164/phosphagenics-appoints-three-new-non-executive-directors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/3164/phosphagenics-appoints-three-new-non-executive-directors.html</link>
			<pubDate>Tue, 04 Mar 2014 11:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100166303.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/3164/phosphagenics-appoints-three-new-non-executive-directors.html</guid>
		</item>	
				<item>
			<title>Nuvilex, Lincoln Park Fund sign $27 mn stock deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/1995/nuvilex-lincoln-park-fund-sign-27-mn-stock-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1995/nuvilex-lincoln-park-fund-sign-27-mn-stock-deal.html</link>
			<pubDate>Fri, 21 Feb 2014 18:18:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nuvilex-lands-usd27-million-to-advance-late-phase-clinical-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1995/nuvilex-lincoln-park-fund-sign-27-mn-stock-deal.html</guid>
		</item>	
				<item>
			<title>Jubilant, Janssen expand drug discovery alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/3236/jubilant-janssen-expand-drug-discovery-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3236/jubilant-janssen-expand-drug-discovery-alliance.html</link>
			<pubDate>Fri, 21 Feb 2014 11:31:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jubilant-biosys-and-janssen-pharmaceutica-expand-collaboration-in-multiple-therapeutic-areas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3236/jubilant-janssen-expand-drug-discovery-alliance.html</guid>
		</item>	
				<item>
			<title>Prana gets +ve results in phase II Huntington trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/6160/prana-gets-ve-results-in-phase-ii-huntington-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6160/prana-gets-ve-results-in-phase-ii-huntington-trial.html</link>
			<pubDate>Wed, 19 Feb 2014 15:21:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-based-prana-s-phase-ii-clinical-trial-investigating-pbt2-as-a-treatment-for-huntington-disease-shows-positive-results.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6160/prana-gets-ve-results-in-phase-ii-huntington-trial.html</guid>
		</item>	
				<item>
			<title>MedImmune, UCSF enter 3-year R&amp;D deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/3016/medimmune-ucsf-enter-3-year-rd-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3016/medimmune-ucsf-enter-3-year-rd-deal.html</link>
			<pubDate>Tue, 18 Feb 2014 11:32:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astrazeneca-global-biologics-r-d-arm-medimmune-entered-into-a-three-year-deal-with-university-of-california-san-francisco-ucsf.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3016/medimmune-ucsf-enter-3-year-rd-deal.html</guid>
		</item>	
				<item>
			<title>Novartis acquires cancer firm CoStim </title>
			<atom:link href="https://biospectrumasia.com/news/34/1229/novartis-acquires-cancer-firm-costim-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1229/novartis-acquires-cancer-firm-costim-.html</link>
			<pubDate>Tue, 18 Feb 2014 10:45:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-acquires-costim.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1229/novartis-acquires-cancer-firm-costim-.html</guid>
		</item>	
				<item>
			<title>Biogen to commercialize MS therapies in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/34/2990/biogen-to-commercialize-ms-therapies-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2990/biogen-to-commercialize-ms-therapies-in-asia.html</link>
			<pubDate>Tue, 11 Feb 2014 13:26:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2990/biogen-to-commercialize-ms-therapies-in-asia.html</guid>
		</item>	
				<item>
			<title>Alchemia appoints new chairman</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/954/alchemia-appoints-new-chairman.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/954/alchemia-appoints-new-chairman.html</link>
			<pubDate>Tue, 11 Feb 2014 11:50:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/954/alchemia-appoints-new-chairman.html</guid>
		</item>	
				<item>
			<title>Merck, Samsung to co-develop diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4132/merck-samsung-to-co-develop-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4132/merck-samsung-to-co-develop-diabetes-drug.html</link>
			<pubDate>Tue, 11 Feb 2014 11:36:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4132/merck-samsung-to-co-develop-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Aspirin may reduce ovarian cancer risk: NIH</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5196/aspirin-may-reduce-ovarian-cancer-risk-nih.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5196/aspirin-may-reduce-ovarian-cancer-risk-nih.html</link>
			<pubDate>Fri, 07 Feb 2014 12:28:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10015739.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5196/aspirin-may-reduce-ovarian-cancer-risk-nih.html</guid>
		</item>	
				<item>
			<title>Edison Pharma, DSP enter $4 bn metablosim drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html</link>
			<pubDate>Tue, 04 Feb 2014 14:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edison-pharma-dsp-to-co-develop-cellular-metablosim-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/430/edison-pharma-dsp-enter-4-bn-metablosim-drug-deal.html</guid>
		</item>	
				<item>
			<title>Cancer claimed 8.2 mn lives in 2012: UN</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/896/cancer-claimed-8-2-mn-lives-in-2012-un.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/896/cancer-claimed-8-2-mn-lives-in-2012-un.html</link>
			<pubDate>Tue, 04 Feb 2014 14:41:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/un-cancer-is-the-biggest-killer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/896/cancer-claimed-8-2-mn-lives-in-2012-un.html</guid>
		</item>	
				<item>
			<title>Suven gets patents for NCE in Canada, China and India </title>
			<atom:link href="https://biospectrumasia.com/news/34/8290/suven-gets-patents-for-nce-in-canada-china-and-india-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8290/suven-gets-patents-for-nce-in-canada-china-and-india-.html</link>
			<pubDate>Tue, 04 Feb 2014 07:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-neurodegenerative-patients-suven-gets-patents-in-canada-china-and-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8290/suven-gets-patents-for-nce-in-canada-china-and-india-.html</guid>
		</item>	
				<item>
			<title>Pall to acquire Atmi for $185 million</title>
			<atom:link href="https://biospectrumasia.com/news/34/974/pall-to-acquire-atmi-for-185-million.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/974/pall-to-acquire-atmi-for-185-million.html</link>
			<pubDate>Mon, 03 Feb 2014 13:05:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pall-to-acquire-atmi-for-usd185-million.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/974/pall-to-acquire-atmi-for-185-million.html</guid>
		</item>	
				<item>
			<title>Bionomics cancer trial shows +ve results </title>
			<atom:link href="https://biospectrumasia.com/news/34/1014/bionomics-cancer-trial-shows-ve-results-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1014/bionomics-cancer-trial-shows-ve-results-.html</link>
			<pubDate>Mon, 03 Feb 2014 12:32:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-ovarian-cancer-patients-bionomics-phase-i-clinical-trial-of-cancer-drug-candidate-bnc105-positive-results.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1014/bionomics-cancer-trial-shows-ve-results-.html</guid>
		</item>	
				<item>
			<title>Singapore&#039;s first flu vaccine clears phase I trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/3504/singapores-first-flu-vaccine-clears-phase-i-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3504/singapores-first-flu-vaccine-clears-phase-i-trial.html</link>
			<pubDate>Thu, 30 Jan 2014 13:14:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-s-first-flu-vaccine-clears-phase-i-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3504/singapores-first-flu-vaccine-clears-phase-i-trial.html</guid>
		</item>	
				<item>
			<title>Sanofi begins biopharmaceutical plant construction</title>
			<atom:link href="https://biospectrumasia.com/news/34/3448/sanofi-begins-biopharmaceutical-plant-construction.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3448/sanofi-begins-biopharmaceutical-plant-construction.html</link>
			<pubDate>Thu, 30 Jan 2014 13:08:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sanofi-begins-biopharmaceutical-plant-construction.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3448/sanofi-begins-biopharmaceutical-plant-construction.html</guid>
		</item>	
				<item>
			<title>STA to commercialize leukemia drug in Australia</title>
			<atom:link href="https://biospectrumasia.com/news/34/6051/sta-to-commercialize-leukemia-drug-in-australia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6051/sta-to-commercialize-leukemia-drug-in-australia.html</link>
			<pubDate>Thu, 30 Jan 2014 13:02:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ariad-pharmaceuticals-has-granted-specialised-therapeutics-australia-sta-exclusive-rights-to-commercialize-iclusig-ponatinib-in-australia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6051/sta-to-commercialize-leukemia-drug-in-australia.html</guid>
		</item>	
				<item>
			<title>Novartis gets positive regulatory feedback for hive drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4046/novartis-gets-positive-regulatory-feedback-for-hive-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4046/novartis-gets-positive-regulatory-feedback-for-hive-drug.html</link>
			<pubDate>Tue, 28 Jan 2014 13:47:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4046/novartis-gets-positive-regulatory-feedback-for-hive-drug.html</guid>
		</item>	
				<item>
			<title>Takeda initiates Ph3 trial for Ixazomib in Asia</title>
			<atom:link href="https://biospectrumasia.com/news/34/6032/takeda-initiates-ph3-trial-for-ixazomib-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6032/takeda-initiates-ph3-trial-for-ixazomib-in-asia.html</link>
			<pubDate>Tue, 28 Jan 2014 13:47:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6032/takeda-initiates-ph3-trial-for-ixazomib-in-asia.html</guid>
		</item>	
				<item>
			<title>Nanotherapeutics seeks GE help to step up development</title>
			<atom:link href="https://biospectrumasia.com/news/34/3298/nanotherapeutics-seeks-ge-help-to-step-up-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3298/nanotherapeutics-seeks-ge-help-to-step-up-development.html</link>
			<pubDate>Fri, 24 Jan 2014 12:38:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3298/nanotherapeutics-seeks-ge-help-to-step-up-development.html</guid>
		</item>	
				<item>
			<title>TaiGen, Russian firm to co-develop antibiotic</title>
			<atom:link href="https://biospectrumasia.com/news/34/5589/taigen-russian-firm-to-co-develop-antibiotic.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5589/taigen-russian-firm-to-co-develop-antibiotic.html</link>
			<pubDate>Tue, 21 Jan 2014 12:33:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100111799.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5589/taigen-russian-firm-to-co-develop-antibiotic.html</guid>
		</item>	
				<item>
			<title>Cadila, Swedish firm develop arthritis drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/1776/cadila-swedish-firm-develop-arthritis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1776/cadila-swedish-firm-develop-arthritis-drug.html</link>
			<pubDate>Mon, 13 Jan 2014 12:14:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cadila-swedish-firm-develop-arthritis-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1776/cadila-swedish-firm-develop-arthritis-drug.html</guid>
		</item>	
				<item>
			<title>US Pharmacopeial convention expands in China</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/6475/us-pharmacopeial-convention-expands-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/6475/us-pharmacopeial-convention-expands-in-china.html</link>
			<pubDate>Mon, 13 Jan 2014 11:01:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100147494.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/6475/us-pharmacopeial-convention-expands-in-china.html</guid>
		</item>	
				<item>
			<title>Novartis oncology president steps down</title>
			<atom:link href="https://biospectrumasia.com/news/34/2721/novartis-oncology-president-steps-down.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2721/novartis-oncology-president-steps-down.html</link>
			<pubDate>Mon, 13 Jan 2014 10:51:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10045380.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2721/novartis-oncology-president-steps-down.html</guid>
		</item>	
				<item>
			<title>BI, Crystal to co-develop therapeutic antibodies</title>
			<atom:link href="https://biospectrumasia.com/news/34/6885/bi-crystal-to-co-develop-therapeutic-antibodies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6885/bi-crystal-to-co-develop-therapeutic-antibodies.html</link>
			<pubDate>Fri, 10 Jan 2014 16:44:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10016847.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6885/bi-crystal-to-co-develop-therapeutic-antibodies.html</guid>
		</item>	
				<item>
			<title>Rate of drug approvals dips down: Nature Study</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5917/rate-of-drug-approvals-dips-down-nature-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5917/rate-of-drug-approvals-dips-down-nature-study.html</link>
			<pubDate>Fri, 10 Jan 2014 16:43:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100187672.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5917/rate-of-drug-approvals-dips-down-nature-study.html</guid>
		</item>	
				<item>
			<title>BioSpectrum announces the hits and misses of 2013</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7126/biospectrum-announces-the-hits-and-misses-of-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</link>
			<pubDate>Thu, 02 Jan 2014 17:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/what-were-the-biggest-hits-and-misses-of-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7126/biospectrum-announces-the-hits-and-misses-of-2013.html</guid>
		</item>	
				<item>
			<title>Innate Immunotherapeutics completes $9mn IPO</title>
			<atom:link href="https://biospectrumasia.com/news/34/8072/innate-immunotherapeutics-completes-9mn-ipo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8072/innate-immunotherapeutics-completes-9mn-ipo.html</link>
			<pubDate>Wed, 18 Dec 2013 13:47:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innate-immunotherapeutics-completes-usd9mn-ipo.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8072/innate-immunotherapeutics-completes-9mn-ipo.html</guid>
		</item>	
				<item>
			<title>Roche launches FLOW system</title>
			<atom:link href="https://biospectrumasia.com/news/34/442/roche-launches-flow-system.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/442/roche-launches-flow-system.html</link>
			<pubDate>Wed, 18 Dec 2013 13:39:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/roche-launches-flow-system.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/442/roche-launches-flow-system.html</guid>
		</item>	
				<item>
			<title>Drawbridge initiates clinical trial for anaesthetic drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2136/drawbridge-initiates-clinical-trial-for-anaesthetic-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2136/drawbridge-initiates-clinical-trial-for-anaesthetic-drug.html</link>
			<pubDate>Wed, 18 Dec 2013 13:30:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drawbridge-initiates-clinical-trial-for-anaesthetic-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2136/drawbridge-initiates-clinical-trial-for-anaesthetic-drug.html</guid>
		</item>	
				<item>
			<title>Osteoporosis is an emerging crisis in APAC: Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3326/osteoporosis-is-an-emerging-crisis-in-apac-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3326/osteoporosis-is-an-emerging-crisis-in-apac-report.html</link>
			<pubDate>Fri, 13 Dec 2013 17:54:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/number-of-fracture-sufferers-will-rise-dramatically-in-the-coming-decades.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3326/osteoporosis-is-an-emerging-crisis-in-apac-report.html</guid>
		</item>	
				<item>
			<title>Astellas Pharma opens office in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/666/astellas-pharma-opens-office-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/666/astellas-pharma-opens-office-in-singapore.html</link>
			<pubDate>Thu, 12 Dec 2013 12:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-singapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/666/astellas-pharma-opens-office-in-singapore.html</guid>
		</item>	
				<item>
			<title>Admedus acquires Genzyme manufacturing site</title>
			<atom:link href="https://biospectrumasia.com/news/34/1939/admedus-acquires-genzyme-manufacturing-site.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1939/admedus-acquires-genzyme-manufacturing-site.html</link>
			<pubDate>Thu, 12 Dec 2013 11:56:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/as-part-of-the-acquisition-admedus-will-retain-the-necessary-staff-to-run-the-recently-completed-multi-million-dollar-state-of-the-art-facility.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1939/admedus-acquires-genzyme-manufacturing-site.html</guid>
		</item>	
				<item>
			<title>BMS appoints Dr Thomas Lynch to its board</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/7574/bms-appoints-dr-thomas-lynch-to-its-board.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/7574/bms-appoints-dr-thomas-lynch-to-its-board.html</link>
			<pubDate>Wed, 11 Dec 2013 15:05:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-pradeep-k-garg-and-ms-sudha-garg-have-been-hired-to-provide-leadership-to-biomedical-research-foundation-s-brf-louisiana-center-for-molecular-imaging-and-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/7574/bms-appoints-dr-thomas-lynch-to-its-board.html</guid>
		</item>	
				<item>
			<title>Recycled plastic can kill drug-resistant fungi</title>
			<atom:link href="https://biospectrumasia.com/news/34/228/recycled-plastic-can-kill-drug-resistant-fungi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/228/recycled-plastic-can-kill-drug-resistant-fungi.html</link>
			<pubDate>Tue, 10 Dec 2013 10:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100126022.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/228/recycled-plastic-can-kill-drug-resistant-fungi.html</guid>
		</item>	
				<item>
			<title>Singapore scientists engineer human stem cells</title>
			<atom:link href="https://biospectrumasia.com/news/34/7302/singapore-scientists-engineer-human-stem-cells.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7302/singapore-scientists-engineer-human-stem-cells.html</link>
			<pubDate>Mon, 09 Dec 2013 17:48:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-scientists-engineer-human-stem-cells.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7302/singapore-scientists-engineer-human-stem-cells.html</guid>
		</item>	
				<item>
			<title>Scientists use tiniest human protein to heal heart</title>
			<atom:link href="https://biospectrumasia.com/news/34/8214/scientists-use-tiniest-human-protein-to-heal-heart.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8214/scientists-use-tiniest-human-protein-to-heal-heart.html</link>
			<pubDate>Mon, 09 Dec 2013 17:36:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-use-tiniest-human-protein-to-heal-heart.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8214/scientists-use-tiniest-human-protein-to-heal-heart.html</guid>
		</item>	
				<item>
			<title>Forest to acquire rights to Merck&#039;s Saphris</title>
			<atom:link href="https://biospectrumasia.com/news/34/2622/forest-to-acquire-rights-to-mercks-saphris.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2622/forest-to-acquire-rights-to-mercks-saphris.html</link>
			<pubDate>Thu, 05 Dec 2013 14:19:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10056281.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2622/forest-to-acquire-rights-to-mercks-saphris.html</guid>
		</item>	
				<item>
			<title>NIH to invest $100 mn on HIV research</title>
			<atom:link href="https://biospectrumasia.com/news/34/4142/nih-to-invest-100-mn-on-hiv-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4142/nih-to-invest-100-mn-on-hiv-research.html</link>
			<pubDate>Tue, 03 Dec 2013 13:49:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nih-to-invest-usd100-mn-on-hiv-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4142/nih-to-invest-100-mn-on-hiv-research.html</guid>
		</item>	
				<item>
			<title>Aus invests $1mn in antibiotics start-up Auspherix</title>
			<atom:link href="https://biospectrumasia.com/news/34/5083/aus-invests-1mn-in-antibiotics-start-up-auspherix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5083/aus-invests-1mn-in-antibiotics-start-up-auspherix.html</link>
			<pubDate>Tue, 03 Dec 2013 13:42:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aus-invests-usd1mn-in-antibiotics-start-up-auspherix.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5083/aus-invests-1mn-in-antibiotics-start-up-auspherix.html</guid>
		</item>	
				<item>
			<title>New analysis of EndoBarrier reveals high efficacy</title>
			<atom:link href="https://biospectrumasia.com/news/34/4180/new-analysis-of-endobarrier-reveals-high-efficacy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4180/new-analysis-of-endobarrier-reveals-high-efficacy.html</link>
			<pubDate>Tue, 03 Dec 2013 11:15:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medical-devices-such-as-endobarrier-can-help-bridge-the-gap-between-pharmaceuticals-and-bariatric-surgery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4180/new-analysis-of-endobarrier-reveals-high-efficacy.html</guid>
		</item>	
				<item>
			<title>Phyto-pharmaceuticals to hit Indian markets soon</title>
			<atom:link href="https://biospectrumasia.com/news/34/2226/phyto-pharmaceuticals-to-hit-indian-markets-soon.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2226/phyto-pharmaceuticals-to-hit-indian-markets-soon.html</link>
			<pubDate>Mon, 02 Dec 2013 14:06:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10039601.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2226/phyto-pharmaceuticals-to-hit-indian-markets-soon.html</guid>
		</item>	
				<item>
			<title>Novartis pledges to eliminate leprosy </title>
			<atom:link href="https://biospectrumasia.com/news/34/4289/novartis-pledges-to-eliminate-leprosy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4289/novartis-pledges-to-eliminate-leprosy-.html</link>
			<pubDate>Mon, 02 Dec 2013 12:42:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/over-the-past-eight-years-the-number-of-newly-diagnosed-leprosy-patients-has-plateaued-at-around-230-000-cases-per-year.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4289/novartis-pledges-to-eliminate-leprosy-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/566/astrazeneca-bms-gets-positive-regulatory-feedback-on-type-2-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/566/astrazeneca-bms-gets-positive-regulatory-feedback-on-type-2-diabetes-drug.html</link>
			<pubDate>Fri, 29 Nov 2013 12:06:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/566/astrazeneca-bms-gets-positive-regulatory-feedback-on-type-2-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Japan, Singapore to bring innovation in drug, device, technology</title>
			<atom:link href="https://biospectrumasia.com/news/34/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html</link>
			<pubDate>Fri, 29 Nov 2013 11:13:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/907/japan-singapore-to-bring-innovation-in-drug-device-technology.html</guid>
		</item>	
				<item>
			<title>Aus firm to raise $10 mn for multiple sclerosis drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2512/aus-firm-to-raise-10-mn-for-multiple-sclerosis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2512/aus-firm-to-raise-10-mn-for-multiple-sclerosis-drug.html</link>
			<pubDate>Wed, 27 Nov 2013 10:41:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/currently-montrose-produces-active-ingredients-for-a-number-of-medicines-in-important-disease-areas-such-as-respiratory-and-hiv-aids.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2512/aus-firm-to-raise-10-mn-for-multiple-sclerosis-drug.html</guid>
		</item>	
				<item>
			<title>QRxPharma refiles Moxduo NDA with FDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/6681/qrxpharma-refiles-moxduo-nda-with-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6681/qrxpharma-refiles-moxduo-nda-with-fda.html</link>
			<pubDate>Tue, 26 Nov 2013 15:36:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/qrxpharma-refiles-moxduo-nda-with-fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6681/qrxpharma-refiles-moxduo-nda-with-fda.html</guid>
		</item>	
				<item>
			<title>Aus, Canada study find how diabetes drug metformin works</title>
			<atom:link href="https://biospectrumasia.com/news/34/3638/aus-canada-study-find-how-diabetes-drug-metformin-works.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3638/aus-canada-study-find-how-diabetes-drug-metformin-works.html</link>
			<pubDate>Mon, 25 Nov 2013 12:19:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-have-wondered-for-more-than-50-years-whether-metformin-worked-to-lower-blood-glucose-in-patients-by-directly-working-on-the-glucose.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3638/aus-canada-study-find-how-diabetes-drug-metformin-works.html</guid>
		</item>	
				<item>
			<title>Singapore nod for BMS, Pfizer heart drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2528/singapore-nod-for-bms-pfizer-heart-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2528/singapore-nod-for-bms-pfizer-heart-drug.html</link>
			<pubDate>Mon, 25 Nov 2013 10:55:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-patients-with-non-valvular-atrial-fibrillation-nvaf-pfizer-and-bristol-myers-squibb-s-apixaban-stroke-drug-gets-singapore-s-health-sciences-authority-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2528/singapore-nod-for-bms-pfizer-heart-drug.html</guid>
		</item>	
				<item>
			<title>Agilent, Queensland univ join hands for cancer research</title>
			<atom:link href="https://biospectrumasia.com/news/34/7731/agilent-queensland-univ-join-hands-for-cancer-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7731/agilent-queensland-univ-join-hands-for-cancer-research.html</link>
			<pubDate>Thu, 21 Nov 2013 11:42:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agilent-technologies-plans-to-collaborate-with-the-university-of-queensland-center-for-clinical-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7731/agilent-queensland-univ-join-hands-for-cancer-research.html</guid>
		</item>	
				<item>
			<title>Patrys gets 2nd Aus patent for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2609/patrys-gets-2nd-aus-patent-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2609/patrys-gets-2nd-aus-patent-for-cancer-drug.html</link>
			<pubDate>Tue, 19 Nov 2013 10:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patrys-gets-second-australian-patent.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2609/patrys-gets-2nd-aus-patent-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>WuXi PharmaTech partners with Pharmacyclics</title>
			<atom:link href="https://biospectrumasia.com/news/34/2496/wuxi-pharmatech-partners-with-pharmacyclics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2496/wuxi-pharmatech-partners-with-pharmacyclics.html</link>
			<pubDate>Tue, 19 Nov 2013 10:41:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/wuxi-pharmatech-joins-hands-with-pharmacyclics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2496/wuxi-pharmatech-partners-with-pharmacyclics.html</guid>
		</item>	
				<item>
			<title>Pneumonia kills a 5-year-old child every 30 secs: UN</title>
			<atom:link href="https://biospectrumasia.com/news/34/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html</link>
			<pubDate>Thu, 14 Nov 2013 10:56:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pneumonia-kills-one-million-children-each-year-says-the-un.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6460/pneumonia-kills-a-5-year-old-child-every-30-secs-un.html</guid>
		</item>	
				<item>
			<title>Merck, China firm to co-develop DNA repair drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6471/merck-china-firm-to-co-develop-dna-repair-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6471/merck-china-firm-to-co-develop-dna-repair-drug.html</link>
			<pubDate>Thu, 14 Nov 2013 10:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-serono-and-beigene-sign-deal-for-poly-adp-ribose-polymerase-parp-inhibitor-of-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6471/merck-china-firm-to-co-develop-dna-repair-drug.html</guid>
		</item>	
				<item>
			<title>Genovate, ScinoPharm co-develop Hep B Drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4913/genovate-scinopharm-co-develop-hep-b-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4913/genovate-scinopharm-co-develop-hep-b-drug.html</link>
			<pubDate>Thu, 14 Nov 2013 09:54:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4913/genovate-scinopharm-co-develop-hep-b-drug.html</guid>
		</item>	
				<item>
			<title>Novogen progresses on drugs against genetic, degenerative disorders</title>
			<atom:link href="https://biospectrumasia.com/news/34/8481/novogen-progresses-on-drugs-against-genetic-degenerative-disorders.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8481/novogen-progresses-on-drugs-against-genetic-degenerative-disorders.html</link>
			<pubDate>Thu, 14 Nov 2013 09:19:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8481/novogen-progresses-on-drugs-against-genetic-degenerative-disorders.html</guid>
		</item>	
				<item>
			<title>WuXi CRO gets toxicity prediction software license </title>
			<atom:link href="https://biospectrumasia.com/news/34/5045/wuxi-cro-gets-toxicity-prediction-software-license-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5045/wuxi-cro-gets-toxicity-prediction-software-license-.html</link>
			<pubDate>Wed, 13 Nov 2013 08:36:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/simulations-plus-gives-wuxi-pharmatech-a-multiyear-license-to-admet-predictor-toxicity-module.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5045/wuxi-cro-gets-toxicity-prediction-software-license-.html</guid>
		</item>	
				<item>
			<title>Singapore, Korea scientists find clue to tumour suppression mechanism</title>
			<atom:link href="https://biospectrumasia.com/news/34/5381/singapore-korea-scientists-find-clue-to-tumour-suppression-mechanism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5381/singapore-korea-scientists-find-clue-to-tumour-suppression-mechanism.html</link>
			<pubDate>Tue, 12 Nov 2013 11:58:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5381/singapore-korea-scientists-find-clue-to-tumour-suppression-mechanism.html</guid>
		</item>	
				<item>
			<title>Linagliptin efficacy further established in specific patient populations</title>
			<atom:link href="https://biospectrumasia.com/news/34/7784/linagliptin-efficacy-further-established-in-specific-patient-populations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7784/linagliptin-efficacy-further-established-in-specific-patient-populations.html</link>
			<pubDate>Tue, 12 Nov 2013 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7784/linagliptin-efficacy-further-established-in-specific-patient-populations.html</guid>
		</item>	
				<item>
			<title>Starpharma appoints  Robert Thomas as board member</title>
			<atom:link href="https://biospectrumasia.com/news/34/6330/starpharma-appoints-robert-thomas-as-board-member.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6330/starpharma-appoints-robert-thomas-as-board-member.html</link>
			<pubDate>Mon, 11 Nov 2013 10:30:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6330/starpharma-appoints-robert-thomas-as-board-member.html</guid>
		</item>	
				<item>
			<title>Monash-GSK partnership wins collaboration award</title>
			<atom:link href="https://biospectrumasia.com/news/34/5887/monash-gsk-partnership-wins-collaboration-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5887/monash-gsk-partnership-wins-collaboration-award.html</link>
			<pubDate>Mon, 11 Nov 2013 09:45:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5887/monash-gsk-partnership-wins-collaboration-award.html</guid>
		</item>	
				<item>
			<title>Sinovac to supply Hep A vaccine to Jiangsu province</title>
			<atom:link href="https://biospectrumasia.com/news/34/6242/sinovac-to-supply-hep-a-vaccine-to-jiangsu-province.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6242/sinovac-to-supply-hep-a-vaccine-to-jiangsu-province.html</link>
			<pubDate>Mon, 11 Nov 2013 09:14:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6242/sinovac-to-supply-hep-a-vaccine-to-jiangsu-province.html</guid>
		</item>	
				<item>
			<title>Hong Kong approves asthma drug  flutiform </title>
			<atom:link href="https://biospectrumasia.com/news/34/7395/hong-kong-approves-asthma-drug-flutiform-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7395/hong-kong-approves-asthma-drug-flutiform-.html</link>
			<pubDate>Mon, 11 Nov 2013 09:02:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7395/hong-kong-approves-asthma-drug-flutiform-.html</guid>
		</item>	
				<item>
			<title>China plans to phase out mandatory cosmetics animal testing</title>
			<atom:link href="https://biospectrumasia.com/news/34/6031/china-plans-to-phase-out-mandatory-cosmetics-animal-testing.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6031/china-plans-to-phase-out-mandatory-cosmetics-animal-testing.html</link>
			<pubDate>Mon, 11 Nov 2013 08:52:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6031/china-plans-to-phase-out-mandatory-cosmetics-animal-testing.html</guid>
		</item>	
				<item>
			<title>Danish firm, Aussie instiute to co-develop pathological drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/5139/danish-firm-aussie-instiute-to-co-develop-pathological-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5139/danish-firm-aussie-instiute-to-co-develop-pathological-drugs.html</link>
			<pubDate>Fri, 08 Nov 2013 10:11:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5139/danish-firm-aussie-instiute-to-co-develop-pathological-drugs.html</guid>
		</item>	
				<item>
			<title>Eisai expands its anti-obesity drug market</title>
			<atom:link href="https://biospectrumasia.com/news/34/3528/eisai-expands-its-anti-obesity-drug-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3528/eisai-expands-its-anti-obesity-drug-market.html</link>
			<pubDate>Fri, 08 Nov 2013 09:43:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3528/eisai-expands-its-anti-obesity-drug-market.html</guid>
		</item>	
				<item>
			<title>Patrys gets US patent for antibody PAT-LM1</title>
			<atom:link href="https://biospectrumasia.com/news/34/6905/patrys-gets-us-patent-for-antibody-pat-lm1.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6905/patrys-gets-us-patent-for-antibody-pat-lm1.html</link>
			<pubDate>Fri, 08 Nov 2013 09:31:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6905/patrys-gets-us-patent-for-antibody-pat-lm1.html</guid>
		</item>	
				<item>
			<title>BMS seeks Hep C therapy approval in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/2532/bms-seeks-hep-c-therapy-approval-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2532/bms-seeks-hep-c-therapy-approval-in-japan.html</link>
			<pubDate>Thu, 07 Nov 2013 10:50:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2532/bms-seeks-hep-c-therapy-approval-in-japan.html</guid>
		</item>	
				<item>
			<title>Singapore invests $60mn to set up nanomedicine research institute</title>
			<atom:link href="https://biospectrumasia.com/news/34/4144/singapore-invests-60mn-to-set-up-nanomedicine-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4144/singapore-invests-60mn-to-set-up-nanomedicine-research-institute.html</link>
			<pubDate>Thu, 07 Nov 2013 10:38:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellular-biomedicine-launches-a-stromal-adipose-stromal-cell-purification-kit-in-china-and-also-signs-deal-for-proceller-computer-controlled-processing-system-for-mainland-china-and-hong-kong.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4144/singapore-invests-60mn-to-set-up-nanomedicine-research-institute.html</guid>
		</item>	
				<item>
			<title>LabCorp launches 4th gen HIV antigen assay</title>
			<atom:link href="https://biospectrumasia.com/news/34/8040/labcorp-launches-4th-gen-hiv-antigen-assay.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8040/labcorp-launches-4th-gen-hiv-antigen-assay.html</link>
			<pubDate>Thu, 07 Nov 2013 10:23:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8040/labcorp-launches-4th-gen-hiv-antigen-assay.html</guid>
		</item>	
				<item>
			<title>Eisai to launch breast cancer drug in India</title>
			<atom:link href="https://biospectrumasia.com/news/34/1764/eisai-to-launch-breast-cancer-drug-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1764/eisai-to-launch-breast-cancer-drug-in-india.html</link>
			<pubDate>Wed, 06 Nov 2013 14:12:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10044795.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1764/eisai-to-launch-breast-cancer-drug-in-india.html</guid>
		</item>	
				<item>
			<title>FDA follows EU, declares Patrys drug as &#039;orphan&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/1623/fda-follows-eu-declares-patrys-drug-as-orphan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1623/fda-follows-eu-declares-patrys-drug-as-orphan.html</link>
			<pubDate>Wed, 06 Nov 2013 13:04:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-based-patrys-lead-anti-cancer-product-pat-sm6-gets-confirmation-of-orphan-medicinal-product-designation-from-the-us-fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1623/fda-follows-eu-declares-patrys-drug-as-orphan.html</guid>
		</item>	
				<item>
			<title>ETC, AstraZeneca form drug R&amp;D partnership</title>
			<atom:link href="https://biospectrumasia.com/news/34/4261/etc-astrazeneca-form-drug-rd-partnership.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4261/etc-astrazeneca-form-drug-rd-partnership.html</link>
			<pubDate>Tue, 05 Nov 2013 16:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/experimental-therapeutics-center-etc-astar-s-exploit-technologies-and-astrazeneca-sign-a-joint-research-deal-to-develop-new-drugs-to-treat-gram-negative-bacterial-infections.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4261/etc-astrazeneca-form-drug-rd-partnership.html</guid>
		</item>	
				<item>
			<title>Bristol seeks Japanese nod of all-oral hepatitis C treatment</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html</link>
			<pubDate>Mon, 04 Nov 2013 16:32:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10014936.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5470/bristol-seeks-japanese-nod-of-all-oral-hepatitis-c-treatment.html</guid>
		</item>	
				<item>
			<title>Astellas to axe 300 jobs in home country in FY14</title>
			<atom:link href="https://biospectrumasia.com/news/34/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html</link>
			<pubDate>Mon, 04 Nov 2013 15:45:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10099027.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5698/astellas-to-axe-300-jobs-in-home-country-in-fy14.html</guid>
		</item>	
				<item>
			<title>3SBio acquires patents for kidney failure drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4318/3sbio-acquires-patents-for-kidney-failure-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4318/3sbio-acquires-patents-for-kidney-failure-drug.html</link>
			<pubDate>Thu, 31 Oct 2013 12:59:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-based-3sbio-acquires-patents-for-novel-non-tzd-ppargamma-agonist-dj5.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4318/3sbio-acquires-patents-for-kidney-failure-drug.html</guid>
		</item>	
				<item>
			<title>Israel firm gets US, China patent for neuro-peptide</title>
			<atom:link href="https://biospectrumasia.com/news/34/5248/israel-firm-gets-us-china-patent-for-neuro-peptide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5248/israel-firm-gets-us-china-patent-for-neuro-peptide.html</link>
			<pubDate>Thu, 31 Oct 2013 12:34:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/israel-based-d-pharm-recieved-patent-in-the-us-and-china-for-thr-18-a-synthetic-therapeutic-peptide-used-in-thromboembolic-diseases-and-pathological-conditions-associated-with-neurological-damage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5248/israel-firm-gets-us-china-patent-for-neuro-peptide.html</guid>
		</item>	
				<item>
			<title>Phosphagenics achieves biggest milestone yet</title>
			<atom:link href="https://biospectrumasia.com/news/34/7201/phosphagenics-achieves-biggest-milestone-yet.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7201/phosphagenics-achieves-biggest-milestone-yet.html</link>
			<pubDate>Tue, 29 Oct 2013 11:13:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phosphagenics-achieves-biggest-milestone-in-its-history-by-successfully-completing-its-multi-dose-oxymorphone-patch-phase-i-trial-in-12-subjects.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7201/phosphagenics-achieves-biggest-milestone-yet.html</guid>
		</item>	
				<item>
			<title>Aussie anesthetic firm gets patent from 7 nations </title>
			<atom:link href="https://biospectrumasia.com/news/34/8131/aussie-anesthetic-firm-gets-patent-from-7-nations-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8131/aussie-anesthetic-firm-gets-patent-from-7-nations-.html</link>
			<pubDate>Tue, 29 Oct 2013 10:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/propofol-which-is-considered-as-the-industry-gold-standard-due-to-its-predictable-onset-and-recovery-from-anesthesia-and-sedation-gets-patent-in-7-countries.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8131/aussie-anesthetic-firm-gets-patent-from-7-nations-.html</guid>
		</item>	
				<item>
			<title>ShangPharma appoints new CSO, president</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/6152/shangpharma-appoints-new-cso-president.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/6152/shangpharma-appoints-new-cso-president.html</link>
			<pubDate>Mon, 28 Oct 2013 16:39:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/arthur-taveras.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/6152/shangpharma-appoints-new-cso-president.html</guid>
		</item>	
				<item>
			<title>Zydus, Pieris to develop anticalin-based protein drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/4788/zydus-pieris-to-develop-anticalin-based-protein-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4788/zydus-pieris-to-develop-anticalin-based-protein-drug.html</link>
			<pubDate>Fri, 18 Oct 2013 10:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/zydus-has-been-granted-marketing-rights-for-anticalin-based-protein-therapeutics-in-india-and-several-other-emerging-markets-while-pieris-retains-exclusive-marketing-rights-in-key-developed-markets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4788/zydus-pieris-to-develop-anticalin-based-protein-drug.html</guid>
		</item>	
				<item>
			<title>Boehringer seeks EU marketing nod for cancer drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2368/boehringer-seeks-eu-marketing-nod-for-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2368/boehringer-seeks-eu-marketing-nod-for-cancer-drug.html</link>
			<pubDate>Fri, 18 Oct 2013 10:11:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-ingelheim-seeks-marketing-authorization-from-european-medicines-agency-ema-for-non-small-cell-lung-cancer-nsclc-drug-nintedanib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2368/boehringer-seeks-eu-marketing-nod-for-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Singapore firm, Stehlin Foundation collaborate on anti-cancer drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/485/singapore-firm-stehlin-foundation-collaborate-on-anti-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/485/singapore-firm-stehlin-foundation-collaborate-on-anti-cancer-drug-.html</link>
			<pubDate>Tue, 15 Oct 2013 10:17:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-muscular-dystrophy-patients-quintiles-and-muscular-dystrophy-association-mda-form-partnership-to-develop-and-implement-the-us-neuromuscular-disease-registry.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/485/singapore-firm-stehlin-foundation-collaborate-on-anti-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Novartis acquires antibody technology license to develop cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/6134/novartis-acquires-antibody-technology-license-to-develop-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6134/novartis-acquires-antibody-technology-license-to-develop-cancer-therapy.html</link>
			<pubDate>Mon, 14 Oct 2013 11:13:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-s-experimental-therapeutics-center-etc-and-debiopharm-join-hands-for-epigenetic-modulator-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6134/novartis-acquires-antibody-technology-license-to-develop-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Dainippon sets up cancer drug subsidiary in the US</title>
			<atom:link href="https://biospectrumasia.com/news/34/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html</link>
			<pubDate>Thu, 10 Oct 2013 11:51:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dainippon-sumitomo-pharma-dsp-owned-boston-biomedical-will-set-up-an-anti-cancer-drugs-sales-subsidiary-in-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5130/dainippon-sets-up-cancer-drug-subsidiary-in-the-us.html</guid>
		</item>	
				<item>
			<title>Gilead to halt phase III study of leukemia drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3064/gilead-to-halt-phase-iii-study-of-leukemia-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3064/gilead-to-halt-phase-iii-study-of-leukemia-drug.html</link>
			<pubDate>Thu, 10 Oct 2013 10:50:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-to-halt-phase-iii-study-of-chronic-lymphocytic-leukemia-cll-drug-idelalisib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3064/gilead-to-halt-phase-iii-study-of-leukemia-drug.html</guid>
		</item>	
				<item>
			<title>FDA approves Bayer thromboembolic BP drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/2337/fda-approves-bayer-thromboembolic-bp-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2337/fda-approves-bayer-thromboembolic-bp-drug-.html</link>
			<pubDate>Wed, 09 Oct 2013 14:59:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-approves-bayer-healthcare-s-adempas-riociguat-for-chronic-thromboembolic-pulmonary-hypertension-cteph-and-pulmonary-arterial-hypertension-pah.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2337/fda-approves-bayer-thromboembolic-bp-drug-.html</guid>
		</item>	
				<item>
			<title>Novogen to develop new class of cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/3188/novogen-to-develop-new-class-of-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3188/novogen-to-develop-new-class-of-cancer-drugs.html</link>
			<pubDate>Wed, 09 Oct 2013 14:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novogen-adds-a-new-class-of-cancer-drugs-called-anti-tropomyosins-anti-tms-to-its-pipeline.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3188/novogen-to-develop-new-class-of-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>QRx Pharma gets FDA inputs on Moxduo </title>
			<atom:link href="https://biospectrumasia.com/news/34/3895/qrx-pharma-gets-fda-inputs-on-moxduo-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3895/qrx-pharma-gets-fda-inputs-on-moxduo-.html</link>
			<pubDate>Wed, 09 Oct 2013 14:40:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/qrxpharma-has-got-complete-understanding-of-the-requirements-for-submission-of-the-revised-nda-of-moxduo-from-the-us-fda.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3895/qrx-pharma-gets-fda-inputs-on-moxduo-.html</guid>
		</item>	
				<item>
			<title>Eli Lilly pipeline will counter patent cliff in 2014</title>
			<atom:link href="https://biospectrumasia.com/news/34/4007/eli-lilly-pipeline-will-counter-patent-cliff-in-2014.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4007/eli-lilly-pipeline-will-counter-patent-cliff-in-2014.html</link>
			<pubDate>Mon, 07 Oct 2013 11:39:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mystic-pharma-gets-notices-of-allowance-from-china-for-its-deep-draw-container-forming-method-and-japan-for-its-combination-unit-dose-dispensing-container.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4007/eli-lilly-pipeline-will-counter-patent-cliff-in-2014.html</guid>
		</item>	
				<item>
			<title>UK, Belgium nod for Bone Therapeutics&#039; therapy </title>
			<atom:link href="https://biospectrumasia.com/news/34/913/uk-belgium-nod-for-bone-therapeutics-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/913/uk-belgium-nod-for-bone-therapeutics-therapy-.html</link>
			<pubDate>Fri, 04 Oct 2013 16:37:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-delayed-union-fracture-patients-bone-therapeutics-cell-therapy-products-get-belgium-and-the-uk-nod-for-phase-iiia-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/913/uk-belgium-nod-for-bone-therapeutics-therapy-.html</guid>
		</item>	
				<item>
			<title>Daiichi US appoints Glenn Gormley as chairman</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html</link>
			<pubDate>Fri, 04 Oct 2013 12:57:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-glenn-gormley-the-new-president-and-chairman-of-daiichi-sankyo-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/2530/daiichi-us-appoints-glenn-gormley-as-chairman.html</guid>
		</item>	
				<item>
			<title>Novartis Gilenya reduces multiple sclerosis relapse</title>
			<atom:link href="https://biospectrumasia.com/news/34/5834/novartis-gilenya-reduces-multiple-sclerosis-relapse.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5834/novartis-gilenya-reduces-multiple-sclerosis-relapse.html</link>
			<pubDate>Thu, 03 Oct 2013 14:24:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/msbase-study-registry-and-ims-pharmetrics-database-highlight-that-novartis-gilenya-fingolimod-reduce-multiple-sclerosis-relapses.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5834/novartis-gilenya-reduces-multiple-sclerosis-relapse.html</guid>
		</item>	
				<item>
			<title>Phylogica gets patent to model libraries from protein </title>
			<atom:link href="https://biospectrumasia.com/news/34/2063/phylogica-gets-patent-to-model-libraries-from-protein-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2063/phylogica-gets-patent-to-model-libraries-from-protein-.html</link>
			<pubDate>Thu, 03 Oct 2013 13:33:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-core-us-patent-covers-generic-methods-of-designing-synthetic-phylomer-peptide-libraries-based-on-the-identification-of-parts-of-natural-proteins.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2063/phylogica-gets-patent-to-model-libraries-from-protein-.html</guid>
		</item>	
				<item>
			<title> Eye diseases cost upto $27bn to Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/2283/-eye-diseases-cost-upto-27bn-to-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2283/-eye-diseases-cost-upto-27bn-to-europe.html</link>
			<pubDate>Wed, 02 Oct 2013 12:31:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2283/-eye-diseases-cost-upto-27bn-to-europe.html</guid>
		</item>	
				<item>
			<title>TB claims 74000 children each year: WHO</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7055/tb-claims-74000-children-each-year-who.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7055/tb-claims-74000-children-each-year-who.html</link>
			<pubDate>Wed, 02 Oct 2013 11:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/healthcare.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7055/tb-claims-74000-children-each-year-who.html</guid>
		</item>	
				<item>
			<title>Candidate drug to treat Batten disease identified</title>
			<atom:link href="https://biospectrumasia.com/news/34/5872/candidate-drug-to-treat-batten-disease-identified.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5872/candidate-drug-to-treat-batten-disease-identified.html</link>
			<pubDate>Tue, 01 Oct 2013 14:19:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/molecular-structure.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5872/candidate-drug-to-treat-batten-disease-identified.html</guid>
		</item>	
				<item>
			<title>Nexavar seeks marketing authorization in Japan </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1135/nexavar-seeks-marketing-authorization-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1135/nexavar-seeks-marketing-authorization-in-japan-.html</link>
			<pubDate>Tue, 01 Oct 2013 11:39:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1135/nexavar-seeks-marketing-authorization-in-japan-.html</guid>
		</item>	
				<item>
			<title>FDA nod for Genentech pre-surgical cancer drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1466/fda-nod-for-genentech-pre-surgical-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1466/fda-nod-for-genentech-pre-surgical-cancer-drug.html</link>
			<pubDate>Tue, 01 Oct 2013 11:15:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-early-stage-breast-cancer-patients-genentech-neoadjuvant-cancer-treatment-perjeta-pertuzumab-gets-us-fda-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1466/fda-nod-for-genentech-pre-surgical-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Inversion of ibuprofen in body helps fight cancer: Study</title>
			<atom:link href="https://biospectrumasia.com/news/34/1356/inversion-of-ibuprofen-in-body-helps-fight-cancer-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1356/inversion-of-ibuprofen-in-body-helps-fight-cancer-study.html</link>
			<pubDate>Mon, 30 Sep 2013 12:15:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ibuprofen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1356/inversion-of-ibuprofen-in-body-helps-fight-cancer-study.html</guid>
		</item>	
				<item>
			<title>AbbVie, Galapagos to make drugs for cystic fibrosis mutations</title>
			<atom:link href="https://biospectrumasia.com/news/34/1615/abbvie-galapagos-to-make-drugs-for-cystic-fibrosis-mutations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1615/abbvie-galapagos-to-make-drugs-for-cystic-fibrosis-mutations.html</link>
			<pubDate>Mon, 30 Sep 2013 11:37:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/galapagos-and-abbvie-will-discover-develop-and-commercialize-novel-potentiator-and-combination-therapies-in-cystic-fibrosis-cf.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1615/abbvie-galapagos-to-make-drugs-for-cystic-fibrosis-mutations.html</guid>
		</item>	
				<item>
			<title>Gilead HIV/AIDS &#039;blood booster&#039; gets EU nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1368/gilead-hiv-aids-blood-booster-gets-eu-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1368/gilead-hiv-aids-blood-booster-gets-eu-nod.html</link>
			<pubDate>Thu, 26 Sep 2013 10:39:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hiv-aids-patients-gilead-sciences-recieved-european-commission-marketing-authorization-for-once-daily-tybost-cobicistat.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1368/gilead-hiv-aids-blood-booster-gets-eu-nod.html</guid>
		</item>	
				<item>
			<title>UK commits $1.6 bn to fight AIDS, TB, Malaria</title>
			<atom:link href="https://biospectrumasia.com/news/34/8334/uk-commits-1-6-bn-to-fight-aids-tb-malaria.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8334/uk-commits-1-6-bn-to-fight-aids-tb-malaria.html</link>
			<pubDate>Tue, 24 Sep 2013 10:22:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-uk-commitment-is-geared-towards-encouraging-other-donors-to-maximize-their-own-pledges-to-the-global-fund-effectively-unlocking-additional-funds-with-each-contribution.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8334/uk-commits-1-6-bn-to-fight-aids-tb-malaria.html</guid>
		</item>	
				<item>
			<title>Chugai gets Japanese nod cancer drug Kadcyla</title>
			<atom:link href="https://biospectrumasia.com/news/34/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html</link>
			<pubDate>Mon, 23 Sep 2013 13:32:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10060402.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1148/chugai-gets-japanese-nod-cancer-drug-kadcyla.html</guid>
		</item>	
				<item>
			<title>Takeda gets Japanese NDA approval for obesity drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</link>
			<pubDate>Mon, 23 Sep 2013 10:55:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oblean-is-a-lipase-inhibitor-discovered-by-uk-based-alizyme-therapeutics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/939/takeda-gets-japanese-nda-approval-for-obesity-drug.html</guid>
		</item>	
				<item>
			<title>LCT conducts first implant of regenerative therapy </title>
			<atom:link href="https://biospectrumasia.com/news/34/2293/lct-conducts-first-implant-of-regenerative-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2293/lct-conducts-first-implant-of-regenerative-therapy-.html</link>
			<pubDate>Fri, 20 Sep 2013 13:41:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/living-cell-technologies-lct-implanted-regenerative-cell-therapy-for-parkinson-s-disease-called-ntcell.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2293/lct-conducts-first-implant-of-regenerative-therapy-.html</guid>
		</item>	
				<item>
			<title>Zydus Cadila launches indigenous diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6660/zydus-cadila-launches-indigenous-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6660/zydus-cadila-launches-indigenous-diabetes-drug.html</link>
			<pubDate>Fri, 20 Sep 2013 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100120542.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6660/zydus-cadila-launches-indigenous-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>NIH funds $45 mn Alzheimer&#039;s drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/2323/nih-funds-45-mn-alzheimers-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2323/nih-funds-45-mn-alzheimers-drug-development.html</link>
			<pubDate>Thu, 19 Sep 2013 13:38:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nih-provides-usd45-million-funds-for-research-aimed-at-identifyng-and-validating-biological-targets-for-novel-therapies.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2323/nih-funds-45-mn-alzheimers-drug-development.html</guid>
		</item>	
				<item>
			<title>Nose cancer emerges as a potent killer in Asia</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2171/nose-cancer-emerges-as-a-potent-killer-in-asia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2171/nose-cancer-emerges-as-a-potent-killer-in-asia.html</link>
			<pubDate>Thu, 19 Sep 2013 09:54:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/while-nasopharyngeal-carcinoma-npc-is-initially-highly-sensitive-to-chemotherapy-it-eventually-develops-resistance-to-treatment-and-longer-term-survival-is-limited.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2171/nose-cancer-emerges-as-a-potent-killer-in-asia.html</guid>
		</item>	
				<item>
			<title>Viralytics melanoma trial meets primary endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/34/6583/viralytics-melanoma-trial-meets-primary-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6583/viralytics-melanoma-trial-meets-primary-endpoint.html</link>
			<pubDate>Wed, 18 Sep 2013 12:47:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/viralytics-phase-ii-clinical-trial-of-cavatak-calm-achieves-primary-endpoint-prior-to-patient-recruitment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6583/viralytics-melanoma-trial-meets-primary-endpoint.html</guid>
		</item>	
				<item>
			<title>Merck, AstraZeneca sign deal for cancer drug therapy </title>
			<atom:link href="https://biospectrumasia.com/news/34/1361/merck-astrazeneca-sign-deal-for-cancer-drug-therapy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1361/merck-astrazeneca-sign-deal-for-cancer-drug-therapy-.html</link>
			<pubDate>Tue, 17 Sep 2013 16:54:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-ovarian-cancer-patients-merck-and-astrazeneca-sign-agreement-for-merck-s-oral-small-molecule-inhibitor-of-wee1-kinase-mk-1775.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1361/merck-astrazeneca-sign-deal-for-cancer-drug-therapy-.html</guid>
		</item>	
				<item>
			<title>GSK, Genmab leukemia drug gets FDA breakthrough status</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5838/gsk-genmab-leukemia-drug-gets-fda-breakthrough-status.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5838/gsk-genmab-leukemia-drug-gets-fda-breakthrough-status.html</link>
			<pubDate>Tue, 17 Sep 2013 15:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-lymphocytic-leukemia-cll-patients-genmab-and-glaxosmithkline-gsk-gets-us-fda-breakthrough-therapy-designation-for-arzerra-ofatumumab-in-combination-with-chlorambucil.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5838/gsk-genmab-leukemia-drug-gets-fda-breakthrough-status.html</guid>
		</item>	
				<item>
			<title>Rectal cancer drug can be used to treat diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/34/2110/rectal-cancer-drug-can-be-used-to-treat-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2110/rectal-cancer-drug-can-be-used-to-treat-diabetes.html</link>
			<pubDate>Mon, 16 Sep 2013 14:58:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-study-identified-a-previously-unexpected-link-between-a-low-oxygen-condition-called-hypoxia-and-the-ability-of-cells-in-the-liver-to-respond-to-insulin.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2110/rectal-cancer-drug-can-be-used-to-treat-diabetes.html</guid>
		</item>	
				<item>
			<title>Eisai expands R&amp;D in Belgium with office in Brussels</title>
			<atom:link href="https://biospectrumasia.com/news/34/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html</link>
			<pubDate>Mon, 16 Sep 2013 14:35:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-emea-europe-middle-east-africa-russia-and-oceania-opens-office-in-brussels-belgium.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5447/eisai-expands-rd-in-belgium-with-office-in-brussels.html</guid>
		</item>	
				<item>
			<title>Sanofi withdraws diabetes drug NDA in the US</title>
			<atom:link href="https://biospectrumasia.com/news/34/708/sanofi-withdraws-diabetes-drug-nda-in-the-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/708/sanofi-withdraws-diabetes-drug-nda-in-the-us.html</link>
			<pubDate>Fri, 13 Sep 2013 10:55:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sanofi-temporarily-withdraws-nda-for-type-2-diabetes-mellitus-drug-lixisenatide.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/708/sanofi-withdraws-diabetes-drug-nda-in-the-us.html</guid>
		</item>	
				<item>
			<title>Gilead submits NDA for cancer drug Idelalisib</title>
			<atom:link href="https://biospectrumasia.com/news/34/7325/gilead-submits-nda-for-cancer-drug-idelalisib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7325/gilead-submits-nda-for-cancer-drug-idelalisib.html</link>
			<pubDate>Fri, 13 Sep 2013 10:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-10073371-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7325/gilead-submits-nda-for-cancer-drug-idelalisib.html</guid>
		</item>	
				<item>
			<title>Eisai UK site to make epilepsy drug for US</title>
			<atom:link href="https://biospectrumasia.com/news/34/4494/eisai-uk-site-to-make-epilepsy-drug-for-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4494/eisai-uk-site-to-make-epilepsy-drug-for-us.html</link>
			<pubDate>Thu, 12 Sep 2013 12:32:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-gets-us-fda-nod-to-supply-epilepsy-drug-fycompa-perampanel-from-its-hatfield-site-in-uk-to-the-us.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4494/eisai-uk-site-to-make-epilepsy-drug-for-us.html</guid>
		</item>	
				<item>
			<title>EMA gives Patrys cancer drug orphan status </title>
			<atom:link href="https://biospectrumasia.com/news/34/6459/ema-gives-patrys-cancer-drug-orphan-status-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6459/ema-gives-patrys-cancer-drug-orphan-status-.html</link>
			<pubDate>Thu, 12 Sep 2013 09:23:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-gives-patrys-cancer-drug-orphan-status.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6459/ema-gives-patrys-cancer-drug-orphan-status-.html</guid>
		</item>	
				<item>
			<title>Linaclotide phase III trial initiated in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/494/linaclotide-phase-iii-trial-initiated-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/494/linaclotide-phase-iii-trial-initiated-in-china.html</link>
			<pubDate>Wed, 11 Sep 2013 14:02:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100184384.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/494/linaclotide-phase-iii-trial-initiated-in-china.html</guid>
		</item>	
				<item>
			<title>TWi gets US patent for type II diabetes drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2173/twi-gets-us-patent-for-type-ii-diabetes-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2173/twi-gets-us-patent-for-type-ii-diabetes-drug.html</link>
			<pubDate>Wed, 11 Sep 2013 13:52:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-patent-is-part-of-twi-biotechnology-s-broad-intellectual-property-portfolio-for-ac-201.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2173/twi-gets-us-patent-for-type-ii-diabetes-drug.html</guid>
		</item>	
				<item>
			<title>Avantor launches polysorbates for pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/4297/avantor-launches-polysorbates-for-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4297/avantor-launches-polysorbates-for-pharma.html</link>
			<pubDate>Wed, 11 Sep 2013 13:43:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/avantor-performance-materials-introduces-higher-purity-super-refined-grade-of-polysorbate-products.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4297/avantor-launches-polysorbates-for-pharma.html</guid>
		</item>	
				<item>
			<title>Eloxatin shows +ve results in tumor inhibition</title>
			<atom:link href="https://biospectrumasia.com/news/34/6340/eloxatin-shows-ve-results-in-tumor-inhibition.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6340/eloxatin-shows-ve-results-in-tumor-inhibition.html</link>
			<pubDate>Wed, 11 Sep 2013 13:00:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dendrimer-enhanced-version-of-starpharma-s-cancer-drug-eloxatin-oxaliplatin-achieved-improved-tumor-inhibiting-efficacy-and-reduced-overall-toxicity.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6340/eloxatin-shows-ve-results-in-tumor-inhibition.html</guid>
		</item>	
				<item>
			<title>NZ firm migrates to Aus to capitalize on MS drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/6738/nz-firm-migrates-to-aus-to-capitalize-on-ms-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6738/nz-firm-migrates-to-aus-to-capitalize-on-ms-drug.html</link>
			<pubDate>Wed, 11 Sep 2013 11:22:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-zealand-based-secondary-progressive-multiple-screlosis-spms-drug-firm-innate-immunotherapeutics-is-moving-to-australia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6738/nz-firm-migrates-to-aus-to-capitalize-on-ms-drug.html</guid>
		</item>	
				<item>
			<title>Cytos reveals trial data allergic asthma immune modulator </title>
			<atom:link href="https://biospectrumasia.com/news/34/1207/cytos-reveals-trial-data-allergic-asthma-immune-modulator-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1207/cytos-reveals-trial-data-allergic-asthma-immune-modulator-.html</link>
			<pubDate>Mon, 09 Sep 2013 11:26:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-concludes-that-patients-in-the-lower-beos-group-were-not-dependent-on-ics-therapy-to-achieve-adequate-control-of-their-asthma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1207/cytos-reveals-trial-data-allergic-asthma-immune-modulator-.html</guid>
		</item>	
				<item>
			<title>Japanese biomedical firm sets up lab in Singapore</title>
			<atom:link href="https://biospectrumasia.com/news/34/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html</link>
			<pubDate>Mon, 09 Sep 2013 11:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyowa-hakko-kirin-khk-has-setup-singapore-translational-research-laboratory-strl-an-international-r-d-center-in-singapore-for-biomedical-sciences.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2311/japanese-biomedical-firm-sets-up-lab-in-singapore.html</guid>
		</item>	
				<item>
			<title>Medivir, Daewoong end hepatitis drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/3112/medivir-daewoong-end-hepatitis-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3112/medivir-daewoong-end-hepatitis-drug-development.html</link>
			<pubDate>Mon, 09 Sep 2013 10:38:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sweden-based-medivir-has-discontinued-the-development-of-its-hepatitis-b-compound-miv-210-based-on-a-joint-decision-with-korea-based-daewoong-pharmaceutical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3112/medivir-daewoong-end-hepatitis-drug-development.html</guid>
		</item>	
				<item>
			<title>Latanoprost improves glucose, lipid disorder in diabetes </title>
			<atom:link href="https://biospectrumasia.com/news/34/6682/latanoprost-improves-glucose-lipid-disorder-in-diabetes-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6682/latanoprost-improves-glucose-lipid-disorder-in-diabetes-.html</link>
			<pubDate>Mon, 09 Sep 2013 10:22:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cell-based-assays-on-3t3-l1-adipocytes-and-c2c12-myotubes-demonstrated-that-latanoprost-could-promote-glucose-uptake-inhibit-pre-adipocyte-differentiation-and-regulate-the-main-genes-responsible-for-glucos.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6682/latanoprost-improves-glucose-lipid-disorder-in-diabetes-.html</guid>
		</item>	
				<item>
			<title>miRNA tools market clocked $110 mn in 2012: Frost </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4624/mirna-tools-market-clocked-110-mn-in-2012-frost-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4624/mirna-tools-market-clocked-110-mn-in-2012-frost-.html</link>
			<pubDate>Mon, 09 Sep 2013 09:56:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-growth-of-therapeutic-and-diagnostic-enterprises-higher-research-funding-and-increased-outsourcing-to-contract-research-organiszations-in-the-us-will-present-immense-opportunities-for-the-mirna-tools.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4624/mirna-tools-market-clocked-110-mn-in-2012-frost-.html</guid>
		</item>	
				<item>
			<title>Novartis, Regenerex further immune tolerance R&amp;D </title>
			<atom:link href="https://biospectrumasia.com/news/34/1415/novartis-regenerex-further-immune-tolerance-rd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1415/novartis-regenerex-further-immune-tolerance-rd-.html</link>
			<pubDate>Fri, 06 Sep 2013 17:27:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-and-regenerex-sign-licensing-and-research-collaboration-deal-for-novel-facilitating-cell-therapy-fcrx-platform-to-induce-immune-tolerance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1415/novartis-regenerex-further-immune-tolerance-rd-.html</guid>
		</item>	
				<item>
			<title>GSK melanoma phase III misses co-primary endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/34/2289/gsk-melanoma-phase-iii-misses-co-primary-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2289/gsk-melanoma-phase-iii-misses-co-primary-endpoint.html</link>
			<pubDate>Fri, 06 Sep 2013 09:16:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/in-line-with-the-independent-data-monitoring-committee-s-idmc-unanimous-recommendation-gsk-will-continue-the-study-until-the-second-co-primary-endpoint-is-assessed.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2289/gsk-melanoma-phase-iii-misses-co-primary-endpoint.html</guid>
		</item>	
				<item>
			<title>Oramed submits pre-IND to FDA for exenatide</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/6574/oramed-submits-pre-ind-to-fda-for-exenatide.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/6574/oramed-submits-pre-ind-to-fda-for-exenatide.html</link>
			<pubDate>Wed, 04 Sep 2013 14:19:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oramed-submitted-pre-ind-to-us-fda-for-its-an-orally-administered-exenatide-capsule-ormd-0901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/6574/oramed-submits-pre-ind-to-fda-for-exenatide.html</guid>
		</item>	
				<item>
			<title>Google, Facebook, Apple invite nominations for 2014 &#039;Breakthrough Prize&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/1021/google-facebook-apple-invite-nominations-for-2014-breakthrough-prize.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1021/google-facebook-apple-invite-nominations-for-2014-breakthrough-prize.html</link>
			<pubDate>Wed, 04 Sep 2013 13:31:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/google-co-founder-sergey-brin-l-and-facebook-co-founder-mark-zuckerberg-r-along-with-their-spouses-and-russian-entrepreneur-yuri-milner-have-invited-nominations-for-awarding-the-2014-breakthrough-prize.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1021/google-facebook-apple-invite-nominations-for-2014-breakthrough-prize.html</guid>
		</item>	
				<item>
			<title>Bayer cancer drug Stivarga gets Singapore nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/2285/bayer-cancer-drug-stivarga-gets-singapore-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2285/bayer-cancer-drug-stivarga-gets-singapore-nod.html</link>
			<pubDate>Tue, 03 Sep 2013 12:20:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-colorectal-cancer-patients-health-sciences-authority-hsa-of-singapore-approves-bayer-s-stivarga.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2285/bayer-cancer-drug-stivarga-gets-singapore-nod.html</guid>
		</item>	
				<item>
			<title>Eisai gets WHO prequalification, will donate 2.2 bn doses</title>
			<atom:link href="https://biospectrumasia.com/news/34/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html</link>
			<pubDate>Tue, 03 Sep 2013 11:57:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-s-100-mg-tablet-of-diethylcarbamazine-dec-for-treatment-of-elephantiasis-gets-who-prequalification.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2744/eisai-gets-who-prequalification-will-donate-2-2-bn-doses.html</guid>
		</item>	
				<item>
			<title>Elsevier: Prana drug among &#039;Top 10 CNS Projects&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/2150/elsevier-prana-drug-among-top-10-cns-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2150/elsevier-prana-drug-among-top-10-cns-projects.html</link>
			<pubDate>Tue, 03 Sep 2013 11:11:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/elsevier-business-intelligence-recognizes-prana-s-clinical-drug-for-cns-as-one-of-the-top-10-neuroscience-projects-to-watch.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2150/elsevier-prana-drug-among-top-10-cns-projects.html</guid>
		</item>	
				<item>
			<title>Daiichi&#039;s thrombosis drug meets primary endpoint </title>
			<atom:link href="https://biospectrumasia.com/news/34/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html</link>
			<pubDate>Mon, 02 Sep 2013 13:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/daiichi-sankyo-phase-iii-clinical-trial-of-once-daily-edoxaban-for-the-treatment-of-acute-symptomatic-deep-vein-thrombosis-dvt-and-pulmonary-embolism-pe-met-its-primary-efficacy-endpoint.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6558/daiichis-thrombosis-drug-meets-primary-endpoint-.html</guid>
		</item>	
				<item>
			<title>FDA to further review Otsuka kidney drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/5178/fda-to-further-review-otsuka-kidney-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5178/fda-to-further-review-otsuka-kidney-drug-.html</link>
			<pubDate>Mon, 02 Sep 2013 11:37:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-us-fda-requested-otsuka-to-provide-additional-data-to-further-evaluate-the-efficacy-and-safety-of-tolvaptan-in-patients-with-autosomal-dominant-polycystic-kidney-disease-adpkd.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5178/fda-to-further-review-otsuka-kidney-drug-.html</guid>
		</item>	
				<item>
			<title>AB Sciex launches data analysis software</title>
			<atom:link href="https://biospectrumasia.com/news/34/2295/ab-sciex-launches-data-analysis-software.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2295/ab-sciex-launches-data-analysis-software.html</link>
			<pubDate>Fri, 30 Aug 2013 12:56:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ab-sciex-masterview-software-has-built-in-automation-that-turns-huge-amounts-of-analytical-data-into-simplified-information-for-safer-food-cleaner-environments-and-more-reliable-forensic-drug-screening.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2295/ab-sciex-launches-data-analysis-software.html</guid>
		</item>	
				<item>
			<title>NIH: Gilead&#039;s sofosbuvir + ribavirin cures hepatitis C</title>
			<atom:link href="https://biospectrumasia.com/news/34/6266/nih-gileads-sofosbuvir-ribavirin-cures-hepatitis-c.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6266/nih-gileads-sofosbuvir-ribavirin-cures-hepatitis-c.html</link>
			<pubDate>Thu, 29 Aug 2013 09:04:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-hepatitis-c-patients-niaid-and-nih-trial-with-gilead-s-sofosbuvir-plus-ribavirin-shows-promise.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6266/nih-gileads-sofosbuvir-ribavirin-cures-hepatitis-c.html</guid>
		</item>	
				<item>
			<title>QRxPharma pain killer&#039;s NDA gets FDA response </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4236/qrxpharma-pain-killers-nda-gets-fda-response-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4236/qrxpharma-pain-killers-nda-gets-fda-response-.html</link>
			<pubDate>Wed, 28 Aug 2013 14:41:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-us-fda-has-given-a-complete-response-letter-crl-to-qrxpharma-for-the-new-drug-application-nda-of-moxduo-which-is-used-for-the-treatment-of-moderate-to-severe-acute-pain.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4236/qrxpharma-pain-killers-nda-gets-fda-response-.html</guid>
		</item>	
				<item>
			<title>FranÃƒÂ§ois-Xavier Roge is Takeda&#039;s new CFO</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/1416/franois-xavier-roge-is-takedas-new-cfo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/1416/franois-xavier-roge-is-takedas-new-cfo.html</link>
			<pubDate>Wed, 28 Aug 2013 12:32:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mr-fran-ois-xavier-roger-the-chief-financial-officer-cfo-of-takeda-pharmaceutical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/1416/franois-xavier-roge-is-takedas-new-cfo.html</guid>
		</item>	
				<item>
			<title>Competition intensifies for type 2 diabetes drugs </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2887/competition-intensifies-for-type-2-diabetes-drugs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2887/competition-intensifies-for-type-2-diabetes-drugs-.html</link>
			<pubDate>Wed, 28 Aug 2013 11:25:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fisher-paykel-healthcare-raised-its-earnings-guidance-for-the-financial-year-ending-march-31-2014.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2887/competition-intensifies-for-type-2-diabetes-drugs-.html</guid>
		</item>	
				<item>
			<title>Hodgkin lymphoma therapy may lead to other cancers</title>
			<atom:link href="https://biospectrumasia.com/news/34/2699/hodgkin-lymphoma-therapy-may-lead-to-other-cancers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2699/hodgkin-lymphoma-therapy-may-lead-to-other-cancers.html</link>
			<pubDate>Tue, 27 Aug 2013 12:15:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-by-nih-s-national-cancer-institute-nci-suggests-that-while-the-cure-rate-in-hodgkin-lymphoma-is-high-there-is-a-risk-of-developing-secondary-malignancies-such-as-breast-cancer-lung-cancer-and-stomach.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2699/hodgkin-lymphoma-therapy-may-lead-to-other-cancers.html</guid>
		</item>	
				<item>
			<title>AstraZeneca biologics R&amp;D arm acquires Amplimmune</title>
			<atom:link href="https://biospectrumasia.com/news/34/3206/astrazeneca-biologics-rd-arm-acquires-amplimmune.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3206/astrazeneca-biologics-rd-arm-acquires-amplimmune.html</link>
			<pubDate>Tue, 27 Aug 2013 11:08:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astrazeneca-s-global-biologics-r-d-arm-medimmune-plans-to-acquire-amplimmune-and-bolster-its-oncology-pipeline-by-obtaining-multiple-early-stage-assets-for-its-immune-mediated-cancer-therapy-imt-c-portfolio.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3206/astrazeneca-biologics-rd-arm-acquires-amplimmune.html</guid>
		</item>	
				<item>
			<title>US firm files antibody patent in Japan, Korea </title>
			<atom:link href="https://biospectrumasia.com/news/34/5350/us-firm-files-antibody-patent-in-japan-korea-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5350/us-firm-files-antibody-patent-in-japan-korea-.html</link>
			<pubDate>Tue, 27 Aug 2013 10:43:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mmr-global-files-divisional-application-for-its-antibody-technology-in-japan-and-south-korea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5350/us-firm-files-antibody-patent-in-japan-korea-.html</guid>
		</item>	
				<item>
			<title>Amgen to acquire Onyx for $10 bn cash </title>
			<atom:link href="https://biospectrumasia.com/news/34/699/amgen-to-acquire-onyx-for-10-bn-cash-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/699/amgen-to-acquire-onyx-for-10-bn-cash-.html</link>
			<pubDate>Mon, 26 Aug 2013 11:45:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amgen-plans-to-acquire-all-the-outstanding-shares-of-onyx-pharmaceuticals-for-usd125-per-share.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/699/amgen-to-acquire-onyx-for-10-bn-cash-.html</guid>
		</item>	
				<item>
			<title>GSK shuts phase III studies of Crohn&#039;s drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2083/gsk-shuts-phase-iii-studies-of-crohns-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2083/gsk-shuts-phase-iii-studies-of-crohns-drug.html</link>
			<pubDate>Mon, 26 Aug 2013 09:18:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-indicated-that-it-intends-to-continue-to-explore-the-safety-and-efficacy-results-to-inform-decisions-about-the-clinical-development-program-for-vercirnon.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2083/gsk-shuts-phase-iii-studies-of-crohns-drug.html</guid>
		</item>	
				<item>
			<title>Oramed recruits patients for oral insulin trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/1757/oramed-recruits-patients-for-oral-insulin-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1757/oramed-recruits-patients-for-oral-insulin-trial-.html</link>
			<pubDate>Thu, 22 Aug 2013 12:47:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oramed-recently-published-its-clinical-trial-results-of-oral-insulin-capsule-in-plos-one-with-the-title-glucose-reducing-effect-of-the-ormd-0801-oral-insulin-preparation-in-patients-with-uncontrolled-diabetes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1757/oramed-recruits-patients-for-oral-insulin-trial-.html</guid>
		</item>	
				<item>
			<title>Epilepsy Foundation asks DEA to better review process</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1659/epilepsy-foundation-asks-dea-to-better-review-process.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1659/epilepsy-foundation-asks-dea-to-better-review-process.html</link>
			<pubDate>Thu, 22 Aug 2013 12:10:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/epilepsy-foundation-of-us-asks-the-drug-enforcement-administration-dea-us-to-revise-its-process-for-reviewing-new-treatments.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1659/epilepsy-foundation-asks-dea-to-better-review-process.html</guid>
		</item>	
				<item>
			<title>Bayer gets Japan&#039;s nod for gastro tumor drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html</link>
			<pubDate>Thu, 22 Aug 2013 09:35:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-gets-japan-s-nod-for-gastro-tumor-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1677/bayer-gets-japans-nod-for-gastro-tumor-drug.html</guid>
		</item>	
				<item>
			<title>Johnson &amp; Johnson acquires Aragon Pharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/3843/johnson-johnson-acquires-aragon-pharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3843/johnson-johnson-acquires-aragon-pharma.html</link>
			<pubDate>Wed, 21 Aug 2013 14:28:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/johnson-johnson-acquires-aragon-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3843/johnson-johnson-acquires-aragon-pharma.html</guid>
		</item>	
				<item>
			<title>Chinese medicine improves spinal injury in rats</title>
			<atom:link href="https://biospectrumasia.com/news/34/3834/chinese-medicine-improves-spinal-injury-in-rats.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3834/chinese-medicine-improves-spinal-injury-in-rats.html</link>
			<pubDate>Wed, 21 Aug 2013 13:29:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chinese-herbal-medicine-improves-spinal-cord-injury-in-rats.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3834/chinese-medicine-improves-spinal-injury-in-rats.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; bimagrumab gets breakthrough nod from FDA</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7111/novartis-bimagrumab-gets-breakthrough-nod-from-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7111/novartis-bimagrumab-gets-breakthrough-nod-from-fda.html</link>
			<pubDate>Wed, 21 Aug 2013 08:48:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sporadic-inclusion-body-myositis-sibm-is-a-rare-yet-life-threatening-muscle-wasting-condition-where-patients-gradually-lose-the-ability-to-walk-experience-falls-and-injuries-lose-hand-function-and-have.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7111/novartis-bimagrumab-gets-breakthrough-nod-from-fda.html</guid>
		</item>	
				<item>
			<title>Astellas receives approval of Irribow in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6651/astellas-receives-approval-of-irribow-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6651/astellas-receives-approval-of-irribow-in-japan.html</link>
			<pubDate>Mon, 19 Aug 2013 10:36:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6651/astellas-receives-approval-of-irribow-in-japan.html</guid>
		</item>	
				<item>
			<title>BI, Lilly&#039;s diabetes drug Linagliptin shows efficacy </title>
			<atom:link href="https://biospectrumasia.com/news/34/4438/bi-lillys-diabetes-drug-linagliptin-shows-efficacy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4438/bi-lillys-diabetes-drug-linagliptin-shows-efficacy-.html</link>
			<pubDate>Fri, 16 Aug 2013 10:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bi-lilly-s-diabetes-drug-linagliptin-shows-efficacy.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4438/bi-lillys-diabetes-drug-linagliptin-shows-efficacy-.html</guid>
		</item>	
				<item>
			<title>GSK&#039;s cancer drug gets EU marketing authorization </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1324/gsks-cancer-drug-gets-eu-marketing-authorization-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1324/gsks-cancer-drug-gets-eu-marketing-authorization-.html</link>
			<pubDate>Fri, 16 Aug 2013 09:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-s-cancer-drug-gets-eu-marketing-authorization.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1324/gsks-cancer-drug-gets-eu-marketing-authorization-.html</guid>
		</item>	
				<item>
			<title>Fosun Pharma listed in CCTV Financial 50 Index Sample Stock</title>
			<atom:link href="https://biospectrumasia.com/company-results/34/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/34/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html</link>
			<pubDate>Wed, 14 Aug 2013 12:19:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-business.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/34/5386/fosun-pharma-listed-in-cctv-financial-50-index-sample-stock.html</guid>
		</item>	
				<item>
			<title>Clue to future universal dengue vaccine found</title>
			<atom:link href="https://biospectrumasia.com/news/34/7140/clue-to-future-universal-dengue-vaccine-found.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7140/clue-to-future-universal-dengue-vaccine-found.html</link>
			<pubDate>Wed, 14 Aug 2013 12:16:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/allied-increases-stake-in-herpes-vaccine-firm-coridon-vaccines.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7140/clue-to-future-universal-dengue-vaccine-found.html</guid>
		</item>	
				<item>
			<title>Agilent, SomaLogic to expand proteomic tech</title>
			<atom:link href="https://biospectrumasia.com/news/34/2184/agilent-somalogic-to-expand-proteomic-tech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2184/agilent-somalogic-to-expand-proteomic-tech.html</link>
			<pubDate>Wed, 14 Aug 2013 12:08:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/israel-based-compugen-and-bayer-jointly-pursue-r-d-and-commercialization-of-antibody-based-therapeutics-for-cancer-immunotherapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2184/agilent-somalogic-to-expand-proteomic-tech.html</guid>
		</item>	
				<item>
			<title>Lilly phase III lung cancer study meets endpoint </title>
			<atom:link href="https://biospectrumasia.com/news/34/6060/lilly-phase-iii-lung-cancer-study-meets-endpoint-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6060/lilly-phase-iii-lung-cancer-study-meets-endpoint-.html</link>
			<pubDate>Wed, 14 Aug 2013 09:41:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/isis-pharma-rheumatoid-arthritis-ra-drug-isis-crprx-did-not-make-statistically-significant-improvements-as-compared-to-those-observed-in-patients-in-the-placebo-group.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6060/lilly-phase-iii-lung-cancer-study-meets-endpoint-.html</guid>
		</item>	
				<item>
			<title>Takeda, Dainippon to market schizophrenia drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/3269/takeda-dainippon-to-market-schizophrenia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3269/takeda-dainippon-to-market-schizophrenia-drug-.html</link>
			<pubDate>Tue, 13 Aug 2013 11:25:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-schizophrenia-patients-dainippon-sumitomo-pharma-and-takeda-pharmaceutical-get-approval-for-marketing-authorization-by-swissmedic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3269/takeda-dainippon-to-market-schizophrenia-drug-.html</guid>
		</item>	
				<item>
			<title>Taiwan develops carbohydrate-based cancer vaccine </title>
			<atom:link href="https://biospectrumasia.com/news/34/2074/taiwan-develops-carbohydrate-based-cancer-vaccine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2074/taiwan-develops-carbohydrate-based-cancer-vaccine-.html</link>
			<pubDate>Tue, 13 Aug 2013 11:02:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/academia-sinica-researchers-developed-vaccine-candidates-against-prostate-cancer-and-the-pathogen-that-causes-meningococcal-meningitis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2074/taiwan-develops-carbohydrate-based-cancer-vaccine-.html</guid>
		</item>	
				<item>
			<title>Lupin hires top Teva, Sandoz staff for R&amp;D in US</title>
			<atom:link href="https://biospectrumasia.com/news/34/7137/lupin-hires-top-teva-sandoz-staff-for-rd-in-us.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7137/lupin-hires-top-teva-sandoz-staff-for-rd-in-us.html</link>
			<pubDate>Tue, 13 Aug 2013 10:52:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupin-sets-up-r-d-center-in-the-us-to-get-respiratory-and-dermatology-products-into-the-market-as-soon-as-possible.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7137/lupin-hires-top-teva-sandoz-staff-for-rd-in-us.html</guid>
		</item>	
				<item>
			<title>FDA green signal for joint GSK-Pfizer HIV drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/4042/fda-green-signal-for-joint-gsk-pfizer-hiv-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4042/fda-green-signal-for-joint-gsk-pfizer-hiv-drug-.html</link>
			<pubDate>Tue, 13 Aug 2013 10:45:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-has-approved-gsk-and-pfizer-owned-hiv-dedicated-firm-viiv-healthcare-s-tivicay-dolutegravir-50-mg-tablets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4042/fda-green-signal-for-joint-gsk-pfizer-hiv-drug-.html</guid>
		</item>	
				<item>
			<title>Biocon&#039;s novel anti-psoriasis biotech drug Itolizumab released in India</title>
			<atom:link href="https://biospectrumasia.com/news/34/6628/biocons-novel-anti-psoriasis-biotech-drug-itolizumab-released-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6628/biocons-novel-anti-psoriasis-biotech-drug-itolizumab-released-in-india.html</link>
			<pubDate>Mon, 12 Aug 2013 11:19:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/another-feather-in-the-cap-dr-kiran-mazumdar-shaw-cmd-biocon-named-as-the-second-non-us-member-on-the-board-of-trustees-of-us-pharmacopeial-convention-usp.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6628/biocons-novel-anti-psoriasis-biotech-drug-itolizumab-released-in-india.html</guid>
		</item>	
				<item>
			<title>Hong Kong to host international TCM exhibition, conference</title>
			<atom:link href="https://biospectrumasia.com/news/34/6592/hong-kong-to-host-international-tcm-exhibition-conference.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</link>
			<pubDate>Mon, 12 Aug 2013 10:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotec-nstda-took-part-in-an-exhibition-of-kelantan-international-bio-carnival-conference-and-exhibition-2013-bio-k-on-february-28-march-2-2013-in-kelantan-malaysia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6592/hong-kong-to-host-international-tcm-exhibition-conference.html</guid>
		</item>	
				<item>
			<title>Novartis liver cancer trial with Afinitor flops</title>
			<atom:link href="https://biospectrumasia.com/news/34/227/novartis-liver-cancer-trial-with-afinitor-flops.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/227/novartis-liver-cancer-trial-with-afinitor-flops.html</link>
			<pubDate>Fri, 09 Aug 2013 10:15:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-phase-iii-study-of-afinitor-everolimus-in-advanced-liver-cancer-metastatic-hepatocellular-carcinoma-hcc-does-not-meet-primary-endpoint.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/227/novartis-liver-cancer-trial-with-afinitor-flops.html</guid>
		</item>	
				<item>
			<title>Gilead&#039;s Viread patent revoked in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/4846/gileads-viread-patent-revoked-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4846/gileads-viread-patent-revoked-in-china.html</link>
			<pubDate>Thu, 08 Aug 2013 16:40:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-s-sipo-invalidates-gilead-sciences-drug-viread.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4846/gileads-viread-patent-revoked-in-china.html</guid>
		</item>	
				<item>
			<title>China will overtake Japan in R&amp;D spending: Report</title>
			<atom:link href="https://biospectrumasia.com/news/34/366/china-will-overtake-japan-in-rd-spending-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/366/china-will-overtake-japan-in-rd-spending-report.html</link>
			<pubDate>Thu, 08 Aug 2013 12:32:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-country-s-elderly-population-will-account-for-about-19-percent-of-china-s-total-population-which-is-projected-to-be-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/366/china-will-overtake-japan-in-rd-spending-report.html</guid>
		</item>	
				<item>
			<title>Jazz Pharma clocks $208 mn in Q2 2013</title>
			<atom:link href="https://biospectrumasia.com/company-results/34/2031/jazz-pharma-clocks-208-mn-in-q2-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/34/2031/jazz-pharma-clocks-208-mn-in-q2-2013.html</link>
			<pubDate>Wed, 07 Aug 2013 12:45:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/jazz-pharma-reports-earnings-worth-usd208.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/34/2031/jazz-pharma-clocks-208-mn-in-q2-2013.html</guid>
		</item>	
				<item>
			<title>Taiwan to get its first biosafety level 3 plant</title>
			<atom:link href="https://biospectrumasia.com/news/34/2141/taiwan-to-get-its-first-biosafety-level-3-plant.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2141/taiwan-to-get-its-first-biosafety-level-3-plant.html</link>
			<pubDate>Tue, 06 Aug 2013 14:13:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amaran-biotechnology-s-usd33.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2141/taiwan-to-get-its-first-biosafety-level-3-plant.html</guid>
		</item>	
				<item>
			<title>FDA not in favour of Otsuka&#039;s kidney drug Tolvaptan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html</link>
			<pubDate>Tue, 06 Aug 2013 07:57:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-not-in-favour-of-otsuka-s-kidney-drug-tolvaptan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6168/fda-not-in-favour-of-otsukas-kidney-drug-tolvaptan.html</guid>
		</item>	
				<item>
			<title>Bayer, Compugen enter $500 mn cancer deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/1477/bayer-compugen-enter-500-mn-cancer-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1477/bayer-compugen-enter-500-mn-cancer-deal.html</link>
			<pubDate>Tue, 06 Aug 2013 07:38:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/israel-based-compugen-and-bayer-jointly-pursue-r-d-and-commercialization-of-antibody-based-therapeutics-for-cancer-immunotherapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1477/bayer-compugen-enter-500-mn-cancer-deal.html</guid>
		</item>	
				<item>
			<title>NIH: Alcohol addiction depends on gene combination</title>
			<atom:link href="https://biospectrumasia.com/news/34/2659/nih-alcohol-addiction-depends-on-gene-combination.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2659/nih-alcohol-addiction-depends-on-gene-combination.html</link>
			<pubDate>Mon, 05 Aug 2013 13:14:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/combination-of-genes-that-regulate-serotonin-activity-help-in-treating-alcohol-dependence.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2659/nih-alcohol-addiction-depends-on-gene-combination.html</guid>
		</item>	
				<item>
			<title>Oramed submits pre-IND for exenatide to FDA </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/226/oramed-submits-pre-ind-for-exenatide-to-fda-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/226/oramed-submits-pre-ind-for-exenatide-to-fda-.html</link>
			<pubDate>Fri, 02 Aug 2013 13:38:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oramed-submits-pre-ind-meeting-request-to-fda-for-its-oral-exenatide-capsule-ormd-0901.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/226/oramed-submits-pre-ind-for-exenatide-to-fda-.html</guid>
		</item>	
				<item>
			<title>Prana Biotech readies to progress PBT2 to market</title>
			<atom:link href="https://biospectrumasia.com/news/34/1763/prana-biotech-readies-to-progress-pbt2-to-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1763/prana-biotech-readies-to-progress-pbt2-to-market.html</link>
			<pubDate>Fri, 02 Aug 2013 10:34:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-discovery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1763/prana-biotech-readies-to-progress-pbt2-to-market.html</guid>
		</item>	
				<item>
			<title>Kinex receives funds from Hong Kong govt ITC</title>
			<atom:link href="https://biospectrumasia.com/news/34/3508/kinex-receives-funds-from-hong-kong-govt-itc.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3508/kinex-receives-funds-from-hong-kong-govt-itc.html</link>
			<pubDate>Fri, 02 Aug 2013 10:00:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mesoblast-gets-usd4.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3508/kinex-receives-funds-from-hong-kong-govt-itc.html</guid>
		</item>	
				<item>
			<title>Military univ, Shanghai Pharma form alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/5385/military-univ-shanghai-pharma-form-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5385/military-univ-shanghai-pharma-form-alliance.html</link>
			<pubDate>Thu, 01 Aug 2013 12:42:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shanghai-pharmaceuticals-and-secondary-military-medical-university-smmu-to-form-shanghai-pharmaceuticals-translational-medicine-alliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5385/military-univ-shanghai-pharma-form-alliance.html</guid>
		</item>	
				<item>
			<title>Takeda&#039;s diabetes drug gets Chinese FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/931/takedas-diabetes-drug-gets-chinese-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/931/takedas-diabetes-drug-gets-chinese-fda-nod.html</link>
			<pubDate>Thu, 01 Aug 2013 11:45:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes-innovators-can-win-usd75-000-at-boehringer-ingelheim-funded-healthcare-innovation-world-cup.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/931/takedas-diabetes-drug-gets-chinese-fda-nod.html</guid>
		</item>	
				<item>
			<title>NIH to develop therapeutics for nicotine addiction</title>
			<atom:link href="https://biospectrumasia.com/news/34/847/nih-to-develop-therapeutics-for-nicotine-addiction.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/847/nih-to-develop-therapeutics-for-nicotine-addiction.html</link>
			<pubDate>Thu, 01 Aug 2013 11:32:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nih-blueprint-neurotherapeutics-network-is-going-to-fund-projects-to-develop-therapeutics-for-nicotine-addiction-among-others.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/847/nih-to-develop-therapeutics-for-nicotine-addiction.html</guid>
		</item>	
				<item>
			<title>Charles River manages 2.9% growth in Q2, 2013</title>
			<atom:link href="https://biospectrumasia.com/company-results/34/3416/charles-river-manages-2-9-growth-in-q2-2013.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/company-results/34/3416/charles-river-manages-2-9-growth-in-q2-2013.html</link>
			<pubDate>Thu, 01 Aug 2013 10:36:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/a-live-and-archived-webcast-of-the-conference-call-will-be-available-through-the-company-s-investor-relations-website.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/company-results/34/3416/charles-river-manages-2-9-growth-in-q2-2013.html</guid>
		</item>	
				<item>
			<title>Merck pays Bionomics $172mn for pain molecules</title>
			<atom:link href="https://biospectrumasia.com/news/34/783/merck-pays-bionomics-172mn-for-pain-molecules.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/783/merck-pays-bionomics-172mn-for-pain-molecules.html</link>
			<pubDate>Thu, 01 Aug 2013 07:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-pain-patients-bionomics-pays-usd172mn-to-merck-to-commercialize-chronic-pain-molecules.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/783/merck-pays-bionomics-172mn-for-pain-molecules.html</guid>
		</item>	
				<item>
			<title>Astellas, FibroGen start CKD anemia trial in Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html</link>
			<pubDate>Wed, 31 Jul 2013 13:28:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-anemic-patients-with-chronic-kidney-disease-ckd-astellas-pharma-and-fibrogen-initiate-phase-ii-clinical-study-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7359/astellas-fibrogen-start-ckd-anemia-trial-in-japan-.html</guid>
		</item>	
				<item>
			<title>NIH study: Diabetes drug Metformin extends life</title>
			<atom:link href="https://biospectrumasia.com/news/34/238/nih-study-diabetes-drug-metformin-extends-life.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/238/nih-study-diabetes-drug-metformin-extends-life.html</link>
			<pubDate>Wed, 31 Jul 2013 12:38:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/long-term-treatment-with-the-type-2-diabetes-drug-metformin-improves-health-and-longevity-of-male-mice-when-started-at-middle-age.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/238/nih-study-diabetes-drug-metformin-extends-life.html</guid>
		</item>	
				<item>
			<title>Novartis finds no evidence of wrongdoing in clinical trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html</link>
			<pubDate>Wed, 31 Jul 2013 10:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-service.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4442/novartis-finds-no-evidence-of-wrongdoing-in-clinical-trials.html</guid>
		</item>	
				<item>
			<title>Lonza, BioWa sign research agreements with Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/34/2673/lonza-biowa-sign-research-agreements-with-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2673/lonza-biowa-sign-research-agreements-with-pfizer.html</link>
			<pubDate>Wed, 31 Jul 2013 09:55:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cap-s-laboratory-accreditation-surveys-pt-programs-and-other-quality-management-resources-combined-with-bd-s-in-depth-clinical-knowledge-of-preanalytical-systems-will-provide-a-comprehensive-expert-base.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2673/lonza-biowa-sign-research-agreements-with-pfizer.html</guid>
		</item>	
				<item>
			<title>FDA to review Vanda blindness drug Tasimelteon </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1090/fda-to-review-vanda-blindness-drug-tasimelteon-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1090/fda-to-review-vanda-blindness-drug-tasimelteon-.html</link>
			<pubDate>Wed, 31 Jul 2013 09:38:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-warned-against-the-use-of-antimalarial-drug-mefloquine-hydrochloride-as-it-causes-neurologic-and-psychiatric-side-effects.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1090/fda-to-review-vanda-blindness-drug-tasimelteon-.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo expands drug discovery program </title>
			<atom:link href="https://biospectrumasia.com/news/34/1312/daiichi-sankyo-expands-drug-discovery-program-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1312/daiichi-sankyo-expands-drug-discovery-program-.html</link>
			<pubDate>Tue, 30 Jul 2013 11:51:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharma-clinical-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1312/daiichi-sankyo-expands-drug-discovery-program-.html</guid>
		</item>	
				<item>
			<title>WHO urges nations to act on hepatitis threat</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/6357/who-urges-nations-to-act-on-hepatitis-threat.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/6357/who-urges-nations-to-act-on-hepatitis-threat.html</link>
			<pubDate>Fri, 26 Jul 2013 12:29:51 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/who-governments-should-act-against-the-five-hepatitis-viruses-that-can-cause-severe-liver-infections-and-lead-to-1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/6357/who-urges-nations-to-act-on-hepatitis-threat.html</guid>
		</item>	
				<item>
			<title>Roche study: Obinutuzumab better than Rituxan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6787/roche-study-obinutuzumab-better-than-rituxan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6787/roche-study-obinutuzumab-better-than-rituxan.html</link>
			<pubDate>Thu, 25 Jul 2013 13:17:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/roche-s-obinutuzumab-ga101-is-the-first-type-ii-anti-cd20-medicine-that-is-glycoengineered.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6787/roche-study-obinutuzumab-better-than-rituxan.html</guid>
		</item>	
				<item>
			<title>IOF, Fonterra grants $43K to Indonesian for bone R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/34/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html</link>
			<pubDate>Thu, 25 Jul 2013 10:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-suharti-suherman-of-the-faculty-of-medicine-university-of-indonesia-has-been-awarded-a-grant-of-approximately-usd43-000-for-bone-research-by-international-osteoporosis-foundation-iof-and-fonterra.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1260/iof-fonterra-grants-43k-to-indonesian-for-bone-rd.html</guid>
		</item>	
				<item>
			<title>Prana completes phase II trial with PBT2</title>
			<atom:link href="https://biospectrumasia.com/news/34/7157/prana-completes-phase-ii-trial-with-pbt2.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7157/prana-completes-phase-ii-trial-with-pbt2.html</link>
			<pubDate>Wed, 24 Jul 2013 11:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/moleac-s-neuroaid-develops-stroke-treatment-based-on-traditional-chinese-medicine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7157/prana-completes-phase-ii-trial-with-pbt2.html</guid>
		</item>	
				<item>
			<title>Quest signs $2mn development deal with Korean firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/1080/quest-signs-2mn-development-deal-with-korean-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1080/quest-signs-2mn-development-deal-with-korean-firm.html</link>
			<pubDate>Wed, 24 Jul 2013 10:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/quest-pharmatech-signs-development-and-commercialization-deal-with-south-korea-based-ad-biotech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1080/quest-signs-2mn-development-deal-with-korean-firm.html</guid>
		</item>	
				<item>
			<title>Taiwan seeks to attract global investors</title>
			<atom:link href="https://biospectrumasia.com/news/34/6132/taiwan-seeks-to-attract-global-investors.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6132/taiwan-seeks-to-attract-global-investors.html</link>
			<pubDate>Tue, 23 Jul 2013 12:53:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biobusiness-asia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6132/taiwan-seeks-to-attract-global-investors.html</guid>
		</item>	
				<item>
			<title>Aussie firm initiates bronchitis drug trial for smokers</title>
			<atom:link href="https://biospectrumasia.com/news/34/5218/aussie-firm-initiates-bronchitis-drug-trial-for-smokers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5218/aussie-firm-initiates-bronchitis-drug-trial-for-smokers.html</link>
			<pubDate>Tue, 23 Jul 2013 12:48:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/invion-commenced-patient-enrolment-in-its-phase-ii-clinical-trial-of-inv102-nadolol-in-patients-with-chronic-bronchitis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5218/aussie-firm-initiates-bronchitis-drug-trial-for-smokers.html</guid>
		</item>	
				<item>
			<title>Korea to spend $8.9 bn to develop 20 drugs by 2017</title>
			<atom:link href="https://biospectrumasia.com/news/34/1991/korea-to-spend-8-9-bn-to-develop-20-drugs-by-2017.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1991/korea-to-spend-8-9-bn-to-develop-20-drugs-by-2017.html</link>
			<pubDate>Tue, 23 Jul 2013 12:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-liposome-company-nce.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1991/korea-to-spend-8-9-bn-to-develop-20-drugs-by-2017.html</guid>
		</item>	
				<item>
			<title>Self monitoring diabetes market to reach $358 mn</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/7453/self-monitoring-diabetes-market-to-reach-358-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/7453/self-monitoring-diabetes-market-to-reach-358-mn.html</link>
			<pubDate>Tue, 23 Jul 2013 10:27:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/self-monitoring-diabetes-market-to-reach-usd358-mn.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/7453/self-monitoring-diabetes-market-to-reach-358-mn.html</guid>
		</item>	
				<item>
			<title>Phylogica appoints CEO, CSO, CFO</title>
			<atom:link href="https://biospectrumasia.com/news/34/7982/phylogica-appoints-ceo-cso-cfo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7982/phylogica-appoints-ceo-cso-cfo.html</link>
			<pubDate>Tue, 23 Jul 2013 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-richard-hopkins-the-new-ceo-of-phylogica.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7982/phylogica-appoints-ceo-cso-cfo.html</guid>
		</item>	
				<item>
			<title>Phylogica gets $400K grant to boost drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/1564/phylogica-gets-400k-grant-to-boost-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1564/phylogica-gets-400k-grant-to-boost-drug-discovery.html</link>
			<pubDate>Mon, 22 Jul 2013 13:48:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phylogica-and-institute-for-molecular-bioscience-imb-get-linkage-grant-from-australian-research-council.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1564/phylogica-gets-400k-grant-to-boost-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Edinburgh Univ, Biogen to study neuro diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/1947/edinburgh-univ-biogen-to-study-neuro-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1947/edinburgh-univ-biogen-to-study-neuro-diseases.html</link>
			<pubDate>Mon, 22 Jul 2013 13:39:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/university-of-edinburgh-uk-and-biogen-idec-us-entered-a-three-year-collaboration-to-seek-greater-insight-into-multiple-sclerosis-and-other-motor-neurone-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1947/edinburgh-univ-biogen-to-study-neuro-diseases.html</guid>
		</item>	
				<item>
			<title>Tetraphase antibiotic gets FDA QIDP designation</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1010/tetraphase-antibiotic-gets-fda-qidp-designation.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1010/tetraphase-antibiotic-gets-fda-qidp-designation.html</link>
			<pubDate>Mon, 22 Jul 2013 13:32:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tetraphase-s-antibiotic-eravacycline-which-is-a-broad-spectrum-oral-antibiotic-monotherapy-for-the-treatment-of-multi-drug-resistant-infections-gets-us-fda-qualified-infectious-disease-product-qidp-designat.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1010/tetraphase-antibiotic-gets-fda-qidp-designation.html</guid>
		</item>	
				<item>
			<title>Astellas gets FDA nod for kidney transplant drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html</link>
			<pubDate>Mon, 22 Jul 2013 10:28:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-gets-fda-nod-for-kidney-transplant-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/360/astellas-gets-fda-nod-for-kidney-transplant-drug.html</guid>
		</item>	
				<item>
			<title>Viralytics presents +ve results of phase II Cavatak trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/2891/viralytics-presents-ve-results-of-phase-ii-cavatak-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2891/viralytics-presents-ve-results-of-phase-ii-cavatak-trial-.html</link>
			<pubDate>Fri, 19 Jul 2013 14:04:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-late-stage-melanoma-patients-viralytics-reports-progressive-interim-results-from-its-phase-ii-clinical-trial-of-cavatak.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2891/viralytics-presents-ve-results-of-phase-ii-cavatak-trial-.html</guid>
		</item>	
				<item>
			<title>Celgene halts phase III trial of cancer drug Revlimid</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2534/celgene-halts-phase-iii-trial-of-cancer-drug-revlimid.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2534/celgene-halts-phase-iii-trial-of-cancer-drug-revlimid.html</link>
			<pubDate>Fri, 19 Jul 2013 10:27:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/celgene-halts-phase-iii-trial-of-cancer-drug-revlimid.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2534/celgene-halts-phase-iii-trial-of-cancer-drug-revlimid.html</guid>
		</item>	
				<item>
			<title>FDA warns Genentech researcher for trial data validity </title>
			<atom:link href="https://biospectrumasia.com/news/34/980/fda-warns-genentech-researcher-for-trial-data-validity-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/980/fda-warns-genentech-researcher-for-trial-data-validity-.html</link>
			<pubDate>Fri, 19 Jul 2013 07:40:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-warns-genentech-s-dr-bernard-doft-for-validity-reliability-and-integrity-of-the-data.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/980/fda-warns-genentech-researcher-for-trial-data-validity-.html</guid>
		</item>	
				<item>
			<title>FDA scraps advisory committee on Merck&#039;s drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2195/fda-scraps-advisory-committee-on-mercks-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2195/fda-scraps-advisory-committee-on-mercks-drug-.html</link>
			<pubDate>Wed, 17 Jul 2013 13:38:29 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-27-andas-cancelled-by-us-fda.png" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2195/fda-scraps-advisory-committee-on-mercks-drug-.html</guid>
		</item>	
				<item>
			<title>Japan to help export regenerative medicine tech to Qatar, KSA</title>
			<atom:link href="https://biospectrumasia.com/news/34/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html</link>
			<pubDate>Wed, 17 Jul 2013 11:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/are-regulatory-bodies-purposely-delaying-approvals-in-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4211/japan-to-help-export-regenerative-medicine-tech-to-qatar-ksa.html</guid>
		</item>	
				<item>
			<title>GSK, Theravance withdraw COPD drug from Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/5605/gsk-theravance-withdraw-copd-drug-from-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5605/gsk-theravance-withdraw-copd-drug-from-japan.html</link>
			<pubDate>Tue, 16 Jul 2013 18:09:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/copd.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5605/gsk-theravance-withdraw-copd-drug-from-japan.html</guid>
		</item>	
				<item>
			<title>Merck alzheimer&#039;s trial is a success</title>
			<atom:link href="https://biospectrumasia.com/news/34/2639/merck-alzheimers-trial-is-a-success.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2639/merck-alzheimers-trial-is-a-success.html</link>
			<pubDate>Tue, 16 Jul 2013 11:11:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-patients-merck-s-mk-8931-decreases-b-amyloid-levels-in-cerebral-spinal-fluid-csf.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2639/merck-alzheimers-trial-is-a-success.html</guid>
		</item>	
				<item>
			<title>China invests $160 bn in biomedicine sector</title>
			<atom:link href="https://biospectrumasia.com/news/34/1870/china-invests-160-bn-in-biomedicine-sector.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1870/china-invests-160-bn-in-biomedicine-sector.html</link>
			<pubDate>Fri, 12 Jul 2013 14:15:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/where-is-the-money-coming-from.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1870/china-invests-160-bn-in-biomedicine-sector.html</guid>
		</item>	
				<item>
			<title>BMS, Pfizer gets FDA nod to review Eliquis </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5450/bms-pfizer-gets-fda-nod-to-review-eliquis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5450/bms-pfizer-gets-fda-nod-to-review-eliquis-.html</link>
			<pubDate>Fri, 12 Jul 2013 10:50:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orexo-received-us-fda-approval-for-opoid-zubsolv-buprenorphinenaloxone-sublingual-tablet.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5450/bms-pfizer-gets-fda-nod-to-review-eliquis-.html</guid>
		</item>	
				<item>
			<title>Mother&#039;s antibodies may cause autism </title>
			<atom:link href="https://biospectrumasia.com/news/34/3378/mothers-antibodies-may-cause-autism-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3378/mothers-antibodies-may-cause-autism-.html</link>
			<pubDate>Thu, 11 Jul 2013 09:33:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3378/mothers-antibodies-may-cause-autism-.html</guid>
		</item>	
				<item>
			<title>BD launches Cell Analyzer to enhance drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/2970/bd-launches-cell-analyzer-to-enhance-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2970/bd-launches-cell-analyzer-to-enhance-drug-discovery.html</link>
			<pubDate>Thu, 11 Jul 2013 08:48:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bd-medtech.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2970/bd-launches-cell-analyzer-to-enhance-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Brisbane biotech secures $14 mn for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/6757/brisbane-biotech-secures-14-mn-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6757/brisbane-biotech-secures-14-mn-for-drug-discovery.html</link>
			<pubDate>Wed, 10 Jul 2013 15:29:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ppps-attract-investment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6757/brisbane-biotech-secures-14-mn-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Australia approves drug for cystic fibrosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/3569/australia-approves-drug-for-cystic-fibrosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3569/australia-approves-drug-for-cystic-fibrosis.html</link>
			<pubDate>Wed, 10 Jul 2013 12:26:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/is-gene-testing-for-breast-cancer-a-preventive-healthcare-option.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3569/australia-approves-drug-for-cystic-fibrosis.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; Enbrel positive in psoriasis study</title>
			<atom:link href="https://biospectrumasia.com/news/34/7643/novartis-enbrel-positive-in-psoriasis-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7643/novartis-enbrel-positive-in-psoriasis-study.html</link>
			<pubDate>Tue, 09 Jul 2013 13:00:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-getting-sued-is-becoming-a-habit.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7643/novartis-enbrel-positive-in-psoriasis-study.html</guid>
		</item>	
				<item>
			<title>EMA to review Eli Lilly&#039;s basal insulin </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5094/ema-to-review-eli-lillys-basal-insulin-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5094/ema-to-review-eli-lillys-basal-insulin-.html</link>
			<pubDate>Tue, 09 Jul 2013 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-find-that-air-pollution-increased-the-risk-of-insulin-resistance-in-children.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5094/ema-to-review-eli-lillys-basal-insulin-.html</guid>
		</item>	
				<item>
			<title>Role of oxidative stress in autism disorder found</title>
			<atom:link href="https://biospectrumasia.com/news/34/3460/role-of-oxidative-stress-in-autism-disorder-found.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3460/role-of-oxidative-stress-in-autism-disorder-found.html</link>
			<pubDate>Mon, 08 Jul 2013 16:50:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-autism-patients-professor-yoshinobu-ebisawa-at-japan-s-shizuoka-university-developed-a-autism-eye-gaze-detection-system-to-predict-likelihood-of-autism.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3460/role-of-oxidative-stress-in-autism-disorder-found.html</guid>
		</item>	
				<item>
			<title>Pharmaxis gets grants for fibrotic research </title>
			<atom:link href="https://biospectrumasia.com/news/34/608/pharmaxis-gets-grants-for-fibrotic-research-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/608/pharmaxis-gets-grants-for-fibrotic-research-.html</link>
			<pubDate>Mon, 08 Jul 2013 11:03:28 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/608/pharmaxis-gets-grants-for-fibrotic-research-.html</guid>
		</item>	
				<item>
			<title>CSL Behring progresses on novel drug for Hemophilia A</title>
			<atom:link href="https://biospectrumasia.com/news/34/3457/csl-behring-progresses-on-novel-drug-for-hemophilia-a.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3457/csl-behring-progresses-on-novel-drug-for-hemophilia-a.html</link>
			<pubDate>Thu, 04 Jul 2013 12:10:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/csl-behring-progresses-on-novel-drug-for-hemophilia-a.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3457/csl-behring-progresses-on-novel-drug-for-hemophilia-a.html</guid>
		</item>	
				<item>
			<title>Bioventus gets global rights for Pfizer&#039;s bone portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/34/6623/bioventus-gets-global-rights-for-pfizers-bone-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6623/bioventus-gets-global-rights-for-pfizers-bone-portfolio.html</link>
			<pubDate>Thu, 04 Jul 2013 11:17:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bioventus-acquires-exclusive-worldwide-license-to-pfizer-s-bone-morphogenetic-protein-bmp-portfolio.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6623/bioventus-gets-global-rights-for-pfizers-bone-portfolio.html</guid>
		</item>	
				<item>
			<title>Verinata Health joins hands with Teva in  Israel</title>
			<atom:link href="https://biospectrumasia.com/news/34/2869/verinata-health-joins-hands-with-teva-in-israel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2869/verinata-health-joins-hands-with-teva-in-israel.html</link>
			<pubDate>Tue, 02 Jul 2013 10:55:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/immunocore-genentech-enter-r-d-deal-for-cancer-targets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2869/verinata-health-joins-hands-with-teva-in-israel.html</guid>
		</item>	
				<item>
			<title>AstraZeneca acquires Pearl Therapeutics</title>
			<atom:link href="https://biospectrumasia.com/news/34/1536/astrazeneca-acquires-pearl-therapeutics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1536/astrazeneca-acquires-pearl-therapeutics.html</link>
			<pubDate>Mon, 01 Jul 2013 12:17:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ajinomoto-acquires-althea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1536/astrazeneca-acquires-pearl-therapeutics.html</guid>
		</item>	
				<item>
			<title>Roche, AstraZeneca form firm to share R&amp;D data </title>
			<atom:link href="https://biospectrumasia.com/news/34/4803/roche-astrazeneca-form-firm-to-share-rd-data-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4803/roche-astrazeneca-form-firm-to-share-rd-data-.html</link>
			<pubDate>Thu, 27 Jun 2013 12:27:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medchemica-the-new-data-sharing-consortium-formed-by-roche-and-astrazeneca-to-accelerate-drug-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4803/roche-astrazeneca-form-firm-to-share-rd-data-.html</guid>
		</item>	
				<item>
			<title>Today scientists have poor frustration tolerance: Glivec discoverer</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/6386/today-scientists-have-poor-frustration-tolerance-glivec-discoverer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/6386/today-scientists-have-poor-frustration-tolerance-glivec-discoverer.html</link>
			<pubDate>Tue, 25 Jun 2013 11:40:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-alex-matter-ceo-experimental-therapeutics-center-astar-singapore-and-inventor-of-glivec.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/6386/today-scientists-have-poor-frustration-tolerance-glivec-discoverer.html</guid>
		</item>	
				<item>
			<title>Shionogi partners with six Irish universities</title>
			<atom:link href="https://biospectrumasia.com/news/34/2647/shionogi-partners-with-six-irish-universities.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2647/shionogi-partners-with-six-irish-universities.html</link>
			<pubDate>Wed, 19 Jun 2013 11:42:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2647/shionogi-partners-with-six-irish-universities.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo files NDA for Prasugrel in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html</link>
			<pubDate>Wed, 19 Jun 2013 11:20:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sodium-tablets-generic.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8101/daiichi-sankyo-files-nda-for-prasugrel-in-japan.html</guid>
		</item>	
				<item>
			<title>Prism to start PRI-724 trials to treat fibrosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html</link>
			<pubDate>Fri, 14 Jun 2013 12:28:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astars-genome-institute-of-singapore-gis-and-oxford-biodynamics-obd-will-use-episwitch-platform-to-differentiate-epigenetic-footprint-of-various-stem-cells-from-their-cell-lines.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1179/prism-to-start-pri-724-trials-to-treat-fibrosis.html</guid>
		</item>	
				<item>
			<title>VM202 trial completes patient administration</title>
			<atom:link href="https://biospectrumasia.com/news/34/733/vm202-trial-completes-patient-administration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/733/vm202-trial-completes-patient-administration.html</link>
			<pubDate>Thu, 13 Jun 2013 14:30:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/apotex-recalls-15-lots-of-piperacillin-and-tazobactam-for-injection-on-behalf-of-hospira.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/733/vm202-trial-completes-patient-administration.html</guid>
		</item>	
				<item>
			<title>Eisai, Quintiles cancer drug program shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/7542/eisai-quintiles-cancer-drug-program-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7542/eisai-quintiles-cancer-drug-program-shows-ve-results.html</link>
			<pubDate>Thu, 13 Jun 2013 13:31:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-quintiles-joint-program-evaluating-effects-of-lenvatinib-vegf-receptor-tyrosine-kinase-inhibitor-and-multi-kinase-inhibitor-on-melanoma-shows-positive-results.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7542/eisai-quintiles-cancer-drug-program-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Aussie, Indonesia to co-develop AIDS, cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5573/aussie-indonesia-to-co-develop-aids-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5573/aussie-indonesia-to-co-develop-aids-cancer-drugs.html</link>
			<pubDate>Wed, 12 Jun 2013 11:13:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-researchers-from-johns-hopkins-university-of-mississippi-and-university-of-massachusetts-find-a-functional-cure-in-infant-hiv-aids.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5573/aussie-indonesia-to-co-develop-aids-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Bayer progresses on APAC hepatocellular carcinoma trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/4405/bayer-progresses-on-apac-hepatocellular-carcinoma-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4405/bayer-progresses-on-apac-hepatocellular-carcinoma-trial.html</link>
			<pubDate>Tue, 11 Jun 2013 09:37:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-healthcare-s-gideon-global-investigation-of-therapeutic-decisions-in-hepatocellular-carcinoma-and-of-its-treatment-with-sorafenib-study-progressed-with-positive-data-in-phase-iii-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4405/bayer-progresses-on-apac-hepatocellular-carcinoma-trial.html</guid>
		</item>	
				<item>
			<title>Boehringer to open $46 mn biologics plant in Shanghai</title>
			<atom:link href="https://biospectrumasia.com/news/34/230/boehringer-to-open-46-mn-biologics-plant-in-shanghai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/230/boehringer-to-open-46-mn-biologics-plant-in-shanghai.html</link>
			<pubDate>Mon, 10 Jun 2013 08:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bioduro-opens-discovery-lab-in-shanghai.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/230/boehringer-to-open-46-mn-biologics-plant-in-shanghai.html</guid>
		</item>	
				<item>
			<title>Pomalidomide Celgene gets EU nod for multiple myeloma</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4870/pomalidomide-celgene-gets-eu-nod-for-multiple-myeloma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4870/pomalidomide-celgene-gets-eu-nod-for-multiple-myeloma.html</link>
			<pubDate>Tue, 04 Jun 2013 11:44:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-chmp-gives-thumbs-up-to-pomalidomide-celgene-pomalidomide-for-treatment-of-multiple-myeloma-in-combination-with-dexamethasone.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4870/pomalidomide-celgene-gets-eu-nod-for-multiple-myeloma.html</guid>
		</item>	
				<item>
			<title>Aslan gastric cancer phase II study shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/1503/aslan-gastric-cancer-phase-ii-study-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1503/aslan-gastric-cancer-phase-ii-study-shows-ve-results.html</link>
			<pubDate>Tue, 28 May 2013 17:27:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-gastric-cancer-patients-aslan-pharma-s-phase-ii-clinical-trial-with-pan-her-inhibitor-aslan001-in-gastric-cancer-reduced-cell-proliferation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1503/aslan-gastric-cancer-phase-ii-study-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk obesity drug trial confirms weight loss</title>
			<atom:link href="https://biospectrumasia.com/news/34/3984/novo-nordisk-obesity-drug-trial-confirms-weight-loss.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3984/novo-nordisk-obesity-drug-trial-confirms-weight-loss.html</link>
			<pubDate>Tue, 28 May 2013 16:31:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-obese-patients-novo-nordisk-phase-iiia-trial-with-liraglutide-shows-potential-to-induce-and-maintain-weight-loss.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3984/novo-nordisk-obesity-drug-trial-confirms-weight-loss.html</guid>
		</item>	
				<item>
			<title>J&amp;J neuro R&amp;D head uses street drug to treat depression</title>
			<atom:link href="https://biospectrumasia.com/news/34/4490/jj-neuro-rd-head-uses-street-drug-to-treat-depression.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4490/jj-neuro-rd-head-uses-street-drug-to-treat-depression.html</link>
			<pubDate>Mon, 27 May 2013 17:04:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/johnson-johnson-is-hopeful-of-treating-depression-with-popular-street-drug-ketamine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4490/jj-neuro-rd-head-uses-street-drug-to-treat-depression.html</guid>
		</item>	
				<item>
			<title>Merck to halt Parkinson&#039;s trial due to lack of efficacy </title>
			<atom:link href="https://biospectrumasia.com/news/34/6604/merck-to-halt-parkinsons-trial-due-to-lack-of-efficacy-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6604/merck-to-halt-parkinsons-trial-due-to-lack-of-efficacy-.html</link>
			<pubDate>Mon, 27 May 2013 14:23:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merck-sharp-dohme-msd-halts-clinical-trial-on-investigational-adenosine-a2a-receptor-antagonist-preladenant-used-for-the-treatment-of-parkinson-s-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6604/merck-to-halt-parkinsons-trial-due-to-lack-of-efficacy-.html</guid>
		</item>	
				<item>
			<title>BioDiem protozoan drug to get Japanese patent </title>
			<atom:link href="https://biospectrumasia.com/news/34/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html</link>
			<pubDate>Mon, 27 May 2013 12:23:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-based-biodiem-s-anti-protozoan-compound-bdm-i-gets-allowance-of-japanese-patent.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7331/biodiem-protozoan-drug-to-get-japanese-patent-.html</guid>
		</item>	
				<item>
			<title>Actavis &#039;pregnancy preventer&#039; gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/4432/actavis-pregnancy-preventer-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4432/actavis-pregnancy-preventer-gets-fda-nod.html</link>
			<pubDate>Fri, 17 May 2013 13:36:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4432/actavis-pregnancy-preventer-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>Gilead leukemia study gets complete response</title>
			<atom:link href="https://biospectrumasia.com/news/34/2269/gilead-leukemia-study-gets-complete-response.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2269/gilead-leukemia-study-gets-complete-response.html</link>
			<pubDate>Thu, 16 May 2013 16:51:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-leukemia-study-gets-complete-repsonse.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2269/gilead-leukemia-study-gets-complete-response.html</guid>
		</item>	
				<item>
			<title>BioDuro opens discovery lab in Shanghai</title>
			<atom:link href="https://biospectrumasia.com/news/34/3939/bioduro-opens-discovery-lab-in-shanghai.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3939/bioduro-opens-discovery-lab-in-shanghai.html</link>
			<pubDate>Thu, 16 May 2013 15:43:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bioduro-opens-discovery-lab-in-shanghai.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3939/bioduro-opens-discovery-lab-in-shanghai.html</guid>
		</item>	
				<item>
			<title>TaiGen files NDA for Nemonoxacin in Taiwan, China </title>
			<atom:link href="https://biospectrumasia.com/news/34/2877/taigen-files-nda-for-nemonoxacin-in-taiwan-china-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2877/taigen-files-nda-for-nemonoxacin-in-taiwan-china-.html</link>
			<pubDate>Thu, 16 May 2013 11:46:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taigen-biotechnology-submitted-new-drug-application-nda-for-the-oral-formulation-of-nemonoxacin-in-taiwan-and-china.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2877/taigen-files-nda-for-nemonoxacin-in-taiwan-china-.html</guid>
		</item>	
				<item>
			<title>ScinoPharm, Coland develop cancer generics in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/758/scinopharm-coland-develop-cancer-generics-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/758/scinopharm-coland-develop-cancer-generics-in-china.html</link>
			<pubDate>Mon, 13 May 2013 11:44:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scinopharm-taiwan-and-coland-to-develop-generic-oncological-drugs-for-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/758/scinopharm-coland-develop-cancer-generics-in-china.html</guid>
		</item>	
				<item>
			<title>CytRx gets FDA nod Aldoxorubicin cancer trial</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/8281/cytrx-gets-fda-nod-aldoxorubicin-cancer-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/8281/cytrx-gets-fda-nod-aldoxorubicin-cancer-trial.html</link>
			<pubDate>Fri, 10 May 2013 12:35:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cytrx-reached-an-agreement-with-the-us-fda-under-a-special-protocol-assessment-spa-for-a-global-pivotal-phase-iii-trial-with-aldoxorubicin-as-a-treatment-for-patients-with-soft-tissue-sarcomas.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/8281/cytrx-gets-fda-nod-aldoxorubicin-cancer-trial.html</guid>
		</item>	
				<item>
			<title>Bayer stops haemophilia trial amidst drug safety concern</title>
			<atom:link href="https://biospectrumasia.com/news/34/2391/bayer-stops-haemophilia-trial-amidst-drug-safety-concern.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2391/bayer-stops-haemophilia-trial-amidst-drug-safety-concern.html</link>
			<pubDate>Thu, 09 May 2013 09:53:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-healthcare-stops-phase-ii-trial-of-haemophilia-a-and-b-drug-bay-86-6150-after-detecting-neutralizing-antibody-led.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2391/bayer-stops-haemophilia-trial-amidst-drug-safety-concern.html</guid>
		</item>	
				<item>
			<title>Patrys cancer drug gives hope to patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/2187/patrys-cancer-drug-gives-hope-to-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2187/patrys-cancer-drug-gives-hope-to-patients.html</link>
			<pubDate>Wed, 08 May 2013 13:32:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patrys-cancer-drug-gives-hope-to-patients.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2187/patrys-cancer-drug-gives-hope-to-patients.html</guid>
		</item>	
				<item>
			<title>Chinese, Hong Kong scientists map H7N9 risk infection </title>
			<atom:link href="https://biospectrumasia.com/news/34/951/chinese-hong-kong-scientists-map-h7n9-risk-infection-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/951/chinese-hong-kong-scientists-map-h7n9-risk-infection-.html</link>
			<pubDate>Wed, 08 May 2013 13:28:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chinese-and-hong-kong-researchers-develop-map-of-avian-influenza-h7n9-comprising-of-bird-migration-patterns-and-estimations-of-poultry-production-and-consumption.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/951/chinese-hong-kong-scientists-map-h7n9-risk-infection-.html</guid>
		</item>	
				<item>
			<title>Novartis: Lucentis reduces AMD blindness by 50%</title>
			<atom:link href="https://biospectrumasia.com/news/34/4917/novartis-lucentis-reduces-amd-blindness-by-50.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4917/novartis-lucentis-reduces-amd-blindness-by-50.html</link>
			<pubDate>Wed, 08 May 2013 11:18:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4917/novartis-lucentis-reduces-amd-blindness-by-50.html</guid>
		</item>	
				<item>
			<title>Concert Pharma, Celgene enter in $300 mn merger</title>
			<atom:link href="https://biospectrumasia.com/news/34/3389/concert-pharma-celgene-enter-in-300-mn-merger.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3389/concert-pharma-celgene-enter-in-300-mn-merger.html</link>
			<pubDate>Wed, 08 May 2013 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/concert-pharma-and-celgene-s-strategic-collaboration-is-directed-towards-deuterium-modified-compounds-targeting-cancer-and-inflammation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3389/concert-pharma-celgene-enter-in-300-mn-merger.html</guid>
		</item>	
				<item>
			<title>FDA: AbbVie Hepatitis therapy is a &#039;breakthrough&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/858/fda-abbvie-hepatitis-therapy-is-a-breakthrough.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/858/fda-abbvie-hepatitis-therapy-is-a-breakthrough.html</link>
			<pubDate>Tue, 07 May 2013 11:37:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-designates-abbvie-s-hepatitis-c-treatment-as-breakthrough-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/858/fda-abbvie-hepatitis-therapy-is-a-breakthrough.html</guid>
		</item>	
				<item>
			<title>Now 9-yr-old girls can use Cervarix for cancer</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/969/now-9-yr-old-girls-can-use-cervarix-for-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/969/now-9-yr-old-girls-can-use-cervarix-for-cancer.html</link>
			<pubDate>Tue, 07 May 2013 09:40:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-approves-cervarix-for-use-in-females-aged-nine-to-25-years.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/969/now-9-yr-old-girls-can-use-cervarix-for-cancer.html</guid>
		</item>	
				<item>
			<title>Regeneron acquires Sanofi eye care antibodies</title>
			<atom:link href="https://biospectrumasia.com/news/34/520/regeneron-acquires-sanofi-eye-care-antibodies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/520/regeneron-acquires-sanofi-eye-care-antibodies.html</link>
			<pubDate>Mon, 06 May 2013 13:23:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regeneron-acquires-rights-to-sanofi-s-ophthalmology-antibodies-targeting-the-pdgf-platelet-derived-growth-factor-and-ang2-angiopoietin2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/520/regeneron-acquires-sanofi-eye-care-antibodies.html</guid>
		</item>	
				<item>
			<title>Novartis follows Time Warner, Twitter to join malaria campaign</title>
			<atom:link href="https://biospectrumasia.com/news/34/2660/novartis-follows-time-warner-twitter-to-join-malaria-campaign.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2660/novartis-follows-time-warner-twitter-to-join-malaria-campaign.html</link>
			<pubDate>Thu, 25 Apr 2013 14:17:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-follows-time-warner-twitter-to-join-malaria-campaign.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2660/novartis-follows-time-warner-twitter-to-join-malaria-campaign.html</guid>
		</item>	
				<item>
			<title>WHO launches emergency response to drug resistance</title>
			<atom:link href="https://biospectrumasia.com/news/34/6797/who-launches-emergency-response-to-drug-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6797/who-launches-emergency-response-to-drug-resistance.html</link>
			<pubDate>Thu, 25 Apr 2013 14:10:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-who-is-concerned-that-in-the-south-east-asia-region-the-malaria-parasite-is-becoming-resistant-to-some-of-the-drugs-that-have-helped-make-progress.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6797/who-launches-emergency-response-to-drug-resistance.html</guid>
		</item>	
				<item>
			<title>EU patent for Phylomer ischemia peptides</title>
			<atom:link href="https://biospectrumasia.com/news/34/3540/eu-patent-for-phylomer-ischemia-peptides.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3540/eu-patent-for-phylomer-ischemia-peptides.html</link>
			<pubDate>Thu, 25 Apr 2013 11:44:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-ischemia-patients-phylogica-gets-european-patent-for-its-peptide-inhibitors-that-target-the-ap-1-pathway.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3540/eu-patent-for-phylomer-ischemia-peptides.html</guid>
		</item>	
				<item>
			<title>Alchemia gets new CEO</title>
			<atom:link href="https://biospectrumasia.com/news/34/396/alchemia-gets-new-ceo.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/396/alchemia-gets-new-ceo.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/396/alchemia-gets-new-ceo.html</guid>
		</item>	
				<item>
			<title>GSK gets EU nod for metastatic melanoma inhibitor</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/408/gsk-gets-eu-nod-for-metastatic-melanoma-inhibitor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/408/gsk-gets-eu-nod-for-metastatic-melanoma-inhibitor.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pills-10046658.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/408/gsk-gets-eu-nod-for-metastatic-melanoma-inhibitor.html</guid>
		</item>	
				<item>
			<title>TB prevention faces gap of $1.6bn: WHO estimates</title>
			<atom:link href="https://biospectrumasia.com/news/34/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/434/tb-prevention-faces-gap-of-1-6bn-who-estimates.html</guid>
		</item>	
				<item>
			<title>Regenerative Therapy for heart failure enters Ph III Trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/603/regenerative-therapy-for-heart-failure-enters-ph-iii-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/603/regenerative-therapy-for-heart-failure-enters-ph-iii-trial.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/603/regenerative-therapy-for-heart-failure-enters-ph-iii-trial.html</guid>
		</item>	
				<item>
			<title>Researchers find gene mutation to lower heart disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/730/researchers-find-gene-mutation-to-lower-heart-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/730/researchers-find-gene-mutation-to-lower-heart-disease.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/id-100128760.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/730/researchers-find-gene-mutation-to-lower-heart-disease.html</guid>
		</item>	
				<item>
			<title>Singapore opens research centre for circulating tumour cell</title>
			<atom:link href="https://biospectrumasia.com/news/34/877/singapore-opens-research-centre-for-circulating-tumour-cell.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/877/singapore-opens-research-centre-for-circulating-tumour-cell.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/877/singapore-opens-research-centre-for-circulating-tumour-cell.html</guid>
		</item>	
				<item>
			<title>Novartis to ship 30 mn flu vaccine to US </title>
			<atom:link href="https://biospectrumasia.com/news/34/1000/novartis-to-ship-30-mn-flu-vaccine-to-us-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1000/novartis-to-ship-30-mn-flu-vaccine-to-us-.html</link>
			<pubDate>Wed, 24 Apr 2013 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1000/novartis-to-ship-30-mn-flu-vaccine-to-us-.html</guid>
		</item>	
				<item>
			<title>Patrys gets nod to continue myeloma trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/5362/patrys-gets-nod-to-continue-myeloma-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5362/patrys-gets-nod-to-continue-myeloma-trial-.html</link>
			<pubDate>Wed, 24 Apr 2013 10:29:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patrys-will-start-recruiting-for-the-third-patient-group-for-its-pat-sm6-multiple-myeloma-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5362/patrys-gets-nod-to-continue-myeloma-trial-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, Alchemia sign $240 mn drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/944/astrazeneca-alchemia-sign-240-mn-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/944/astrazeneca-alchemia-sign-240-mn-drug-deal.html</link>
			<pubDate>Tue, 23 Apr 2013 12:59:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astrazeneca-alchemia-sign-usd240-mn-drug-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/944/astrazeneca-alchemia-sign-240-mn-drug-deal.html</guid>
		</item>	
				<item>
			<title>HSA nod for Aslan rheumatoid arthritis drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7930/hsa-nod-for-aslan-rheumatoid-arthritis-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7930/hsa-nod-for-aslan-rheumatoid-arthritis-drug-.html</link>
			<pubDate>Tue, 23 Apr 2013 07:43:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/singapore-health-sciences-authority-hsa-nod-for-aslan-pharma-rheumatoid-arthritis-drug-aslan003.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7930/hsa-nod-for-aslan-rheumatoid-arthritis-drug-.html</guid>
		</item>	
				<item>
			<title>Steroid pioneer gets Heritage Foundation, BIO award</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/3294/steroid-pioneer-gets-heritage-foundation-bio-award.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/3294/steroid-pioneer-gets-heritage-foundation-bio-award.html</link>
			<pubDate>Mon, 22 Apr 2013 12:24:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-george-rosenkranz-the-winner-of-the-2013-biotechnology-heritage-award-by-chemical-heritage-foundation-chf-and-biotechnology-industry-organization-bio.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/3294/steroid-pioneer-gets-heritage-foundation-bio-award.html</guid>
		</item>	
				<item>
			<title>FDA nod for Novartis eyecare firm&#039;s glaucoma drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7389/fda-nod-for-novartis-eyecare-firms-glaucoma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7389/fda-nod-for-novartis-eyecare-firms-glaucoma-drug.html</link>
			<pubDate>Mon, 22 Apr 2013 11:47:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-glaucoma-patients-novartis-eye-care-firm-alcon-gets-us-fda-approval-for-elevated-intraocular-pressure-drug-simbrinza.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7389/fda-nod-for-novartis-eyecare-firms-glaucoma-drug.html</guid>
		</item>	
				<item>
			<title>India, EU firms fight &#039;epidemic of drug-resistance&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/2939/india-eu-firms-fight-epidemic-of-drug-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2939/india-eu-firms-fight-epidemic-of-drug-resistance.html</link>
			<pubDate>Fri, 19 Apr 2013 12:45:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orchid-allecra-to-develop-antibiotics-to-combat-multi-drug-resistant-bacterial-infections.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2939/india-eu-firms-fight-epidemic-of-drug-resistance.html</guid>
		</item>	
				<item>
			<title>GSK, Theravance COPD drug gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1713/gsk-theravance-copd-drug-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1713/gsk-theravance-copd-drug-gets-fda-nod.html</link>
			<pubDate>Fri, 19 Apr 2013 11:46:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-obstructive-pulmonary-disease-copd-patients-glaxosmithkline-gsk-and-theravance-s-breo-ellipta-gets-us-fda-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1713/gsk-theravance-copd-drug-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>BMS uses Santaris platform for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/8205/bms-uses-santaris-platform-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8205/bms-uses-santaris-platform-for-drug-discovery.html</link>
			<pubDate>Thu, 18 Apr 2013 11:48:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bristol-myers-squibb-bms-to-use-santaris-pharma-s-proprietary-locked-nucleic-acid-lna-drug-platform-for-drug-discovery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8205/bms-uses-santaris-platform-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Chipscreen gets SFDA nod after accelerated review</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/722/chipscreen-gets-sfda-nod-after-accelerated-review.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/722/chipscreen-gets-sfda-nod-after-accelerated-review.html</link>
			<pubDate>Wed, 17 Apr 2013 11:14:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chipscreen-gets-sfda-nod-after-accelerated-review.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/722/chipscreen-gets-sfda-nod-after-accelerated-review.html</guid>
		</item>	
				<item>
			<title>John Vernachio is Arthritis Foundation research VP</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/298/john-vernachio-is-arthritis-foundation-research-vp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/298/john-vernachio-is-arthritis-foundation-research-vp.html</link>
			<pubDate>Tue, 16 Apr 2013 13:50:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-john-vernachio-the-new-vice-president-research-of-arthritis-foundation.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/298/john-vernachio-is-arthritis-foundation-research-vp.html</guid>
		</item>	
				<item>
			<title>GRPE elements to help cure HIV via gene therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/3425/grpe-elements-to-help-cure-hiv-via-gene-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3425/grpe-elements-to-help-cure-hiv-via-gene-therapy.html</link>
			<pubDate>Tue, 16 Apr 2013 13:32:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/study-new-discovery-may-enhance-hiv-gene-therapy.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3425/grpe-elements-to-help-cure-hiv-via-gene-therapy.html</guid>
		</item>	
				<item>
			<title>Infect mosquitoes with Wolbachia, stop diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/8044/infect-mosquitoes-with-wolbachia-stop-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8044/infect-mosquitoes-with-wolbachia-stop-diseases.html</link>
			<pubDate>Thu, 11 Apr 2013 13:34:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mosquito-infection-with-a-new-strain-of-wolbachia-bacteria-called-wmelpop-prevents-them-from-laying-eggs-and-spreading-diseases-such-as-dengue-yellow-fever-and-malaria.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8044/infect-mosquitoes-with-wolbachia-stop-diseases.html</guid>
		</item>	
				<item>
			<title>Patrys&#039; 2nd group concludes treatment in Germany</title>
			<atom:link href="https://biospectrumasia.com/news/34/3214/patrys-2nd-group-concludes-treatment-in-germany.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3214/patrys-2nd-group-concludes-treatment-in-germany.html</link>
			<pubDate>Wed, 10 Apr 2013 10:47:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patrys-conducts-treatment-of-another-patient-group-in-multiple-myeloma-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3214/patrys-2nd-group-concludes-treatment-in-germany.html</guid>
		</item>	
				<item>
			<title>Nektar&#039;s therapy helps the body kill its own cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/5276/nektars-therapy-helps-the-body-kill-its-own-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5276/nektars-therapy-helps-the-body-kill-its-own-cancer.html</link>
			<pubDate>Tue, 09 Apr 2013 15:23:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nektar-therapeutics-nktr-214-targets-il-2-receptor-complex-and-activates-il2r-subtype-which-promotes-tumor-killing-by-the-body-s-own-immune-system.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5276/nektars-therapy-helps-the-body-kill-its-own-cancer.html</guid>
		</item>	
				<item>
			<title>Viralytics multi-cancer drug shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/2634/viralytics-multi-cancer-drug-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2634/viralytics-multi-cancer-drug-shows-ve-results.html</link>
			<pubDate>Tue, 09 Apr 2013 15:05:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/viralytics-cavatak-is-well-tolerated-in-phase-i-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2634/viralytics-multi-cancer-drug-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Gilead hepatitis drug to axe treatment time by half</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2282/gilead-hepatitis-drug-to-axe-treatment-time-by-half.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2282/gilead-hepatitis-drug-to-axe-treatment-time-by-half.html</link>
			<pubDate>Tue, 09 Apr 2013 14:41:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gilead-s-sofosbuvir-anda-if-approved-by-the-us-fda-would-reduce-treatment-time-from-24-to-48-weeks-to-12-to-16-weeks.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2282/gilead-hepatitis-drug-to-axe-treatment-time-by-half.html</guid>
		</item>	
				<item>
			<title>A*STAR, GSK develop medicines for emerging markets</title>
			<atom:link href="https://biospectrumasia.com/news/34/652/astar-gsk-develop-medicines-for-emerging-markets.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/652/astar-gsk-develop-medicines-for-emerging-markets.html</link>
			<pubDate>Tue, 09 Apr 2013 09:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astar-gsk-develop-medicines-for-emerging-markets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/652/astar-gsk-develop-medicines-for-emerging-markets.html</guid>
		</item>	
				<item>
			<title>Prana Alzheimer&#039;s trial shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/1237/prana-alzheimers-trial-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1237/prana-alzheimers-trial-shows-ve-results.html</link>
			<pubDate>Mon, 08 Apr 2013 12:31:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prana-biotechnology-s-phase-ii-trial-for-huntington-reach2hd-and-alzheimer-s-disease-imagine-shows-that-37-percent-have-well-tolerated-and-are-demonstrating-pleasing-retention-rates-and-compliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1237/prana-alzheimers-trial-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Oxycodone patch resumes clinical development</title>
			<atom:link href="https://biospectrumasia.com/news/34/6337/oxycodone-patch-resumes-clinical-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6337/oxycodone-patch-resumes-clinical-development.html</link>
			<pubDate>Fri, 05 Apr 2013 13:24:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/oxycodone-patch-resumes-clinical-development.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6337/oxycodone-patch-resumes-clinical-development.html</guid>
		</item>	
				<item>
			<title>NIH gives $2.2 mn to VaxInnate for dengue vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/34/336/nih-gives-2-2-mn-to-vaxinnate-for-dengue-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/336/nih-gives-2-2-mn-to-vaxinnate-for-dengue-vaccine.html</link>
			<pubDate>Fri, 05 Apr 2013 12:33:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/vaxinnate-gets-usd2.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/336/nih-gives-2-2-mn-to-vaxinnate-for-dengue-vaccine.html</guid>
		</item>	
				<item>
			<title>Astellas to pay $300 mn for cancer drug conjugates</title>
			<atom:link href="https://biospectrumasia.com/news/34/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html</link>
			<pubDate>Fri, 05 Apr 2013 11:58:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-to-pay-ambrx-close-to-usd300-million-for-its-antibody-drug-conjugates-adcs-in-oncology.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3259/astellas-to-pay-300-mn-for-cancer-drug-conjugates.html</guid>
		</item>	
				<item>
			<title>Glivec inventor wins Szent-GyÃƒÂ¶rgyi Prize</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/4736/glivec-inventor-wins-szent-gyrgyi-prize.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/4736/glivec-inventor-wins-szent-gyrgyi-prize.html</link>
			<pubDate>Fri, 05 Apr 2013 11:14:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/inventor-of-glivec-dr-alex-matter-winner-of-the-8th-annual-szent-gy-rgyi-prize-for-progress-in-cancer-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/4736/glivec-inventor-wins-szent-gyrgyi-prize.html</guid>
		</item>	
				<item>
			<title>Astellas to do interim analysis of cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html</link>
			<pubDate>Wed, 03 Apr 2013 13:42:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/medivation-and-astellas-pharma-to-conduct-an-interim-analysis-for-the-prevail-clinical-trial-in-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1231/astellas-to-do-interim-analysis-of-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>CPR ventures into large molecule analytics</title>
			<atom:link href="https://biospectrumasia.com/news/34/5913/cpr-ventures-into-large-molecule-analytics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5913/cpr-ventures-into-large-molecule-analytics.html</link>
			<pubDate>Tue, 26 Mar 2013 10:59:14 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cpr-pharma-s-new-lab-at-adelaide-australia-will-offer-large-molecule-immunochemistry-analytical-service.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5913/cpr-ventures-into-large-molecule-analytics.html</guid>
		</item>	
				<item>
			<title>Viralytics melanoma study shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/2946/viralytics-melanoma-study-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2946/viralytics-melanoma-study-shows-ve-results.html</link>
			<pubDate>Mon, 25 Mar 2013 14:42:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-robert-andtbacka-revealed-cavatak-in-late-stage-melanoma-phase-ii-study-results-at-the-hemonc-today-melanoma-and-cutaneous-malignancies-meeting-in-new-york.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2946/viralytics-melanoma-study-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>CellSeed withdraws stem cell drug application</title>
			<atom:link href="https://biospectrumasia.com/news/34/3371/cellseed-withdraws-stem-cell-drug-application.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3371/cellseed-withdraws-stem-cell-drug-application.html</link>
			<pubDate>Fri, 22 Mar 2013 12:49:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cellseed-withdraws-stem-cell-drug-application.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3371/cellseed-withdraws-stem-cell-drug-application.html</guid>
		</item>	
				<item>
			<title>Austrianova starts cell bank for cancer therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/3292/austrianova-starts-cell-bank-for-cancer-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3292/austrianova-starts-cell-bank-for-cancer-therapy.html</link>
			<pubDate>Thu, 21 Mar 2013 12:10:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-service.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3292/austrianova-starts-cell-bank-for-cancer-therapy.html</guid>
		</item>	
				<item>
			<title>Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes</title>
			<atom:link href="https://biospectrumasia.com/news/34/579/boehringer-eli-lilly-to-evaluate-trajenta-for-type-2-diabetes.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/579/boehringer-eli-lilly-to-evaluate-trajenta-for-type-2-diabetes.html</link>
			<pubDate>Thu, 21 Mar 2013 11:38:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/diabetes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/579/boehringer-eli-lilly-to-evaluate-trajenta-for-type-2-diabetes.html</guid>
		</item>	
				<item>
			<title>Taiwan firm NCE to get priority review in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/578/taiwan-firm-nce-to-get-priority-review-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/578/taiwan-firm-nce-to-get-priority-review-in-china.html</link>
			<pubDate>Thu, 21 Mar 2013 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taiwan-liposome-company-nce.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/578/taiwan-firm-nce-to-get-priority-review-in-china.html</guid>
		</item>	
				<item>
			<title>Fight against TB needs $1.6 bn funding annually</title>
			<atom:link href="https://biospectrumasia.com/news/34/1639/fight-against-tb-needs-1-6-bn-funding-annually.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1639/fight-against-tb-needs-1-6-bn-funding-annually.html</link>
			<pubDate>Tue, 19 Mar 2013 11:07:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tb-fight-needs-money.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1639/fight-against-tb-needs-1-6-bn-funding-annually.html</guid>
		</item>	
				<item>
			<title>Antisense Therapeutics ties up with China CRO for trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/4015/antisense-therapeutics-ties-up-with-china-cro-for-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4015/antisense-therapeutics-ties-up-with-china-cro-for-trial.html</link>
			<pubDate>Tue, 19 Mar 2013 10:52:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antisense-therapeutics-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4015/antisense-therapeutics-ties-up-with-china-cro-for-trial.html</guid>
		</item>	
				<item>
			<title>Novartis eye care firm gets EU nod for Jetrea</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1389/novartis-eye-care-firm-gets-eu-nod-for-jetrea.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1389/novartis-eye-care-firm-gets-eu-nod-for-jetrea.html</link>
			<pubDate>Mon, 18 Mar 2013 14:06:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-eye-care-firm-gets-eu-nod-for-jetrea.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1389/novartis-eye-care-firm-gets-eu-nod-for-jetrea.html</guid>
		</item>	
				<item>
			<title>Dainippon, Nippon Shinyaku sign deal for new drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html</link>
			<pubDate>Mon, 18 Mar 2013 11:09:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dsp-nippon-partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1831/dainippon-nippon-shinyaku-sign-deal-for-new-drug.html</guid>
		</item>	
				<item>
			<title>Daiichi gets positive results in prasugrel trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/1552/daiichi-gets-positive-results-in-prasugrel-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1552/daiichi-gets-positive-results-in-prasugrel-trial.html</link>
			<pubDate>Mon, 18 Mar 2013 10:54:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1552/daiichi-gets-positive-results-in-prasugrel-trial.html</guid>
		</item>	
				<item>
			<title>Vanda Pharma withdraws application for Fanaptum</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1255/vanda-pharma-withdraws-application-for-fanaptum.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1255/vanda-pharma-withdraws-application-for-fanaptum.html</link>
			<pubDate>Fri, 15 Mar 2013 11:43:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/marketing-application.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1255/vanda-pharma-withdraws-application-for-fanaptum.html</guid>
		</item>	
				<item>
			<title>Old drug gives hope for new treatment in autism</title>
			<atom:link href="https://biospectrumasia.com/news/34/2565/old-drug-gives-hope-for-new-treatment-in-autism.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2565/old-drug-gives-hope-for-new-treatment-in-autism.html</link>
			<pubDate>Fri, 15 Mar 2013 11:34:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/autism-disorder.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2565/old-drug-gives-hope-for-new-treatment-in-autism.html</guid>
		</item>	
				<item>
			<title>AseaCyte gets BioSpectrum award for drug discovery efforts</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/483/aseacyte-gets-biospectrum-award-for-drug-discovery-efforts.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/483/aseacyte-gets-biospectrum-award-for-drug-discovery-efforts.html</link>
			<pubDate>Fri, 15 Mar 2013 06:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-team-behind-the-success-of-aseacyte-biospectrum-asia-pacific-awards-2013-winner-in-the-emerging-company-of-the-year-2013-category-l-r-dr-colin-wilde-dr-joanna-oliver-ser.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/483/aseacyte-gets-biospectrum-award-for-drug-discovery-efforts.html</guid>
		</item>	
				<item>
			<title>Amid rising concern, need for novel antibiotics</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5495/amid-rising-concern-need-for-novel-antibiotics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5495/amid-rising-concern-need-for-novel-antibiotics.html</link>
			<pubDate>Thu, 14 Mar 2013 10:49:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibiotic-drug-development.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5495/amid-rising-concern-need-for-novel-antibiotics.html</guid>
		</item>	
				<item>
			<title>TSRI, Takeda expand research collaboration</title>
			<atom:link href="https://biospectrumasia.com/news/34/797/tsri-takeda-expand-research-collaboration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/797/tsri-takeda-expand-research-collaboration.html</link>
			<pubDate>Thu, 14 Mar 2013 10:13:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/797/tsri-takeda-expand-research-collaboration.html</guid>
		</item>	
				<item>
			<title>Astellas, Ambit terminate cancer drug deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/452/astellas-ambit-terminate-cancer-drug-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/452/astellas-ambit-terminate-cancer-drug-deal.html</link>
			<pubDate>Tue, 12 Mar 2013 13:03:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-pharma-and-ambit-biosciences-end-collaboration-and-development-deal.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/452/astellas-ambit-terminate-cancer-drug-deal.html</guid>
		</item>	
				<item>
			<title>Daiichi to aid drug discovery projects</title>
			<atom:link href="https://biospectrumasia.com/news/34/1634/daiichi-to-aid-drug-discovery-projects.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1634/daiichi-to-aid-drug-discovery-projects.html</link>
			<pubDate>Tue, 12 Mar 2013 10:53:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-discovery.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1634/daiichi-to-aid-drug-discovery-projects.html</guid>
		</item>	
				<item>
			<title>Biogen, Elan drug effective for multiple sclerosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/4810/biogen-elan-drug-effective-for-multiple-sclerosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4810/biogen-elan-drug-effective-for-multiple-sclerosis.html</link>
			<pubDate>Mon, 11 Mar 2013 12:21:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biogen-elan-drug-effective-for-multiple-sclerosis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4810/biogen-elan-drug-effective-for-multiple-sclerosis.html</guid>
		</item>	
				<item>
			<title>Gilead&#039;s angina drug shows +ve result in diabetics</title>
			<atom:link href="https://biospectrumasia.com/news/34/3664/gileads-angina-drug-shows-ve-result-in-diabetics.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3664/gileads-angina-drug-shows-ve-result-in-diabetics.html</link>
			<pubDate>Mon, 11 Mar 2013 11:53:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-angina-patients-gilead-sciences-phase-iv-terisa-study-shows-that-addition-of-ranolazine-to-antianginal-therapy-reduced-weekly-angina-frequency.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3664/gileads-angina-drug-shows-ve-result-in-diabetics.html</guid>
		</item>	
				<item>
			<title>HUYA partners with Shanghai Zhangjiang Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/34/4792/huya-partners-with-shanghai-zhangjiang-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4792/huya-partners-with-shanghai-zhangjiang-biotech.html</link>
			<pubDate>Thu, 07 Mar 2013 11:18:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4792/huya-partners-with-shanghai-zhangjiang-biotech.html</guid>
		</item>	
				<item>
			<title>China, Taiwan firms join hands for cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/1843/china-taiwan-firms-join-hands-for-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1843/china-taiwan-firms-join-hands-for-cancer-drugs.html</link>
			<pubDate>Tue, 05 Mar 2013 12:08:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmaengine-and-guangzhou-bebetter-medicine-technology-sign-research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1843/china-taiwan-firms-join-hands-for-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Ex-sanofi cancer head is PharmaEngine advisor</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/1449/ex-sanofi-cancer-head-is-pharmaengine-advisor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/1449/ex-sanofi-cancer-head-is-pharmaengine-advisor.html</link>
			<pubDate>Tue, 05 Mar 2013 11:37:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-alain-herrera-the-new-senior-advisor-of-pharmaengine-for-clinical-strategy-operations-corporate-strategy-licensing-and-alliance-management.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/1449/ex-sanofi-cancer-head-is-pharmaengine-advisor.html</guid>
		</item>	
				<item>
			<title>TauRx gets $10.5 mn funding from Dundee Corp</title>
			<atom:link href="https://biospectrumasia.com/news/34/871/taurx-gets-10-5-mn-funding-from-dundee-corp.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/871/taurx-gets-10-5-mn-funding-from-dundee-corp.html</link>
			<pubDate>Tue, 05 Mar 2013 11:07:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taurx-pharma-gets-usd10.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/871/taurx-gets-10-5-mn-funding-from-dundee-corp.html</guid>
		</item>	
				<item>
			<title>Bionomics to raise $16.4 mn for Alzheimer&#039;s R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/34/1514/bionomics-to-raise-16-4-mn-for-alzheimers-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1514/bionomics-to-raise-16-4-mn-for-alzheimers-rd.html</link>
			<pubDate>Mon, 04 Mar 2013 14:22:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bionomics-to-raise-usd16.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1514/bionomics-to-raise-16-4-mn-for-alzheimers-rd.html</guid>
		</item>	
				<item>
			<title>Boehringer starts phase III leukaemia study</title>
			<atom:link href="https://biospectrumasia.com/news/34/3690/boehringer-starts-phase-iii-leukaemia-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3690/boehringer-starts-phase-iii-leukaemia-study.html</link>
			<pubDate>Mon, 04 Mar 2013 14:03:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-ingelheim-initiates-trial-of-volasertib-for-acute-myeloid-leukaemia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3690/boehringer-starts-phase-iii-leukaemia-study.html</guid>
		</item>	
				<item>
			<title>Myeloma Network raises cancer awareness</title>
			<atom:link href="https://biospectrumasia.com/news/34/3700/myeloma-network-raises-cancer-awareness.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3700/myeloma-network-raises-cancer-awareness.html</link>
			<pubDate>Mon, 04 Mar 2013 13:48:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/asian-myeloma-network-develops-regional-collaboration-to-raise-multiple-myeloma-mm-awareness.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3700/myeloma-network-raises-cancer-awareness.html</guid>
		</item>	
				<item>
			<title>Alchemia enrolls patients for cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/3078/alchemia-enrolls-patients-for-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3078/alchemia-enrolls-patients-for-cancer-trial-.html</link>
			<pubDate>Fri, 01 Mar 2013 16:51:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/alchemia-enrols-patients-for-cancer-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3078/alchemia-enrolls-patients-for-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>Prima recruits patients for cancer vaccine trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/784/prima-recruits-patients-for-cancer-vaccine-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/784/prima-recruits-patients-for-cancer-vaccine-trial.html</link>
			<pubDate>Fri, 01 Mar 2013 15:07:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prima-biomed-starts-patient-recruitment-for-phase-ii-iii-ovarian-cancer-vaccine-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/784/prima-recruits-patients-for-cancer-vaccine-trial.html</guid>
		</item>	
				<item>
			<title>Otsuka schizophrenia relapse gets FDA nod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html</link>
			<pubDate>Fri, 01 Mar 2013 10:46:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-nod-for-the-first-drug-abilify-maintena-to-be-commercialized-by-the-otsuka-and-lundbeck-alliance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3191/otsuka-schizophrenia-relapse-gets-fda-nod.html</guid>
		</item>	
				<item>
			<title>GlobalData: New Zealand focuses on generics </title>
			<atom:link href="https://biospectrumasia.com/news/34/1745/globaldata-new-zealand-focuses-on-generics-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1745/globaldata-new-zealand-focuses-on-generics-.html</link>
			<pubDate>Wed, 27 Feb 2013 13:59:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/globaldata-new-zealand-pharmaceutical-management-agency-pharmac-is-emphasising-on-generics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1745/globaldata-new-zealand-focuses-on-generics-.html</guid>
		</item>	
				<item>
			<title>Crystal Pharmatech, Partner Sciences join hands</title>
			<atom:link href="https://biospectrumasia.com/news/34/7545/crystal-pharmatech-partner-sciences-join-hands.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7545/crystal-pharmatech-partner-sciences-join-hands.html</link>
			<pubDate>Wed, 27 Feb 2013 13:47:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/china-based-crystal-pharmatech-partners-with-us-partner-sciences.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7545/crystal-pharmatech-partner-sciences-join-hands.html</guid>
		</item>	
				<item>
			<title>Genentech skin hive drug shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/3554/genentech-skin-hive-drug-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3554/genentech-skin-hive-drug-shows-ve-results.html</link>
			<pubDate>Mon, 25 Feb 2013 13:12:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-idiopathic-urticaria-patients-genentech-phase-iii-omalizumab-trial-has-shown-success-in-reducing-disease-severity.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3554/genentech-skin-hive-drug-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Omega-3 can reduce brain problems after stroke</title>
			<atom:link href="https://biospectrumasia.com/news/34/2550/omega-3-can-reduce-brain-problems-after-stroke.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2550/omega-3-can-reduce-brain-problems-after-stroke.html</link>
			<pubDate>Fri, 22 Feb 2013 12:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/columbia-university-medical-center-research-triglyceride-lipid-emulsions-may-reduce-neurological-problems-in-humans-as-it-does-in-mice.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2550/omega-3-can-reduce-brain-problems-after-stroke.html</guid>
		</item>	
				<item>
			<title>BioDiem BDM-1 gets Chinese divisional patent </title>
			<atom:link href="https://biospectrumasia.com/news/34/2091/biodiem-bdm-1-gets-chinese-divisional-patent-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2091/biodiem-bdm-1-gets-chinese-divisional-patent-.html</link>
			<pubDate>Thu, 21 Feb 2013 12:57:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biodiem-novel-anti-microbial-bdm-1-gets-chinese-divisional-patent.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2091/biodiem-bdm-1-gets-chinese-divisional-patent-.html</guid>
		</item>	
				<item>
			<title>Antidepressant can treat sickle cell disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/3087/antidepressant-can-treat-sickle-cell-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3087/antidepressant-can-treat-sickle-cell-disease.html</link>
			<pubDate>Wed, 20 Feb 2013 11:48:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/an-antidepressant-a-day-keeps-sickle-cell-disease-at-bay.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3087/antidepressant-can-treat-sickle-cell-disease.html</guid>
		</item>	
				<item>
			<title>Aveo, Astellas report cancer trial results</title>
			<atom:link href="https://biospectrumasia.com/news/34/919/aveo-astellas-report-cancer-trial-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/919/aveo-astellas-report-cancer-trial-results.html</link>
			<pubDate>Tue, 19 Feb 2013 12:32:06 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/aveo-oncology-and-astellas-pharma-announce-overall-survival-os-for-phase-iii-tivozanib-versus-sorafenib-study-in-advanced-renal-cell-carcinoma-rcc.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/919/aveo-astellas-report-cancer-trial-results.html</guid>
		</item>	
				<item>
			<title>Daiichi forms new firm to treat muscular dystrophy</title>
			<atom:link href="https://biospectrumasia.com/news/34/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html</link>
			<pubDate>Mon, 18 Feb 2013 10:25:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-duchenne-muscular-dystrophy-dmd-patients-daiichi-sankyo-innovation-network-corporation-of-japan-incj-and-mitsubishi-ufj-capital-to-develop-new-treatment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6248/daiichi-forms-new-firm-to-treat-muscular-dystrophy.html</guid>
		</item>	
				<item>
			<title>Allied to soon get CE mark approval from EU </title>
			<atom:link href="https://biospectrumasia.com/news/34/1729/allied-to-soon-get-ce-mark-approval-from-eu-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1729/allied-to-soon-get-ce-mark-approval-from-eu-.html</link>
			<pubDate>Fri, 15 Feb 2013 12:54:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-s-allied-healthcare-receives-iso-13485-to-progresses-in-the-regulatory-process-for-obtaining-european-ce-mark-approval-for-cardiocel.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1729/allied-to-soon-get-ce-mark-approval-from-eu-.html</guid>
		</item>	
				<item>
			<title>AstraZeneca begins cancer research in Russia</title>
			<atom:link href="https://biospectrumasia.com/news/34/4283/astrazeneca-begins-cancer-research-in-russia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4283/astrazeneca-begins-cancer-research-in-russia.html</link>
			<pubDate>Fri, 15 Feb 2013 11:51:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/russia-celebrates-as-its-nn-petrov-institute-of-oncology-signs-collaboration-agreement-with-astrazeneca.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4283/astrazeneca-begins-cancer-research-in-russia.html</guid>
		</item>	
				<item>
			<title>Singapore univ prepares for trial of glaucoma drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3944/singapore-univ-prepares-for-trial-of-glaucoma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3944/singapore-univ-prepares-for-trial-of-glaucoma-drug.html</link>
			<pubDate>Tue, 12 Feb 2013 12:21:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye-glaucoma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3944/singapore-univ-prepares-for-trial-of-glaucoma-drug.html</guid>
		</item>	
				<item>
			<title>FDA offers guidance on Alzheimer&#039;s drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/4338/fda-offers-guidance-on-alzheimers-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4338/fda-offers-guidance-on-alzheimers-drug-development.html</link>
			<pubDate>Fri, 08 Feb 2013 12:04:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/draft-guidance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4338/fda-offers-guidance-on-alzheimers-drug-development.html</guid>
		</item>	
				<item>
			<title>Changing the paradigm of drug development</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/3128/changing-the-paradigm-of-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/3128/changing-the-paradigm-of-drug-development.html</link>
			<pubDate>Fri, 08 Feb 2013 07:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/leigh-berryman-ceo-maccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/3128/changing-the-paradigm-of-drug-development.html</guid>
		</item>	
				<item>
			<title>Orphan blood disease drugs to gain market</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5462/orphan-blood-disease-drugs-to-gain-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5462/orphan-blood-disease-drugs-to-gain-market.html</link>
			<pubDate>Thu, 07 Feb 2013 10:32:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rare-blood-disorder-treatments.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5462/orphan-blood-disease-drugs-to-gain-market.html</guid>
		</item>	
				<item>
			<title>GSK to publish clinical study reports of drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/1457/gsk-to-publish-clinical-study-reports-of-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1457/gsk-to-publish-clinical-study-reports-of-drugs.html</link>
			<pubDate>Thu, 07 Feb 2013 10:13:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gsk-clinical-study-data.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1457/gsk-to-publish-clinical-study-reports-of-drugs.html</guid>
		</item>	
				<item>
			<title>Alchemia recruits patients for rectal cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/5507/alchemia-recruits-patients-for-rectal-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5507/alchemia-recruits-patients-for-rectal-cancer-trial-.html</link>
			<pubDate>Tue, 05 Feb 2013 16:51:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-metastatic-colorectal-cancer-patients-alchemia-recruits-full-patient-quota-to-pivotal-phase-iii-ha-irinotecan-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5507/alchemia-recruits-patients-for-rectal-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>Sanofi, Regeneron cancer drug Zaltrap gets EU nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/1498/sanofi-regeneron-cancer-drug-zaltrap-gets-eu-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1498/sanofi-regeneron-cancer-drug-zaltrap-gets-eu-nod.html</link>
			<pubDate>Tue, 05 Feb 2013 13:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-metastatic-colorectal-cancer-mcrc-patients-sanofi-and-regeneron-pharmaceuticals-zaltrap-25mgml-concentrate-gets-marketing-authorization-in-the-european-union.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1498/sanofi-regeneron-cancer-drug-zaltrap-gets-eu-nod.html</guid>
		</item>	
				<item>
			<title>Johns Hopkins releases NCD policy briefs </title>
			<atom:link href="https://biospectrumasia.com/analysis/34/8300/johns-hopkins-releases-ncd-policy-briefs-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/8300/johns-hopkins-releases-ncd-policy-briefs-.html</link>
			<pubDate>Tue, 05 Feb 2013 12:41:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/johns-hopkins-s-released-policy-briefs-for-improving-non-communicable-disease-ncd-policy-research-and-care.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/8300/johns-hopkins-releases-ncd-policy-briefs-.html</guid>
		</item>	
				<item>
			<title>FDA gets biomarker database license from GVK Bio </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/296/fda-gets-biomarker-database-license-from-gvk-bio-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/296/fda-gets-biomarker-database-license-from-gvk-bio-.html</link>
			<pubDate>Tue, 05 Feb 2013 11:45:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gvk-biosciences-extend-gobiom-license-to-us-fda-s-biomarker-qualification-group.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/296/fda-gets-biomarker-database-license-from-gvk-bio-.html</guid>
		</item>	
				<item>
			<title>Glenmark develops first-of-its-kind antibody </title>
			<atom:link href="https://biospectrumasia.com/news/34/8469/glenmark-develops-first-of-its-kind-antibody-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8469/glenmark-develops-first-of-its-kind-antibody-.html</link>
			<pubDate>Tue, 05 Feb 2013 11:00:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-rheumatoid-arthritis-and-inflammatory-bowel-disease-patients-glenmark-develops-anti-ox40-monoclonal-antibody-gbr-830.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8469/glenmark-develops-first-of-its-kind-antibody-.html</guid>
		</item>	
				<item>
			<title>RaQualia, Interprotein to research on pain drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/7669/raqualia-interprotein-to-research-on-pain-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7669/raqualia-interprotein-to-research-on-pain-drug-.html</link>
			<pubDate>Mon, 04 Feb 2013 12:39:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-patients-suffering-from-pain-raqualia-pharma-and-interprotein-enter-into-collaborative-research-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7669/raqualia-interprotein-to-research-on-pain-drug-.html</guid>
		</item>	
				<item>
			<title>Cytomegalovirus treatments to improve</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2240/cytomegalovirus-treatments-to-improve.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2240/cytomegalovirus-treatments-to-improve.html</link>
			<pubDate>Fri, 01 Feb 2013 18:00:03 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cytomegalovirus-treatments-to-improve.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2240/cytomegalovirus-treatments-to-improve.html</guid>
		</item>	
				<item>
			<title>Chugai seeks nod for breast cancer drug in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html</link>
			<pubDate>Fri, 01 Feb 2013 11:16:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-application-japan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2899/chugai-seeks-nod-for-breast-cancer-drug-in-japan.html</guid>
		</item>	
				<item>
			<title>ScinoPharm, Foresee form joint venture</title>
			<atom:link href="https://biospectrumasia.com/news/34/7229/scinopharm-foresee-form-joint-venture.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7229/scinopharm-foresee-form-joint-venture.html</link>
			<pubDate>Fri, 01 Feb 2013 10:31:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scinopharm-foresee-joint-venture.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7229/scinopharm-foresee-form-joint-venture.html</guid>
		</item>	
				<item>
			<title>Phylogica extends collaboration with Janssen Biotech</title>
			<atom:link href="https://biospectrumasia.com/news/34/574/phylogica-extends-collaboration-with-janssen-biotech.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/574/phylogica-extends-collaboration-with-janssen-biotech.html</link>
			<pubDate>Thu, 31 Jan 2013 11:20:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/phylogica-janssen-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/574/phylogica-extends-collaboration-with-janssen-biotech.html</guid>
		</item>	
				<item>
			<title>Bone Medical reveals results of arthritis study</title>
			<atom:link href="https://biospectrumasia.com/news/34/8443/bone-medical-reveals-results-of-arthritis-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8443/bone-medical-reveals-results-of-arthritis-study.html</link>
			<pubDate>Wed, 30 Jan 2013 12:28:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-rheumatoid-arthritis-ra-patients-bone-medical-reveals-positive-findings-from-a-proof-of-concept-study-of-mozaic-peptide-discovery-technology-based-drug-candidate-bn006.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8443/bone-medical-reveals-results-of-arthritis-study.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, Orexo to do respiratory drug trials </title>
			<atom:link href="https://biospectrumasia.com/news/34/6893/astrazeneca-orexo-to-do-respiratory-drug-trials-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6893/astrazeneca-orexo-to-do-respiratory-drug-trials-.html</link>
			<pubDate>Fri, 25 Jan 2013 15:08:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/orexo-grants-astrazeneca-rights-to-conduct-trials-in-its-ox-cli-respiratory-program.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6893/astrazeneca-orexo-to-do-respiratory-drug-trials-.html</guid>
		</item>	
				<item>
			<title>Exjade gets FDA nod for iron overload treatment</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3498/exjade-gets-fda-nod-for-iron-overload-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3498/exjade-gets-fda-nod-for-iron-overload-treatment.html</link>
			<pubDate>Thu, 24 Jan 2013 12:15:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-chronic-iron-overload-patients-us-fda-approved-exjade-deferasirox.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3498/exjade-gets-fda-nod-for-iron-overload-treatment.html</guid>
		</item>	
				<item>
			<title>IBM, A*Star co-develop anti-microbial hydrogel</title>
			<atom:link href="https://biospectrumasia.com/news/34/7939/ibm-astar-co-develop-anti-microbial-hydrogel.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7939/ibm-astar-co-develop-anti-microbial-hydrogel.html</link>
			<pubDate>Thu, 24 Jan 2013 12:08:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ibn-develops-anti-microbial-hydrogel.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7939/ibm-astar-co-develop-anti-microbial-hydrogel.html</guid>
		</item>	
				<item>
			<title>Aspirin use increases risk of age-related eye disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/8234/aspirin-use-increases-risk-of-age-related-eye-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8234/aspirin-use-increases-risk-of-age-related-eye-disease.html</link>
			<pubDate>Wed, 23 Jan 2013 14:32:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eye-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8234/aspirin-use-increases-risk-of-age-related-eye-disease.html</guid>
		</item>	
				<item>
			<title>EU approves Novartis&#039; Bexsero for meningitis</title>
			<atom:link href="https://biospectrumasia.com/news/34/1056/eu-approves-novartis-bexsero-for-meningitis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1056/eu-approves-novartis-bexsero-for-meningitis.html</link>
			<pubDate>Wed, 23 Jan 2013 11:16:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-novartis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1056/eu-approves-novartis-bexsero-for-meningitis.html</guid>
		</item>	
				<item>
			<title>Dong-A Pharma gets positive trial results for Evogliptin</title>
			<atom:link href="https://biospectrumasia.com/news/34/6054/dong-a-pharma-gets-positive-trial-results-for-evogliptin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6054/dong-a-pharma-gets-positive-trial-results-for-evogliptin.html</link>
			<pubDate>Tue, 22 Jan 2013 11:11:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6054/dong-a-pharma-gets-positive-trial-results-for-evogliptin.html</guid>
		</item>	
				<item>
			<title>Activation of mTorc1 causes colon, gastric cancers</title>
			<atom:link href="https://biospectrumasia.com/news/34/4388/activation-of-mtorc1-causes-colon-gastric-cancers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4388/activation-of-mtorc1-causes-colon-gastric-cancers.html</link>
			<pubDate>Tue, 22 Jan 2013 10:43:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientists-identify-protein-complex-responsible-for-gastrointestinal-cancers.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4388/activation-of-mtorc1-causes-colon-gastric-cancers.html</guid>
		</item>	
				<item>
			<title>NovAliX, Kyowa Hakko Kirin sign deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/4105/novalix-kyowa-hakko-kirin-sign-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4105/novalix-kyowa-hakko-kirin-sign-deal.html</link>
			<pubDate>Tue, 15 Jan 2013 14:17:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novalix-and-kyowa-hakko-kirin-to-co-develop-novel-drug-candidates-against-protein-protein-interaction-targets.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4105/novalix-kyowa-hakko-kirin-sign-deal.html</guid>
		</item>	
				<item>
			<title>Patrys gets nod to progress myeloma trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/4414/patrys-gets-nod-to-progress-myeloma-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4414/patrys-gets-nod-to-progress-myeloma-trial.html</link>
			<pubDate>Mon, 14 Jan 2013 14:05:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patrys-progresses-multiple-myeloma-clinical-trial-to-second-patient-group.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4414/patrys-gets-nod-to-progress-myeloma-trial.html</guid>
		</item>	
				<item>
			<title>GSK, Theravance seek EU nod for COPD drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3465/gsk-theravance-seek-eu-nod-for-copd-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3465/gsk-theravance-seek-eu-nod-for-copd-drug.html</link>
			<pubDate>Fri, 11 Jan 2013 13:17:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-copd-patients-gsk-theravance-submit-marketing-authorisation-application-for-umecvi-to-ema.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3465/gsk-theravance-seek-eu-nod-for-copd-drug.html</guid>
		</item>	
				<item>
			<title>Study: Novartis&#039; Afinitor hinders kidney tumor</title>
			<atom:link href="https://biospectrumasia.com/news/34/3390/study-novartis-afinitor-hinders-kidney-tumor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3390/study-novartis-afinitor-hinders-kidney-tumor.html</link>
			<pubDate>Fri, 11 Jan 2013 12:30:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-renal-angiomyolipomas-patients-novartis-afinitor-everolimus-tablets-reduce-tumor-size-and-progression.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3390/study-novartis-afinitor-hinders-kidney-tumor.html</guid>
		</item>	
				<item>
			<title>Allied abdominal hernia study shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/3437/allied-abdominal-hernia-study-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3437/allied-abdominal-hernia-study-shows-ve-results.html</link>
			<pubDate>Thu, 10 Jan 2013 16:56:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/allied-study-meets-positive-result-in-abdominal-hernia-pelvic-floor-reconstructions.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3437/allied-abdominal-hernia-study-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Bayer, 5 cancer institutes set up oncology network</title>
			<atom:link href="https://biospectrumasia.com/news/34/3069/bayer-5-cancer-institutes-set-up-oncology-network.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3069/bayer-5-cancer-institutes-set-up-oncology-network.html</link>
			<pubDate>Thu, 10 Jan 2013 14:09:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-collaborates-with-5-cancer-institutes-to-set-up-integrated-translational-oncology-network-in-singapore.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3069/bayer-5-cancer-institutes-set-up-oncology-network.html</guid>
		</item>	
				<item>
			<title>GVK, Onconova to develop cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/3708/gvk-onconova-to-develop-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3708/gvk-onconova-to-develop-cancer-drugs.html</link>
			<pubDate>Thu, 10 Jan 2013 13:37:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-new-for-cancer-patients-gvk-and-onconova-to-develop-oncology-therapeutics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3708/gvk-onconova-to-develop-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Daiichi, Amplimmune join hands for protein R&amp;D </title>
			<atom:link href="https://biospectrumasia.com/news/34/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html</link>
			<pubDate>Tue, 08 Jan 2013 12:02:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-patients-suffering-from-autoimmune-diseases-daiichi-sankyo-amplimmune-to-collaborate-on-fusion-protein-r-d.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3885/daiichi-amplimmune-join-hands-for-protein-rd-.html</guid>
		</item>	
				<item>
			<title>Boehringer terminates insulin deal with Lilly</title>
			<atom:link href="https://biospectrumasia.com/news/34/1299/boehringer-terminates-insulin-deal-with-lilly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1299/boehringer-terminates-insulin-deal-with-lilly.html</link>
			<pubDate>Tue, 08 Jan 2013 11:31:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-deal-is-off-boehringer-ingelheim-terminated-its-alliance-with-lilly-for-novel-basal-insulin-analog-ly2605541.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1299/boehringer-terminates-insulin-deal-with-lilly.html</guid>
		</item>	
				<item>
			<title>Pfizer, Repligen to push spinal muscular atrophy program</title>
			<atom:link href="https://biospectrumasia.com/news/34/8336/pfizer-repligen-to-push-spinal-muscular-atrophy-program.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8336/pfizer-repligen-to-push-spinal-muscular-atrophy-program.html</link>
			<pubDate>Mon, 07 Jan 2013 11:11:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-repligen-pfizer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8336/pfizer-repligen-to-push-spinal-muscular-atrophy-program.html</guid>
		</item>	
				<item>
			<title>KHK advances DsiRNA cancer target, pays $5 mn</title>
			<atom:link href="https://biospectrumasia.com/news/34/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html</link>
			<pubDate>Fri, 04 Jan 2013 12:05:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kyowa-hakko-kirin-khk-will-pay-dicerna-pharma-usd5-million-milestone-payment-for-advancing-second-therapeutic-oncology-candidate-dicer-substrate-sirna-from-the-r-d-stage.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2541/khk-advances-dsirna-cancer-target-pays-5-mn.html</guid>
		</item>	
				<item>
			<title>Taiwan, China firms to co-develop cancer NCEs</title>
			<atom:link href="https://biospectrumasia.com/news/34/1766/taiwan-china-firms-to-co-develop-cancer-nces.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1766/taiwan-china-firms-to-co-develop-cancer-nces.html</link>
			<pubDate>Thu, 03 Jan 2013 13:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmaengine-guangzhou-bebetter-medicine-technology-collaborate-on-anti-cancer-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1766/taiwan-china-firms-to-co-develop-cancer-nces.html</guid>
		</item>	
				<item>
			<title>Merck resubmits NDA for ezetimibe, atorvastatin </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4011/merck-resubmits-nda-for-ezetimibe-atorvastatin-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4011/merck-resubmits-nda-for-ezetimibe-atorvastatin-.html</link>
			<pubDate>Thu, 03 Jan 2013 13:04:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hopefully-the-us-fda-will-complete-the-review-of-merck-s-new-drug-application-nda-for-ezetimibe-and-atorvastatin-tablets-during-the-first-half-of-2013.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4011/merck-resubmits-nda-for-ezetimibe-atorvastatin-.html</guid>
		</item>	
				<item>
			<title>Material science firm Crystal to open lab in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/1053/material-science-firm-crystal-to-open-lab-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1053/material-science-firm-crystal-to-open-lab-in-china.html</link>
			<pubDate>Wed, 02 Jan 2013 10:30:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-new-crystal-pharmatech-laboratory-will-provide-materials-science-development-service-packages-in-drug-r-d-in-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1053/material-science-firm-crystal-to-open-lab-in-china.html</guid>
		</item>	
				<item>
			<title>European Commission nod for Novartis&#039; Exjade</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/314/european-commission-nod-for-novartis-exjade.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/314/european-commission-nod-for-novartis-exjade.html</link>
			<pubDate>Wed, 26 Dec 2012 15:45:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hoe-for-thalassemia-patients-novartis-exjade-gets-approval-from-european-commission.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/314/european-commission-nod-for-novartis-exjade.html</guid>
		</item>	
				<item>
			<title>Thailand develops its first-ever indigenous drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7247/thailand-develops-its-first-ever-indigenous-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7247/thailand-develops-its-first-ever-indigenous-drug.html</link>
			<pubDate>Wed, 26 Dec 2012 12:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-malaria-patients-anti-plasmodium-medicine-becomes-thailands-first-ever-indigenous-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7247/thailand-develops-its-first-ever-indigenous-drug.html</guid>
		</item>	
				<item>
			<title>Protagonist, Ironwood expand peptide R&amp;D deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/894/protagonist-ironwood-expand-peptide-rd-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/894/protagonist-ironwood-expand-peptide-rd-deal.html</link>
			<pubDate>Fri, 21 Dec 2012 13:30:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/protagonist-ironwood-expand-peptide-drug-discovery-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/894/protagonist-ironwood-expand-peptide-rd-deal.html</guid>
		</item>	
				<item>
			<title>AstraZeneca, LegoChem drug to curb superbugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/2794/astrazeneca-legochem-drug-to-curb-superbugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2794/astrazeneca-legochem-drug-to-curb-superbugs.html</link>
			<pubDate>Fri, 21 Dec 2012 13:13:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astrazeneca-legochem-collaborate-to-develop-antibiotic-resistant-bacterial-infections-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2794/astrazeneca-legochem-drug-to-curb-superbugs.html</guid>
		</item>	
				<item>
			<title>Ian Frazer gets $200k to make HPV DNA vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/34/4348/ian-frazer-gets-200k-to-make-hpv-dna-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4348/ian-frazer-gets-200k-to-make-hpv-dna-vaccine.html</link>
			<pubDate>Thu, 20 Dec 2012 11:55:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/national-health-and-medical-research-council-nhmrc-gives-usd200-000-to-professor-ian-frazer-to-develop-a-novel-dna-vaccine-for-hpv.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4348/ian-frazer-gets-200k-to-make-hpv-dna-vaccine.html</guid>
		</item>	
				<item>
			<title>Astellas completes patient recruitment in drug trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/1318/astellas-completes-patient-recruitment-in-drug-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1318/astellas-completes-patient-recruitment-in-drug-trial.html</link>
			<pubDate>Wed, 19 Dec 2012 11:36:35 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-patient-recruitment.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1318/astellas-completes-patient-recruitment-in-drug-trial.html</guid>
		</item>	
				<item>
			<title>Clinuvel gets positive results in Scenesse trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2111/clinuvel-gets-positive-results-in-scenesse-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2111/clinuvel-gets-positive-results-in-scenesse-trial.html</link>
			<pubDate>Wed, 19 Dec 2012 11:22:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinuvel-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2111/clinuvel-gets-positive-results-in-scenesse-trial.html</guid>
		</item>	
				<item>
			<title>GE fortifies iPS cell-derived cellular assay avenue</title>
			<atom:link href="https://biospectrumasia.com/news/34/6561/ge-fortifies-ips-cell-derived-cellular-assay-avenue.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6561/ge-fortifies-ips-cell-derived-cellular-assay-avenue.html</link>
			<pubDate>Wed, 19 Dec 2012 11:06:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/induced-pluripotent-stem-cell-assay.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6561/ge-fortifies-ips-cell-derived-cellular-assay-avenue.html</guid>
		</item>	
				<item>
			<title>Astrazeneca, China university in research deal</title>
			<atom:link href="https://biospectrumasia.com/news/34/575/astrazeneca-china-university-in-research-deal.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/575/astrazeneca-china-university-in-research-deal.html</link>
			<pubDate>Wed, 19 Dec 2012 11:00:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-collaboration-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/575/astrazeneca-china-university-in-research-deal.html</guid>
		</item>	
				<item>
			<title>Global collaborations is the way forward for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/346/global-collaborations-is-the-way-forward-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/346/global-collaborations-is-the-way-forward-for-drug-discovery.html</link>
			<pubDate>Wed, 19 Dec 2012 07:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/can-india-become-a-global-drug-discovery-collboration-hot-spot.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/346/global-collaborations-is-the-way-forward-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>Eisai, UCL form neuro R&amp;D alliance</title>
			<atom:link href="https://biospectrumasia.com/news/34/3826/eisai-ucl-form-neuro-rd-alliance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3826/eisai-ucl-form-neuro-rd-alliance.html</link>
			<pubDate>Fri, 14 Dec 2012 12:26:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3826/eisai-ucl-form-neuro-rd-alliance.html</guid>
		</item>	
				<item>
			<title>Rockefeller University finds genetic link to autism </title>
			<atom:link href="https://biospectrumasia.com/news/34/1728/rockefeller-university-finds-genetic-link-to-autism-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1728/rockefeller-university-finds-genetic-link-to-autism-.html</link>
			<pubDate>Fri, 14 Dec 2012 12:06:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/duke-university-medical-center-and-rockefeller-university-study-pinpoint-genetic-footprint-that-links-fragile-x-syndrome-and-autism.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1728/rockefeller-university-finds-genetic-link-to-autism-.html</guid>
		</item>	
				<item>
			<title>EMA says no to risky schizophrenia drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4798/ema-says-no-to-risky-schizophrenia-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4798/ema-says-no-to-risky-schizophrenia-drug-.html</link>
			<pubDate>Fri, 14 Dec 2012 11:45:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-risks-of-vanda-pharma-s-schizophrenia-drug-fanaptum-outweigh-its-benefits.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4798/ema-says-no-to-risky-schizophrenia-drug-.html</guid>
		</item>	
				<item>
			<title>Teva, Xenon enter $335 mn deal for pain drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/505/teva-xenon-enter-335-mn-deal-for-pain-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/505/teva-xenon-enter-335-mn-deal-for-pain-drug-.html</link>
			<pubDate>Wed, 12 Dec 2012 13:39:43 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teva-will-pay-xenon-usd41-million-upfront-and-also-pay-milestones-worth-usd335-million-for-pain-killer-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/505/teva-xenon-enter-335-mn-deal-for-pain-drug-.html</guid>
		</item>	
				<item>
			<title>Boehringer leukaemia study shows +ve results</title>
			<atom:link href="https://biospectrumasia.com/news/34/5842/boehringer-leukaemia-study-shows-ve-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5842/boehringer-leukaemia-study-shows-ve-results.html</link>
			<pubDate>Wed, 12 Dec 2012 13:31:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-acute-myeloid-leukemia-aml-patients-phase-ii-boehringer-ingelheim-study-with-volasertib-shows-positive-signs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5842/boehringer-leukaemia-study-shows-ve-results.html</guid>
		</item>	
				<item>
			<title>Zytiga, Xtandi to dominate prostrate cancer market</title>
			<atom:link href="https://biospectrumasia.com/news/34/4093/zytiga-xtandi-to-dominate-prostrate-cancer-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4093/zytiga-xtandi-to-dominate-prostrate-cancer-market.html</link>
			<pubDate>Wed, 12 Dec 2012 12:49:36 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prostrate-cancer-market-update-by-globaldata-zytiga-sales-to-be-worth-usd1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4093/zytiga-xtandi-to-dominate-prostrate-cancer-market.html</guid>
		</item>	
				<item>
			<title>FibroGen, Astellas start trial of anemia therapeutic agent</title>
			<atom:link href="https://biospectrumasia.com/news/34/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html</link>
			<pubDate>Wed, 12 Dec 2012 11:47:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-fibrogen-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4039/fibrogen-astellas-start-trial-of-anemia-therapeutic-agent.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; Jakavi improves myelofibrosis </title>
			<atom:link href="https://biospectrumasia.com/news/34/1089/novartis-jakavi-improves-myelofibrosis-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1089/novartis-jakavi-improves-myelofibrosis-.html</link>
			<pubDate>Tue, 11 Dec 2012 12:28:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-myelofibrosis-patients-phase-iii-studies-of-jakavi-inc424-ruxolitinib-by-novartis-shows-promise.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1089/novartis-jakavi-improves-myelofibrosis-.html</guid>
		</item>	
				<item>
			<title>Patrys begins multiple myeloma trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/3721/patrys-begins-multiple-myeloma-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3721/patrys-begins-multiple-myeloma-trial.html</link>
			<pubDate>Mon, 10 Dec 2012 10:23:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-patrys.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3721/patrys-begins-multiple-myeloma-trial.html</guid>
		</item>	
				<item>
			<title>Sol-Gel to treat rosacea using acne drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2233/sol-gel-to-treat-rosacea-using-acne-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2233/sol-gel-to-treat-rosacea-using-acne-drug.html</link>
			<pubDate>Thu, 06 Dec 2012 13:41:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sol-gel-to-treat-rosacea-using-acne-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2233/sol-gel-to-treat-rosacea-using-acne-drug.html</guid>
		</item>	
				<item>
			<title>New drug slows cancer significantly </title>
			<atom:link href="https://biospectrumasia.com/news/34/1013/new-drug-slows-cancer-significantly-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1013/new-drug-slows-cancer-significantly-.html</link>
			<pubDate>Thu, 06 Dec 2012 11:21:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-prostrate-cancer-patients-cabozantinib-slows-down-the-spread-of-the-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1013/new-drug-slows-cancer-significantly-.html</guid>
		</item>	
				<item>
			<title>Chugai, Nippon Shinyaku tie up for drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html</link>
			<pubDate>Thu, 06 Dec 2012 11:12:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-development-chugai-nippon-shinyaku.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2018/chugai-nippon-shinyaku-tie-up-for-drug-development.html</guid>
		</item>	
				<item>
			<title>UCLA finds new compound to curb Alzheimer&#039;s</title>
			<atom:link href="https://biospectrumasia.com/news/34/1833/ucla-finds-new-compound-to-curb-alzheimers.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1833/ucla-finds-new-compound-to-curb-alzheimers.html</link>
			<pubDate>Fri, 30 Nov 2012 11:35:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-parkinson-s-and-alzheimer-s-disease-patients-ucla-scientists-are-developing-a-new-compound-called-clr01.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1833/ucla-finds-new-compound-to-curb-alzheimers.html</guid>
		</item>	
				<item>
			<title>Orient, NanoCarrier sign deal for Nanoplatin trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html</link>
			<pubDate>Thu, 29 Nov 2012 13:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-nanocarrier-orient.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8272/orient-nanocarrier-sign-deal-for-nanoplatin-trial.html</guid>
		</item>	
				<item>
			<title>UK firm withdraws insulin marketing applications</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3081/uk-firm-withdraws-insulin-marketing-applications.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3081/uk-firm-withdraws-insulin-marketing-applications.html</link>
			<pubDate>Wed, 28 Nov 2012 13:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/marvel-lifescience-withdraws-centralized-marketing-authorizations-for-human-insulins-solumarv-isomarv-and-combimarv.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3081/uk-firm-withdraws-insulin-marketing-applications.html</guid>
		</item>	
				<item>
			<title>Starpharma to receive $6 mn for overseas R&amp;D</title>
			<atom:link href="https://biospectrumasia.com/news/34/1130/starpharma-to-receive-6-mn-for-overseas-rd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1130/starpharma-to-receive-6-mn-for-overseas-rd.html</link>
			<pubDate>Fri, 23 Nov 2012 14:18:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/starpharma-to-get-usd6-mn-cash-incentives-for-overseas-research-of-vivagel.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1130/starpharma-to-receive-6-mn-for-overseas-rd.html</guid>
		</item>	
				<item>
			<title>Genzyme multiple sclerosis drug gets TGA nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/4082/genzyme-multiple-sclerosis-drug-gets-tga-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4082/genzyme-multiple-sclerosis-drug-gets-tga-nod.html</link>
			<pubDate>Thu, 22 Nov 2012 10:19:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tga-approves-genzyme-aubagio-teriflunomide-for-multiple-sclerosis-ms.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4082/genzyme-multiple-sclerosis-drug-gets-tga-nod.html</guid>
		</item>	
				<item>
			<title>Eliquis approved in EU for stroke prevention</title>
			<atom:link href="https://biospectrumasia.com/news/34/6072/eliquis-approved-in-eu-for-stroke-prevention.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6072/eliquis-approved-in-eu-for-stroke-prevention.html</link>
			<pubDate>Wed, 21 Nov 2012 18:14:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eliquis-approved-in-eu-for-stroke-prevention.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6072/eliquis-approved-in-eu-for-stroke-prevention.html</guid>
		</item>	
				<item>
			<title>Sihuan, NeuroVive to develop heart and brain products</title>
			<atom:link href="https://biospectrumasia.com/news/34/3054/sihuan-neurovive-to-develop-heart-and-brain-products.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3054/sihuan-neurovive-to-develop-heart-and-brain-products.html</link>
			<pubDate>Wed, 21 Nov 2012 17:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sihuan-pharmaceutical-and-collaborate-to-develop-ciclomulsion-and-neurostat.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3054/sihuan-neurovive-to-develop-heart-and-brain-products.html</guid>
		</item>	
				<item>
			<title>GVK Bio establishes largest isotope labeling factory in India</title>
			<atom:link href="https://biospectrumasia.com/news/34/6853/gvk-bio-establishes-largest-isotope-labeling-factory-in-india.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6853/gvk-bio-establishes-largest-isotope-labeling-factory-in-india.html</link>
			<pubDate>Tue, 20 Nov 2012 13:33:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gvk-biosciences-received-approvals-from-india-s-atomic-energy-regulatory-board-to-develop-isotopes.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6853/gvk-bio-establishes-largest-isotope-labeling-factory-in-india.html</guid>
		</item>	
				<item>
			<title>Genting to acquire 20% equity stake in TauRx</title>
			<atom:link href="https://biospectrumasia.com/news/34/3305/genting-to-acquire-20-equity-stake-in-taurx.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3305/genting-to-acquire-20-equity-stake-in-taurx.html</link>
			<pubDate>Tue, 20 Nov 2012 11:06:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/taurx-gets-usd31.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3305/genting-to-acquire-20-equity-stake-in-taurx.html</guid>
		</item>	
				<item>
			<title>Novartis&#039; thalassemia drug Exjade get EMA nod</title>
			<atom:link href="https://biospectrumasia.com/news/34/2214/novartis-thalassemia-drug-exjade-get-ema-nod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2214/novartis-thalassemia-drug-exjade-get-ema-nod.html</link>
			<pubDate>Mon, 19 Nov 2012 15:26:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-thalassemia-patients-novartis-exjade-gets-ema-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2214/novartis-thalassemia-drug-exjade-get-ema-nod.html</guid>
		</item>	
				<item>
			<title>Boehringer, Lilly complete type 2 diabetes study</title>
			<atom:link href="https://biospectrumasia.com/news/34/7818/boehringer-lilly-complete-type-2-diabetes-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7818/boehringer-lilly-complete-type-2-diabetes-study.html</link>
			<pubDate>Mon, 12 Nov 2012 12:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-lilly-complete-type-2-diabetes-study.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7818/boehringer-lilly-complete-type-2-diabetes-study.html</guid>
		</item>	
				<item>
			<title>Novartis has a substantial drug pipeline for all diseases </title>
			<atom:link href="https://biospectrumasia.com/news/34/3817/novartis-has-a-substantial-drug-pipeline-for-all-diseases-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3817/novartis-has-a-substantial-drug-pipeline-for-all-diseases-.html</link>
			<pubDate>Fri, 09 Nov 2012 13:57:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novartis-to-boost-its-already-substantial-drug-pipeline.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3817/novartis-has-a-substantial-drug-pipeline-for-all-diseases-.html</guid>
		</item>	
				<item>
			<title>MerLion completes phase I of finafloxacin study</title>
			<atom:link href="https://biospectrumasia.com/news/34/3160/merlion-completes-phase-i-of-finafloxacin-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3160/merlion-completes-phase-i-of-finafloxacin-study.html</link>
			<pubDate>Thu, 08 Nov 2012 18:11:18 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/merlion-completes-phase-i-of-finafloxacin-study.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3160/merlion-completes-phase-i-of-finafloxacin-study.html</guid>
		</item>	
				<item>
			<title>Safety concerns delay launch of Pfizer&#039;s arthritis drug Xeljanz</title>
			<atom:link href="https://biospectrumasia.com/news/34/6221/safety-concerns-delay-launch-of-pfizers-arthritis-drug-xeljanz.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6221/safety-concerns-delay-launch-of-pfizers-arthritis-drug-xeljanz.html</link>
			<pubDate>Thu, 08 Nov 2012 15:41:01 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-big-question-when-will-pfizer-launch-lower-doses-of-arthritis-drug-xeljanz.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6221/safety-concerns-delay-launch-of-pfizers-arthritis-drug-xeljanz.html</guid>
		</item>	
				<item>
			<title>FDA nod for Novartis Cushing&#039;s disease drug Signifor</title>
			<atom:link href="https://biospectrumasia.com/news/34/8439/fda-nod-for-novartis-cushings-disease-drug-signifor.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8439/fda-nod-for-novartis-cushings-disease-drug-signifor.html</link>
			<pubDate>Thu, 08 Nov 2012 15:24:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/us-fda-s-endocrinologic-and-metabolic-drugs-advisory-committee-emdac-approves-the-use-of-novartis-signifor-pasireotide-for-cushing-s-disease.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8439/fda-nod-for-novartis-cushings-disease-drug-signifor.html</guid>
		</item>	
				<item>
			<title>OSDD starts Youtube competition for TB </title>
			<atom:link href="https://biospectrumasia.com/news/34/4642/osdd-starts-youtube-competition-for-tb-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4642/osdd-starts-youtube-competition-for-tb-.html</link>
			<pubDate>Fri, 02 Nov 2012 13:57:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/good-news-for-tb-awareness-india-s-open-source-drug-discovery-initiative-vigyan-prasar-start-youtube-competition.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4642/osdd-starts-youtube-competition-for-tb-.html</guid>
		</item>	
				<item>
			<title>UK recommends BMS&#039;s Yervoy for skin cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/889/uk-recommends-bmss-yervoy-for-skin-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/889/uk-recommends-bmss-yervoy-for-skin-cancer.html</link>
			<pubDate>Fri, 02 Nov 2012 11:44:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-skin-cancer-patients-national-institute-of-health-and-clinical-excellence-uk-recommends-bristol-myers-squibb-s-yervoy-ipilimumab.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/889/uk-recommends-bmss-yervoy-for-skin-cancer.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo enrolls patients for edoxaban trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html</link>
			<pubDate>Tue, 30 Oct 2012 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/edoxaban-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3890/daiichi-sankyo-enrolls-patients-for-edoxaban-trial.html</guid>
		</item>	
				<item>
			<title>EMA to review marketing plea for antipsychotic medication</title>
			<atom:link href="https://biospectrumasia.com/news/34/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html</link>
			<pubDate>Mon, 29 Oct 2012 17:15:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ema-marketing-authorization-application.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/726/ema-to-review-marketing-plea-for-antipsychotic-medication.html</guid>
		</item>	
				<item>
			<title>Starpharma drug targets cancer more effectively </title>
			<atom:link href="https://biospectrumasia.com/news/34/2053/starpharma-drug-targets-cancer-more-effectively-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2053/starpharma-drug-targets-cancer-more-effectively-.html</link>
			<pubDate>Mon, 29 Oct 2012 13:03:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/starpharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2053/starpharma-drug-targets-cancer-more-effectively-.html</guid>
		</item>	
				<item>
			<title>Abraxane cancer trial shows positive results in Australia      </title>
			<atom:link href="https://biospectrumasia.com/news/34/461/abraxane-cancer-trial-shows-positive-results-in-australia-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/461/abraxane-cancer-trial-shows-positive-results-in-australia-.html</link>
			<pubDate>Mon, 29 Oct 2012 10:20:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-metastatic-melanoma-patients-abraxane-works-better-than-chemotherapy-agent-dacarbazine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/461/abraxane-cancer-trial-shows-positive-results-in-australia-.html</guid>
		</item>	
				<item>
			<title>TNI Biotech, Hubei Qianjian to develop cancer drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/3651/tni-biotech-hubei-qianjian-to-develop-cancer-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3651/tni-biotech-hubei-qianjian-to-develop-cancer-drugs.html</link>
			<pubDate>Fri, 19 Oct 2012 12:03:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tni-biotech-hubei-qianjian-to-develop-cancer-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3651/tni-biotech-hubei-qianjian-to-develop-cancer-drugs.html</guid>
		</item>	
				<item>
			<title>Biodiem develops killer for drug-resistant microbes </title>
			<atom:link href="https://biospectrumasia.com/news/34/3362/biodiem-develops-killer-for-drug-resistant-microbes-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3362/biodiem-develops-killer-for-drug-resistant-microbes-.html</link>
			<pubDate>Thu, 18 Oct 2012 12:55:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/you-can-run-but-you-cannot-hide-biodiem-develops-broad-spectrum-antimicrobial-compound-bdm-i.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3362/biodiem-develops-killer-for-drug-resistant-microbes-.html</guid>
		</item>	
				<item>
			<title>Daiichi develops antibody to prevent fracture </title>
			<atom:link href="https://biospectrumasia.com/news/34/3066/daiichi-develops-antibody-to-prevent-fracture-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3066/daiichi-develops-antibody-to-prevent-fracture-.html</link>
			<pubDate>Tue, 16 Oct 2012 11:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-human-monoclonal-antibody-by-daiichi-sankyo-denosumab-reduces-or-prevents-vertebral-fractures.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3066/daiichi-develops-antibody-to-prevent-fracture-.html</guid>
		</item>	
				<item>
			<title>Biotron to report data from hepatitis C trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/6643/biotron-to-report-data-from-hepatitis-c-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6643/biotron-to-report-data-from-hepatitis-c-trial.html</link>
			<pubDate>Tue, 16 Oct 2012 10:11:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/biotron-will-reveal-results-of-its-phase-iia-hepatitis-c-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6643/biotron-to-report-data-from-hepatitis-c-trial.html</guid>
		</item>	
				<item>
			<title>Australian firm gets rights to Anamorelin</title>
			<atom:link href="https://biospectrumasia.com/news/34/4334/australian-firm-gets-rights-to-anamorelin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4334/australian-firm-gets-rights-to-anamorelin.html</link>
			<pubDate>Mon, 15 Oct 2012 12:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/commercialization-right.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4334/australian-firm-gets-rights-to-anamorelin.html</guid>
		</item>	
				<item>
			<title>Austrianova&#039;s trial data proves efficacy</title>
			<atom:link href="https://biospectrumasia.com/news/34/3564/austrianovas-trial-data-proves-efficacy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3564/austrianovas-trial-data-proves-efficacy.html</link>
			<pubDate>Mon, 15 Oct 2012 11:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/austrianova-trial-data.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3564/austrianovas-trial-data-proves-efficacy.html</guid>
		</item>	
				<item>
			<title>Merck Millipore enhances bioavailability portfolio</title>
			<atom:link href="https://biospectrumasia.com/news/34/392/merck-millipore-enhances-bioavailability-portfolio.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/392/merck-millipore-enhances-bioavailability-portfolio.html</link>
			<pubDate>Wed, 10 Oct 2012 10:22:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/392/merck-millipore-enhances-bioavailability-portfolio.html</guid>
		</item>	
				<item>
			<title>Bayer and Sanofi battle to cure colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/2727/bayer-and-sanofi-battle-to-cure-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2727/bayer-and-sanofi-battle-to-cure-colorectal-cancer.html</link>
			<pubDate>Mon, 08 Oct 2012 12:46:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/who-will-win-the-fight-against-colorectal-cancer-bayer-stivarga-or-sanofi-regeneron-zaltrap.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2727/bayer-and-sanofi-battle-to-cure-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>Anaphore changes corporate name to RuiYi</title>
			<atom:link href="https://biospectrumasia.com/news/34/1573/anaphore-changes-corporate-name-to-ruiyi.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1573/anaphore-changes-corporate-name-to-ruiyi.html</link>
			<pubDate>Fri, 05 Oct 2012 11:50:02 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/anaphore-is-now-ruiyi.jpeg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1573/anaphore-changes-corporate-name-to-ruiyi.html</guid>
		</item>	
				<item>
			<title>Theravance, Alfa Wassermann collaborate</title>
			<atom:link href="https://biospectrumasia.com/news/34/1669/theravance-alfa-wassermann-collaborate.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1669/theravance-alfa-wassermann-collaborate.html</link>
			<pubDate>Thu, 04 Oct 2012 13:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/theravance-and-alfa-wassermann-sign-agreement-for-velusetrag-theravance-s-investigational-5-ht4-agonist-in-development-for-gastrointestinal-motility-disorders.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1669/theravance-alfa-wassermann-collaborate.html</guid>
		</item>	
				<item>
			<title>Cipla malaria drug gets WHO pre-qualification</title>
			<atom:link href="https://biospectrumasia.com/news/34/4392/cipla-malaria-drug-gets-who-pre-qualification.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4392/cipla-malaria-drug-gets-who-pre-qualification.html</link>
			<pubDate>Thu, 04 Oct 2012 12:56:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-malaria-patients-cipla-dndi-get-who-pre-qualification-for-fixed-dose-combination-of-artesunate-mefloquine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4392/cipla-malaria-drug-gets-who-pre-qualification.html</guid>
		</item>	
				<item>
			<title>Sankyo halts phase III trial of cancer drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html</link>
			<pubDate>Thu, 04 Oct 2012 11:34:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sankyo-s-phase-iii-marquee-cancer-trial-is-stopped.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3884/sankyo-halts-phase-iii-trial-of-cancer-drug.html</guid>
		</item>	
				<item>
			<title>Advinus gets $36 mn research funding from Takeda</title>
			<atom:link href="https://biospectrumasia.com/news/34/1505/advinus-gets-36-mn-research-funding-from-takeda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1505/advinus-gets-36-mn-research-funding-from-takeda.html</link>
			<pubDate>Wed, 03 Oct 2012 16:46:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/done-deal-takeda-will-receive-commercial-rights-to-drug-candidates-and-advinus-will-receive-research-funding-of-usd36-million.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1505/advinus-gets-36-mn-research-funding-from-takeda.html</guid>
		</item>	
				<item>
			<title>NDA for Lundbeck&#039;s vortioxetine with US FDA</title>
			<atom:link href="https://biospectrumasia.com/news/34/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html</link>
			<pubDate>Wed, 03 Oct 2012 10:21:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antidepressant.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4062/nda-for-lundbecks-vortioxetine-with-us-fda.html</guid>
		</item>	
				<item>
			<title>Boehringer offers fast-track path to launch biopharma</title>
			<atom:link href="https://biospectrumasia.com/news/34/4122/boehringer-offers-fast-track-path-to-launch-biopharma.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4122/boehringer-offers-fast-track-path-to-launch-biopharma.html</link>
			<pubDate>Tue, 02 Oct 2012 11:12:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4122/boehringer-offers-fast-track-path-to-launch-biopharma.html</guid>
		</item>	
				<item>
			<title>Deal with Janssen gets Astellas $65 million up-front</title>
			<atom:link href="https://biospectrumasia.com/news/34/143/deal-with-janssen-gets-astellas-65-million-up-front.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/143/deal-with-janssen-gets-astellas-65-million-up-front.html</link>
			<pubDate>Tue, 02 Oct 2012 09:18:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astellas-payment-from-janssen.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/143/deal-with-janssen-gets-astellas-65-million-up-front.html</guid>
		</item>	
				<item>
			<title>Alzheimer&#039;s research gets a push from Servier</title>
			<atom:link href="https://biospectrumasia.com/news/34/6765/alzheimers-research-gets-a-push-from-servier.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6765/alzheimers-research-gets-a-push-from-servier.html</link>
			<pubDate>Tue, 02 Oct 2012 08:58:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/neuro-degenerative-disorder.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6765/alzheimers-research-gets-a-push-from-servier.html</guid>
		</item>	
				<item>
			<title>AVEO, Astellas file NDA for tivozanib</title>
			<atom:link href="https://biospectrumasia.com/news/34/1781/aveo-astellas-file-nda-for-tivozanib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1781/aveo-astellas-file-nda-for-tivozanib.html</link>
			<pubDate>Mon, 01 Oct 2012 10:28:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-nda-aveo-astellas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1781/aveo-astellas-file-nda-for-tivozanib.html</guid>
		</item>	
				<item>
			<title>Teijin, Pulmagen enter agreement for asthma drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html</link>
			<pubDate>Fri, 28 Sep 2012 10:37:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/teijin-pulmagen-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7743/teijin-pulmagen-enter-agreement-for-asthma-drug.html</guid>
		</item>	
				<item>
			<title>New antibody-based drug to cure diabetes </title>
			<atom:link href="https://biospectrumasia.com/news/34/2724/new-antibody-based-drug-to-cure-diabetes-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2724/new-antibody-based-drug-to-cure-diabetes-.html</link>
			<pubDate>Thu, 27 Sep 2012 10:58:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-diabetes-patients-a-new-drug-is-on-the-way.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2724/new-antibody-based-drug-to-cure-diabetes-.html</guid>
		</item>	
				<item>
			<title>Eisai, Santen enter agreement for new ophthalmic drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html</link>
			<pubDate>Wed, 26 Sep 2012 15:10:42 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ophthalmology-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6037/eisai-santen-enter-agreement-for-new-ophthalmic-drugs.html</guid>
		</item>	
				<item>
			<title>US FDA sets up task force for antibacterial drugs</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5989/us-fda-sets-up-task-force-for-antibacterial-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5989/us-fda-sets-up-task-force-for-antibacterial-drugs.html</link>
			<pubDate>Wed, 26 Sep 2012 14:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/antibacterial-drugs-task-force.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5989/us-fda-sets-up-task-force-for-antibacterial-drugs.html</guid>
		</item>	
				<item>
			<title>Cold Spring Harbor Lab uses cancer drugs to treat  Alzheimer&#039;s </title>
			<atom:link href="https://biospectrumasia.com/news/34/1448/cold-spring-harbor-lab-uses-cancer-drugs-to-treat-alzheimers-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1448/cold-spring-harbor-lab-uses-cancer-drugs-to-treat-alzheimers-.html</link>
			<pubDate>Wed, 26 Sep 2012 11:56:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-alzheimer-s-patients-cold-spring-harbor-laboratory-uses-cancer-drugs-to-reverse-alzheimer-s-like-memory-loss.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1448/cold-spring-harbor-lab-uses-cancer-drugs-to-treat-alzheimers-.html</guid>
		</item>	
				<item>
			<title>Astellas, KEK sign deal for neglected diseases research</title>
			<atom:link href="https://biospectrumasia.com/news/34/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html</link>
			<pubDate>Wed, 26 Sep 2012 10:46:20 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drugs-infectious-diseases.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6780/astellas-kek-sign-deal-for-neglected-diseases-research.html</guid>
		</item>	
				<item>
			<title>Sanofi to develop novel drugs for drug-resistant TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/3173/sanofi-to-develop-novel-drugs-for-drug-resistant-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3173/sanofi-to-develop-novel-drugs-for-drug-resistant-tb.html</link>
			<pubDate>Tue, 25 Sep 2012 12:53:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-tb-patients-sanofi-and-tb-alliance-collaborate-to-fight-drug-resistance.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3173/sanofi-to-develop-novel-drugs-for-drug-resistant-tb.html</guid>
		</item>	
				<item>
			<title>Chugai seeks approval for anti-cancer agent Avastin in Japan</title>
			<atom:link href="https://biospectrumasia.com/news/34/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html</link>
			<pubDate>Tue, 25 Sep 2012 12:09:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/what-will-japan-do-chugai-seeks-approval-for-anti-cancer-agent-avastin.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6111/chugai-seeks-approval-for-anti-cancer-agent-avastin-in-japan.html</guid>
		</item>	
				<item>
			<title>BMS to develop novel therapies for Parkinsons&#039; disease</title>
			<atom:link href="https://biospectrumasia.com/news/34/2596/bms-to-develop-novel-therapies-for-parkinsons-disease.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2596/bms-to-develop-novel-therapies-for-parkinsons-disease.html</link>
			<pubDate>Tue, 25 Sep 2012 10:19:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-parkinson-s-patients-bristol-myers-squibb-collaborates-with-vanderbilt-university.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2596/bms-to-develop-novel-therapies-for-parkinsons-disease.html</guid>
		</item>	
				<item>
			<title>Patrys gets regulatory approval for Multiple Myeloma trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2665/patrys-gets-regulatory-approval-for-multiple-myeloma-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2665/patrys-gets-regulatory-approval-for-multiple-myeloma-trial.html</link>
			<pubDate>Thu, 20 Sep 2012 10:24:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/regulatory-nod-for-patrys-multiple-myeloma-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2665/patrys-gets-regulatory-approval-for-multiple-myeloma-trial.html</guid>
		</item>	
				<item>
			<title>10 top global pharma firms join hands for drug discovery</title>
			<atom:link href="https://biospectrumasia.com/news/34/2002/10-top-global-pharma-firms-join-hands-for-drug-discovery.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2002/10-top-global-pharma-firms-join-hands-for-drug-discovery.html</link>
			<pubDate>Thu, 20 Sep 2012 01:48:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaboration-hands-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2002/10-top-global-pharma-firms-join-hands-for-drug-discovery.html</guid>
		</item>	
				<item>
			<title>J&amp;J to open innovation centers in US, UK and China</title>
			<atom:link href="https://biospectrumasia.com/news/34/5341/jj-to-open-innovation-centers-in-us-uk-and-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5341/jj-to-open-innovation-centers-in-us-uk-and-china.html</link>
			<pubDate>Wed, 19 Sep 2012 09:10:05 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/innovation-center.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5341/jj-to-open-innovation-centers-in-us-uk-and-china.html</guid>
		</item>	
				<item>
			<title>FDA approval gives new hope to Multiple Sclerosis patients</title>
			<atom:link href="https://biospectrumasia.com/news/34/2886/fda-approval-gives-new-hope-to-multiple-sclerosis-patients.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2886/fda-approval-gives-new-hope-to-multiple-sclerosis-patients.html</link>
			<pubDate>Thu, 13 Sep 2012 12:01:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-multiple-sclerosis-patients-fda-approves-genzyme-s-aubagio.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2886/fda-approval-gives-new-hope-to-multiple-sclerosis-patients.html</guid>
		</item>	
				<item>
			<title>Panacea JV to yield generics revenue of $25 bn </title>
			<atom:link href="https://biospectrumasia.com/news/34/5388/panacea-jv-to-yield-generics-revenue-of-25-bn-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5388/panacea-jv-to-yield-generics-revenue-of-25-bn-.html</link>
			<pubDate>Wed, 12 Sep 2012 15:50:47 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/panacea-biotec-collaborates-with-osmatica-pharamaceutical-on-18-key-generic-projects.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5388/panacea-jv-to-yield-generics-revenue-of-25-bn-.html</guid>
		</item>	
				<item>
			<title>SFJ Pharma, Pfizer collaborate for dacomitinib trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2366/sfj-pharma-pfizer-collaborate-for-dacomitinib-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2366/sfj-pharma-pfizer-collaborate-for-dacomitinib-trial.html</link>
			<pubDate>Mon, 10 Sep 2012 11:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/files-drug-development.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2366/sfj-pharma-pfizer-collaborate-for-dacomitinib-trial.html</guid>
		</item>	
				<item>
			<title>AstraZeneca halts development of obesity drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/1917/astrazeneca-halts-development-of-obesity-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1917/astrazeneca-halts-development-of-obesity-drug-.html</link>
			<pubDate>Mon, 10 Sep 2012 11:06:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/astrazeneca-halts-collaborative-obesity-drug-development-with-palatin.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1917/astrazeneca-halts-development-of-obesity-drug-.html</guid>
		</item>	
				<item>
			<title>Boehringer, Swiss institute collaborate on diabetes and obesity research </title>
			<atom:link href="https://biospectrumasia.com/news/34/2557/boehringer-swiss-institute-collaborate-on-diabetes-and-obesity-research-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2557/boehringer-swiss-institute-collaborate-on-diabetes-and-obesity-research-.html</link>
			<pubDate>Fri, 07 Sep 2012 13:04:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-ingelheim-and-eth-zurich-join-hands-in-diabetes-and-obesity-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2557/boehringer-swiss-institute-collaborate-on-diabetes-and-obesity-research-.html</guid>
		</item>	
				<item>
			<title>Merck gets cancer drug license from Symphogen </title>
			<atom:link href="https://biospectrumasia.com/news/34/3524/merck-gets-cancer-drug-license-from-symphogen-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3524/merck-gets-cancer-drug-license-from-symphogen-.html</link>
			<pubDate>Thu, 06 Sep 2012 12:28:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-colorectal-cancer-merck-and-symphogen-sign-global-agreement-for-sym004.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3524/merck-gets-cancer-drug-license-from-symphogen-.html</guid>
		</item>	
				<item>
			<title>NZ firm to raise funds for Australia trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/813/nz-firm-to-raise-funds-for-australia-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/813/nz-firm-to-raise-funds-for-australia-trial.html</link>
			<pubDate>Thu, 06 Sep 2012 11:38:46 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/raise-funds-trial-innate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/813/nz-firm-to-raise-funds-for-australia-trial.html</guid>
		</item>	
				<item>
			<title>FDA end-of-phase II for head lice product </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3777/fda-end-of-phase-ii-for-head-lice-product-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3777/fda-end-of-phase-ii-for-head-lice-product-.html</link>
			<pubDate>Thu, 06 Sep 2012 11:37:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lice-no-more-hatchtech-s-head-lice-product-deovo-ends-phase-ii-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3777/fda-end-of-phase-ii-for-head-lice-product-.html</guid>
		</item>	
				<item>
			<title>Low R&amp;D output, patent cliffs drives big pharma nuts</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/1478/low-rd-output-patent-cliffs-drives-big-pharma-nuts.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/1478/low-rd-output-patent-cliffs-drives-big-pharma-nuts.html</link>
			<pubDate>Wed, 05 Sep 2012 11:13:39 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/increasing-r-d-expenditure-is-cause-of-concern-for-big-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/1478/low-rd-output-patent-cliffs-drives-big-pharma-nuts.html</guid>
		</item>	
				<item>
			<title>Strides subsidiary gets FDA nod for cancer drug </title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4762/strides-subsidiary-gets-fda-nod-for-cancer-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4762/strides-subsidiary-gets-fda-nod-for-cancer-drug-.html</link>
			<pubDate>Tue, 04 Sep 2012 14:32:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stride-subsidiary-s-cancer-drug-vinorelbine-to-be-launched-through-pfizer-following-us-fda-approval.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4762/strides-subsidiary-gets-fda-nod-for-cancer-drug-.html</guid>
		</item>	
				<item>
			<title>Janssen seeks approval for drug resistant TB drug in EU</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/7248/janssen-seeks-approval-for-drug-resistant-tb-drug-in-eu.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/7248/janssen-seeks-approval-for-drug-resistant-tb-drug-in-eu.html</link>
			<pubDate>Tue, 04 Sep 2012 14:14:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-mdr-tb-bedaquiline-by-janssen-cilag.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/7248/janssen-seeks-approval-for-drug-resistant-tb-drug-in-eu.html</guid>
		</item>	
				<item>
			<title>Ono ties up with BioFocus for drug research</title>
			<atom:link href="https://biospectrumasia.com/news/34/3778/ono-ties-up-with-biofocus-for-drug-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3778/ono-ties-up-with-biofocus-for-drug-research.html</link>
			<pubDate>Tue, 04 Sep 2012 10:28:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ono-biofocus-agreement.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3778/ono-ties-up-with-biofocus-for-drug-research.html</guid>
		</item>	
				<item>
			<title>Novartis announces positive results in COPD portfolio trials</title>
			<atom:link href="https://biospectrumasia.com/news/34/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html</link>
			<pubDate>Tue, 04 Sep 2012 10:14:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/copd-portfolio-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4177/novartis-announces-positive-results-in-copd-portfolio-trials.html</guid>
		</item>	
				<item>
			<title>Takeda to collaborate with BC Cancer Agency for new drugs</title>
			<atom:link href="https://biospectrumasia.com/news/34/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html</link>
			<pubDate>Mon, 03 Sep 2012 16:45:09 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/scientist-takeda-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4219/takeda-to-collaborate-with-bc-cancer-agency-for-new-drugs.html</guid>
		</item>	
				<item>
			<title>FDA red signal for Genzyme, Bayer multiple sclerosis drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2335/fda-red-signal-for-genzyme-bayer-multiple-sclerosis-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2335/fda-red-signal-for-genzyme-bayer-multiple-sclerosis-drug.html</link>
			<pubDate>Mon, 03 Sep 2012 11:23:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-gives-refuse-to-file-letter-to-genzyme-bayer-s-multiple-sclerosis-drug-lemtrada.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2335/fda-red-signal-for-genzyme-bayer-multiple-sclerosis-drug.html</guid>
		</item>	
				<item>
			<title>Eisai seeks approval for antiepileptic agent in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html</link>
			<pubDate>Fri, 31 Aug 2012 10:30:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eisai-anti-epileptic-pill.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4412/eisai-seeks-approval-for-antiepileptic-agent-in-japan.html</guid>
		</item>	
				<item>
			<title>Drug developed in New Zealand gets go ahead for trial</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3598/drug-developed-in-new-zealand-gets-go-ahead-for-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3598/drug-developed-in-new-zealand-gets-go-ahead-for-trial.html</link>
			<pubDate>Thu, 30 Aug 2012 17:17:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-apprval-clinical-trial-proacta.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3598/drug-developed-in-new-zealand-gets-go-ahead-for-trial.html</guid>
		</item>	
				<item>
			<title>FDA approves Gilead&#039;s Stribild</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/4240/fda-approves-gileads-stribild.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/4240/fda-approves-gileads-stribild.html</link>
			<pubDate>Tue, 28 Aug 2012 16:10:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/approval-fda-stribild.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/4240/fda-approves-gileads-stribild.html</guid>
		</item>	
				<item>
			<title>Eisai cancer drug gets orphan drug designation from Japan </title>
			<atom:link href="https://biospectrumasia.com/news/34/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html</link>
			<pubDate>Mon, 27 Aug 2012 12:01:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/japan-s-health-ministry-gives-orphan-drug-designation-to-eisai-s-lenvatinib.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3916/eisai-cancer-drug-gets-orphan-drug-designation-from-japan-.html</guid>
		</item>	
				<item>
			<title>Effient trial by Daiichi, Lilly fails to meet primary endpoint</title>
			<atom:link href="https://biospectrumasia.com/news/34/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html</link>
			<pubDate>Mon, 27 Aug 2012 10:53:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bigstock-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/690/effient-trial-by-daiichi-lilly-fails-to-meet-primary-endpoint.html</guid>
		</item>	
				<item>
			<title>CoDa Therapeutics raises $19.8 mn from Russian firm</title>
			<atom:link href="https://biospectrumasia.com/news/34/2929/coda-therapeutics-raises-19-8-mn-from-russian-firm.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2929/coda-therapeutics-raises-19-8-mn-from-russian-firm.html</link>
			<pubDate>Fri, 24 Aug 2012 16:02:30 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/funding-coda-therapeutics.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2929/coda-therapeutics-raises-19-8-mn-from-russian-firm.html</guid>
		</item>	
				<item>
			<title>BMS stops Hepatitis C inhibitor development</title>
			<atom:link href="https://biospectrumasia.com/news/34/2340/bms-stops-hepatitis-c-inhibitor-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2340/bms-stops-hepatitis-c-inhibitor-development.html</link>
			<pubDate>Fri, 24 Aug 2012 11:42:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stop-trial-bms.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2340/bms-stops-hepatitis-c-inhibitor-development.html</guid>
		</item>	
				<item>
			<title>All you need to know about Glivec</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2241/all-you-need-to-know-about-glivec.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2241/all-you-need-to-know-about-glivec.html</link>
			<pubDate>Mon, 01 Apr 2013 11:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/imatinib-mesylate-branded-by-novartis-as-gleevec-in-the-us-and-as-glivec-in-china-and-india.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2241/all-you-need-to-know-about-glivec.html</guid>
		</item>	
				<item>
			<title>Boehringer and Lilly get FDA nod for add-on insulin drug</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2181/boehringer-and-lilly-get-fda-nod-for-add-on-insulin-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2181/boehringer-and-lilly-get-fda-nod-for-add-on-insulin-drug.html</link>
			<pubDate>Mon, 20 Aug 2012 15:23:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-and-lilly-get-fda-nod.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2181/boehringer-and-lilly-get-fda-nod-for-add-on-insulin-drug.html</guid>
		</item>	
				<item>
			<title>Amgen terninates phase III cancer trial </title>
			<atom:link href="https://biospectrumasia.com/news/34/7869/amgen-terninates-phase-iii-cancer-trial-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7869/amgen-terninates-phase-iii-cancer-trial-.html</link>
			<pubDate>Thu, 09 Aug 2012 11:14:32 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/amgen-terminates-ganitumab-phase-iii-study-of-metastatic-pancreatic-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7869/amgen-terninates-phase-iii-cancer-trial-.html</guid>
		</item>	
				<item>
			<title>Aquavit, Green Cross sign MoU</title>
			<atom:link href="https://biospectrumasia.com/news/34/1156/aquavit-green-cross-sign-mou.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1156/aquavit-green-cross-sign-mou.html</link>
			<pubDate>Thu, 09 Aug 2012 10:23:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-green-cross-aquavit.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1156/aquavit-green-cross-sign-mou.html</guid>
		</item>	
				<item>
			<title>Lilly reveals phase III trial data on back pain</title>
			<atom:link href="https://biospectrumasia.com/news/34/936/lilly-reveals-phase-iii-trial-data-on-back-pain.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/936/lilly-reveals-phase-iii-trial-data-on-back-pain.html</link>
			<pubDate>Wed, 08 Aug 2012 12:49:52 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eli-lilly-phase-iii-trial-compares-effects-of-forteo-and-risedronate-on-back-pain.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/936/lilly-reveals-phase-iii-trial-data-on-back-pain.html</guid>
		</item>	
				<item>
			<title>J&amp;J, Pfizer halt phase III trial of Alzheimer&#039;s drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/6552/jj-pfizer-halt-phase-iii-trial-of-alzheimers-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6552/jj-pfizer-halt-phase-iii-trial-of-alzheimers-drug-.html</link>
			<pubDate>Tue, 07 Aug 2012 11:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hindrance-for-alzheimer-s-ph-iii-trial-of-bapineuzumab-stopped.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6552/jj-pfizer-halt-phase-iii-trial-of-alzheimers-drug-.html</guid>
		</item>	
				<item>
			<title>FDA approves ZALTRAP for colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3933/fda-approves-zaltrap-for-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3933/fda-approves-zaltrap-for-colorectal-cancer.html</link>
			<pubDate>Mon, 06 Aug 2012 10:29:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-gives-a-nod-to-zaltrap.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3933/fda-approves-zaltrap-for-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>Target for potent first-strike influenza drugs identified </title>
			<atom:link href="https://biospectrumasia.com/news/34/1534/target-for-potent-first-strike-influenza-drugs-identified-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1534/target-for-potent-first-strike-influenza-drugs-identified-.html</link>
			<pubDate>Fri, 03 Aug 2012 14:57:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/influenza-drugs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1534/target-for-potent-first-strike-influenza-drugs-identified-.html</guid>
		</item>	
				<item>
			<title>Mylan to produce generic of Gilead&#039;s HIV drug </title>
			<atom:link href="https://biospectrumasia.com/news/34/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html</link>
			<pubDate>Fri, 03 Aug 2012 10:55:10 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mylan-will-produce-generic-version-of-gilead-s-arv-emtriva.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1594/mylan-to-produce-generic-of-gileads-hiv-drug-.html</guid>
		</item>	
				<item>
			<title>Tachycardia holds room to grow: Report</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/4268/tachycardia-holds-room-to-grow-report.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/4268/tachycardia-holds-room-to-grow-report.html</link>
			<pubDate>Fri, 03 Aug 2012 10:14:49 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/heart-rate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/4268/tachycardia-holds-room-to-grow-report.html</guid>
		</item>	
				<item>
			<title>BMS halts Hep C drug administration</title>
			<atom:link href="https://biospectrumasia.com/news/34/2057/bms-halts-hep-c-drug-administration.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2057/bms-halts-hep-c-drug-administration.html</link>
			<pubDate>Thu, 02 Aug 2012 10:30:44 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bms-clinical-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2057/bms-halts-hep-c-drug-administration.html</guid>
		</item>	
				<item>
			<title>One drug for three diseases</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/1886/one-drug-for-three-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/1886/one-drug-for-three-diseases.html</link>
			<pubDate>Wed, 01 Aug 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/one-drug-three-uses.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/1886/one-drug-for-three-diseases.html</guid>
		</item>	
				<item>
			<title>Takeda resubmits NDA to the US FDA for alogliptin</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html</link>
			<pubDate>Mon, 30 Jul 2012 11:30:38 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-receives-resubmissions-of-alogliptin-ndas.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3677/takeda-resubmits-nda-to-the-us-fda-for-alogliptin.html</guid>
		</item>	
				<item>
			<title>New TB cocktail drug holds great promise</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3977/new-tb-cocktail-drug-holds-great-promise.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3977/new-tb-cocktail-drug-holds-great-promise.html</link>
			<pubDate>Fri, 27 Jul 2012 10:24:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cocktail-tb-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3977/new-tb-cocktail-drug-holds-great-promise.html</guid>
		</item>	
				<item>
			<title>Eisai publishes phase III results of anti-seizure drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html</link>
			<pubDate>Thu, 26 Jul 2012 14:43:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/hope-for-seizure-patients-eisai-reports-phase-iii-results-of-perampanel.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7495/eisai-publishes-phase-iii-results-of-anti-seizure-drug.html</guid>
		</item>	
				<item>
			<title>Advinus collaborates with P2D Bioscience for ADHD</title>
			<atom:link href="https://biospectrumasia.com/news/34/2260/advinus-collaborates-with-p2d-bioscience-for-adhd.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2260/advinus-collaborates-with-p2d-bioscience-for-adhd.html</link>
			<pubDate>Wed, 25 Jul 2012 11:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/collaborate-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2260/advinus-collaborates-with-p2d-bioscience-for-adhd.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim enriches drug pipeline</title>
			<atom:link href="https://biospectrumasia.com/news/34/382/boehringer-ingelheim-enriches-drug-pipeline.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/382/boehringer-ingelheim-enriches-drug-pipeline.html</link>
			<pubDate>Tue, 24 Jul 2012 16:07:22 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-candidate-acquired.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/382/boehringer-ingelheim-enriches-drug-pipeline.html</guid>
		</item>	
				<item>
			<title>Kowa Pharma and Eli Lilly release PK study result  </title>
			<atom:link href="https://biospectrumasia.com/news/34/7978/kowa-pharma-and-eli-lilly-release-pk-study-result-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7978/kowa-pharma-and-eli-lilly-release-pk-study-result-.html</link>
			<pubDate>Mon, 23 Jul 2012 11:12:54 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/pharmacokinetic-study-co-administration-of-livalo-and-prezista-norvir-doesnt-cause-any-change-in-blood.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7978/kowa-pharma-and-eli-lilly-release-pk-study-result-.html</guid>
		</item>	
				<item>
			<title>BioDiem gets positive results for eye disease drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/1868/biodiem-gets-positive-results-for-eye-disease-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1868/biodiem-gets-positive-results-for-eye-disease-drug.html</link>
			<pubDate>Mon, 23 Jul 2012 10:10:57 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1868/biodiem-gets-positive-results-for-eye-disease-drug.html</guid>
		</item>	
				<item>
			<title>Korea Drug Development Fund collaborates with PAREXEL </title>
			<atom:link href="https://biospectrumasia.com/news/34/4174/korea-drug-development-fund-collaborates-with-parexel-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4174/korea-drug-development-fund-collaborates-with-parexel-.html</link>
			<pubDate>Fri, 20 Jul 2012 11:08:23 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/parexel-becomes-first-cro-to-form-alliance-with-the-korea-drug-development-fund-kddf.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4174/korea-drug-development-fund-collaborates-with-parexel-.html</guid>
		</item>	
				<item>
			<title>Researchers working on new drug for Lupus</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2582/researchers-working-on-new-drug-for-lupus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2582/researchers-working-on-new-drug-for-lupus.html</link>
			<pubDate>Fri, 20 Jul 2012 10:35:16 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupus-drug-research.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2582/researchers-working-on-new-drug-for-lupus.html</guid>
		</item>	
				<item>
			<title>Novo Nordisk announces trial data of NovoMix 30</title>
			<atom:link href="https://biospectrumasia.com/news/34/3698/novo-nordisk-announces-trial-data-of-novomix-30.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3698/novo-nordisk-announces-trial-data-of-novomix-30.html</link>
			<pubDate>Thu, 19 Jul 2012 15:12:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/novomix30-study.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3698/novo-nordisk-announces-trial-data-of-novomix-30.html</guid>
		</item>	
				<item>
			<title>China develops revolutionary TCM migraine medication</title>
			<atom:link href="https://biospectrumasia.com/news/34/1398/china-develops-revolutionary-tcm-migraine-medication.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1398/china-develops-revolutionary-tcm-migraine-medication.html</link>
			<pubDate>Wed, 18 Jul 2012 12:03:56 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/revolutionary-cure-for-migraine-using-traditional-chinese-medicine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1398/china-develops-revolutionary-tcm-migraine-medication.html</guid>
		</item>	
				<item>
			<title>Ampio takes drug candidate to preclinical stage</title>
			<atom:link href="https://biospectrumasia.com/news/34/6201/ampio-takes-drug-candidate-to-preclinical-stage.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6201/ampio-takes-drug-candidate-to-preclinical-stage.html</link>
			<pubDate>Mon, 16 Jul 2012 15:07:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/preclinical-research-syngene-ampio.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6201/ampio-takes-drug-candidate-to-preclinical-stage.html</guid>
		</item>	
				<item>
			<title>Chugai expands in Singapore with research institute</title>
			<atom:link href="https://biospectrumasia.com/news/34/1438/chugai-expands-in-singapore-with-research-institute.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1438/chugai-expands-in-singapore-with-research-institute.html</link>
			<pubDate>Mon, 16 Jul 2012 10:05:17 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chugai-research-institute.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1438/chugai-expands-in-singapore-with-research-institute.html</guid>
		</item>	
				<item>
			<title>Verastem acquires FAK inhibitor from Pfizer</title>
			<atom:link href="https://biospectrumasia.com/news/34/5588/verastem-acquires-fak-inhibitor-from-pfizer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5588/verastem-acquires-fak-inhibitor-from-pfizer.html</link>
			<pubDate>Thu, 12 Jul 2012 09:58:34 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/verastem-pfizer-acquisition-fak.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5588/verastem-acquires-fak-inhibitor-from-pfizer.html</guid>
		</item>	
				<item>
			<title>Customized treatments to dominate oncology therapy</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3471/customized-treatments-to-dominate-oncology-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3471/customized-treatments-to-dominate-oncology-therapy.html</link>
			<pubDate>Wed, 11 Jul 2012 10:43:12 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-therapy-personalized.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3471/customized-treatments-to-dominate-oncology-therapy.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim collaborates with Harvard University </title>
			<atom:link href="https://biospectrumasia.com/news/34/6665/boehringer-ingelheim-collaborates-with-harvard-university-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6665/boehringer-ingelheim-collaborates-with-harvard-university-.html</link>
			<pubDate>Tue, 10 Jul 2012 10:42:41 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/boehringer-ingelheim-research-collaboration.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6665/boehringer-ingelheim-collaborates-with-harvard-university-.html</guid>
		</item>	
				<item>
			<title>Eisai reveals phase III results of breast cancer drug Halaven </title>
			<atom:link href="https://biospectrumasia.com/news/34/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html</link>
			<pubDate>Tue, 10 Jul 2012 07:07:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/new-hope-for-breast-cancer-phase-iii-results-of-halaven-revealed.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3106/eisai-reveals-phase-iii-results-of-breast-cancer-drug-halaven-.html</guid>
		</item>	
				<item>
			<title>Bayer initiates trial of new rFVIII to treat hemophilia A</title>
			<atom:link href="https://biospectrumasia.com/news/34/782/bayer-initiates-trial-of-new-rfviii-to-treat-hemophilia-a.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/782/bayer-initiates-trial-of-new-rfviii-to-treat-hemophilia-a.html</link>
			<pubDate>Mon, 09 Jul 2012 08:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bayer-enrolling-for-hemophilia-trial-protect-viii.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/782/bayer-initiates-trial-of-new-rfviii-to-treat-hemophilia-a.html</guid>
		</item>	
				<item>
			<title>Report on strategies to manage patent protection loss</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3922/report-on-strategies-to-manage-patent-protection-loss.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3922/report-on-strategies-to-manage-patent-protection-loss.html</link>
			<pubDate>Fri, 06 Jul 2012 10:20:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent-loss-protection.JPG" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3922/report-on-strategies-to-manage-patent-protection-loss.html</guid>
		</item>	
				<item>
			<title>Boehringer Ingelheim appoints board member</title>
			<atom:link href="https://biospectrumasia.com/news/34/1413/boehringer-ingelheim-appoints-board-member.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1413/boehringer-ingelheim-appoints-board-member.html</link>
			<pubDate>Fri, 06 Jul 2012 10:11:53 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-joachim-hasenmaier-boehringer-ingelheim-gmbh.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1413/boehringer-ingelheim-appoints-board-member.html</guid>
		</item>	
				<item>
			<title>Shionogi launches London headquarter</title>
			<atom:link href="https://biospectrumasia.com/news/34/1011/shionogi-launches-london-headquarter.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1011/shionogi-launches-london-headquarter.html</link>
			<pubDate>Fri, 06 Jul 2012 10:03:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shionogi.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1011/shionogi-launches-london-headquarter.html</guid>
		</item>	
				<item>
			<title>Asia witnessing rise in COPD, says Dr David Price</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/5538/asia-witnessing-rise-in-copd-says-dr-david-price.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/5538/asia-witnessing-rise-in-copd-says-dr-david-price.html</link>
			<pubDate>Fri, 06 Jul 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prof-david-price.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/5538/asia-witnessing-rise-in-copd-says-dr-david-price.html</guid>
		</item>	
				<item>
			<title>Cancer Therapeutics reveals new targeted drug</title>
			<atom:link href="https://biospectrumasia.com/news/34/2753/cancer-therapeutics-reveals-new-targeted-drug.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2753/cancer-therapeutics-reveals-new-targeted-drug.html</link>
			<pubDate>Thu, 05 Jul 2012 10:25:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2753/cancer-therapeutics-reveals-new-targeted-drug.html</guid>
		</item>	
				<item>
			<title>Stem cell therapy effective in liver cirrhosis</title>
			<atom:link href="https://biospectrumasia.com/news/34/2571/stem-cell-therapy-effective-in-liver-cirrhosis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2571/stem-cell-therapy-effective-in-liver-cirrhosis.html</link>
			<pubDate>Wed, 04 Jul 2012 09:52:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/stem-cell-therapy-effective-in-liver-cirrhosis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2571/stem-cell-therapy-effective-in-liver-cirrhosis.html</guid>
		</item>	
				<item>
			<title>Cellworks, AstraZeneca join hands for TB research</title>
			<atom:link href="https://biospectrumasia.com/news/34/7419/cellworks-astrazeneca-join-hands-for-tb-research.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7419/cellworks-astrazeneca-join-hands-for-tb-research.html</link>
			<pubDate>Tue, 03 Jul 2012 10:54:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/tb-research-tie-up.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7419/cellworks-astrazeneca-join-hands-for-tb-research.html</guid>
		</item>	
				<item>
			<title>Trajenta shows blood glucose improvements</title>
			<atom:link href="https://biospectrumasia.com/news/34/1902/trajenta-shows-blood-glucose-improvements.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1902/trajenta-shows-blood-glucose-improvements.html</link>
			<pubDate>Mon, 02 Jul 2012 11:02:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/trajenta-study.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1902/trajenta-shows-blood-glucose-improvements.html</guid>
		</item>	
				<item>
			<title>Eisai, Toyama get marketing approval for iguratimod</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html</link>
			<pubDate>Mon, 02 Jul 2012 10:36:40 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/rheumatoid-arthritis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2036/eisai-toyama-get-marketing-approval-for-iguratimod.html</guid>
		</item>	
				<item>
			<title>Mitsubishi Tanabe to manufacture diabetes drug Tenelia</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html</link>
			<pubDate>Mon, 02 Jul 2012 10:07:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/mitusubishi-tanabe-approval-diabetes-drug.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/8186/mitsubishi-tanabe-to-manufacture-diabetes-drug-tenelia.html</guid>
		</item>	
				<item>
			<title>Pharma majors join hands to find new cure for TB</title>
			<atom:link href="https://biospectrumasia.com/news/34/1464/pharma-majors-join-hands-to-find-new-cure-for-tb.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1464/pharma-majors-join-hands-to-find-new-cure-for-tb.html</link>
			<pubDate>Fri, 29 Jun 2012 13:14:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/big-pharma-join-hands.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1464/pharma-majors-join-hands-to-find-new-cure-for-tb.html</guid>
		</item>	
				<item>
			<title>FDA issues complete response letter for XARELTO</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/3174/fda-issues-complete-response-letter-for-xarelto.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/3174/fda-issues-complete-response-letter-for-xarelto.html</link>
			<pubDate>Fri, 22 Jun 2012 10:28:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/3174/fda-issues-complete-response-letter-for-xarelto.html</guid>
		</item>	
				<item>
			<title>Pfizer gets FDA nod for tafamidis meglumine</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/5773/pfizer-gets-fda-nod-for-tafamidis-meglumine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/5773/pfizer-gets-fda-nod-for-tafamidis-meglumine.html</link>
			<pubDate>Wed, 20 Jun 2012 09:44:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-nod-pfizer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/5773/pfizer-gets-fda-nod-for-tafamidis-meglumine.html</guid>
		</item>	
				<item>
			<title>Lupin aims high with a strong R&amp;D focus</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/3169/lupin-aims-high-with-a-strong-rd-focus.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/3169/lupin-aims-high-with-a-strong-rd-focus.html</link>
			<pubDate>Mon, 18 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/lupin-graph.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/3169/lupin-aims-high-with-a-strong-rd-focus.html</guid>
		</item>	
				<item>
			<title>Bionomics, Merck Serono end agreement</title>
			<atom:link href="https://biospectrumasia.com/news/34/953/bionomics-merck-serono-end-agreement.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/953/bionomics-merck-serono-end-agreement.html</link>
			<pubDate>Fri, 15 Jun 2012 12:11:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-end-bionomics-merck.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/953/bionomics-merck-serono-end-agreement.html</guid>
		</item>	
				<item>
			<title>FDA approves GSK meningococcal vaccine</title>
			<atom:link href="https://biospectrumasia.com/news/34/2611/fda-approves-gsk-meningococcal-vaccine.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2611/fda-approves-gsk-meningococcal-vaccine.html</link>
			<pubDate>Fri, 15 Jun 2012 10:06:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-gsk-vaccine.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2611/fda-approves-gsk-meningococcal-vaccine.html</guid>
		</item>	
				<item>
			<title>Australia ideal for early-stage drug development</title>
			<atom:link href="https://biospectrumasia.com/opinion/34/1355/australia-ideal-for-early-stage-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/opinion/34/1355/australia-ideal-for-early-stage-drug-development.html</link>
			<pubDate>Thu, 14 Jun 2012 12:15:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/australia-drug-development.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/opinion/34/1355/australia-ideal-for-early-stage-drug-development.html</guid>
		</item>	
				<item>
			<title>BHR expands brain injury treatment trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2444/bhr-expands-brain-injury-treatment-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2444/bhr-expands-brain-injury-treatment-trial.html</link>
			<pubDate>Wed, 13 Jun 2012 11:01:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/traumatic-brain-injury-trials-to-be-held-in-thailand-china-and-russia.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2444/bhr-expands-brain-injury-treatment-trial.html</guid>
		</item>	
				<item>
			<title>Ranbaxy redesigns strategy to meet regulations</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html</link>
			<pubDate>Tue, 12 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/ranbaxy-laboratories-graph-7.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/5380/ranbaxy-redesigns-strategy-to-meet-regulations.html</guid>
		</item>	
				<item>
			<title>Boehringer, Eli Lilly reveal post-hoc results for linagliptin</title>
			<atom:link href="https://biospectrumasia.com/news/34/1178/boehringer-eli-lilly-reveal-post-hoc-results-for-linagliptin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1178/boehringer-eli-lilly-reveal-post-hoc-results-for-linagliptin.html</link>
			<pubDate>Mon, 11 Jun 2012 13:29:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/the-results-are-out-boehringer-and-eli-lilly-linagliptin-analysis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1178/boehringer-eli-lilly-reveal-post-hoc-results-for-linagliptin.html</guid>
		</item>	
				<item>
			<title>Sanofi seeks approval for Lyxumia in Japan</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html</link>
			<pubDate>Mon, 11 Jun 2012 13:14:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/1777/sanofi-seeks-approval-for-lyxumia-in-japan.html</guid>
		</item>	
				<item>
			<title>CSL hemophilia therapy gets orphan drug status</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/309/csl-hemophilia-therapy-gets-orphan-drug-status.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/309/csl-hemophilia-therapy-gets-orphan-drug-status.html</link>
			<pubDate>Mon, 11 Jun 2012 12:49:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/csl-hemophilia-therapy-gets-orphan-drug-status.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/309/csl-hemophilia-therapy-gets-orphan-drug-status.html</guid>
		</item>	
				<item>
			<title>HUYA, Sanzao Park partner for drug development</title>
			<atom:link href="https://biospectrumasia.com/news/34/1329/huya-sanzao-park-partner-for-drug-development.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1329/huya-sanzao-park-partner-for-drug-development.html</link>
			<pubDate>Mon, 11 Jun 2012 12:24:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/partner-huya-sanzao-park.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1329/huya-sanzao-park-partner-for-drug-development.html</guid>
		</item>	
				<item>
			<title>Mesoblast to develop neuro diseases therapies</title>
			<atom:link href="https://biospectrumasia.com/news/34/2061/mesoblast-to-develop-neuro-diseases-therapies.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2061/mesoblast-to-develop-neuro-diseases-therapies.html</link>
			<pubDate>Mon, 11 Jun 2012 10:20:48 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2061/mesoblast-to-develop-neuro-diseases-therapies.html</guid>
		</item>	
				<item>
			<title>Pharmaxis to launch cystic fibrosis drug in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/3082/pharmaxis-to-launch-cystic-fibrosis-drug-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3082/pharmaxis-to-launch-cystic-fibrosis-drug-in-europe.html</link>
			<pubDate>Mon, 11 Jun 2012 10:12:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bronchitol-pharmaxis-cystic-fibrosis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3082/pharmaxis-to-launch-cystic-fibrosis-drug-in-europe.html</guid>
		</item>	
				<item>
			<title>FDA approves Perjeta for metastatic breast cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/5893/fda-approves-perjeta-for-metastatic-breast-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5893/fda-approves-perjeta-for-metastatic-breast-cancer.html</link>
			<pubDate>Mon, 11 Jun 2012 10:03:08 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-approval-genentech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5893/fda-approves-perjeta-for-metastatic-breast-cancer.html</guid>
		</item>	
				<item>
			<title>Openvas by Daiichi Sankyo launched in Mexico</title>
			<atom:link href="https://biospectrumasia.com/news/34/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html</link>
			<pubDate>Mon, 11 Jun 2012 09:55:25 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3330/openvas-by-daiichi-sankyo-launched-in-mexico.html</guid>
		</item>	
				<item>
			<title>Researchers find new link to study brain tumor </title>
			<atom:link href="https://biospectrumasia.com/news/34/2105/researchers-find-new-link-to-study-brain-tumor-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2105/researchers-find-new-link-to-study-brain-tumor-.html</link>
			<pubDate>Fri, 08 Jun 2012 10:17:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/brain-tumor.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2105/researchers-find-new-link-to-study-brain-tumor-.html</guid>
		</item>	
				<item>
			<title>Positive results for Otsuka&#039;s MDR-TB treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/7836/positive-results-for-otsukas-mdr-tb-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7836/positive-results-for-otsukas-mdr-tb-treatment.html</link>
			<pubDate>Thu, 07 Jun 2012 13:09:31 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-otsuka.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7836/positive-results-for-otsukas-mdr-tb-treatment.html</guid>
		</item>	
				<item>
			<title>FDA affirms superiority of Pradaxa over warfarin</title>
			<atom:link href="https://biospectrumasia.com/news/34/715/fda-affirms-superiority-of-pradaxa-over-warfarin.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/715/fda-affirms-superiority-of-pradaxa-over-warfarin.html</link>
			<pubDate>Thu, 07 Jun 2012 10:17:21 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/fda-pradaxa-warfarin.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/715/fda-affirms-superiority-of-pradaxa-over-warfarin.html</guid>
		</item>	
				<item>
			<title>Phase III data: STELARA reduces active psoriatic arthritis</title>
			<atom:link href="https://biospectrumasia.com/news/34/2697/phase-iii-data-stelara-reduces-active-psoriatic-arthritis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2697/phase-iii-data-stelara-reduces-active-psoriatic-arthritis.html</link>
			<pubDate>Wed, 06 Jun 2012 13:15:19 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/centocor-stelara-improves-conditions-of-patients-with-active-psoriatic-arthritis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2697/phase-iii-data-stelara-reduces-active-psoriatic-arthritis.html</guid>
		</item>	
				<item>
			<title>Abbott reveals 10-year study data for HUMIRA</title>
			<atom:link href="https://biospectrumasia.com/news/34/1976/abbott-reveals-10-year-study-data-for-humira.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1976/abbott-reveals-10-year-study-data-for-humira.html</link>
			<pubDate>Wed, 06 Jun 2012 13:01:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/abbott-s-humira-hope-for-rheumatoid-arthritis.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1976/abbott-reveals-10-year-study-data-for-humira.html</guid>
		</item>	
				<item>
			<title>Astellas, Ambit Biosciences begin quizartinib trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html</link>
			<pubDate>Wed, 06 Jun 2012 11:45:11 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/blood-cells1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/2438/astellas-ambit-biosciences-begin-quizartinib-trial.html</guid>
		</item>	
				<item>
			<title>Millennium announces positive results of orteronel study</title>
			<atom:link href="https://biospectrumasia.com/news/34/3773/millennium-announces-positive-results-of-orteronel-study.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3773/millennium-announces-positive-results-of-orteronel-study.html</link>
			<pubDate>Wed, 06 Jun 2012 09:55:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3773/millennium-announces-positive-results-of-orteronel-study.html</guid>
		</item>	
				<item>
			<title>ShangPharma celebrates 10 years with Eli Lilly</title>
			<atom:link href="https://biospectrumasia.com/news/34/1033/shangpharma-celebrates-10-years-with-eli-lilly.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1033/shangpharma-celebrates-10-years-with-eli-lilly.html</link>
			<pubDate>Tue, 05 Jun 2012 14:38:58 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shangpharma-eli-lilly.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1033/shangpharma-celebrates-10-years-with-eli-lilly.html</guid>
		</item>	
				<item>
			<title>Positive result for Genentech in breast cancer trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/4096/positive-result-for-genentech-in-breast-cancer-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4096/positive-result-for-genentech-in-breast-cancer-trial.html</link>
			<pubDate>Tue, 05 Jun 2012 10:04:45 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/breast-cancer-trial-genentech.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4096/positive-result-for-genentech-in-breast-cancer-trial.html</guid>
		</item>	
				<item>
			<title>Phylogica achieves research milestone</title>
			<atom:link href="https://biospectrumasia.com/news/34/3673/phylogica-achieves-research-milestone.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3673/phylogica-achieves-research-milestone.html</link>
			<pubDate>Tue, 05 Jun 2012 09:54:59 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/research-agreement-milestone.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3673/phylogica-achieves-research-milestone.html</guid>
		</item>	
				<item>
			<title>Afatinib proves efficacy in lung cancer treatment</title>
			<atom:link href="https://biospectrumasia.com/news/34/3337/afatinib-proves-efficacy-in-lung-cancer-treatment.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3337/afatinib-proves-efficacy-in-lung-cancer-treatment.html</link>
			<pubDate>Tue, 05 Jun 2012 09:50:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/positive-result-trial.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3337/afatinib-proves-efficacy-in-lung-cancer-treatment.html</guid>
		</item>	
				<item>
			<title>Diabetes drug Actos doubles risk of bladder cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/1773/diabetes-drug-actos-doubles-risk-of-bladder-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1773/diabetes-drug-actos-doubles-risk-of-bladder-cancer.html</link>
			<pubDate>Mon, 04 Jun 2012 14:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/actos-increases-risk-of-bladder-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1773/diabetes-drug-actos-doubles-risk-of-bladder-cancer.html</guid>
		</item>	
				<item>
			<title>Daiichi Sankyo reports positive results for tivantinib</title>
			<atom:link href="https://biospectrumasia.com/news/34/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html</link>
			<pubDate>Mon, 04 Jun 2012 11:27:26 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/clinical-trial-tivantinib1.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3534/daiichi-sankyo-reports-positive-results-for-tivantinib.html</guid>
		</item>	
				<item>
			<title>Former Pfizer executive joins Agenix</title>
			<atom:link href="https://biospectrumasia.com/news/34/4109/former-pfizer-executive-joins-agenix.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4109/former-pfizer-executive-joins-agenix.html</link>
			<pubDate>Mon, 04 Jun 2012 11:16:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/appointment-agenix.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4109/former-pfizer-executive-joins-agenix.html</guid>
		</item>	
				<item>
			<title>Eli Lilly and Kowa Pharma report positive results of PREVAIL study </title>
			<atom:link href="https://biospectrumasia.com/news/34/4785/eli-lilly-and-kowa-pharma-report-positive-results-of-prevail-study-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4785/eli-lilly-and-kowa-pharma-report-positive-results-of-prevail-study-.html</link>
			<pubDate>Fri, 01 Jun 2012 18:02:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/prevail-us-study-compares-effect-of-pitavastatin-with-pravastatin-in-lowering-ldl-c.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4785/eli-lilly-and-kowa-pharma-report-positive-results-of-prevail-study-.html</guid>
		</item>	
				<item>
			<title>BNC105 effective in treating cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/4238/bnc105-effective-in-treating-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4238/bnc105-effective-in-treating-cancer.html</link>
			<pubDate>Fri, 01 Jun 2012 10:39:27 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/bnc105-effective-in-treating-renal-and-mesothelioma-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4238/bnc105-effective-in-treating-cancer.html</guid>
		</item>	
				<item>
			<title>Big pharma yet to warm up to drug resistance</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/2757/big-pharma-yet-to-warm-up-to-drug-resistance.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/2757/big-pharma-yet-to-warm-up-to-drug-resistance.html</link>
			<pubDate>Fri, 01 Jun 2012 10:06:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/e-coli-bacteria.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/2757/big-pharma-yet-to-warm-up-to-drug-resistance.html</guid>
		</item>	
				<item>
			<title>CSL files marketing plea for Privigen in Europe</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/8273/csl-files-marketing-plea-for-privigen-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/8273/csl-files-marketing-plea-for-privigen-in-europe.html</link>
			<pubDate>Fri, 01 Jun 2012 09:45:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/market-authorization-europe.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/8273/csl-files-marketing-plea-for-privigen-in-europe.html</guid>
		</item>	
				<item>
			<title>Eli Lilly opens diabetes R&amp;D center in China</title>
			<atom:link href="https://biospectrumasia.com/news/34/5537/eli-lilly-opens-diabetes-rd-center-in-china.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/5537/eli-lilly-opens-diabetes-rd-center-in-china.html</link>
			<pubDate>Fri, 01 Jun 2012 07:30:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/eli-lilly-research-center-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/5537/eli-lilly-opens-diabetes-rd-center-in-china.html</guid>
		</item>	
				<item>
			<title>Taiho to start ph III trial in colorectal cancer</title>
			<atom:link href="https://biospectrumasia.com/news/34/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html</link>
			<pubDate>Thu, 31 May 2012 12:17:04 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/cancer-cell-taiho.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1475/taiho-to-start-ph-iii-trial-in-colorectal-cancer.html</guid>
		</item>	
				<item>
			<title>FDA issues complete response letter for PREZISTA</title>
			<atom:link href="https://biospectrumasia.com/news/34/1465/fda-issues-complete-response-letter-for-prezista.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1465/fda-issues-complete-response-letter-for-prezista.html</link>
			<pubDate>Thu, 31 May 2012 11:44:55 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1465/fda-issues-complete-response-letter-for-prezista.html</guid>
		</item>	
				<item>
			<title>CSL files biologics license plea with FDA</title>
			<atom:link href="https://biospectrumasia.com/regulatory/34/2318/csl-files-biologics-license-plea-with-fda.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/regulatory/34/2318/csl-files-biologics-license-plea-with-fda.html</link>
			<pubDate>Wed, 30 May 2012 09:53:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/regulatory/34/2318/csl-files-biologics-license-plea-with-fda.html</guid>
		</item>	
				<item>
			<title>Bioxyne to report COPD trial results in June </title>
			<atom:link href="https://biospectrumasia.com/news/34/3034/bioxyne-to-report-copd-trial-results-in-june-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3034/bioxyne-to-report-copd-trial-results-in-june-.html</link>
			<pubDate>Tue, 29 May 2012 10:31:37 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/results-announced-bioxyne-copd-trials.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3034/bioxyne-to-report-copd-trial-results-in-june-.html</guid>
		</item>	
				<item>
			<title>China SFDA passes Sihuan Pharma&#039;s Roxatidine </title>
			<atom:link href="https://biospectrumasia.com/news/34/7920/china-sfda-passes-sihuan-pharmas-roxatidine-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/7920/china-sfda-passes-sihuan-pharmas-roxatidine-.html</link>
			<pubDate>Mon, 28 May 2012 12:00:07 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/sihuan-pharma.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/7920/china-sfda-passes-sihuan-pharmas-roxatidine-.html</guid>
		</item>	
				<item>
			<title>Eisai receives positive opinion on epilepsy treatments in Europe</title>
			<atom:link href="https://biospectrumasia.com/news/34/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html</link>
			<pubDate>Mon, 28 May 2012 10:25:33 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/chmp-opinion.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4067/eisai-receives-positive-opinion-on-epilepsy-treatments-in-europe.html</guid>
		</item>	
				<item>
			<title>MicuRx next gen antibiotic gets US patent</title>
			<atom:link href="https://biospectrumasia.com/news/34/3026/micurx-next-gen-antibiotic-gets-us-patent.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3026/micurx-next-gen-antibiotic-gets-us-patent.html</link>
			<pubDate>Thu, 24 May 2012 10:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/patent.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3026/micurx-next-gen-antibiotic-gets-us-patent.html</guid>
		</item>	
				<item>
			<title>Gout therapeutics market clocks $988.7 mn in 2011</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/8386/gout-therapeutics-market-clocks-988-7-mn-in-2011.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/8386/gout-therapeutics-market-clocks-988-7-mn-in-2011.html</link>
			<pubDate>Wed, 23 May 2012 11:38:50 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/gout-hands.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/8386/gout-therapeutics-market-clocks-988-7-mn-in-2011.html</guid>
		</item>	
				<item>
			<title>Xiangxue Pharma acquires rights for Kinex KX02</title>
			<atom:link href="https://biospectrumasia.com/news/34/958/xiangxue-pharma-acquires-rights-for-kinex-kx02.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/958/xiangxue-pharma-acquires-rights-for-kinex-kx02.html</link>
			<pubDate>Tue, 22 May 2012 10:38:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kinex-and-xiangxue-enter-into-a-deal-for-kx02-cancer-drug-candidate.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/958/xiangxue-pharma-acquires-rights-for-kinex-kx02.html</guid>
		</item>	
				<item>
			<title>Agilent LC/MS for &#039;dried blood-spot analysis&#039;</title>
			<atom:link href="https://biospectrumasia.com/news/34/3615/agilent-lc-ms-for-dried-blood-spot-analysis.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/3615/agilent-lc-ms-for-dried-blood-spot-analysis.html</link>
			<pubDate>Tue, 22 May 2012 09:26:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agilentlsca-212-dbs.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/3615/agilent-lc-ms-for-dried-blood-spot-analysis.html</guid>
		</item>	
				<item>
			<title>ASLAN announces global license agreement with Almirall</title>
			<atom:link href="https://biospectrumasia.com/news/34/4353/aslan-announces-global-license-agreement-with-almirall.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4353/aslan-announces-global-license-agreement-with-almirall.html</link>
			<pubDate>Mon, 21 May 2012 10:36:24 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/agreement-aslan.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4353/aslan-announces-global-license-agreement-with-almirall.html</guid>
		</item>	
				<item>
			<title>Tivozanib shows superiority over sorafenib in trial</title>
			<atom:link href="https://biospectrumasia.com/news/34/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html</link>
			<pubDate>Fri, 18 May 2012 12:20:15 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/kidney-cancer.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/8465/tivozanib-shows-superiority-over-sorafenib-in-trial.html</guid>
		</item>	
				<item>
			<title>Novartis, BIOTEC tie-up to explore Thailand&#039;s biodiversity</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/7127/novartis-biotec-tie-up-to-explore-thailands-biodiversity.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/7127/novartis-biotec-tie-up-to-explore-thailands-biodiversity.html</link>
			<pubDate>Thu, 17 May 2012 09:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/drug-discovery-partnership.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/7127/novartis-biotec-tie-up-to-explore-thailands-biodiversity.html</guid>
		</item>	
				<item>
			<title>Drug delivery: 11 technologies of the future</title>
			<atom:link href="https://biospectrumasia.com/news/34/6332/drug-delivery-11-technologies-of-the-future.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/6332/drug-delivery-11-technologies-of-the-future.html</link>
			<pubDate>Wed, 16 May 2012 14:05:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/autoinjectors.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/6332/drug-delivery-11-technologies-of-the-future.html</guid>
		</item>	
				<item>
			<title>MNCs bet on China to tide over patent cliff</title>
			<atom:link href="https://biospectrumasia.com/analysis/34/1583/mncs-bet-on-china-to-tide-over-patent-cliff.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/analysis/34/1583/mncs-bet-on-china-to-tide-over-patent-cliff.html</link>
			<pubDate>Wed, 16 May 2012 09:59:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/shanghai-people-square-china.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/analysis/34/1583/mncs-bet-on-china-to-tide-over-patent-cliff.html</guid>
		</item>	
				<item>
			<title>Phylogica looks for tie-ups in Asia: COO Nick Woolf</title>
			<atom:link href="https://biospectrumasia.com/influencers/34/3781/phylogica-looks-for-tie-ups-in-asia-coo-nick-woolf.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/influencers/34/3781/phylogica-looks-for-tie-ups-in-asia-coo-nick-woolf.html</link>
			<pubDate>Tue, 15 May 2012 10:33:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/nick-woolf.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/influencers/34/3781/phylogica-looks-for-tie-ups-in-asia-coo-nick-woolf.html</guid>
		</item>	
				<item>
			<title>Takeda Gemini II trial shows positive results</title>
			<atom:link href="https://biospectrumasia.com/news/34/1266/takeda-gemini-ii-trial-shows-positive-results.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/1266/takeda-gemini-ii-trial-shows-positive-results.html</link>
			<pubDate>Mon, 14 May 2012 10:35:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/1266/takeda-gemini-ii-trial-shows-positive-results.html</guid>
		</item>	
				<item>
			<title>Biodiem gets US patent allowance for antifungal therapy</title>
			<atom:link href="https://biospectrumasia.com/news/34/129/biodiem-gets-us-patent-allowance-for-antifungal-therapy.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/129/biodiem-gets-us-patent-allowance-for-antifungal-therapy.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/129/biodiem-gets-us-patent-allowance-for-antifungal-therapy.html</guid>
		</item>	
				<item>
			<title>Lorcaserin receives positive vote from FDA advisory committee</title>
			<atom:link href="https://biospectrumasia.com/news/34/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/132/lorcaserin-receives-positive-vote-from-fda-advisory-committee.html</guid>
		</item>	
				<item>
			<title>Bayer initiates Phase II/III trial of a new compound for Hemophilia A</title>
			<atom:link href="https://biospectrumasia.com/news/34/168/bayer-initiates-phase-ii-iii-trial-of-a-new-compound-for-hemophilia-a.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/168/bayer-initiates-phase-ii-iii-trial-of-a-new-compound-for-hemophilia-a.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/168/bayer-initiates-phase-ii-iii-trial-of-a-new-compound-for-hemophilia-a.html</guid>
		</item>	
				<item>
			<title>Janssen to develop therapy for immunological diseases</title>
			<atom:link href="https://biospectrumasia.com/news/34/322/janssen-to-develop-therapy-for-immunological-diseases.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/322/janssen-to-develop-therapy-for-immunological-diseases.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/322/janssen-to-develop-therapy-for-immunological-diseases.html</guid>
		</item>	
				<item>
			<title>Singapore scientists, clinicians collaborate on 8 projects </title>
			<atom:link href="https://biospectrumasia.com/news/34/386/singapore-scientists-clinicians-collaborate-on-8-projects-.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/386/singapore-scientists-clinicians-collaborate-on-8-projects-.html</link>
			<pubDate>Tue, 24 Apr 2012 16:33:13 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/386/singapore-scientists-clinicians-collaborate-on-8-projects-.html</guid>
		</item>	
				<item>
			<title>South Korea firm emerges as R&amp;D force</title>
			<atom:link href="https://biospectrumasia.com/news/34/4345/south-korea-firm-emerges-as-rd-force.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4345/south-korea-firm-emerges-as-rd-force.html</link>
			<pubDate>Thu, 12 Apr 2012 12:10:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/joong-myung-cho-crystalgenomics.gif" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4345/south-korea-firm-emerges-as-rd-force.html</guid>
		</item>	
				<item>
			<title>Accelerating drug discovery process</title>
			<atom:link href="https://biospectrumasia.com/news/34/236/accelerating-drug-discovery-process.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/236/accelerating-drug-discovery-process.html</link>
			<pubDate>Mon, 26 Mar 2012 20:31:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/yong-zu-kim-legochem.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/236/accelerating-drug-discovery-process.html</guid>
		</item>	
				<item>
			<title>Spinifex capitalizes on pain management market</title>
			<atom:link href="https://biospectrumasia.com/news/34/4855/spinifex-capitalizes-on-pain-management-market.html" rel="self" type="application/rss+xml" />
			<link>https://biospectrumasia.com/news/34/4855/spinifex-capitalizes-on-pain-management-market.html</link>
			<pubDate>Wed, 14 Mar 2012 22:00:00 +0530</pubDate>
			<description></description>
			<media:content medium="image" url="https://biospectrumasia.com/uploads/articles/dr-joshua-funder-spinifex-pharmaceutical.jpg" height="151" width="151" />
			<guid>https://biospectrumasia.com/news/34/4855/spinifex-capitalizes-on-pain-management-market.html</guid>
		</item>	
				</channel>
</rss>
